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I General introduction 
I.l Preview 
This thesis consists of a collection of papers which are all concerned 
with mortality. Mortality is one of the most tangible expressions of 
that intangible "public health": the frequency and distribution of 
health problems in a population. The age at which people die, the 
conditions they die from, and many other aspects of mortality patterns 
provide important information on the occurrence of health problems in 
populations. 
The description and analysis of mortality patterns is there-
fore of interest to the health sciences, because differences in morta-
lity between "times, places and persons" may suggest factors that play 
a causal role in the incidence or prognosis of specific health 
problems. The study of mortality may have a straightforward practical 
interest too, when it leads to the identification of health problems, 
geographical areas, population subgroups etc., where some kind of 
intervention is warranted. This may be an intervention through the 
health care system or through another agency, and will frequently have 
to be initiated by health policy makers. 
There are four interrelated themes in this thesis. 
I.l.l Theme no. 1: The validity of cause-of-death statistics 
The first theme is that of the validity of cause-of-death statistics 
as measures of the frequency of cause-specific mortality in the 
population. The main threat to the validity of this measurement lies 
in the fact that the classification of deaths by "underlying" condi-
tion is based on a reporting system involving a large number of prac-
ticing physicians. A substantial amount of "interobserver variation" 
is probable, due to e.g. differences in medical education, available 
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diagnostic facilities, care in filling out ,the death certificate etc. 
In addition, some variation in the coding of death certificates, over 
time as well as between countries, is likely to occur. Systematic 
differences in cause-of-death certification or coding may seriously 
bias estimates of trends or differences in cause-specific mortality. 
Dutch studies of the validity of cause-of-death statistics 
have up to now been very scarce. In the framework of two studies of 
differences in certification and coding between countries of the 
European Community, the Dutch certification and coding process for two 
causes of death (Chronic Obstructive Pulmonary Disease and a number of 
cancers) was investigated. The over-all performance of the Dutch 
certification and coding process could be assessed and compared to 
that of other countries of the European Community. A detailed analysis 
of errors in certification and coding was undertaken in order to find 
possibilities for (further) improvement (chapter II). 
1.1.2 Theme no. 2: The use of mortality data to address health 
care policy questions 
The second theme is that of the use of mortality data t~ address 
health care policy questions. Applications of mortality analyses to 
health policy questions have a long history. Recent developments in 
health care policy in The Netherlands have provided reasons for explo-
ring possible applications to health care policy questions. 
Some years ago, new legislation specified increased 
responsibilities of national, regional and local authorities for the 
health care system, and gave rise to questions regarding the criteria 
that should be used in developing and evaluating health care policy at 
each of these three levels. Recent government papers have emphasized 
the importance of using data on the health status of the population as 
both starting-point and touchstone of health care policy [1]. 
During one of the early phases of this development an oppor-
tunity arose to study some of the conceptual and practical problems 
which have to be addressed before this can be put into practice. At 
that time, serious consideration was given to the idea of using objec-
tive guidelines for the regional distribution of financial resources. 
In some other countries, regional mortality data by cause of death 
play a prominent role in such allocation formulas, as proxies for the 
"need" for health care. The question arose whether these data can 
indeed be used as a criterion for the allocation of resources (chapter 
III). 
The third and fourth themes are elaborations upon issues 
raised by the second theme. Do mortality data by cause of death only 
reflect a "need" for, or also an "outcome11 of health care? The extent 
to which changes and differences in mortality rates reflect improve-
ments in the outcome of health care services has in fact been the 
subject of considerable debate. The greater part of this thesis is 
2 
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concerned with this debate, and with the use of mortality as an 
indicator of the effectiveness of health care, more specifically of 
"medical care". 
Medical care is that part of the health care system where 
preventive, curative and rehabilitative services are delivered in a 
personal encounter between a health care professional (such as a 
doctor) and a client. From a mortality perspective, medical care is 
only one of many possible determinants, and perhaps not the most 
important. From a medical care perspective, however, mortality 
reduction is a very important objective, and an objective for .which 
empirical evaluation at population level is feasible. 
1.1.3 Theme no. 3:. Time trends of cause-specific mortality and 
the effect of improvements in medical care 
The third theme of this thesis is that of time trends of cause-
specific mortality and the effect of improvements in medical care. 
Since the eighteenth century, mortality has declined dramatically in 
developed countries. The cause of this decline has been debated inten-
sely. Some have claimed that medical care was largely responsible; 
others have attributed the decline to improved living conditions. The 
latter or "revisionist" [2] view has gained considerably in popularity 
in recent years. 
One of the main protagonists of this view, Thomas McKeown, 
has shown that the mortality decline was the result mainly of a 
decline in incidence and case fatality of infectious diseases, and 
that this decline for the greatest part antedated the introduction -of 
specific and effective medical therapies [3]. 
Moreover, after World War II, when the costs of health care 
and especially medical care began to rise dramatically in industria-
lized countries, the mortality decline seemed to slow down. This gave 
rise to the wide-spread opinion, cited recently in a Dutch government 
paper [1], that "the rapid increase in real terms (i.e. of health care 
costs, corrected for inflation, JPM) has not led to a commensurate 
improvement in standardized mortality rates" [4]. 
Both observations have had an enormous impact on the atti-
tude towards medical care of the educated public in general and health 
care policy makers specifically. A certain degree of skepticism pre-
vails, and hampers attempts to account for the denominator in the 
debate on the cost-effectiveness of medical care. This has therefore 
almost entirely focussed on the numerator. We will show that recent 
mortality trends by cause of death do in fact not justify such 
skepticism. 
Chapter IV presents an analysis of changes in infectious 
disease mortality coincident with the introduction of antibiotics. 
Efficacious antibacterial drugs were introduced during the second half 
of the 1930 1 s and in the 1940 1 s, and were generally regarded as 
miracle drugs, curing many patients who formerly were likely to die 
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from these diseases. Although methodologically sound evidence on the 
efficacy of these drugs in reducing case fatality is scarce, there is 
no particular reason to doubt this impression of a whole generation of 
doctors. Most analyses of this question, including the one by McKeown 
cited above, have been of an informal nature, but the analysis 
presented in chapter IV is a formalized attempt to obtain quantitative 
estimates of changes coinciding with th introduction of antibiotics 
in The Netherlands. 
Chapter V describes improvements in survival of cancer pa-
tients. This is another much frequented topic for debate, which is the 
more important as cancer is one of the major health problems of the 
industrialized world, and large sums of money have been spent on the 
development of efficacious treatment methods. For most other condi-
tions it is not possible to study trends in survival at population 
level, but for cancer it is possible, thanks to the existence of 
incidence and survival registries in a number of countries. 
A systematic approach to the study of the mortality effects 
of medical care requires a comprehensive list of causes of death which 
have become amenable to medical intervention. Infectious diseases and 
some forms of cancer are only a small subset of this. In 1976 Rutstein 
et al. published a list of diseases for which progress supposedly had 
been so dramatic, that any death from one of these conditions is to be 
interpreted as a "warning signal" of possible shortcomings of the 
health care system [5]. 
This and other lists in the same publication provided a good 
starting-point for a comprehensive study of the mortality effects of 
medical care. Chapter VI examines the issue, and presents an analysis 
of post-1950 mortality trends for those conditions, for which the 
evidence on medical care effects is relatively undisputed. Did morta-
lity indeed decline for these conditions? Is the timing of cause-
specific mortality declines consistent with the moment of introduction 
of the innovations? What was the over-all effect of these mortality 
reductions on life expectancy? 
!.1.4 Theme no. 4: Regional variation in cause-specific mortality 
and the level of supply of medical care 
The fourth and final theme is that of regional variation in cause-
specific mortality rates and its relationship with the level of supply 
of medical care. Regional mortality differences are an intriguing 
phenomenon, and suggest that there is an opportunity for mortality 
reduction in regions with relatively high rates. 
This would seem to apply even more to variation in mortality 
from conditions which have become amenable to medical intervention. 
The use of such a selection of conditions in regional mortality ana-
lyses was first recommended by a group from the Rand Corporation, as 
part of a wider effort to develop "Algorithms for health planners" 
[6]. In 1983 Charlton et al. proposed a similar idea and were the 
4 
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first to publish the results of a descriptive study of geographical 
variation in such "avoidable" mortality; this study covered England 
and Wales [7]. The studies reported in chapters VII-IX form part of a 
series of studies in several countries of the European Community, 
stimulated by the dramatic nature of the geographical differences 
first demonstrated by these English researchers. 
We have tried to contribute to a further understanding of 
these differences with three analyses, in which we related regional 
mortality rates for selected conditions to a number of other regional 
characteristics, including the level of supply of medical care. A 
recently prepared Atlas of regional variation in mortality from con-
ditions amenable to medical intervention in countries of the European 
Community [8] provided material with which the association between 
levels of resource provision and mortality could be studied in a wide 
variety of settings. European Community countries differ with respect 
to the organization of medical care, the over-all level of resource 
prov1s1on, as well as the pattern and extent of regional variation in 
resource provision (Chapter VII). 
It soon became clear that within The Netherlands, as well as 
within other countries, important regional differences in mortality 
from conditions amenable to medical intervention exist. Chapter VIII 
examines the relationship between regional mortality rates and the 
level of supply of medical care in The Netherlands. It adds a compari-
son with three earlier time-periods to the analysis of the situation 
in 1980-84, in order to see wether the dynamic evolution of mortality 
over time is reflected in a dynamic evolution of its association with 
medical care at the regional level. 
Most studies of geographical variation in mortality, in-
cluding the two of chapters VII and VIII, focus on cross-sectional 
differences in level of mortality at one or more moments in time. In 
The Netherlands, the development of mortality since ca. 1970 has· been 
characterized by the rapid decline of a number of important causes of 
death. This applies to conditions amenable to medical intervention, 
but also to some other causes of death. An analysis of regional 
differences in the rate of mortality decline was undertaken. A 
description of these differences was expected to identify regions 
where progress has been unsatisfactory; also, associations with other 
regional characteristics, including changes in the supply of medical 
care and in socio-economic circumstances, were investigated (chapter 
IX). 
I.l.S The structure of this thesis 
The rest of chapter I is devoted to a general introduction on the 
studies reported in the papers. In section I.2 the production of 
mortality data by cause of death in The Netherlands will be described 
in some detail, followed by a few notes on the use of mortality data 
for health policy purposes in section I.3. In section I.4 the debate 
5 
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on "the role of medicine" as a factor in the decline of mortality 
since the eighteenth century will be reviewed. An introduction to the 
theme of regional mortality differences is the subject of section I.S. 
The general introduction is concluded by some methodological 
considerations (section I.6). 
Chapters II-IX contain 8 different papers, which can be read 
independently from each other, and each of which ends with a summary 
for the hurried reader. 
Chapter X starts with a general summary of the main 
findings, which differs from the separate summaries of the papers in 
that it emphasizes the relevance of the findings for the four general 
themes mentioned above. This is followed by a number of additional 
comments on the effect of medical care on mortality time trends and 
regional mortality patterns. Some material additional to that of the 
papers will be presented as well. Section X.4 contains a small number 
of recommendations. 
6 
Ignorance 
Strange to know nothing, never to be sure 
Of what is true or right or real, 
But forced to qualify "or so I feel", 
Or "Well, it does seem so: 
Someone must know". 
Strange to be ignorant of the way things work: 
Their skill at finding what they need, 
Their sense of shape, and punctual spread of seed, 
And willingness to change; 
Yes, it is strange, 
Even to wear such knowledge -for our flesh 
Surrounds us with its own decisions-
And yet spend all our life on imprecisions, 
That when we start to die 
Have no idea why. 
From: The Whitsun Weddings 
Philip Larkin 
1.2 The production of mortality data ~ cause of death 
Mortality statistics, although full of imprecisions, give a fascina-
ting picture of (medical) "causes" of death. A study of these causes 
of death, which primarily describe the biological aspects of dying, 
does not directly answer the question on which the poem cited above 
ends, and a certain ignorance on even the medical causes of death 
cannot be denied. Still, the regular patterns and sudden changes as 
seen in mortality data do sometimes shed light on the complex 
backgrounds of death. 
1.2.1 Administrative procedures and over-all results 
In The Netherlands, a national registry of deaths has been kept, as 
part of the population register, since the early nineteenth century. 
In 1865 a law was issued which is still in force and which requires a 
medical certification of the cause of death, before permission for 
burial or cremation is given. National data on causes of death have 
been collected and published by the Central Bureau of Statistics since 
1903. 
The purpose of cause-of-death certification, apart from the 
recognition of unnatural forms of death for which a judicial 
7 
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investigation is required, is the assignment of a so-called 
"underlying cause of death". The underlying cause of death, also 
called the "primary cause of death", is defined as "the disease or 
injury that initiated the train of morbid events resulting in death, 
or the circumstances or violence that produced the fatal injury" [9). 
In order to arrive at this underlying cause of death, the 
Dutch death certificate, which is a translation with minor 
modifications of the internationally agreed medical certificate of 
cause of death, has been arranged as follows (figure I.1). From an 
"immediate" cause of death, i.e. the disease, injury or complication 
which directly preceded death, the certifier has to make a backward 
reconstruction of the chain of events which originated in the 
underlying cause of death. Any other conditions which contributed to 
death, but do not have a causal relationship to the sequence mentioned 
under 1, should be mentioned under 2. 
Although basically the certificates are similar, there are 
some subtle differences between the lay-out and phrasing of the Dutch 
death certificate and that of the internationally agreed upon 
certificate. On the Dutch certificate, the word "rechtstreeks" 
("directly") under 1a. is placed in italics, suggesting that the 
immediate cause of death is more important than the underlying cause 
of death to be filled in under 1c. Also the word "bijkomstige" 
(adventitious) under 2. is not a correct translation of "other 
significant". 
Coding of causes of death 
Dutch death certificates are coded at the Central Bureau of 
Statistics, according to the "Rules for selection of cause of death 
for primary mortality tabulation" [9). This is a set of rules which 
enable the coder to select the most plausible diagnostic entity 
present on the certificate for the assignment of the underlying .cause 
of death code. The "general rule" is to select the condition entered 
under 1c., "unless it is highly improbable that this condition could 
have given rise to all the conditions entered above it". A Dutch study 
from 1963 showed that application of one or more specific rules for 
selection of the cause of death was necessary in ca. 20 % of all 
deaths, and that this percentage increased with the age of the 
deceased, suggesting an increase in ambiguity of cause-of-death 
certification with age [10). 
Knowledge of these Rules for selection of the underlying 
cause of death is essential for a good understanding of cause-specific 
mortality rates. It is important to know, for example, that death 
during or after appendectomy, cholecystectomy, or another surgical 
procedure will be coded as due to Appendicitis, Cholecystitis, etc. if 
these conditions are reported on the certificate as having given rise 
to the surgical procedure. 
8 
Introduction: data production 
Figure I.l The Dutch death certificate, section D ("Natural death"), 
and the internationally agreed upon medical certificate of 
cause of death 
•. NATUURLIJKE DOOD 
(Voor nitt nat. dood :it> E; 1•oordoodgebortn :ie F) 
I. a. Ziekte. welke N'C'htstrteks de duod ten gevolge 
had 
b. en c. Ziekten, welkehebbengeleidtotdedoods-
oorzaak onder a. Bij vermelding van meerdere 
ziekten de aan het overlijden ten grondslag Jig-
geode het laatst opgeven (:ie toelichring) 
2. Bijkomstige. bij overlijden nog beslaande ziekten 
en bijzonderheden. welke tot de dood hebben bij-
gedrasen, doch niet met de onder I senoemde 
ziekten in causaal verband staan 
I. a ....•....•.............•....................................... 
veroorzaakt door/gevolg van 
b. ····•························································· 
veroorzaakt door/gevolg van 
c. ······························································ 
Duur russcn begin 
ziekte en overlijden 
(bij benadering): 
INTERNATIONAL FORM OF MEDICAL CERTIFICATE OF CAUSE OF DEATH 
CAU~E OF DEATH 
Disease or condition directly 
leading to death• 
(a) 
due to (or as a consequence of) 
Antecedent causes 
Morbid conditions, if any, 
giving rise to the above cause, 
stating the underlying con-
dition last 1 
~~e to (or as a consequence of) 
(c) 
II 
Other significant conditions r 
contributing to the death, but { 
not related to the disease or [ 
condition causing it 
* This does not mean the mode 
of dying, e.g., heart failure, asthenia, 
etc. It means the disese. injury. or 
complication which caused death. 
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interval between 
onset and death 
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Lists of code-numbers and the corresponding nosological 
entities are provided, as are the Rules for selection of cause of 
death, by the International Classification of Diseases (ICD). Since 
1979 the ninth Revision is in force in The Netherlands [9]. Changes in 
the International Classification of Diseases have occurred 
approximately every ten years. These changes reflect scientific 
developments in medicine, as well as developments in the relative 
importance of specific health problems. 
An example of the first is that Cerebrovascular disease was 
coded as a Disease of the nervous system and sense organs until the 
eighth Revision (in force since 1969 in The Netherlands), which was 
the first to classify it as a Disease of the circulatory system. An 
example of the second is that deaths from Traffic accidents, which 
were infrequent before modern means of transport, such as the automo-
bile, came in common use, first were coded in a rubric called 
"smashing due to landslides, tramways, etc" ("verplettering door aard-
verschuiving, trams etc."). It was only in the fifth revision, in 
force in The Netherlands since 1941, that Traffic accidents were 
distinguished as a separate category. 
Although the primary objective of the coding process is to 
assign a correct underlying cause-of-death code, some extra informa-
tion is available on many certificates. This information is coded and 
tabulated as "secondary" causes of death~ In The Netherlands, this is 
done on a limited scale, and results in an average number of coded 
entities per deceased of 1.5 (including the underlying cause of death) 
for both men and women [11]. In the United States, all diagnostic 
information present on the death certificate i~ coded in a systematic 
way [12]; this results in an average number of coded entities per 
deceased of 2.7 for white men and 2.8 for white women [13]. 
Over-all results 
Table I.1 gives an impression of the over-all results of certification 
and coding of causes of death in The Netherlands. Mortality rates by 
primary (or underlying) cause are dominated by two ICD-chapters, 
Diseases of the circulatory system and Neoplasms. Together, these two 
groups of conditions account for appr. 70 % of Total mortality in both 
males and females. Although there is no reason to doubt the quanti-
tative importance of these conditions as "true" underlying causes of 
death, some degree of overestimation may well be present in these 
percentages. 
For Neoplasms, the percentage of all deaths receiving a code 
from this ICD-chapter as a secondary cause of death is very low (table 
I.1). This reflects the fact that patients with Neoplasms usually have 
short survival times, so that the chance that a Neoplasm is certified 
as "other significant condition" after the patient has died from 
another disease is relatively low. On the other hand, the Rules for 
selection of the underlying cause favour well-defined conditions such 
as Neoplasms at the expense of less clearly defined conditions, even 
if the Neoplasm has not been entered under 1c. of the certificate. 
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Table 1.1 Assignment of "primary" and "secondary" causes of death by ICD-chapter, 
The Netherlands, 1984. 
% of deaths receiving code from ICD-chapter as 
Primary c. of d. Secondary c. of d. 
I CD-chapter males females males females 
I Infective/parasitic diseases 0.5 0.6 2.3 2.9 
II Neoplasms 29.8 25.2 2.6 1.6 
III Endocrine/nutritional/metabolic diseases 1.4 2.6 2.6 5.0 
IV Diseases of blood/blood-forming organs 0.2 0.4 0.4 0.6 
v Mental disorders 0.3 0.7 1.1 0.7 
VI Diseases nervous system/sense organs 1.6 1.6 1.4 1.3 
VII Diseases circulatory system 43.0 46.3 17.8 20.3 
VIII Diseases respiratory system 8.0 5.9 16.1 10.0 
IX Diseases digestive system 3.0 4.1 2.6 2.6 
X Diseases genito-urinary system 1.9 2.6 3.0 3.3 
XI Pregnancy/childbirth/puerperium 0.0 0.0 
XII Diseases skin/subcutaneous tissue 0.2 0.6 0.9 2.0 
XIII Diseases musc.skeletal syst./connect. tiss. 0.3 0.8 0.7 1.6 
XIV Congenital anomalies 0.7 0.6 0.2 0.2 
XV Certain causes of perinatal morbidity 0.5 0.4 0.4 0.3 
XVI Symptoms/ill-defined conditions 3.1 3.2 
XVII Accidents/poisonings/violence (E-code) 5.5 4.4 
Total 100.0 100.0 52.1 52.2 
Note: The % of deaths receiving a secondary cause-of-death code, per ICD-chapter, may 
be slightly overestimated because each death may receive more than one secQnda-
ry cause code from the same ICD-chapter. 
Data from ref. 11. 
For Diseases of the circulatory system it is the 
certification process which will tend to overestimate the importance 
of these conditions as causes of death. In cases of doubt, for example 
sudden death without prior history of disease, myocardial infarction 
will frequently be a convenient, not too implausible underlying cause 
of death. 
Secondary cause-of-death codes are dominated by the ICD-
chapters Diseases of the circulatory system and Diseases of the 
respiratory system. Together, these groups of conditions are coded in 
30 % of all deaths and account for appr. 60 % of all secondary cause-
of-death codes. Ischemic heart disease, Diseases of the lung circula-
tion (i.e. cor pulmonale), and Heart failure are the most frequently 
coded among the Diseases of the circulatory system. In some cases, 
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these will. be contributing causes ("other significant conditions, 
contributing to death"), in other cases immediate causes (sequelae of 
other conditions, "directly leading to death"). Chronic Obstructive 
Lung Disease and Pneumonia are the most frequently coded among the 
Diseases of the Respiratory system. Pneumonia, just like Septicemia 
(in chapter I, Infective and parasitic diseases), is an example of a 
frequent immediate cause. 
It is worth noting that some of the smaller ICD-chapters are 
more frequently coded as a secondary cause of death than as a primary 
cause of death; this is the more remarkable given the low frequency of 
secondary cause-of-death coding in The Netherlands. If we assume that 
one death does not receive a code from the same ICD-chapter both as a 
primary and as a secondary cause of death, the sum of the percentages 
for primary and secondary causes of death gives an indication of the 
prevalence of different conditions (contributing to death) at death. 
Potentially, secondary causes of death could add valuable information 
on the presence, at the moment of dying, of conditions which are not 
likely to be selected as the underlying cause of death. 
Unfortunately, the low frequency of coding and the lack of 
systematic "Rules for selection of secondary causes of death" at 
present seriously hamper the analysis and interpretation of these data 
in The Netherlands (cf. section X.4.1) [11]. 
1.2.2 The validity of cause-of-death statistics 
There is not much direct evidence on the validity of cause-of-death 
statistics in The Netherlands. As stated in section I.l, a certain 
degree of misclassification is likely, if only because of the 
(necessarily) decentralized system of cause-of-death certification. 
In general, the medical profession has a skeptical attitude 
towards the value of this information, partly because it is acutely 
aware of the fact that it may be quite difficult to complete the death 
certificate properly [14]. The certificate asks for certainty, but in 
practice it is sometimes very difficult to reach a firm conclusion on 
the true and only underlying cause of death. A study among a small 
number of Dutch general practitioners has shown that more frequently 
than reflected in national cause-of-death statistics they themselves 
prefer a code-number from the ICD-chapter "Symptoms and ill-defined 
conditions" [15]. 
The "production" of the underlying cause-of-death code 
involves three steps: diagnosis of the health problems of the patient; 
filling in a death certificate; and assignment of a code-number. In 
each of these steps an error may occur, leading to misclassification 
of the death for purposes of tabulation by underlying cause-of-death. 
Due to the fact that coding of death certificates is centralized and 
subject to quality assurance procedures in The Netherlands, this is 
probably not a major source of error. As a matter of fact, a study 
from the early 1960 1 s showed that coding of death certificates in The 
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Netherlands compared favourably to that in other European countries 
[16]. 
Validation studies 
In the literature, a large number of studies has been reported in 
which the validity of cause-of-death information was investigated 
(for a bibliography, see ref. 17). Two frequent types of study involve 
the comparison between death certificates and autopsy reports, and the 
comparison between death certificates and hospital records. Considera-
tion must however be given to the fact that not every condition 
revealed at autopsy, or present on hospital records, is necessarily a 
true underlying cause of death. 
In general, the concordance with diagnoses from other sour-
ces varies substantially between causes of death, and declines with 
age. For illustrative purposes the results of a small number of 
studies will be discussed. 
Autopsy may reveal conditions which were not recognized ante 
mortem. One of the very few Dutch studies of the validity of cause-of-
death information compared clinical diagnoses of cancer with autopsy 
findings. In 30 (4 7.) out of 751 autopsies a cancer was found which 
had not been diagnosed clinically, and which was retrospectively 
considered to be the underlying cause of death [18]. 
Unfortunately, most autopsy series cover selected popula-
tions. precluding more general conclusions. An exception is a series 
of appr. 400 consecutive deaths in a department of internal medicine 
in Sweden, in which autopsy was performed in 96 7. of the cases. In 30 
7. of the autopsied deaths the clinical diagnosis proved to be 
erroneous on a three-digit level of the ICD. Of these 307., 
approximately half was a serious error, taking a death from one 
(sub)group of diseases to another. Fewer errors were discovered in 
patients below, than in patients above 70 years of age, and cli~ical 
diagnoses of Neoplasms were less frequently found to be erroneous than 
diagnoses of other conditions [19]. 
A comparison between death certificate information and 
hospital record information is less subject to selection bias, al-
though not all patients die in a hospital. In a study of hospital 
discharge diagnoses and underlying causes of death in England it was 
found that for 39 7. of the patients both diagnoses differed to such an 
extent, that they had to be coded to different subgroups of diseases. 
This disagreement may accurately reflect the actual situation (death 
may be due to another condition than the principal condition treated 
during hospital admission), but it can also be due to errors in one or 
both of the records. In a careful study of the causes of the dis-
crepancies it was found that appr. 20 7. of the death certificates were 
in error. Again, there were fewer errors in cases of malignant neo-
plasms than in other categories of disease, but age was not a factor 
here [20]. 
In a study of deaths among a cohort of Swedish twins, all 
below 70 years of age, death certificate information was compared with 
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information from all other records available, including hospital 
records, autopsy reports, information from general practitioners etc. 
Detection fractions (proportions of deaths with true underlying causes 
X which actually receive the code number for X) and confirmation 
fractions (the proportions of deaths coded as X which actually died 
from X) were determined, using a careful review of the other records 
as the standard. Both detection fractions and confirmation fractions 
were above 95 % for most forms of cancer, Ischemic heart disease, 
Cerebrovascular disease, Chronic Obstructive Pulmonary Disease, 
Accidents and Suicide. Lower detection and confirmation fractions were 
found for Diabetes mellitus (60 and 82 %), Other forms of heart 
disease (65 and 37 %), and Pneumonia (67 and 33 %) [21]. 
We will finally briefly discuss two pieces of evidence on 
the quality of certification of causes of death in The Netherlands: 
the frequency of autopsy; and the percentage of deaths coded in the 
ICD-chapter "Symptoms and ill-defined conditions". 
Quality of cause-of-death information in The Netherlands: 
autopsy rates 
The percentage of all deaths for which an autopsy was performed was 
10.4 % in 1984 [22], and appr. 11 % in 1963 [10]. Although this 
suggests stable rates, the percentage of in-hospital deaths for which 
an autopsy was performed shows that rates have been rather dynamic in 
recent years. (Autopsies for deaths that have occurred outside 
hospital are rare.) In 1970, the percentage of in-hospital deaths for 
which an autopsy was performed was 25.5; this percentage rose to a 
maximum of 32.8 in 1977, and has since then started a gradual decline 
to 24.9% in 1983 [22]. This decline has also been observed elsewhere 
[23]. 
Figure I.2 gives the frequency of autopsy by age and &ex in 
The Netherlands in 1984. Differences in the proportion of deaths for 
which an autopsy is performed, reflect both differences in uncertainty 
on the underlying cause of death, and differences in the wish to 
obtain more certainty. The lower frequency of autopsy in deaths among 
elderly people is probably not a reflection of more certainty, but of 
a lesser motivation to obtain certainty in doctor and family. 
Quality of cause-of-death information in The Netherlands: 
"Symptoms and ill-defined conditions" 
A crude indicator of the over-all success of the certification and 
coding process in assigning an underlying cause of death to the 
deceased, is provided by the percentage of deaths which receives a 
code for "Symptoms and ill-defined conditions". 
This indicator first of all reflects the extensiveness of 
the information mentioned on the death certificate. The "Rules for 
selection of cause of death" state that, if the certificate suggests 
an underlying cause which is classifiable to "Symptoms and ill-defined 
conditions", but a condition classifiable to another category is 
14 
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Figure 1.2 Percentage of all deaths for which autopsy was performed, 
by age and sex, The Netherlands, 1984. 
cbs 24722.2 
70 --------------------------------------------------------------
l 0 --~~--~~~~~~--~~~~~~--~~~--._~--~~--
0 1- 5- 10- 15- 20- 25- 30- 35- 40- 45- 50- 55- 60- 65- 70- 75- 80- 85+ 
4 9 14 19 24 29 34 39 44 49 54 59 64 69 74 79 84 years 
Reprinted from ref. 22 
presen~ (anywhere) on the certificate, this other condition should be 
selected as the underlying cause of death. (On the other hand, the 
coding office can influence the percentage of deaths for which there 
is insufficient information. In appr. 5 % of cases, the Dutch coding 
office directs queries to certifying doctors in order to ask for 
supplementary information [24].) 
We will discern the following three subcategories of the 
ICD-chapter of "Symptoms and ill-defined conditions": 
- "Senility without mention of psychosis" (i.e. without 
mention of dementia); 
- "Sudden death" (in our analyses, this category excludes 
those "found dead, cause unknown"); 
- "Other ill-defined conditions", including symptoms, com-
plications etc. 
That these are quite different phenomena is apparent from figure 1.3. 
"Senility" is of course limited to older ages. Of deaths 
over 95 years of age, appr. 7% is classified as due to Senility. (Only 
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Figure 1.3 Percentage of all deaths classified as due to "Symptoms 
and ill-defined conditions", by age, 1980-84. 
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Age 
appr. 17. of all deaths over age 95 is classified as due to Dementia, 
not shown in figure 1.3.) 
"Sudden death" has a high relative frequency in infants 
(Sudden Infant Death Syndrome or cot death). At higher ages, some 
deaths classified as "Sudden death" might in fact be due to Acute 
myocardial infarction or other cardiovascular calamities. 
"Other ill-defined conditions" has a relative frequency 
between 5 and 107. at younger ages. After age 35, this category 
gradually declines in importance. 
The highest frequencies of all "Symptoms and ill-defined 
conditions" together are found in the youngest age-groups. At first 
sight, the lower relative frequency of "Symptoms and ill-defined 
conditions" at higher ages (except 95+) seems to be at odds with the 
finding from many studies, cited above, that the validity of cause-
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Table !.2 Development 
classified 
tions". 
over time of the percentage of all 
as due to "Symptoms and ill-defined 
deaths 
condi-
1910 
1920 
1930 
1940 
1950 
1960 
1970 
1980 
Percentage of all deaths due to 
Senility 
incl. 
dementia 
15.5 
7.2 
5.4 
6.4 
4.2 
1.9 
1.3 
1.0 
Senility 
excl. 
dementia 
4.9 
5.3 
2.9 
1.5 
0.7 
0.8 
Sudden 
death 
0.4 
0.5 
0.9 
2.1 
0.0 
0.7 
0.5 
0.8 
Other 
ill-def. 
All "Symptoms 
and ill-def. 
conditions conditions" 
[a] 
6.6 
5.0 
3.8 9.6 
1.5 8.9 
3.6 6.5 
1.3 3.5 
1.4 2.6 
3.1 4.7 
Note: The cause-of-death categories presented in this table differ slightly in content 
from those used elsewhere in this thesis. 
[a] Excluding dementia. 
of-death 
the fact 
at the 
relevant 
information decreases with age. It may however simply reflect 
that at higher ages more diagnostic information is available 
moment of death, so that some specific condition, whether 
or not, can always be entered on the certificate. 
The percentage of all deaths classified as due to Senility 
and Other symptoms and ill-defined conditions has rather drastically 
declined during this century (table I.2). In recent years, the decline 
of Other ill-defined conditions has slowed down and may even have 
reversed to a slight increase. 
Figure I.4 shows this in more detail for the period 1950-
1984. Standardized Mortality Ratios (SMRs) have been calculated in 
order to correct for changes in the age- and sex-composition of the 
population (see section I.6.3). For each cause of death, the average 
value for the complete period is 1.00. The category of "Sudden death" 
shows an erratic pattern, probably due to a change in the 
International Classification of Disease. In 1958 mortality due to 
Sudden death rose sharply, and a drop was registered for "Other ill-
defined conditions". The latter category gradually increased in impor-
tance from 1960 to 1980, but may since then have been declining again. 
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Trends in age-standardized mortality (SMR.s) for "Symptoms 
and ill-defined conditions", 1950-84. 
1950 
SENILITY 
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1960 1970 1980 1984 
SMR 
.s 
SUDDEN DEATH 
males and females 
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Note: The rates shown at the bottom of each graph are the average crude death rates 
(per person-year) for the entire period 1950-84. 
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1.2.3 The utility of mortality data 
The value of routinely collected information on the health status of 
the population depends on a number of factors, which can be summarized 
under the following four headings: 
1) Accessibility for analysis. 
2) Coverage, with regard to 
- the population; 
- the range of health problems; 
- the range of consequences of health problems; 
- the time-period. 
3) Availability of additional information, permitting a 
comparison between different time-units, geographical 
units, population subgroups, etc. 
4) Measurement quality, i.e. a comparison between different 
"times, places, and persons" has sufficient 
- precision (absence of random error) 
- validity (absence of systematic error). 
Compared with other sources of information, the 
accessibility for analysis of mortality data is rather good. National 
data on mortality by cause of death have been published since 1903 in 
a more or less standard format. On a more limited scale, regional and 
local data have also been published, whereas more detailed data can be 
obtained upon request. On the other hand, linkage with other routine 
data sources is difficult due to privacy protection rules. 
"Coverage" is among the main assets of mortality 
cause of death. Mortality data cover the whole population, 
health problems which cause death, even if infrequently. 
data by 
and all 
Although 
death is only one consequence of health problems, it is a very 
important one. Furthermore, mortality statistics permit the analysis 
of long-term time trends. 
Some additional information is available in mortality 
statistics, permitting an analysis of differences between time-units 
(e.g. calendar-years), geographical units (e.g. domiciliary region of 
the deceased), and population subgroups (e.g. by age, sex, and marital 
status). Unfortunately, socio-economic characteristics of the deceased 
are not registered in the Dutch mortality registry. 
For most purposes, the crucial issue in measurement quality 
is that a comparison of cause-specific mortality between "times, 
places, and persons" is possible. The precision of such comparisons is 
sometimes insufficient in smaller causes of death. Possible threats to 
validity are differences in the probability of being registered, and 
differential misclassification of causes of death. These issues will 
be taken up in more detail in section I.6.1, whereas chapter II pre-
sents the results of an international study of differential misclassi-
fication of selected underlying causes of death. 
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1.3.1 
Mortality and health policy 
A historical note on the development of the study 
of mortality 
The discovery of mortality as a phenomenon worthy of scientific and 
also political interest dates back to the seventeenth century. The 
application of quantitative methods to the study of mortality and 
other social problems was one of the most important scientific break-
throughs of that century. John Graunt's "Natural and political ob-
servations( ... ) upon the Bills of mortality" (1662) demonstrated the 
regularity of a number of mortality phenomena, for example the fact 
that from year to year certain causes of death formed a constant 
proportion of the total number of deaths. The first life tables also 
date from the second half of the seventeenth century (Christiaan 
Huygens, 1669; Edmund Halley, 1693) [25]. 
The further development of the study of mortality was close-
ly related to the development of health policy. It was favoured by the 
fact, that it was increasingly recognized to be in the interest of the 
state to have the largest possible number of healthy, productive 
subjects [26]. Johann Peter Frank's "System einer vollstandigen medi-
cinischen Polizey" (1779) was one of the most clear expressions of 
this attitude. The concept of "medical police", i.e. the creation of a 
medical policy by governments and its implementation through ad-
ministrative regulation, was based upon the recognition that there was 
a connection between problems of health and disease on the one hand, 
and the aim of augmenting the population on the other hand [27]. 
This political and administrative line of development was 
paralleled by a growth of interest among the medical profession for 
the relationship between health and environment. The French "Societe 
Royale de Medecine'' (1778) collected meteorological and disease data 
from all over France, as part of efforts to gain control over epidem-
ics [28, 29]. In The Netherlands, a "Correspondentie-Societeit" of 
medical and other learned men did the same [30]. 
In the nineteenth century, the "sanitary reformers" built 
upon these early experiences, both in their application of quantita-
tive methods and in their study of the relationship between environ-
ment and health. In the 1820's and 1830's, the "numerical method" had 
gained considerable popularity in the French medical profession, due 
to the works of Pinel, Louis, the Belgian Quetelet, and others. 
Statistical information gradually began to be collected. 
This enabled Villerme to write his "Recherches statistiques 
sur la ville de Paris" (1828), "Tableau de l 1 etat physique et moral 
des ouvriers" (1840), and many other works demonstrating the appalling 
state of health of the poor [31]. In England, the early public health 
movement culminated with Edwin Chadwick's "Report on the sanitary 
condition of the labouring population of Great Britain" (1842), 
William Farr's "Report on the mortality of cholera in England" (1852) 
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and other works of sanitary reformers [32, 33]. In all these reports, 
extensive use was made of mortality data. The Dutch counterpart of 
this movement, the "Hygienisten", also used mortality data in their 
arguments for sanitary reform [34]. 
In the eighteenth and nineteenth centuries, the study of 
phenomena relating to health and disease often had a geographical 
focus. Survival of elements of the Hippocratic tradition in medicine 
have played an important role in this interest in "medical geography". 
One of the Hippocratic writings ("On airs, waters, places") stated: 
"Whoever would study medicine aright must learn of the following 
subjects. First he must consider the effect of each of the seasons of 
the year and the differences between them. Secondly he must study the 
warm and the cold winds, both those which are common to every country 
and those peculiar to a particular locality. Lastly, the effect of 
water on the health must not be forgotten. Just as it varies in taste 
and when weighed, so does its effect on the body vary as well. When, 
therefore, a physician comes to a district previously unknown to him, 
he should consider both its situation and its aspect to the winds" 
[35]. 
The main instrument of medical geography in the eighteenth 
and nineteenth centuries was the writing of "medical topographies", 
detailed descriptions of all aspects of a city or region that could be 
of relevance to the state of health of the population [e.g. ref. 36, 
37]. These topographies followed a standard protocol [38], which had 
been prepared by the German Finke in 1795 [39]. 
The study of the city of Middelburg by Fokker and De Man of 
1856 is a good example of a medical topography [37]. Characteristic-
ally, the study starts with a description of the physico-geographical 
aspects of the city's location and gives a detailed account of the 
lay-out of the city and the quality of its housing. Each description 
is followed by the authors' very tentative assessment of the possible 
effects of these characteristics on the population's health. 
There was only a small number of studies which compared the 
situation in many different localities. These were mainly descriptive 
studies of differences in mortality. The most important of these 
studies was a mortality atlas published by the Dutch Medical 
Association, displaying mortality by municipality for the years 1841-
1860, which showed the high mortality rates in the Western parts of 
the country [40]. Other examples of mortality mapping are the studies 
by Schick on mortality in Zuid-Holland [41], and the study by De Man 
on mortality in Zeeland [42], with its beautiful map (Figure I.5). 
Attempts at explanation of these differences were again very 
provisional. A "geographical determinism" predominated, in which 
physico-geographical factors were thought to be the main determinants 
of observed differences. The high mortality rates in the Western 
provinces, for example, were frequently ascribed to their low alti-
tude, brackish water and clay soil. 
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Figure 1.5 Map of mortality in the province of Zeeland, 1834-1846 
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!.3.2 Mortality~ community diagnosis~ and the circular principle 
The use of data on mortality and causes of death for health policy 
purposes can be summarized under the heading "community diagnosis'' 
[43, 44]: the description and analysis of the frequency and distri-
bution of health problems in a population. Whereas a diagnosis of the 
health problems of an individual patient is intended to give 
suggestions for individual treatment, a community diagnosis may lead 
to suggestions for action on the part of health policy makers 
("community medicine"). 
Although we know more on the origins of health problems than 
our predecessors of the seventeenth, eighteenth and nineteenth 
centuries, so that a twentieth century community diagnosis is likely 
to be more accurate, many effective actions have been taken in the 
past on the basis of completely wrong concepts. Most sanitary re-
formers, for example, were "anticontagionists", and believed that what 
we call "infectious diseases" were caused by filth and its foul 
vapours [33, 45]. 
An idealized representation of health policy making (or any 
other policy making process) is given in Figure I.6. Policy making is 
visualized here as a circular process, in which a series of steps is 
followed in a more or less systematic way. The process starts with the 
identification of a problem, based on a "situation analysis". In the 
phase of the formulation of "objectives", alternative policies are 
considered and priority decisions are taken. The third step involves 
the (ex ante) evaluation of alternative interventions, in the search 
for an appropriate "strategy". This strategy will have to be trans-
lated into an "operational plan", which specifies the details of the 
intervention, including time-tables, the allocation of resources etc. 
In the phase of "implementation" the plan is executed, and during and 
after the implementation an "evaluation" is carried out, to see 
whether the outcomes correspond to the objectives. The evaluation 
phase closes the circle, and may coincide with the situation analysis 
of a following cycle, if the original problem is not completely re-
moved by the intervention [46]. 
Generally speaking, mortality analyses and other forms of 
community diagnosis may contribute to a situation analysis, or, if 
some kind of intervention to reduce mortality risks has been under-
taken, to the evaluation of this intervention. 
"Health policy" is a rather broad term, which is generally 
thought of as encompassing "health care policy". In such a view, the 
health care system is one of the "instruments" of health policy. 
Chapter III presents the results of an attempt to see whether mortali-
ty analyses can also be useful in the framework of health care policy, 
by providing information on the "need" for health care services. 
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The circular principle of (health) policy making': a 
planning cycle 
ENVIRONMENT 
Fmancial constraints: 
Manpower constraints: 
Legal/ethical constraints: 
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expectations: 
Expressions of value 
systems: 
ENVIRONMENT 
Effects upon clients 
and upon adjacent 
(e.g. housing,education) 
systems. 
Operational Plan 
Allocation of 
resources and authority. 
Timetabling. Design 
of monitoring systems. 
Strategies 
Formulat•on of 
alternative programmes, 
evaluation of likely 
outcomes. feasibilities, 
cost. Operational 
choice. 
Reprinted from ref. 46. 
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Most of this thesis; however, is r:;oncerned with the question 
whether mortality analyses can provide information which is useful in 
the evaluation of health care services, more spe~ifically of "medical 
care". 
I.3.3 A definition of medical care 
The current use of the terms "health care" and "medical care" is 
rather confusing. A recent "Dictionary of epidemiology" [47] gives the 
following definition of "health care", which may serve as a f.irst 
approximation: "Those services provided to individuals O'J;" communities 
by agents of the health services or professions, for the purpose of 
promoting, maintaining, monitoring or restoring health. Health ~are is 
broader than, and not li~ited to, medical care, which implies 
therapeutic action by or under the supervision of a physician". 
Note the circul~rity of this definition. The intention of 
including the words "provided by( ..• ) agents of the health services 
or professions" is probably to exclude environmental change, if unde:t;"-
taken by others (collective prevention), from the definition of health 
care. (There is also an entry in this dictionary for "health 
services", which gives a definition almost identical to that for 
health care, but the term medical care is replaced here by "personal 
health care".) 
While probably everybody would agree that medical care is a 
more narrow concept than health care, the exact boundaries may be 
controversial. The definitions cited above suggest that medicql care 
distinguishes itself by its objective (e.g. "therapeutic action"), its 
dominant provider (a physician), a.nd its delivery in a "personal" 
encounter. 
The part of the health care system which forms the focus of 
the analyses in this thesis, and which will be designated with the 
term medical care, contains a bit more than therapeutic actions on the 
part of physicians in a personal encounter with patients. We.will use 
the following definition of medical care: medical care is that part of 
the health care system where preventive, curative, and rehabilitative 
services are delivered in a personal encounter between a health care 
professional and a client. 
This definition includes some other objectives than treat-
ment as well, and also includes more health care professionals than 
physicians only. Many actions that doctors take in their personal 
encounters with patients have preventive aims. Detection and treatment 
of hypertension is a good example. Note that vaccination and screening 
for Cervical cancer, which are provided by doctors in general practice 
and in hospital, but also by health care professionals working in 
public health services, are included in this definition of medic~l 
care. 
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1.4.1 The demographic transition 
The population history of Europe was characterized by long cycles of 
growth and recession. There probably was a prolonged population rise 
between 1100 and 1350, another between 1450 and 1650, and a third 
after 1750 [48]. The first of these was followed by a particularly 
sharp recession, starting with the Black Death of 1348. Because the 
recession removed pressures, after some time the standard of living 
rose considerably [49], and the population increased again. Another 
recession, less severe than the first, started after 1650, partly due 
to climatic changes. The European population still increased, but at a 
relatively slow rate from appr. 100 million in 1650 to appr. 140 
million in 1750. After 1750 a new rapid increase in population numbers 
occurred: the European population counted 190 million in 1800, 270 
million in 1850, 400 million in 1900, and 600 million in 1950 [48]. 
The cause of the rapid increase in population numbers after 
1750 can either be an increased birth rate, or a decreased death rate. 
This has been the subject of intensive debate among historical demo-
graphers. Unfortunately, reliable national statistics on birth and 
death rates are only available since the beginning or middle of the 
nineteenth century for most countries (the second half of the 
eighteenth century for some Scandinavian countries). At the moment 
when national registration started, birth rates were already substan-
tially higher than death rates in many European countries, leaving 
unanswered the question whether increasing fertility or declining 
mortality had caused the surplus of births over deaths. 
Family reconstitution studies 
That declining mortality rates were responsible is strongly suggested 
now by the results of family reconstitution studies and by the results 
of studies of selected populations, fo.r which mortality rates happen 
to be known. The recent technique of family reconstitution studies 
intends to reconstruct "vital events" by the linkage of data on births 
(baptisms), marriages, and deaths (burials) available in parish 
registers. A synthesis of these studies [SO] has led to the con-
clusion that trends in fertility did not show signs of an important 
increase in the eighteenth century. Trends in mortality, however, were 
probably declining. This is at least evident for Infant mortality, 
which was an important component of Total mortality in these days and 
which can be estimated relatively well from this type of study (table 
I. 3). 
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< 1750 
1740-1790 
1780-1820 
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Trends in infant mortality in the eighteenth century, 
estimated from family reconstitution studies. 
Deaths less than 1 year of age per 1000 live births 
England 
187 
161 
122 
France 
252 
213 
195 
Weighted averages of estimates obtained in family reconstitution studies. 
Data from ref. 50. 
Conclusions based on family reconstitution studies are 
supported by the results of studies of selected populations, like the 
British peerage [51] or the Knights of the Order of the Golden Fleece 
[52]. These studies, covering higher age-groups, have shown a decrease 
in death rates and a corresponding increase in survival starting with 
those born in the eighteenth century. 
Nationa1 registrations 
Data from national registrations (figure I.7) also suggest that crude 
mortality rates were already declining before 1850. These data also 
show the importance of "mortality crises", years with exceptionally 
high mortality under the "Ancien regime". War, famine and/or epidemics 
were responsible. The Swedish data suggest that the amplitude of 
mortality fluctuations gradually diminished. The milder mortality 
crises of the mid-nineteenth century are due to epidemics of Cholera 
and other infectious diseases. 
In The Netherlands, levels of mortality were generally 
higher than those in Sweden, England and France, and did not show a 
tendency to decline between 1840 (the first year for which national 
data were available) and ca. 1875. Infant mortality in The Nether-
lands, an important component of Total mortality in this period, even 
showed an increase between 1840 and ca. 1875 [53]. On the other hand, 
a reconstruction of Dutch mortality rates between 1800 and 1840, on 
the basis of data from a large part of the national territory, 
suggests that there was already some decline before 1840 [54], as 
there was in Sweden and France. Mortality decline in The Netherlands 
after 1875 may have been faster than that in Sweden, England and 
France (figure 1.7). 
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These mortality declines mark the first phase of the "demo-
graphic transition". During the demographic transition, a population 
evolves from a state with high mortality rates and high fertility 
rates to a state with low mortality rates and low fertility rates. 
Because fertility declines generally start later than mortality de-
clines, a rapid growth of population numbers occurs [55]. In The 
Netherlands, fertility rates declined gradually since the late nine-
teenth century, but only started to approach the low mortality rates 
after rapid declines in the 1960's and 1970's. 
Changes in life expectancy 
The decline in mortality had important effects on average life ex-
pectancy at birth (table 1.4). At the mortality rates prevailing in 
the period 1840/51 the average individual could expect to live less 
than 40 years. Life expectancy at birth has doubled between 1840/51 
and 1980/84. Most of these gains were realized before 1950. 
This is also evident from figure 1.8, which shows survival 
curves by age since 1840/51. Low average life expectancy at birth 
since the nineteenth century was very much the result of low chances 
of survival in the first years of life. Dramatic changes occurred 
between 1840/41 and 1950/52, but the curves for the three most recent 
periods show rather small differences, especially for males. (Note 
that for males the 1950/52 and 1966/70 the lines cross twice. This is 
due to increasing mortality rates in certain age-groups in males 
between 1950/52 and 1966/70, cf. section 1.4.2.) 
The graphs also suggest a certain "rectangularization" of 
survival curves [58]. Not only has the curve for ages between 1 and 50 
years nearly become horizontal, but the downward part of the curve for 
the periods 1950/52 and later is also considerably steeper than the 
curve for corresponding ages in earlier time-periods. 
Table 1.4 Evolution of average life expectancy at birth 
since the mid-nineteenth century, by sex, 
The Netherlands 
Life expectancy at birth in years 
1840/51 
1900/09 
1950/52 
1966/70 
1980/84 
Data from: ref. 57 
males 
36.2 
51.0 
70.6 
71.0 
72.8 
30 
females 
38.5 
53.4 
72.9 
76.4 
79.4 
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Figure 1.8 Survival curves for successive time-periods since 1840/51, 
by sex, The Netherlands. 
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r.able I.S Death rates per million person-years, age-standardized, in broad groups 
of causes of death, England and Wales, 1848-54 and 1971. 
1848-54 
I. Conditions attributable to 
micro-organisms 
1. Airborne diseases 7259 
2. Water- and food-borne diseases 3562 
3. Other conditions 2144 
Subtotal 12965 
II. Conditions not attributable to 
micro-organisms 8891 
Total mortality, all causes 21856 
Data from ref. 59. 
Cause-specific mortality changes 
1971 
619 
35 
60 
714 
4070 
5384 
% reduction in Total 
mortality attributable 
to category 
40 
21 
13 
74 
26 
100 
Information on causes of death in the eighteenth and nineteenth 
centuries is rather limited, and changes in classification make com-
parisons difficult. McKeown nevertheless succeeded in tracing 
developments in mortality for important causes of death since 1848 in 
England and Wales, the first year this information was available for 
England and Wales (table I.5) [59]. A similar analysis of changes in 
cause-specific mortality in the city of Amsterdam produced largely the 
same findings, possibly with the exception of Tuberculosis, which may 
have been less important for mortality decline than in England and 
Wales [60]. 
Conditions attributable to micro-organisms accounted for a 
large part of total mortality in 1848-54, and declined very fast as a 
cause of mortality between 1848-54 and 1971. The group of "air-borne 
diseases" includes such conditions as Tuberculosis, Bronchitis, 
pneumonia, and influenza, and diseases frequently occurring in 
children, such as Whooping cough, Diphtheria, Measles, and Scarlet 
fever. The group of "water- and food-borne diseases" includes Cholera, 
Dysentery, Typhoid, Typhus, unspecified Diarrhoea, etc. The group of 
other conditions in which micro-organisms are involved contains such 
conditions as "Convulsions" (occurring in children during fever epi-
sodes), Syphilis, Appendicitis, and Puerperal fever. It is clear from 
table I.5 that three-quarters of total mortality decline since the 
mid-nineteenth century can be attributed to a decline of infectious 
disease mortality. 
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1.4.2 Recent changes in mortality 
The main causes of mortality in the period 1950-84 are completely 
different from those in the nineteenth century. As was evident from 
data presented in section I.2.1, the present mortality pattern is 
dominated by Diseases of the circulatory system and Neoplasms. Table 
I.6 presents the fifteen leading causes of death in The Netherlands in 
1980-84 and 1950-54, for males and females separately. 
Ischemic heart disease is the most important cause of death 
in men in 1980-84, and on its own accounts for almost one quarter of 
all deaths. Other important diseases of the circulatory system are 
Cerebrovascular disease, Other (non-rheumatic) heart disease, and 
Diseases of arteries (generalized atherosclerosis, aneurysms, arterial 
thrombosis). The most important cancers causing death in men are 
Cancer of the lung, Cancer of the prostate, Cancer of the stomach, and 
Cancer of the colon. Chronic Obstructive Pulmonary Disease and In-
fluenza and pneumonia are the most important Diseases of the respira-
tory system. 
Between 1950-54 and 1980-84 important changes in ranking 
occurred. Cancer of the lung and Cancer of the prostate increased in 
relative importance, and Cancer of the stomach decreased. Chronic 
Obstructive Pulmonary Disease increased, whereas Influenza and pneumo-
nia decreased. Mortality due to Perinatal causes also decreased con-
siderably in importance. (Please note that mortality due to the ICD-
chapter Causes of perinatal morbidity, abbreviated here as "Perinatal 
causes", is not identical to "Perinatal mortality". The latter also 
includes still-births and first-week deaths due to other than "Peri-
natal causes", and excludes deaths older than 1 week!). Diseases of 
the circulatory system were already very important in 1950-54, but in 
later decades their share of Total mortality still increased con-
siderably. 
The mortality pattern of Dutch women is also dominated by 
Diseases of the circulatory system, but differs from that of men in a 
number of respects. Cerebrovascular disease is more, Ischemic heart 
disease is less important than in men. Cancer of the breast replaces 
Cancer of lung as the most important cancer. 
Non-traffic accidents are also a more important cause of 
death in women. This is partly due to differences in the age-structure 
of the male and female populations. Mortality from Non-traffic 
accidents, which is largely due to accidental fall and hip fracture, 
is a cause of death of the (very) old; due to the higher life 
expectancy of women, the female population has a larger proportion of 
elderly. Another factor is the higher frequency of osteoporosis in 
women, and the resulting higher risk of hip fracture. 
Since 1950-54 Ischemic heart disease climbed from the third 
to the first place in females. Other changes mirror those observed in 
males. 
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Table 1.6 The fifteen leading causes of death, by sex, 1980-84 and 1950-54. 
1980-84 
Cause of death 
Ischemic heart disease 
Cancer of lung 
Cerebrovascular disease 
Other heart disease [a] 
Chronic Obstr. Pulmon. Dis. 
Cancer of prostate 
Cancer of stomach 
Diseases of arteries 
Influenza/pneumonia 
Traffic accidents 
Cancer of colon 
Non-traffic accidents 
Suicide 
Cancer of pancreas 
Cancer of bladder 
Ischemic heart disease 
Cerebrovascular disease 
Other heart disease [a] 
Cancer of breast 
Influenza/pneumonia 
Cancer of colon 
Non-traffic accidents 
Diseases of arteries 
Cancer of stomach 
Chronic Obstr. Pulmon. Dis. 
Diabetes mellitus 
Cancer of ovary 
Cancer of lung 
Nephritis/nephrosis 
Cancer of pancreas 
%of all # 
deaths 
HALES 
23.7 1 
11.4 2 
8.1 3 
7.6 4 
4.7 5 
2.7 6 
2.5 7 
2.4 8 
2.2 9 
2.2 10 
1.9 11 
1. 7 12 
1.5 13 
1.3 14 
1.1 15 
18.5 
12.9 
10.5 
1 
2 
3 
5.4 4 
3.2 5 
2.8 6 
2.3 7 
1.9 8 
1.8 9 
1.8 10 
1.7 11 
1.6 12 
1.5 13 
1.4 14 
1.4 15 
1950-54 
Cause of death 
Ischemic heart disease 
Cerebrovascular disease 
Other heart disease [a] 
Cancer of stomach 
Influenza/pneumonia 
Perinatal causes [b] 
Cancer of lung 
Non-traffic accidents 
Traffic accidents 
Diseases of arteries 
Chronic Obstr. Pulmon. Dis. 
Prostate hyperplasia 
Tuberculosis 
Cancer of prostate 
Hypertensive disease 
Cerebrovascular disease 
Other heart disease [a] 
Ischemic heart disease 
Influenza/pneumonia 
Cancer of stomach 
Cancer of breast 
Perinatal causes [b] 
Diseases of arteries 
Hypertensive disease 
Diabetes mellitus 
Non-traffic accidents 
Nephritis/nephrosis 
Cancer of colon 
Chronic Obstr. Pulmon. Dis. 
Tuberculosis 
%of all 
deaths 
13.0 
10.2 
9.0 
5.5 
4.4 
3.9 
3.6 
3.1 
2.9 
2.6 
2.6 
2.0 
1.8 
1.7 
1.6 
14.1 
11.2 
9.4 
4.9 
4.2 
3.7 
2.8 
2.7 
2.5 
2.1 
2.1 
1.8 
1.8 
1.8 
1.6 
Note: For ICD-code numbers, see Annex 1. Ill-defined and non-specified conditions 
have been excluded. 
[a] Non-ischemic, non-rheumatic heart disease. 
[b] Deaths, any age (excluding still-births), classified under chapter XV of the ICD. 
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Post-1950 time-trends for the leading causes of death 
Changes in mortality rates for the leading causes of death, 
standardized for changes in the age-composition of the population, are 
shown in figure I.9. For men and women separately, Standardized 
Mortality Ratios (SMRs), all ages, were calculated with sex-specific 
standardrates derived from average mortality rates over the entire 
period 1950-1984. Because the SMRs have all been plotted on the same 
logarithmic scale, rates of change can be compared between causes of 
death, between the sexes, and over time. 
Mortality from Ischemic heart disease has been increasing 
until the first half of the 1970 1 s, and then started a gradual 
decrease, both in males and females. Other diseases of the circulatory 
system have shown more favourable trends. Cerebrovascular disease has 
declined gradually throughout the study-period, more in females than 
in males. Hypertensive disease (complications of hypertension not 
classifiable to Ischemic heart disease or Cerebrovascular disease) has 
declined rapidly. 
Cancer of the stomach is the only quantitatively important 
cancer for which mortality has declined since 1950. Cancer of the lung 
has increased dramatically; the rate of increase seems to be 
decelerating in men after 1970, but it is accelerating in women. 
Cancer of the colon, prostate and breast all show slight mortality 
increases. 
Mortality from Influenza and pneumonia has decreased since 
1950; the apparent temporary increase just before 1970 is due to 
changes in coding (see section I.6.1). Deaths due to Perinatal causes 
have declined considerably. Mortality rates from Traffic accidents and 
Non-traffic accidents increased until the early 1970's, then started a 
rapid decrease. The peak in mortality from Non-traffic accidents in 
1953 was caused by a flood disaster. 
For all ages combined, Total mortality in males remained 
more or less stable between 1950 and 1970. Figure I.9 demonstrates 
that this is due to a mixture of decreasing mortality for some, 
increasing mortality for other conditions. Mortality increases are 
apparent especially for Ischemic heart diseases, Cancer of the lung, 
Chronic Obstructive Pulmonary Disease, and Traffic accidents. In the 
early 1970 1 s a trend reversal occurred for Ischemic heart disease and 
Traffic accidents, and mortality increases for Cancer of the lung and 
Chronic Obstructive Pulmonary Disease slowed down. 
The fact that Total mortality did not remain stable for 
females between 1950 and 1970, but decreased, is due to a number of 
factors. Ischemic heart disease, Cancer of the lung, Chronic 
Obstructive Pulmonary Disease, and Traffic accidents are less 
important and increased less in females. And some causes which 
declined even in this period, such as Cerebrovascular disease and 
Cancer of the stomach, are more important and/or declined faster in 
females. 
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Figure !.9 Trends in age-standardized mortality by cause of death and 
sex, The Netherlands, 1950-84. 
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Figure 1.9 (continued) Trends in age-standardized mortality by cause 
of death and sex, The Netherlands, 1950-84. 
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Figure 1.9 (continued) Trends in age-standardized mortality by cause 
of death and sex, The Netherlands, 1950-84. 
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Figure I.9 (continued) Trends in age-standardized mortality by cause 
of death and sex, The Netherlands, 1950-84. 
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Figure 1.9 (continued) Trends in age-standardized mortality by cause 
of death and sex, The Netherlands, 1950-84. 
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Figure 1.9 (continued) Trends in age-standardized mortality by cause 
of death and sex, The Netherlands, 1950-84. 
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Less change after 1950 than before? 
It has frequently been suggested that changes in mortality since 1950 
have been much smaller than those in the period 1850-1950 (cf. section 
I.1). Although the changes in average life expectancy at birth and in 
crude mortality rates (section I.4.1) tend to support this view, a 
closer look at changes in age-specific mortality rates reveals that 
changes have in fact been not so small (see also ref. 61). Changes in 
average life expectancy at birth tend to "overestimate" the importance 
of changes in mortality rates at younger ages, because lives saved at 
younger ages add more years to life expectancy than lives saved at 
older ages. 
Table I.7 shows both the changes in life expectancy and the 
changes in age-specific mortality rates, for selected ages. The period 
since 1950 has been divided into two parts, in order to allow for the 
effect of the trend reversals mentioned above. An "absolute" measure 
of change is used in this table: the difference between the value 
registered at the beginning of each period, and that registered at the 
end. Because the periods do not have the same lengths, the differences 
have been divided by the number of years passed. 
Before 1950, especially between 1900/09 and 1950/52, the 
most impressive changes in mortality rates (per year) are registered 
in the 0-year age-group. This is also a period with rapid gains in 
life expectancy at birth. After 1950 the changes in mortality rates at 
age 0 become more modest, and changes in life expectancy also become 
less. 
In men, mortality ra.tes at ages 10, 20, 40 and 60 increased 
between 1950/52 and 1966/70, but declined again between 1966/70 and 
1980/84. At younger ages, the recent declines are generally smaller 
than those registered before 1950, but at higher ages this is less 
true. In women, mortality declined at all ages during both parts of 
the post-1950 period. At age 80, the mortality declines have become 
larger and larger, and were even more important than those at age 0 
after 1950. 
With declining mortality rates it becomes increasingly 
difficult to achieve the same "absolute" changes in mortality. It may 
be more appropriate, therefore, to compare proportional changes in 
mortality. If the absolute changes (per year) are expressed as a 
percentage of their starting value, i.e. the mortality rate registered 
at the beginning of each period, a measure of "relative" change is 
obtained (table I.8). It appears that generally the relative declines 
were not smaller after 1950 than before, with the exception of changes 
in male mortality between 1950/52 and 1966/70, due to the "epidemics" 
of Ischemic heart disease and other causes of death. 
Although gains in average life expectancy at birth have been 
small in comparison with earlier periods, age-specific mortality rates 
have thus declined considerably in recent years, and skepticism on our 
progress in the reduction of mortality is unwarranted. 
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Table I. 7 "Absolute" changes in average life expectancy at birth and in mortality 
rates by age and sex, The Netherlands. 
"Absolute" changes (per year) 
life expectancy 
at birth 
mortality rate [a] (per 100.000) at age 
(in years) 0 10 20 40 60 
males 
1840/51 - 1900/09 +0.2 - 86 -6 -11 -18 -22 
1900/09 - 1950/52 +0.4 -245 -4 ..: 9 -10 -23 
1950/52 - 1966/70 +0.0 -72 +0 + 1 + 0 +22 
1966/70 - 1980/84 +0.1 - 54 -2 - 2 - 4 -23 
females 
1840/51 - 1900/09 +0.2 - 81 -6 - 8 -15 -15 
1900/09 - 1950/52 +0.4 -209 -4 - 7 -11 -22 
1950/52 - 1966/70 +0.2 - 57 -0 - 1 - 2 -14 
1966/70 - 1980/84 +0.2 - 40 -0 - 1 - 2 -11 
[a] In fact, this table uses the life table measure "mortality quotient". 
Calculated from data in ref. 58. 
See text for further explanation. 
80 
- 40 
- 71 
- 40 
- 18 
- 35 
- 63 
-104 
-183 
Table !.8 "Relative" or proportional changes in average life expectancy at birth and 
in mortality rates by age and sex, The Netherlands. 
Proportional changes (%, per year) 
life expectancy 
at birth 
mortality rate at age 
0 10 20 40 60 80 
-----------~--------------------------------------------------------------------------
males 
1840/51 - 1900/09 +0.7 -0.4 -1.1 -1.0 -1.0 -0.6 -0.2 
1900/09 - 1950/52 +0.8 -1.7 -1.7 -1.8 -1.5 -0.9 -o.s 
1950/52 - 1966/70 +0.0 -2.6 +0.2 +1.0 +0.2 +1.6 -0.4 
1966/70 - 1980/84 +0.2 -3.4 -3.8 -1.5 -1.7 -1.3 -0.2 
fellal.es 
1840/51 - 1900/09 +0.6 -0.5 -1.0 -0.9 -0.9 -0.5 -0.2 
1900/09 - 1950/52 +0,8 -1.8 -1.8 -1.8 -1.6 -1.1 -0.5 
1950/52 - 1966/70 +0.3 -2.7 -1.5 -1.8 -1.4 -1.3 -1.0 
1966/70 - 1980/84 +0.3 -3.4 -1.7 -1.4 -1.7 -1.4 -2.2 
Calculated from from the data in table 1.7, and from life expectancy at birth c.q. 
mortality rate at beginning of each period. 
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1.4.3 The role of medicine 
The most important event in the history of mortality of the last few 
centuries, is, of course, the enormous decline in infectious disease 
mortality (section 1.4.1). McKeown has made an influential analysis of 
the possible causes for the decline in England and Wales, in which he 
considers three possible factors [3, 62]: 
"medical measures" of preventing and treating disease in 
the individual; 
- a "spontaneous" change in the relation between infectious 
agent and human host; 
- and improvements in the "environment". 
We will follow his argument in some detail. 
"Medical measures" 
Medical measures, it is argued, can largely be discarded, because for 
most infectious diseases effective interventions were not available 
before the advent of the sulphonamides and antibiotics in the 1930's 
and 1940's. McKeown has published a large number of impressive graphs, 
in which it is shown that the decline of infectious disease mortality 
indeed had already largely occurred when these drugs became available. 
Figure 1.10 presents the example of Respiratory tuberculosis. 
Approximately the same situation is present in e.g. Bronchitis, 
pneumonia and influenza, and Scarlet fever. 
Figure I.lO Decline in mortality from respiratory tuberculosis (age-
standardized), England and Wales. 
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According to McKeown, there was only a small number of 
exceptions, for example in Diphtheria where the introduction of anti-
toxin in the late nineteenth century may have played an important role 
in the subsequent decline of mortality. Another exception he allows 
for is Syphilis, which, although it had already declined for other 
reasons, was still important as a cause of death when salvarsan became 
available early in the twentieth century. 
For some infectious diseases, immunization was a more im-
portant breakthrough than antibiotics, but most forms of immunization 
were only introduced in England and Wales in the 1940's (Diphtheria) 
and 1950 1 s (Whooping cough), or even later (Measles). McKeown does, 
however, recognize one important exception: Smallpox. Inoculation with 
infected material from Smallpox patients was practiced on a moderately 
large scale during the eighteenth century in England and Wales [63], 
and replaced by compulsory and more effective vaccination of infants 
during the nineteenth century. 
The contribution of these preventive measures to the decline 
of Smallpox mortality is controversial. Some authors claim that Small-
pox was a very important cause of death in the eighteenth and early 
nineteenth centuries, and that the decline of Smallpox incidence had 
an important side-effect in increasing resistance to other infections 
[64]. 
Recognizing that immunizations may have been more important 
in reducing morbidity than in reducing mortality, in a second edition 
of his book "The role of medicine" McKeown shows that notification 
rates for Poliomyelitis, Whooping cough, and Measles indeed declined 
much faster after their introduction. 
Changes in host-agent interaction 
A "spontaneous" change in the relationship between infectious agent 
and host is a second possible explanation for infectious disease 
mortality time trends. This possibility does not lend itself easily to 
empirical verification, but the apparently spontaneous rise and fall 
of a number of infectious diseases in the past have led to suggestions 
that changes in the virulence of micro-organisms and/or the resistance 
of the host do occur [65]. 
McNeill has made an interesting case for this mechanism in 
an attempt at explanation of the rise and fall of many infectious 
diseases. He claims that when new virulent micro-organisms enter a 
population which has not before been exposed to these agents, they 
start by killing off many people. Later, as the result of selection 
processes, milder strains displace those that killed their hosts too 
rapidly, and in addition the resistance of the population increases 
[ 66]. 
Most microbiologists would agree that a decreasing virulence 
of the streptococcus probably has played a major role in the decline 
of Scarlet fever mortality. McKeown states that this mechanism is 
unlikely to have been important for the decline of infectious disease 
mortality in general. 
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Changes in the "environment" 
By exclusion, McKeown considers the third possibility, a favourable 
change in the environment, as the most plausible explanation for the 
decline of infectious disease mortality. Two changes could have had 
major effects: rising standards of living, particularly improved diet, 
and the hygienic measures introduced by the sanitary reformers. The 
latter measures date from about 1880, when improvements in water 
supplies and sewage disposal may have induced a decline in mortality 
from intestinal infections. 
For increased food production during the eighteenth and 
nineteenth centuries there is only circumstantial evidence, based on 
estimates of land areas under cultivation, yields per acre, and 
amounts of imported and exported food. Of course, an increasing food 
production may also have been a consequence of the necessity to 
support larger population numbers, instead of the cause of the popula-
tion increase. Nevertheless, there is some evidence that an "agri-
cultural revolution" preceded the increase in population numbers, 
involving better organisation, new technologies (including new crops) 
and better transport. (In The Netherlands, a lowering of excise-duties 
on food-products caused an important extra increase in food con-
sumption around 1860 [67].) 
Evidence from the Third World indicates that nutritional 
status is indeed an important factor in the incidence and case 
fatality of infectious diseases, especially in infants and children 
[68]. The effect of better nutrition on mortality may have been im-
portant also in the case of Tuberculosis, one of the most important 
contributors to mortality decline in England and Wales. McKeown con-
siders improved nutrition to be the single most important factor in 
the decline of infectious disease mortality. 
McKeown's argument: a review 
McKeown's analyses, and especially the summary of results presented in 
his 1976 book "The role of medicine: dream, mirage or nemesis", have 
exerted a powerful influence on attitudes towards medical care, both 
within and outside the medical profession. It had generally been 
assumed that medical measures have made an important contribution to 
the decline of mortality in the industrialized countries (see e.g. 
ref. 69). A detailed, but essentially simple analysis of the available 
information shows that other influences, especially changes of the 
environment, might have been more important. 
In a discussion of these findings, it is important to dis-
tinguish between McKeown's interpretation of historical data and the 
possible conclusions that one might draw on the "role of medicine" at 
present and in the future. 
McKeown's arguments against any important effects of medical 
measures on the decline of mortality in the past have the structure of 
a syllogism: - the decline in mortality since the eighteenth century 
can be attributed to a decline of infectious disease mortality; - no 
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effective medical interventions were available against infectious 
diseases before the middle of the twentieth century; - thus, most of 
the decline in mortality cannot be attributed to the introduction of 
effective medical interventions. 
The first part of the syllogism is largely beyond dispute. 
Although some critics have pointed to the unreliability of historical 
cause-of-death information [70], it is generally agreed that diseases 
in which micro-organisms were involved dominated the mortality pattern 
of the eighteenth and nineteenth centuries, and were responsible for 
most of the mortality decline since then. 
On the second part of the syllogism more disagreement is 
possible. Some disagreement on the effect of compulsory vaccination 
against Smallpox was already mentioned above. Older historians have 
argued that the rapid growth of hospitals in the eighteenth century 
contributed to the decline of mortality [69], but it is not unlikely 
that hospitalization, surgery, and institutional midwifery did in fact 
more harm than good [63]. Although McKeown may have been a little too 
rigorous for some infectious diseases, for example for Whooping cough, 
where immunization may have been in widespread use earlier than he 
believed [71], the analysis is in fact quite robust against such 
"fallibility in detap" [72]. 
Whether McKeown is right in believing that better nutrition 
was the main factor in mortality decline is beyond the scope of this 
thesis. As stated above, the evidence is largely circumstantial, and 
there is no quantitative precision in the effect estimates. On a more 
general level, however, it can be safely stated that "ecological" 
factors have been the dominant influence on the mortality decline of 
the eighteenth, nineteenth and early twentieth centuries. The exact 
contribution of more specific factors is unknown, and apart from 
better nutrition and sanitation (of water supplies and sewage dis-
posal), declining fertility [73], better and more spacious housing 
[74], and many other factors. 
Interestingly, the increase in the frequency of certain 
other ("Western") diseases, which occurred during or after the decline 
in infectious diseases, can also be viewed in terms of changes in the 
ecosystem. Changes in food-habits may be responsible for the rise in 
Hypertension, Diabetes mellitus, Ischemic heart disease, Colorectal 
cancer and other diseases; changes in fertility to the rise in Breast 
cancer; etc. [75]. 
Finally, it is important to note that at least some of the 
"environmental" changes which caused the decline of infectious disease 
mortality, were the results of conscious efforts to reduce health 
risks, and that these efforts were based on knowledge gained by the 
medical profession in its study of the determinants of disease (cf. 
section I. 3 .1) . 
The potential importance of conscious, as opposed to more 
spontaneous, environmental change is also suggested by the results of 
47 
Introduction: history of mortality 
two cross-sectional analyses of the relationship between life 
expectancy at birth and per capital national income, one for 1930 and 
one for 1960. The data available for this analysis covered a large 
number of countries from all over the world. At both moments in time, 
a higher national income went together with a higher life expectancy, 
but in 1960 a given level of the national income was associated with a 
substantially higher life expectancy than in 1930 (national income for 
1930 expressed in 1960 values). This was true over the complete range 
of national income values, and suggests that other factors than those 
associated with economic progress were at work too in lowering 
mortality rates. For the less developed countries public health 
efforts directed against a number of infectious and parasitic 
diseases, such as Smallpox, Cholera and Malaria, may have played an 
important role, independent of that of economic change [76]. 
Wider implications 
McKeown drew a number of more far-reaching conclusions from his 
historical analyses which appear to be less robust. McKeown has 
repeatedly argued that the historical evidence suggests that today's 
health problems are also more likely to be controlled by removing 
their causes (i.e. by changing the environment) than by intervening in 
disease mechanisms (i.e. by medical care for those that are already 
sick). However, from the fact that environmental change has made a 
larger contribution to mortality decline in the past than medical 
intervention, it does not necessarily follow that environmental change 
is a more effective means of intervention under all circumstances. 
In some less developed populations, for example Navajo 
indians in the United States [2] and Eskimos in Greenland [77], the 
introduction of effective tuberculosis treatment had a much greater 
impact, because it came at a time when environmental changes had not 
yet been substantial, and because mortality rates from this disease 
were still as high as those in European countries in the nineteenth 
century. 
In fact, a universal comparison of the effectiveness of 
environmental change and medical measures is not possible with 
McKeown's historical data. "Environmental measures were tested when 
mortality was high, antibiotics when mortality was low; environmental 
measures were tested alone, antibiotics against a background of en-
vironmental change. ( ... )English archers at Agincourt did better than 
English riflemen on the Somme, and it does not follow that archers 
have greater military potential" [72]. 
One could further argue that the comparison between the 
changes induced by the introduction of antibiotics and immunization, 
and the changes that occurred in a very long period of time before 
that, does injustice to and belittles the advances of medical care. 
For contemporary patients, only contemporary effects count. "To have 
witnessed the change in outlook that modern chemotherapy brought for 
an individual patient with tuberculosis has been a thrilling and 
48 
Introduction: history of mortality 
unforgettable experience. McKeown has, unfortunately, experienced this 
only by inspection of the mortality slope. ( ... )What was the point in 
even calculating the effect of specific anti-tuberculous therapy on 
the number of deaths due to tuberculosis since 1848, when the first 
effective drug came into use a century later?" [70] 
McKeown's brief treatment of the actual effects of these 
drugs, in which he shows enlargements of the "tail" of the mortality 
curves for Tuberculosis and Pneumonia, which suggest important changes 
in mortality trend at the moment of introduction of antibiotics [3], 
is rather unsatisfactory. 
The main problem with which we are left after reading 
McKeown is, that the effect of medical care on mortality in the second 
half of this century remains essentially unknown. Mortality develop-
ments after 1950 have been quite dynamic, and a comprehensive analysis 
of possible changes induced by improvements in medical care is simply 
not available. The analyses in chapters IV, V and VI are attempts to 
fill parts of this gap. 
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!.5.1 International differences in mortality 
As shown in section I.4.1, the average life expectancy at birth in The 
Netherlands in 1980-84 was 72.8 years for males, and 79.4 years for 
females, thus approximately 76 years for both sexes combined. These 
life expectancy values are among the highest in the world. An average 
life expectancy at birth of more than 70 years is only found in Europe 
(excluding the USSR, where life expectancy was exactly 70.0 years in 
1980-84), North America, Australia, New Zealand, and Japan (figure 
I.11), and in a small number of countries in other world regions, such 
as Israel, Costa Rica, Chili and Taiwan. 
In certain parts of Africa, life expectancy was still below 
50 years: 47.0 years in Middle Africa, 48.5 years in Western Africa, 
and 49.2 years in Eastern Africa. These values are similar to those 
for The Netherlands in 1890-1899. The region containing India and 
neighbouring countries, Middle South Asia, had an average life ex-
pectancy of 51.2 years (a value comparable to that calculated for The 
Netherlands in 1900-1909). 
These differences in life expectancy between different 
regions of the world reflect the fact that many Third World countries 
are probably only at the beginning of a "demographic transition". 
Increases in life expectancy in the Third World have started in the 
twentieth century, for some countries only after World War II, but 
have been rather rapid in the last decades. The rate of increase has 
sometimes even exceeded that registered in European countries in a 
similar phase of the demographic transition [55]. 
Of the regions distinguished in figure I.ll, China had the 
largest increase in life expectancy since 1960-64: 14.8 years were 
added in 20 years time. It rose from 55.0 to 69.8 years, values 
reached by The Netherlands in the early 1910's and the late 1940's 
respectively, which represents a period of appr. 35 years. The 
explosive growth of population numbers in the Third World has largely 
been caused by these mortality reductions, which were not paralleled 
by fertility reductions. 
Mortality rates in The Netherlands are not only low by world 
standards, they also rate among the lowest of the industrialized 
countries (table I.9). Only Switzerland, Japan, Iceland, Sweden, Nor-
way and Greece(!) had lower age-standardized death rates in the early 
1980 1 s than The Netherlands. The relatively low over-all mortality 
rates in The Netherlands are due to lower than average standardized 
death rates for three of the four largest cause-of-death groups: 
Diseases of the circulatory system, Diseases of the respiratory sys-
tem, and Accidents, poisonings and violence (External causes). Dutch 
mortality rates are relatively high, however, for Malignant neoplasms. 
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Introduction: geography of mortality 
Table 1.9 Age-standardized death rates per 100.000 person-years [a], 
both sexes, in a number of industrialized countries, 1982 
(or year nearest to 1982 for which data were published). 
All causes Circula-
tory 
diseases 
Malignant 
neoplasms 
Respira-
tory 
diseases 
External 
causes 
----------------------------------------------------------------------
Switzerland [4, b] 712 314 195 34 68 
Japan 720 306 163 63 48 
Iceland [3] 750 361 188 67 64 
Sweden 789 422 172 51 53 
Norway 795 376 181 63 58 
Greece 797 352 159 49 47 
The Netherlands 798 351 222 52 41 
Australia [3] 821 414 192 58 50 
Canada 825 385 202 58 59 
USA 842 407 193 53 62 
France 842 286 206 53 84 
Italy [1] 870 402 198 63 49 
Denmark 880 398 226 59 67 
Finland [3] 913 476 187 69 76 
New Zealand [3] 923 442 214 104 53 
England/Wales 930 442 215 135 36 
West-Germany 931 450 210 53 62 
Belgium 946 402 231 64 76 
Portugal 980 421 152 65 78 
Austria 983 495 209 49 86 
Scotland [3] 1044 519 238 116 52 
Ireland [3] 1073 544 214 146 49 
Yugoslavia 1102 580 161 62 68 
Poland [3] 1138 578 205 58 77 
Bulgaria 1142 654 149 91 62 
Romania 1211 724 143 147 70 
Czechoslovakia [3] 1243 674 235 101 81 
Hungary 1277 682 244 69 113 
----------------------------------------------------------------------
[a] Directly standardized, European standard population; 
[b) In 1984, the age-standardized death rate, all causes, was 699 in Japan (and 784 in The 
Netherlands). 
[1] 1981 [3] 1983 [4] 1984. 
Data from ref. 78. 
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Dutch over-all mortality rates are also substantially lower 
than those of its immediate neighbours: West-Germany, Belgium and, 
across the North Sea, England and Wales. These three countries have 
higher death rates for Diseases of the circulatory system and Diseases 
of the respiratory system (with extremely high rates in England and 
Wales). Death rates for Malignant neoplasms are approximately the 
same. With regard to Accidents, poisonings and violence England and 
Wales is the only country with lower death rates than The Netherlands. 
The highest over-all mortality rates of the industrialized countries 
are found in Eastern Europe. High rates for Diseases of the circula-
tory system are the main factor. 
Mortality from Malignant neoplasms has less variation at the 
international level than any of the other groups of causes of death 
mentioned in table I.9. The variation coefficient of mortality from 
Malignant neoplasms is only 14 %, whereas it is 25 % for mortality due 
to Diseases of the circulatory system, 41 % for Diseases of the 
respiratory system, and 25 % for Accidents, poisonings and violence. 
This may be due to greater internal heterogeneity of the cause-of-
death group Malignant neoplasms (and averaging out of more outspoken 
patterns of variation for specific cancers), or to more uniform certi-
fication and coding of cancer, or to both. 
I.5.2 Regional mortality differences within The Netherlands 
A note on the level of analysis 
Within The Netherlands mortality rates differ between geographical 
areas. The level of analysis which has been chosen in most of the 
regional analyses to be reported in this thesis is that of the so-
called COROP-regions (figure I.12). Exceptions are chapters III and 
VII, where provinces have been used, and chapter VIII, where COROP-
regions have been amalgamated to 28 larger regions. COROP-regions have 
been created for statistical purposes, without any relationship to 
existing levels of administration, except that all COROP-regions fit 
within provincial boundaries. 
Although a few regions are rather small for mortality ana-
lysis (cf. chapter VIII), from a point of view of statistical power 
the 40 COROP-regions seem a good compromise between the level of 
provinces (n 11 during the study-period), and the level of e.g 
Economic-geographic regions (n = 129) or Nodal regions (n = 80), all 
in use for presentation of statistical information. COROP-regions have 
been formed according to a "nodal'' classification principle, i.e. 
COROP-regions have been formed around towns acting as primary or 
secondary regional centres. Frequently these towns will also act as 
centres for health service provision, so that COROP-regions are ex-
pected to have a certain discriminatory power with regard to 
differences in medical care, especially hospital care. 
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Figure !.12 COROP-regions. 
1 Oost-Groningen 
2 Oelfzijl e.o. 
3 O...erig Groningen (J 
4 Noord·Friealand 
5 Zuidwen-Frietland 
6 Zuidoost-Frinland 
7 Noord·Drenthe 
8 Zuidoost-Drenthe 
9 Zuidwest-Drenthe 
10 Noord-Overijssel 
11 Zuidwest-Overljssel 
12 Twente 
13 Veluwe 
14 Achterhoek 
15 Aoglomeraties Arnhem en Niim891!n 
16 Zuidwest-Gelderland 
17 Utrecht 
18 Kopvan Noord-Holland 
19 Alkmaar e.o. 
20 IJmond 
21 Agglomerat•e Haerlem 
22 Zunstreek 
23 Groat-Amsterdam 
24 Het Gooi en Vechtstreek 
25 Agglomeratle Leiden en Bollenstreek 
26 Agglomeratie 's-Gr811enhage 
27 Delft en Westland 
28 Oost Zuid-Holland 
29 Groot Aijnmond 
30 ZuidoOit Zuid-Holland 
31 Zeeuwsch-VI .. nderen 
32 Overig Zeeland 
33 West Noord-Brabant 
34 Midden Noord-Brabant 
35 Noordoost Noord-Brebant 
36 Zuidoott Noord-Br.tlant 
37 Noord·Limburg 
38 Midden-Limburg 
39 Zuid·Limburg 
40 Zuideliike IJsselmeerpolders 
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Regional variation in Total mortality, 1950-84 
Regional differences in Total mortality in 1950-54, 1960-64, 1970-74 
and 1980-84, standardized for differences in age- and sex-composition 
of the population are mapped in figure 1.13. The Standardized Mortali-
ty Ratios (SMR 1 s) have been calculated with the national mortality 
rates by age and sex of the same time-period as standardrates. Al-
though some minor differences in regional pattern between males and 
females exist, we will ignore these for presentational purposes. 
An important feature of regional mortality patterns in The 
Netherlands in 1980-84 is the contiguous area of relatively high 
mortality in the south-east (parts of the province of Gelderland, and 
all regions in Noord-Brabant and Limburg). Other areas with relatively 
high mortality are Twente, Kop van Noord-Holland, and Groat-Amsterdam. 
A belt of relatively low mortality stretches from the north-east into 
the middle and western parts of the country. The south-west, i.e. the 
province of Zeeland, is also characterized by low Total mortality 
rates. 
The differences are not particularly large: the region with 
highest mortality, Zuid-Limburg, has an SMR of 1.09 (mortality rates 
are 9% above the national average), followed by Noord-Limburg with an 
SMR of 1.07. The region with lowest mortality, Zuidelijke 1Jsselmeer-
polders, has an SMR of .85, followed by Overig Zeeland with an SMR of 
.90. 
Since 1950-54 the mortality pattern has changed in a number 
of respects, although differences in SMR 1 s are mostly small. A number 
of regions in the middle part of the country, Utrecht and Veluwe, 
improved their positions from statistically significantly above the 
national level to statistically significantly below. (The temporarily 
high mortality rates in Overig Zeeland in 1950-54 were caused by the 
flood disaster of 1953.) The mortality rate in Groat-Amsterdam, which 
held a favourable position in the early 1950 1 s, is now slightly but 
statistically significantly above the national level. A general trend 
towards more unfavourable positions is also present in the north. The 
range of variation in 1950-54 was not so much different from that in 
1980-84: the lowest SMR in 1950-54 was .90 (Zuidoost-Drenthe), the 
highest 1.15 (Zuid-Limburg). 
Regional mortality by cause of death 
As might have been expected from the dynamic evolution of cause-
specific mortality over time (section 1.4.2), regional cause-specific 
mortality patterns have also changed considerably between 1950-54 and 
1980-84. We will summarize these changes in a statistical way, and 
then illustrate them with some maps. Finally, we will present a few 
maps showing recent mortality patterns for selected causes of death. 
Table 1.10 gives a crude impression of regional mortality 
patterns for the causes of death which were among the ten largest in 
either 1980-84 or 1950-54. Correlations between mortality (SMR's) and 
two variables indicating geographical position ("NORTH", or latitude, 
and "EAST", or longitude) are given. A positive correlation between 
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Table 1.10 Correlations [a) between age-standardized 
mortality by cause of death and two variables 
indicating geographic position, 1980-84 and 
1950-54. 
1980-84 1950-54 
NORTH EAST NORTH EAST 
Ischemic heart disease -.02 .55* -.13 -.45* 
Other heart disease [b) -.20 -.03 -.48* .06 
Cerebrovascular disease -.25 .18 -.42* -.38* 
Hypertensive disease .13 .10 - .47)"< -.43* 
Diseaseses of arteries -.57* -.32* -.09 .06 
Cancer of stomach .05 .07 -.00 .20 
Cancer of colon -.05 .24 .31* -.23 
Cancer of lung -.54* -.36* -.23 -.53* 
Cancer of breast .16 -.18 .11 -.55* 
Cancer of prostate .55* -.20 .19 -.37 
Diabetes mellitus -.05 .35* -.68* -.34* 
Influenza/pneumonia -.16 -.14 -.42* .32* 
Chronic Obstr. Pulmon. Dis. -.34* .20 -.04 .66* 
Perinatal mortality [c) -.07 .16 -.21 .55~' 
Traffic accidents .14 .51* .04 .32* 
Non-traffic accidents .19 .02 .32* .03 
Total mortality -.34* .20 -.69* -.21 
-------------------------------------------------------------
NORTH = latitude, EAST = longitude. 
Significance levels (two-sided test): * p < .OS. 
[a] Product-moment correlations, unweighted (n=39). 
[b] Non-ischemic, non-rheumatic heart disease. 
[c] Still-births plus first week deaths per 1000 births. 
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mortality and "NORTH" means that mortality is generally higher in more 
northerly regions; a positive correlation with "EAST" that there is a 
gradient of mortality from west to east, with higher mortality in the 
east. 
The last row of table I.10 shows the results for Total 
mortality. In 1980-84 Total mortality had a modest negative correla-
tion with NORTH, indicating that mortality rates were generally higher 
in the south (cf. figure I.13). In 1950-54 the correlation between 
Total mortality and NORTH was more negative, probably due to lower 
mortality in the north-east. In 1980-84, most of the specific causes 
of death (10 out of 16) also had negative correlations with NORTH, and 
even more so in 1950-54. 
In 1980-84 mortality from Ischemic heart disease had a 
rather strong west-east gradient. Between 1950-54 and 1980-84, the 
mortality gradient for Ischemic heart disease seems to have reversed: 
in 1950-54, mortality generally was higher in the west. Many other 
changes are apparent too, e.g. for Perinatal mortality and Chronic Ob-
structive Pulmonary Disease, where the strong west-east gradient of 
1950-54 was lost. 
Figure I.14 illustrates the change in the regional pattern 
of Ischemic heart disease mortality. In 1980-84 mortality from Ische-
mic heart disease indeed had an important west-east gradient. Only 
some eastern regions have SMR's of 1.20 or more: Oost-Groningen, 
Midden-Limburg, and Zuid-Limburg. In 1950-54 areas with high mortality 
were also found in the west. Only two (industrialized) regions 
situated in the east, Zuid-Limburg and Twente, already had high 
mortality from Ischemic heart disease in 1950-54. 
Different forms of cancer sometimes have completely 
different patterns of regional variation (figure I.15). Cancer of the 
stomach is a disease of rural and peripherally situated regions, both 
in 1950-54 and in 1980-84. Differences in mortality are particularly 
large for this condition. In Overig Zeeland, a region otherwise 
characterized by low mortality rates in 1980-84, the SMR for Cancer of 
the stomach is 1.61. 
In 1950-54 Mortality from Cancer of the lung had a strong 
east-west gradient, with higher mortality in the highly urbanized 
regions in the western part of the country (table I.10). In 1980-84 
higher than average mortality from Cancer of the lung has also spread 
into the south-east (figure I.15). 
In 1980-84 mortality from Traffic accidents is low in the 
highly urbanized western part of the country, and is very high in 
parts of the north, the east and the south-east (figure I.16). 
Differences are quite large, several regions attaining SMRs of 1.40 or 
higher (Zuidoost-Drenthe, Achterhoek, and Noordoost-Noord-Brabant). 
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1.5.3 Geographical variation in effectiveness of medical care? 
"Medical geography" 
Regional variation in mortality by cause of death has been a favourite 
subject for studies in "medical geography". Two broad subareas of this 
field of research may be distinguished: the study of the geography of 
health problems, and the study of the geography of health care [79, 
80]. The first subarea has a long history, which has briefly been 
mentioned in section I.3.1, but the second subarea is of more recent 
origin. 
If compared to the situation in a number of other countries, 
the study of regional mortality variations has not been flourishing in 
recent years in The Netherlands, and the same applies to medical 
geography in general [81, 82]. The publication of an "Atlas of cancer 
mortality", covering data from the period 1969-1978 [83], has not led 
to many attempts at explanation of the observed differences. There has 
only been a small number of studies of regional variation in mortality 
recently [84-87]. 
The studies reported in chapters VII, VIII and IX of this 
thesis concern regional variation in mortality from selected con-
ditions in The Netherlands (and some other countries), and thus 
naturally fall in the first, or "classical", branch of medical geo-
graphy. The focus, however, is on the relationship with medical care, 
and they may thus perhaps also be classified as studies of the geo-
graphy of health care. 
Regional mortality difference and the supply of medical 
care: literature review 
As an introduction to these studies, we will briefly review some 
earlier work on the relationship between mortality and medical care at 
the regional level. These studies have led to conflicting results, 
mirrorring those of studies of international mortality differences and 
medical care [88]. 
In a large number of studies associations between supply of 
medical care and Total mortality rates were found to be not statisti-
cally significant and inconsistent (e.g. refs. 89-91). Although some 
degree of control for potential confounding factors, such as socio-
demographic variables, was achieved in these studies, the design is 
generally crude. 
It is only in a small number of studies that a more 
elaborate attempt was made to investigate the contribution of 
differences in medical care to the explanation of regional mortality 
differences. Two important studies analysed the effect of differences 
in medical care on perinatal mortality in England and Wales at the end 
of the 1960's [92] and in the mid-1970's [93]. In the first study, it 
was found that the proportion of low-birthweight infants and the 
birthweight-specific perinatal mortality rate were closely related to 
a number of sociodemographic variables. Measures of the "input" of 
medical care were only available on a limited scale, but specific in 
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character (proportions of institutional confinements in different 
birthweight groups), and did only explain a very small part of the 
variance [92]. 
In the second study, a large number of variables describing 
levels of supply and utilization of medical care was available, many 
of them specifically related to obstetrics and neonatal care. Varia-
tions in these characteristics showed little evidence of an effect on 
either the proportion of low birthweights or the birthweight-standard-
ized perinatal mortality rate [93]. 
These findings contrast with the results from a number of 
studies concerning regional variation in mortality in the United 
States, in which the impact of differences in supply and/or use of 
medical care on mortality rates was investigated using econometric 
models [94-96]. The association between state neonatal mortality 
rates, corrected for differences in birthweight and socio-economic 
conditions, and "accessible specialist physician density" (number of 
obstetrician-gynecologists per 1000 births, multiplied by the pro-
portion of hospital-born infants) was found to be negative and 
statistically significant in 1968 [94]. 
In another U.S. study of variation in mortality by state, 
the elasticity of the age-adjusted death rate with respect to ·the 
supply of medical services (a "production function" combining the. 
supply of physicians, paramedical personnel, capital and drugs) was 
statistically significantly negative, although some other variables 
were far more important than medical care [95]. 
A recent and comprehensive analysis of age- and cause-
specific mortality rates by U.S county group in 1970 found that a 
higher utilization of medical care was statistically significantly 
associated with lower mortality rates. After controlling for other 
factors, such as income, education, marital status, work experience, 
cigarette consumption, and an indicator of the prevalence of disabili-
ty, greater use of medical care was associated with lower mortality in 
almost all age-/sex-/race-groups. In a comparison between cardio-
vascular diseases, cancer, and external causes, it was found that the 
largest estimated effect was on mortality from cardiovascular diseases 
[ 96]. 
Small-area variations in medical procedures 
Associations between such "structural" characteristics as the supply 
of medical care and mortality, if any, need further explanation in 
the form of more specific mechanisms. One will have to suppose that 
the structural characteristic has an effect on the frequency, quality, 
or other aspect of specific medical procedures. That mortality is not 
insensitive to structural differences in medical care is evident from 
studies of the relationship between surgical volume and mortality: for 
many forms of surgery, postoperative mortality is lower in .hospitals 
where that type of surgery is more frequently performed, suggesting 
the existence of scale effects [97, 98]. On the regional level, we 
know that regional variation in the frequency of certain medical 
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interventions can be quite large, and that this variation is related 
to the supply of medical care. This has best been documented for 
common surgical procedures [99, 100]. 
A large number of studies has highlighted the existence of 
variations in the frequency of certain procedures among small areas in 
the United States. The total rate of surgery differs as much as two-
fold between areas, and the variation in specific procedures, such as 
tonsillectomy, hysterectomy, and prostatectomy is even much larger. 
While the total rate of surgery is closely related to the supply of 
hospital beds and physicians in the area, the wide variations in 
individual procedures are probably to a large extent due to 
differences in the style of medical practice of local physicians [99]. 
These small-area variations in the use of common surgical 
procedures are not limited to the United States, but have also been 
documented in other countries. Although average rates of surgery 
differ between the United States, England and Norway, the rank order 
of variability of individual procedures was remarkably similar: 
tonsillectomy, hemorrhoidectomy, hysterectomy and prostatectomy varied 
more from area to area than did appendectomy, abdominal hernia repair, 
or cholecystectomy. The degrees of controversy and uncertainty 
concerning the indications for these procedures appear to be similar 
among clinicians in all three countries [100]. Although there is no 
direct evidence, it is generally considered to be highly unlikely that 
such large variations in the frequency of surgical procedures can be 
explained by differences in the incidence or prevalence of underlying 
conditions [101]. 
Geographical variation in the rate of surgical procedures is 
better documented than that in other medical interventions, but there 
is no reason to suppose that the latter is less. A large degree of 
variation in the frequency of medical procedures is bound to cause 
variation in effectiveness of medical care. In the literature on small 
area variations in surgical procedures there has been much speculation 
on the possibility of associated differences in mortality. An ex-
cessively high rate of surgery might lead to more surgical deaths, 
simply due to the risks of operation. Although some associations 
between high rates of appendectomy and high rates of mortality from 
Appendicitis have been claimed, for example for West-Germany [102], 
the issue has not been resolved [103]. It is difficult to reach firm 
conclusions in this type of study, because high mortality rates might 
also indicate a high need for surgery. 
Nevertheless, the existence of regional differences in the 
frequency of specific medical interventions shows that regional varia-
tion in effectiveness of medical care is not impossible, to say the 
least. The studies reported in chapters VII, VIII and IX are intended 
to contribute with new material to this question. 
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!.6 Methodological notes ~ the explanation of time trends and 
regional differences in mortality 
Time trends and regional 
number of factors, which 
headings (cf. ref. 104): 
1) artefact 
2) selection 
3) causation. 
!.6.1 Artefact 
differences in mortality can be due to a 
can be summarized under three general 
Mortality rates by cause of death are based on a numerator (numbers of 
deaths, by underlying cause of death code), and a denominator (number 
of person-years at risk). Changes over time, or regional differences 
in the process of data collection may cause artificial changes or 
differences in mortality rates by cause of death. In The Netherlands, 
the denominator can be derived from the population register, which has 
substantial advantages over the use of data from periodic censuses, 
and consequently presents practically no problems in mortality 
analyses. 
Underregistration of Perinatal mortality 
The registration of numbers of deaths can also be considered to be 
complete for all practical purposes. Perinatal mortality is the only 
important exception. Perinatal mortality is defined as the number of 
still-births and first-week deaths, divided by the sum of the number 
of .still-births and live-births. In The Netherlands, current rules 
specify that only still-births after more than 28 weeks of gestation 
have to be certified; no such restriction applies to deaths within the 
first week among those having vital signs at birth. 
A substantial degree of underregistration of perinatal 
deaths is likely. A recent study from Amsterdam showed that 14% of 
perinatal deaths occurring in hospitals had not been reported. 
Underregistration was more frequent for still-births and first-week 
deaths among children with very low birth weights (< 1000 g) and/or 
low gestational age (< 28 weeks), and for deaths within 24 hours (this 
i.e. treated as a still-birth of less than 28 weeks gestation, these 
difficulties are avoided [105]. 
Although Amsterdam does not have a particularly good record 
for the correct application of certification rules (vide infra), some 
degree of underregistration is probably present everywhere in The 
Netherlands. If the degree of underregistration has changed over time, 
or is different between regions, time trends and geographical 
differences in Perinatal mortality could be biased. 
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Changes in registration criteria for Perinatal mortality 
The analysis of time trends of Perinatal mortality is complicated by 
another problem: a change in the rules for registration of (deaths 
among) live-born infants. In the period 1950-1963, live-born infants 
with a gestational age of less than 28 weeks, dying before 
certification, were not included in national birth and Perinatal 
mortality counts. Fortunately, the original data were preserved by 
the Central Bureau of Statistics, and could be included in our 
analyses of Perinatal mortality. 
Changes over time in coding of causes of death 
For other age-groups, information on the cause of death is more liable 
to bias. The decennial revisions of the International Classification 
of Diseases (ICD) are a major source of concern in analyses of 
mortality time trends by cause of death. The changes caused by these 
revisions can be complicated and even irremediable. 
To bridge each of the recent revisions, the USA coding 
office has double-coded large numbers of death certificates, both 
according to the old and according to the new revision [106-108]. From 
the results "comparability ratios" have been calculated, indicating 
the degree of correspondence between a certain subgroup of diseases 
under the old revision and its most nearly comparable counterpart in 
the new rev~s~on. Large change~ have been demonstrated by these 
studies, necessitating complicated exchanges between subgroups of 
three- and four-digit ICD-codes. Guided by these publications, and by 
an inspection for possible breaks in mortality time trends at the 
moment of introduction of a new ICD-revision, we composed the cause-
of-death groups used in the analyses of the following chapters (see 
Annex 1 for the ICD-codes of these cause-of-death groups). Two 
examples are given as an illustration of the complicated exchanges 
which were sometimes necessary. 
Influenza and pneumonia are coded as part of the ICD-chapter 
Diseases of the respiratory system in ICD-editions 8 and 9, in force 
from 1969-1978 and from 1979 onwards respectively. In ICD-revisions 6 
and 7, however, Pneumonia of the newborn was coded with a number from 
the ICD-chapter Certain causes of perinatal morbidity. The 
"comparability ratio" of Influenza and pneumonia according to ICD-
edition 8, as compared to ICD-edition 7 was calculated as 1.04, 
indicating that the new category contained 4% more deaths than the old 
one. This was mainly due to the transfer of Pneumonia of the newborn 
[ 107]. 
In our category of Influenza and pneumonia, Pneumonia of the 
newborn is included throughout the period studied (see table 1 of 
Annex 1). Despite these precautions, the time trend for mortality due 
to Influenza and pneumonia shows a break coinciding with the 
transition from ICD-edition 7 to ICD-edition 8, which is due to a 
sudden rise in mortality within a four-digit category. 
Ischemic heart disease is an example of the necessity of 
more complicated exchanges. The comparability ratio of Ischemic heart 
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disease according to ICD-edition 8, relative to the most nearly 
comparable category Arteriosclerotic heart disease of ICD-edition 7, 
was 1.15. This was due to a transfer from a number of ICD-7 
categories, the most important of which was Other myocardial 
degeneration with arteriosclerosis, which at first formed part of 
Other heart diseases (422.1) [107]. This ICD-7 (and -6) code-number 
was therefore included in our category Ischemic heart disease. 
Between ICD-editions 8 and 9 again important changes took 
place. The comparability ratio of Ischemic heart disease according to 
ICD-edition 9, relative to the same category in ICD-edition 8, was 
0.88. This was due in great part to the separation of Cardiovascular 
disease, unspecified (ICD-9 429.2), from Ischemic heart disease as 
defined in ICD-edition 8 [108]. Consequently, we retained this ICD-9 
code-number in our category Ischaemic heart disease. 
Not all problems could be solved. Mortality from Asthma, for 
example, shows important breaks between ICD-editions 7 and 8, and 
between ICD-editions 8 and 9, which could only be "repaired" by adding 
Asthma to other Chronic Obstructive Lung Diseases. This precluded a 
separate analysis of this condition, which is a pity from the point of 
view of medical care effectiveness. 
Regional differences in cause-of-death certification 
Regional differences in recording practices may also induce artificial 
differences in mortality by cause of death. The main issue here is the 
possibility of geographical variation in diagnostic procedures and 
death certification practices. The fact that physicians tend to settle 
not far from the university where they obtained their degree [109], 
suggests that systematic differences of this kind are possible. (In 
some countries, e.g. in Belgium, coding of death certificates is 
decentralized, and coding differences may explain some of the observed 
mortality patterns by cause of death. In The Netherlands, there is 
only one, national, coding office.). 
Research into the possible effects of regional variation in 
diagnostic and certification practices on observed mortality differen-
ces is very scarce. In two studies of the regional variation of Cere-
brovascular disease mortality, in which death certificate information 
was compared with the clinical records, it was concluded that there 
was no evidence that differences in diagnosis or certification could 
account for the observed variation in mortality rates [110, 111]. In a 
study in which written case histories were distributed to doctors in 
different British regions, who then completed death certificates on 
the basis of the available information, no significant differences in 
certification were found [112]. 
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Figure 1.17 Regional variation in age-standardized mortality from 
"Symptoms and ill-defined conditions" (SMR.s), 1980-84. 
ALL "SYMPTOMS AND ILL-DEF CONDITIONS", 1980-84 
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11111111111 1.00-1.20 
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Nevertheless, figure !.17 does suggest at least some 
differences in certification of causes of death between regions in The 
Netherlands. Several regions have age-standardized mortality rates 
more than 207. above the national average for the cause-of-death 
category "Symptoms and ill-defined conditions" (cf. section !.2.2). 
The Standardized Mortality Ratio (SMR) for Alkmaar is 1.28, for Groat-
Amsterdam 1.99, for Oost-Zuid-Holland 1.31, and for Zeeuws-Vlaanderen 
2.16. The percentage of all deaths classified in this category is 7.1 
in Groat-Amsterdam, and 8.0 in Zeeuws-Vlaanderen, whereas the average 
for all regions (except the 4 mentioned above) is 3.1. 
The high rates in Groat-Amsterdam are due to the fact that 
coding by the Central Bureau of Statistics is hampered by inadequacies 
in notification. More frequently than elsewhere, no death certificate 
reaches the Central Bureau of Statistics, or the death certificate is 
filled out very incompletely or even not at all. If the name of the 
certifying doctor is also lacking on the certificate, it is impossible 
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certifying doctor is also lacking on the certificate, it is impossible 
to obtain supplementary information (Van der Vlist, personal communi-
cation, august 1987). The high rates in Zeeuws-Vlaanderen may be due 
to the fact that many patients receive hospital care in Belgium, which 
may cause administrative problems in obtaining information on the 
cause of death. 
If all causes of death have an approximately equal chance of 
contributing to the excess of "Symptoms and ill-defined conditions", 
all cause-specific SMR's of Groat-Amsterdam are underestimated with 
appr. 0.04 (7.1 - 3.1 = 4.0), and those of Zeeuws-Vlaanderen with 
appr. 0.05 (8.0 - 3.1 = 4.9). This appears to be a rather minor 
problem in view of the observed range of SMR-values for these regions, 
and is not likely to bias associations between mortality and other 
regional characteristics. 
1.6.2 Selection 
Selection on the basis of health-related mobility is another possible 
explanation of time trends or regional differences in mortality. If 
the health status of individuals (c.q. their risk of dying) acts as a 
selection criterion with regard to movement into and out of the 
aggregate units which are being compared, a difference in average 
health status between these groups arises. 
Health-related selection has been shown to contribute to 
differences in mortality between socio-economic groups, upward social 
mobility being associated with better health [113]; between marital 
status groups, getting married being associated with better health 
[114]; and between emigrants and those that stayed behind [115, 116]. 
Whether health-related selection may be of influence on 
regional mortality patterns is an issue which has been largely 
neglected. Migration between regions usually forms systematic patterns 
for longer periods of time. On the average, those who migrate over 
longer distances are likely to be more healthy than those who do not. 
(Short-distance migration may more frequently be an effect of ill-
health, for example in the case of admission to a nursing home.) 
Regions with sustained net emigration or immigration might thus differ 
in mortality solely as an effect of population flows. 
In a study from England and Wales it was found that those 
who had migrated between regions in the 5 years before the census had 
considerably lower SMR's than the national average. This effect was 
most pronounced in the first years after migration, which is 
consistent with regional migrants excluding people whose ill health 
prevented them moving. Those migrating from the north and west to the 
south and east had lower SMR's than those who stayed behind (but those 
who migrated from the south and east to the north and west had higher 
mortality than those who stayed behind !). Because of the low level of 
interregional migration, however, health-related mobility does not 
make a noticeable contribution to observed mortality patterns between 
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regions in England and Wales (high mortality in the north and west, 
low mortality in the south and east) [117]. 
In The Netherlands, the population of the newly formed 
region of Zuidelijke IJsselmeer Polders has increased from little more 
than 10.000 to more than 100.000 from 1969 to 1984. The complete 
population thus consists of recent (interregional) immigrants. This is 
probably one of the factors explaining the rather low mortality rates 
in this region (cf. section I.5.2). 
I.6.3 Causation 
Whereas an explanation of the "selection" type emphasizes an effect of 
health on the aggregate unit to which one belongs, a "causal" 
explanation specifies an effect of a characteristic of the unit on the 
health of its members. The issue of confounding here becomes 
important. Any other factor which is associated with both mortality 
and the characteristic of interest can act as a confounder. 
In a study of infectious disease mortality in two time-
periods, one before the introduction of antibiotics and another 
thereafter, any factor which is associated with mortality and happens 
to be present more in one of the two subperiods, will act as a 
confounder of the relationship between infectious disease mortality 
and antibiotics. If mortality rates of regions with a different level 
of supply of medical care are compared, any other factor, influencing 
mortality, which in its geographic distribution happens to be 
associated with medical care supply will bias the effect estimate. 
Multiple regression analysis can be used to correct for the influence 
of possible confounding factors. 
Standardization of mortality rates 
One potential confounder, age (and sex), is often removed in the 
descriptive phase of a mortality study through standardization. In 
many of the analyses reported in this thesis, the Standardized 
Mortality Ratio (SMR) has been employed. The SMR is the ratio of the 
observed number of deaths, and the number of deaths that would have 
been expected if the mortality rates by age (and sex) of a certain 
"standard" population had applied in the "index" population. Just as 
every other summary measure of differences in mortality rates, the 
calculation of an SMR assumes that the ratio of mortality rates is the 
same for all age-(and sex-)groups [118]. 
The calculation of an SMR is a form of "indirect" 
standardization; in "direct" standardization, the age-specific 
mortality rates of the index population are applied to the age-(and 
sex-)structure of a standard population. There has been much debate on 
the appropriateness of direct vs. indirect standardization, but in 
practice, the direct and indirect methods mostly give largely 
identical results [119]. An important advantage of the SMR is that it 
has a smaller standard error, because the observed number of deaths, 
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for all ages combined, of an index population is less subject to 
chance fluctuation than a series of age-specific mortality rates, 
which may be based on rather small numbers [120]. 
Some of the analyses to be reported in the next chapters 
make use of a more flexible approach to removing the influence of 
differences in age- and sex-structure between populations: loglinear 
regression analysis (see method sections of chapters IV, VI and IX). 
1.6.4 "Ecological analysis" 
The search for causal explanations of mortality differences over time 
and across geographical units is complicated by the fact that the 
analyses deal with aggregate units. Associations between mortality 
rates and other characteristics of aggregate units are not necessarily 
identical with associations at the individual level. Figure I.18 
provides a diagrammatic representation of the general form that an 
explanation of mortality differences at the aggregate level might 
take. 
It also visualises that fact that studies of possible expla-
nations of time trends and regional differences in mortality 
frequently use independent variables of a rather general nature, such 
as the supply of medical care or socio-economic status. Any associa-
tion between such a general characteristic and mortality requires 
further explanation in the form of more specific causal mechanisms. Is 
the effect on incidence or case fatality? Which attributes of the 
characteristic under study cause the effect on mortality? 
A "group characteristic", for example the hospital bed 
density of a region, can only affect mortality rates through: - an 
effect on the accessibility of hospital care for the individual 
("individual characteristic"); - an effect of accessibility on the 
probability of a correct application of efficacious medical procedures 
in the case the individual falls ill ("individual risk factor", more 
appropriately "individual protection factor" in this example); - and 
an effect of medical procedures on the risk of dying from the disease 
("individual mortality risk"). It is the aggregate of these individual 
mortality risks that we are measuring in conventional mortality 
analyses. 
"Ecological fallacy" 
Empirical studies which involve the group as the unit of analysis, are 
frequently called "ecological" studies in sociology and epidemiology 
(note that in section 1.4.3 the term "ecology" was used in a different 
sense). The primary analytic feature of ecological studies is that we 
do not know the joint distribution of the study factor(s) and disease 
(i.e. mortality risk) within each unit of analysis. This study design 
is therefore sometimes called an "incomplete" design, and is generally 
regarded as inferior for inferring individual level relationships, due 
to the problem of "ecological fallacy" [121]. 
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In the studies reported in the next chapters, however, the 
aggregate level of analysis is not a surrogate for the individual 
level of analysis. The studies aim at inferring the effect of medical 
care on mortality at population level. As in all studies of the 
effectiveness of medical care, aggregate effects are the focus of 
analysis, and the assessment of discrepancies between effects at 
individual and aggregate level are an integral part of evaluation 
efforts. 
The cause of discrepancies between individual and aggregate 
associations was first systematically discussed by Robinson, who 
showed that the effect of aggregation on correlation coefficients 
generally is to exaggerate them. The correlation between two phenomena 
is generally higher at aggregate level than it is at individual level, 
due to the averaging out of individual variations [122]. 
Regression coefficients, although less subject to change 
across different levels of analysis, will however also differ if the 
"ecological" variable (the average value of the individual 
characteristic for an entire aggregate unit) measures a different 
"underlying construct" than the same variable does at the individual 
level [123, 124]. 
This situation may arise, for example, when the aggregate 
effect of a characteristic is different from that of the same 
characteristic on individuals, due to so-called "structural" effects. 
A not too hypothetical example could be a structural effect of 
unemployment. The effect of unemployment as evaluated at an aggregate 
level, e.g. by a comparison of neighbourhoods, may differ from that 
found in studies of individuals, if high average unemployment rates 
have collective effects on these neighbourhoods. The effect of 
unemployment on health may be greater in neighbourhoods with a higher 
average rate of unemployment, due to the disrupting effects of such a 
high rate on the community. The "group characteristic" of the average 
unemployment rate then measures something else (or more) than the 
corresponding "individual characteristic". 
If one is interested in individual level relationships, the 
study of aggregate associations between unemployment and e.g. 
mortality rates would be subject to "ecological fallacy", i.e. 
"positive ecological bias", causing overestimation of the effect of 
unemployment on health. If one is interested in the effect of 
unemployment on communities, there is no bias. 
Structural effects may also be important in the explanation 
of aggregate associations between the level of supply of medical care 
and mortality (section X.3.2). 
1.6.5 Further problems in the explanation of differences in mortality 
at an aggregate level [125] 
1) The effects of changing scale [126] 
The theory of the "ecological fallacy" states that aggregate level 
76 
Introduction: methodological notes 
relationships are not necessarily identical to individual level 
relationships. This can be generalized to apply to studies at 
different levels of aggregation. 
The scale at which the analysis of geographical variation 
takes place can exert a strong influence on the results. In general, 
variables have less variance at larger levels of aggregation; this is 
because extremes are averaged out. The reduction of between-group 
variance with higher levels of aggregation is likely not to be the 
same for all variables of interest. More specifically, in a 
geographical analysis the grouping will frequently not be based on 
different levels of the dependent variable (mortality), but on 
different levels of one or more of the independent variables (such as 
socio-economic characteristics). Between-group variance in mortality 
(and other variables which are not related to the grouping) will 
decrease with higher levels of aggregation; between-group variance in 
the independent variables on which the grouping took place may remain 
the same or decrease less rapidly. 
These scale effects may be critical to the interpretation of 
research results. A higher level of aggregation will tend to inflate 
correlation coefficients between mortality and independent variables 
on which the grouping took place (although regression coefficients 
should be roughly comparable between levels). On the other hand, 
aggregation may result in a reduction of the variance of other indepe-
ndent variables of interest, and in a certain dilution of the effect. 
Consequently, the association between mortality and these other varia-
bles may never reach statistical significance. 
2) Spatial autocorrelation and other simple patterns of 
geographical variation [127, 128] 
Most statistical analyses of the association between mortality and 
other characteristics at the level of geographical units assume that 
each unit provides an independent estimate of the dependent variable, 
mortality. The geographical areas often are, however, far from 
independent, as a result of their proximity. If it is possible to 
explain this non-independence in terms of covariates which are also 
spatially correlated, no problem arises, but mostly the similarity of 
contiguous areas cannot be fully accounted for by known covaiiates. 
The error term in multiple regression models will be spatially 
correlated, and failure to allow for this may result in overestimates 
of the significance .of relationships. 
A frequent specific form of spatial autocorrelation is the 
existence of linear (or non-linear) gradients of mortality across 
geographical space. The existence of such a gradient, for example a 
simple pattern of increasing mortality from north to south, will 
induce spatial autocorrelation, and treating separate regions as 
independent units may be misleading (cf. chapter VIII). 
3) Multicollinearity 
Independent variables tend to be more highly correlated with each 
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other at an aggregate level than they are at the individual level. The 
resulting "multicollinearity" makes it difficult to isolate the 
effects of separate variables on mortality, especially when the number 
of aggregate units is small. 
4) Latency and mobility 
Frequently there is a considerable time-lag between exposure to a 
harmful (or protective) agent and the emergence of disease, let alone 
the moment of dying. The current distribution of mortality thus 
reflects the distribution of causative factors at an earlier moment in 
time. 
Although time-lags, if known, can be incorporated in the 
analysis, complications may still arise from the fact that migration 
occurs. The exposure to mortality risks of people dying in a certain 
area has not only occurred earlier in time, but may also partially 
have occurred elsewhere. Apart from migration, mobility in general 
will tend to reduce associations between mortality and other regional 
characteristics. Mortality from Traffic accidents, for example, may 
partially have occurred outside the domiciliary region of the 
deceased. Use of health care-services i~ neighbouring regions may 
compensate for any deficiencies in the region where the patient 
actually lives. 
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II Certification and coding of two 
underlying causes of death in The 
Nether lands and other countries 
of the European Community 
II.l Introduction 
The interpretation of mortality statistics by cause of death is usual-
ly complicated by uncertainties about possible biases ar~s~ng from 
differences in certification and coding of causes of death. Data are 
reported from two studies which were attempts to obtain detailed 
information on certification and coding practices for a selection of 
causes of death in countries of the European Community. The method 
employed consisted of the distribution of sets of case histories to 
samples of doctors in the participating countries, who filled in death 
certificates for these cases. The certificates were subsequently coded 
by national coding offices and a World Health Organization (WHO) 
reference center. 
In order to understand what is being measured in this type 
of study it is necessary briefly to recall that the production of the 
numerical code representing the so-called "underlying cause of death" 
involves three steps: the diagnostic process; completion of a death 
certificate; and coding of the statements on the death certificate, 
according to the rules and classifications provided by the Internatio-
nal Classification of Diseases (!CD) [1]. In each of these steps, an 
error can take a patient with a (true) underlying cause of death "X" 
to a code number representing another cause of death. Conversely, 
patients with other (true) underlying causes of death can erroneously 
receive the codenumber for "X". This is illustrated in table II.l. 
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Table 11.1 Schematic representation of possible relationships 
between "true" underlying causes of death and observed 
underlying-cause-of-death codes. 
True 
underlying 
cause of 
death 
Detection fraction = 
a 
a+b 
Underlying-cause-of-death code 
Diagnosis X All other 
Diagnosis X a b 
All other c d 
a 
Confirmation fraction = 
a+c 
The schematic representation in table II.l suggests two 
simple measures for the validity of an observed number of deaths from 
cause "X": 
- the "detection fraction": the proportion of deaths with a true 
underlying cause of death X which actually receives the code 
number for X; 
- the "confirmation fraction": the proportion of deaths receiving the 
code number for X which actually died from X. 
Although both detection and confirmation fractions should 
ideally be 100%, for epidemiological purposes it is generally suffi-
cient that there are no important differences in detection and confir-
mation fractions between the "times, places and persons" that are 
being compared. Studies in which sets of case histories are used are, 
essentially, an attempt to estimate (differences in) detection frac-
tions in so far as these are determined by the second and third steps 
mentioned above (certification and coding, respectively). 
Some of the results from the two European Community studies 
on death certification and coding have already been published [2,3], 
concentrating on the overall pattern of differences. This pattern, 
which will be briefly summarized here, raised important questions on 
the exact nature and the relative contribution of differences in 
certification and coding practices. A detailed analysis of the fre-
quency of specific errors in certification, and of the contribution of 
certification and coding differences is presented for The Netherlands. 
II.Z Methods 
In both studies, of which the first was carried out in 1981 and the 
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second in 1983/84~ sets of 10 case histories were sent to (different) 
samples of doctors in the then 8 member countries (excluding Luxem-
bourg) of the European Community. In most countries, including The 
Netherlands, names of doctors were extracted from random samples of 
death certificates received by national coding offices in a given 
month. In France and Italy, many certificates were unsigned or names 
were illegible and untraceable from the central offices. In Italy, 
therefore, a random sample of certifying doctors was obtained from 
regional registry offices stratified by town size. In France, it was 
possible to obtain a list of doctors from a single region, to 
eliminate doctors unlikely to complete certificates and to draw a 
random sample from the remainder. In Germany, data protection policies 
operate which prevent access to death certificates. German doctors 
were therefore selected from registers of practising physicians in the 
Berlin (West) region only. The German sample of the first study 
included general practitioners and internists but excluded physicians 
in hospitals; the sample of the second study consisted of hospital 
internists. 
Although more case histories were sent out, it is with a 
limited number of mutually comparable case histories that this article 
is concerned (table II.2). The other case histories were descriptions 
of a variety of other conditions of which the results cannot easily be 
summarized. The 6 case histories selected from the first study all 
concern a death from Chronic Obstructive Pulmonary Disease (COPD) 
treated here as one diagnostic entity, although the ICD distinguishes 
between chronic bronchitis, emphysema, and asthma. The 5 case histo-
ries selected from the second study all concern a death from a speci-
fic form of cancer. Numbers 1 to 4 were rather straightforward; number 
5 required a choice between 2 causes of death (of which a specific 
form of cancer was the right one). 
The type of information presented in these case histories 
was the diagnostic information which would normally be available to 
hospital doctors or general practitioners certifying the death of a 
patient in their practice. Each doctor was asked to complete a death 
certificate, as used in his/her own country, as if certifying an 
actual death. An incentive of (the equivalent of) £ 20 was offered. 
Reasonable response rates were obtained (table II.3). The 
objective was to obtain approximately 50 doctors in each country. 
Response percentages were between 60% and 92% in the first study 
(excluding West-Germany), and between 56% and 86% in the second study. 
For The Netherlands, response percentages were 67% and 65%, 
respectively. 
Completed certificates were sent for coding at national (in 
some countries: regional) coding offices, which treated the 
certificates according to practices in force at the time of the study. 
Finally, English translations of all certificates were sent to a World 
Health Organisation reference centre (which happened to be the English 
Office of Population Censuses and Surveys (OPCS)) for coding according 
to uniform criteria. 
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table 11.2 Case histories used for further analysis. 
Study Case history: 
I. 1. Chronic Obstructive Pulmonary Disease, 
dies during acute infection 
2. Chronic Obstructive Pulmonary Disease, 
progressieve dyspnoea 
3. Chronic Obstructive Pulmonary Disease, 
dies during pneumonia 
4. Chronic Obstructive Pulmonary Disease, 
dies during acute severe dyspnoea 
s. Chronic Obstructive Pulmonary Disease, 
progressive dyspnoea 
6. Chronic Obstructive Pulmonary Disease, 
cor pulmonale 
II. 1. Bladder cancer, 
dies during pneumonia 
2. Stomach cancer, 
dies during pneumonia 
3. Cancer of cervix uteri, 
dies in cachexia 
4. Malignant melanoma, 
dies during pneumonia 
s. Pleural mesothelioma, 
dies after pulmonary embolism 
One 
One 
One 
One 
One 
One 
Intended 3-digit 
ICD-9 codes 
of: 490-493,496 
of: 490-493,496 
of: 490-493,496 
of: 490-493,496 
of: 490-493,496 
of: 490-493,496 
188 
151 
180 
172 
163 
------------------------------------------------------------------------
Table II.3 Response percentages. 
Study Den- W-Ger- Engl./ Ire- Nether- Bel- France Italy 
mark many Wales land lands gium 
All 
--------------------------------------------------------------------------------------
I Complete re-
plies (n) 69 20 61 53 48 50 45 so 396 
Response (%) 92 25 85 66 67 63 60 63 65 
II Complete re-
plies (n) 50 39 50 63 51 50 53 so 406 
Response (%) 83 71 74 63 65 86 56 70 70 
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Table II.~ Estimates of detection fractions (xlOO%) for Chronic Obstructive 
Pulmonary Disease and a group of 5 specific cancers. 
Study Den-
mark 
I COPD 
(idem, after 
reference center 
coding) 
II 5 cancers 
(idem, after 
reference center 
coding) 
90 
(85) 
85 
(76) 
W-Ger- Engl./ 
many Wales 
90 86 
(88) (86) 
90 80 
(83) (79) 
Ire-
land 
92 
(91) 
74 
(79) 
Nether- Bel- France Italy 
lands gium 
91 72 85 60 
(84) (85) (69) (63) 
94 83 84 82 
(85) (84) (78) (87) 
All 
83 
(82) 
83 
(81) 
Note: For definition of detection fractions see table II.l; for codes used in determi-
ning detection fractions see table II.2. 
11.3 
Some of the material on which this table is based has been published in another 
form by Kelson and Heller [2] and Kelson and Farebrother [3]. 
Results 
After certification and coding by national coding offices, on average 
83% of all cases received a correct underlying-cause-of-death code, 
both in the first and in the second study (table II.4). There were, 
however, important differences between countries. In the first study, 
the degree of variation between countries was larger than in the 
second study. Italy and Belgium had distinctly lower than average 
detection fractions in the first study. Reference center coding im-
proved the detection fractions of Belgium and, although to a lesser 
extent, Italy, which suggests that the differences are completely 
(Belgium) or partly (Italy) explained by differences in coding. Ire-
land had a lower-than-average detection fraction in the second study, 
which improved only slightly after reference center coding. 
An interesting finding in both the first and the second 
study was that reference center coding reduced the detection fractions 
for Denmark, West-Germany, The Netherlands and France (table II.4). 
This suggests that certification practices are less reliable than the 
resulting national codes suggest, and that strict adherence to the 
rules for selection of the underlying cause of death by the reference 
center more clearly exposes the errors in certification. 
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Table 11.5 Errors on death certificates, The Netherlands, first study (6 cases of COPD) 
Type of error (according 
to doctors' entry) 
False diagnosis in part I 
Only symptoms, complications 
etc. in part I and II 
Correct diagnosis in part II 
Correct diagnosis in part I, 
but false sequence>~ 
No error: correct diagnosis 
in part I, correct sequence 
Total number of certificates 
All certi-
ficates 
n (%) 
21 (7) 
13 (5) 
13 (5) 
12 (4) 
228 (79) 
+ 287 (100) 
Note: For "intended" codes, see table II.2. 
Certificates ·certificates 
receiving "inten-' rec~iving "inten-
ded" code. from ded" code from 
national coding 
office 
n 
7 
6 
12 
12 
225 
225 
reference center 
n 
3 
1 
4 
11 
221 
221 
* Not corrected by stating the interval between onset and death. 
+ One certificate was returned empty. 
In order to gain more insight into these overall results, we 
classified the Dutch certificates according to the most serious 
certification error occurring on it. The Dutch death certificate is a 
translation, with minor modifications, of the internationally agreed 
medical certificate of cause of death [1]. Part I contains the 
sequence of events going back from the 11 direct cause of death11 under 
la to the 11underlying cause of death11 under lc. Part II should contain 
other conditions contributing to death which are not causally related 
to the underlying cause of death. 
The types of error considered for counting were, in order of 
diminishing seriousness: 
- a false diagnosis in 
were 11 lung fibrosis 11 
mesothelioma; 
part I of the certificate; examples of 
instead of COPD and 11 lung cancer11 instead 
this 
of 
- no diagnosis is mentioned on the certificate, only signs and 
symptoms or complications; examples of this were 11 cor pulmonale11 
without mention of the underlying COPD, and 11 pneumonia11 without 
mention of the underlying cancer; 
- the correct diagnosis is on the certificate but in part II, 
causally related11 ; a frequent example of this in the first 
90 
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table 11.6 Errors on death certificates, The Netherlands, second study (5 different 
cases of cancer) 
Type of error (according 
to doctors' entry) 
False diagnosis in part I 
Only symptoms, complications 
etc. in part I and II 
Correct diagnosis in part II 
Correct diagnosis in part I, 
but false sequence1: 
No error: correct diagnosis 
in part I, correct sequence 
All certificates 
All certi- Certificates Certificates 
ficates receiving "inten- receiving "inten-
ded" code from ded" code from 
national coding reference center 
office 
n (%) n n 
3 (1) 1 0 
3 (1) 0 0 
37 (14) 27 26 
9 (4) 9 7 
203 (80) 202 183 
255 (100) 239 216 
Note: For "intended" codes, see table II.2. 
* Not corrected by stating the interval between onset and death. 
was "pneumonia" in part I and COPD in part II; 
- the correct diagnosis is in part I but in a wrong sequence, not 
corrected by stating the interval between onset and death; an 
example of this was "cancer of the cervix" "due to cachexia". 
While the first of these four types of error is clearly an 
error of diagnosis, the other three will more often be errors of 
certification (arising when completing the death certificate). 
In both studies, about 207. of Dutch certificates showed one 
of these errors (tables II.5 and II.6). In the first study (table 
II.5) "a false diagnosis in part I" was more frequent than each of the 
errors of certification sensu stricto, but added together these were 
present on not less than 147. of the certificates. Remarkably, many 
certificates, although in error, received an "intended" (i.e. 
corresponding to the case histories) underlying-cause-of-death code 
from the national coding office. Part of this "correction" resulted 
from application of WHO coding rules, as is evident from the fact that 
reference center coding also assigned an "intended" code to some of 
these certificates, especially in cases of a false sequence in part I. 
Another part of this "correction", however, must be the result of 
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strictly national coding practices. These coding practices apparently 
involve a lot of (re-)interpretation of the statements on the death 
certificate. 
In the second study (table II.6), by far the most frequent 
type of error was "correct diagnosis in part II". This was about as 
often corrected by the national coding office as by the reference 
center. Now some discrepancies occurred for certificates which had 
been placed (by the authors) in the category "no error". These discre-
pancies were largely due to the fact that certificates for case histo-
ry no. 5, stating "malignant mesothelioma" without mention of the 
site, were coded by the reference center as "malignant neoplasm, site 
unspecified", and by the Dutch coding office as "malignant neoplasm of 
the pleura". This again is evidence of the interpretative efforts of 
the Dutch coding office. 
II.4 Discussion 
A recent bibliography of cause-of death validation studies published 
between 1958 and 1980 [4] .reveals that the use of sets of case histo-
ries to study differences in certification practices is relatively 
infrequent. Only one study employing this method was published during 
this period [5], studying differences in certification of certain 
causes of death between the United States, the United Kingdom, and 
Norway. Another study from the same period studied international 
differences in coding by supplying sets of completed certificates to 
national coding offices [6]. In 1982 the results of a study employing 
case histories were published [7], investigating regional differences 
in certification practices within England and Wales. 
The studies reported here were unique in the fact that 
certification and coding practices were studied at the same time. The 
studies mentioned above either studied differences in certification 
between countries [5] or differences in coding [6]. 
It is evident from our studies that certification and coding 
practices should preferably be studied in combination. Some differen-
ces in certification will be compensated for in the process of coding. 
The fairly high Dutch detection fractions found for two (groups of) 
underlying causes of death result from reasonable performance in 
certification and a coding process adapted to the frequency of some 
certification errors. Nevertheless, the over-all results, after natio-
nal coding, suggest that differences in certification and coding could 
in some cases be an important determinant of international mortality 
differences by cause of death. 
The main limitation of case history studies is that it is 
very difficult to ensure external validity. Neither choice and content 
of the case histories nor respondents• behaviour are necessarily 
representative of "real life". Nevertheless, the studies reported here 
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have indirectly demonstrated a certain degree of external validity. 
Some of the discrepancies between countries found in the first study 
have been shown to correspond to observed mortality patterns [2]. and 
the discrepancies found with the case history of cancer of the cervix 
in the second study have been shown to correspond to some observed 
mortality differences for this condition [3). 
The frequency of certain certification errors found in our 
detailed analysis of the Dutch material could give some clues for 
improvement. The frequency of a correct diagnosis in part II of the 
certificate instead of in part I suggests that some doctors in The 
Netherlands do not quite understand the meaning of the phrase: "other 
significant conditions contributing to the death, but not related to 
the disease or condition causing it" (which has a rather tortuous 
Dutch translation). Clarifying the objectives of this part of the 
certificate seems necessary. 
In the meantime, 
coding practices would not 
cause of death statistics. 
II.5 Summary 
further international standardization of 
necessarily improve the validity of Dutch 
Differences in certification and coding of causes of death between 
countries of the European Community were studied by sending sets of 
case histories to samples of certifying physicians. Completed 
certificates were coded by national coding offices and by a WHO 
reference center. Detection fractions ranged from 60 to 927. in a first 
study (concerning cases of Chronic Obstructive Pulmonary Disease) and 
from 80 to 947. in a second study (concerning cases of cancer). 
A detailed analysis of the findings for The Netherlands, 
which performed very well in both studies, reveals a substantial 
frequency of errors in certification (as opposed to errors in diagno-
sis). Comparison of national and reference center coding suggests that 
the Dutch coding process is to a certain extent adapted to the fre-
quency of these certification errors, leading to deviations from WHO 
coding rules. It is concluded that certification and coding practices 
should be studied together, and that further international stan-
dardization of coding practices will not necessarily improve the 
validity of national cause of death statistics. 
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III.l 
Health care policy and regional 
epidemiology 
- international comparisons and a case-study from TheN etherlands 
Introduction 
In The Netherlands, as in many other countries, the uncontrolled 
expansion of the health care sector during the 1960's gave rise to 
growing state intervention [1,2]. Extensive legislative efforts in the 
1970's produced several acts, including the important Health Care 
Services Act [3]. This Act (to be built into a largely analogous but 
wider Health Care and Social Services Act in the 1980's) specifies the 
increased responsibilities of the national, regional ("provincial") 
and local (municipal) authorities vis-a-vis the health care system. 
The existence of regional and local levels of health care 
policy is not a uniquely Dutch phenomenon. On the regional level, 
England has its Regional Health Authorities and Scotland its Health 
Boards, whereas in Denmark, Norway and Sweden "amtskommunene", 
"fylkeskommunene" and "landstinge" respectively have responsibilities 
for the health care sector. 
The emergence of these levels of health care policy raises 
two import~~t questions: 
- which criteria should be used for the allocation of financial, 
material and manpower resources to administrative units? 
- which criteria should be used for the development and evaluation 
of regional and local health care policy? 
As the goals of health care provision are related to the 
health status of the population, it is only logical that several 
countries have witnessed attempts to introduce measures of the health 
status of the population into both resource allocation formulas and 
procedures for developing and evaluating regional health care policy. 
We will discuss these attempts in section III.3 of this paper, after a 
specification of the epidemiological information that could be rele-
vant in these contexts (section III.2). The Netherlands are trying to 
keep up with the developments in neighboring countries with a number 
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of studies, recently performed or still in progress [4-7]. The results 
of one of these studies, focussing on the question of allocation of 
finance to regions, will be presented in section III.4. As a result of 
these and other epidemiologically inspired studies there is an in-
creasing awareness among health care policy-makers that the health 
status of the population is influenced by many other factors than 
health care alone. In The Netherlands, as well as in other countries, 
this has led to some propaganda for "health planning" instead of 
"health care planning", involving other policy areas than health care 
policy alone [8, 9]. For the sake of simplicity, however, this paper 
concentrates on health care policy. 
III.2 
III.2.1 
Epidemiological information for the planning and evaluation 
of health care services 
"Need" 
A specification of the type of information that could be relevant for 
the planning of health care services necessarily begins with a short 
elaboration on the concept of "need" for health care services, a 
classic example of health care terminology not settled in its meaning 
[10]. In Bradshaw's taxonomy [11] a distinction has been made between, 
among other things, "normative need", defined by some authority, and 
"felt need", perceived by the individual who is supposed to have the 
need. One form of normative need is "professionally defined need", and 
it is here that epidemiology could make a valuable contribution. 
An appropriate use of measures of need requires a functional 
perspective of health care [12, 13]. For the four basic functions of 
health care, the planning of services could be related to the follow-
ing measures of (professionally defined) need: 
- primary and secondary prevention: the incidence and prevalence of 
risk factors and early stages of disease; 
- medical treatment: the incidence and prevalence of disease; 
- (physical and social) rehabilitation: the incidence and prevalence 
of disabilities and handicaps (in the sense of the International 
Classification of Impairments, Disabilities and Handicaps (ICIDH)) 
- (boarding and nursing) care: the incidence and prevalence of 
restrictions in Activities of Daily Living (ADL). 
Usually, consideration of measures of need serves a policy 
of "equal access" to services. The distribution principle of equal 
access is popular in welfare states, because, to a large extent, it 
avoids having to judge the effectiveness of services [14]. The amount 
and nature of resources to be spent per unit of need (or 11need equi-
valent11 in the terminology of Donabedian [15]) is then simply equal to 
the "usual" amount of the 11usual resources. This procedure does not in 
itself guarantee equality of result, in the sense of an equal distri-
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bution of some kind of outcome measure, e.g. mortality, across the 
population. Some authors therefore argue that one should consider the 
effectiveness of services in assigning need equivalents [16, 17]. 
III.2.2 "Outcome" 
In the evaluation of health care services outcome measures play an 
important role. What has been said about need also applies to "out-
come", if we use this term in its ordinary sense of "final 
consequence": death, disease, disability/handicap, discomfort, dis-
satisfaction [18-20]. There is again a distinction between profession-
ally defined outcomes (death, disease, disability) and the analogues 
of felt need (discomfort, dissatisfaction), with professionally de-
fined outcomes more the domain of epidemiologists. 
Again, each function of health care has its own set of 
relevant outcome measures: 
- primary and secondary prevention: the incidence of preventable con-
ditions; 
- medical treatment: the duration of treatable disease; the incidence 
of avoidable consequences of disease (e.g. a more severe stage of the 
disease, disability, mortality); 
- (physical and social) rehabilitation: the duration of modifiable 
disabilities/handicaps; the incidence of avoidable consequences of 
disabilities/handicaps (e.g. permanent handicaps in the field of work 
or Activities of Daily Living); 
- (boarding and nursing) care: the incidence of avoidable consequences 
of ADL-restrictions (e.g. decubitus ulcers, inadequate food intake). 
Interestingly, then, a need for medical treatment could be 
an outcome of prevention, a need for care could be an outcome of 
medical treatment, and so forth. 
III.2.3 Necessary disaggregation 
With a variation on Lind and Wiseman's dimensions of priority setting 
[21], there are at least three important dimensions for the measure-
ment of needs and outcomes: type of health problem, e.g. disease group 
(HP); population subgroup (POP); geographical subunit (GEO). Without a 
split-up of measures of need and outcome into recognizable health 
problems it is very difficult to decide upon need equivalents or to 
look for deficiencies in the health care system. Ideally, the di-
mensions of population subgroup (age, sex, marital status, some in-
dicator of socio-economic status, ethnic group) and geographical 
subunit (regions, subunits of regions) should be combined with the 
dimension of health problem (POPxHP and GEOxHP; table III.1). 
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Table III.l Availability of information on mortality, 
admissions, disability benefits and health 
responses by "provincie" in The Netherlands, 
to three dimensions of disaggregation 
HP 
POPxHP 
GEOxHP 
Mortality 
+ 
± [a] 
+ 
Hospital 
admissions 
+ 
- [b] 
+ 
Disability 
benefits 
+ 
- [b] 
+ 
Health 
interview 
survey 
(+) 
(+) 
(+) 
HP = according to health problem; POP = according to population subgroups; 
GEO according to geographical subunits within "provincies". 
( ) Small number problems. 
[a] Only age, sex, marital status, nationality. 
[b] Only age, sex. 
hospital 
interview 
according 
III.3 Some British and Scandinavian examples of the use of 
regional epidemiological information for health care policy 
III.3.1 Using regional epidemiological information in resource 
allocation formulas 
The most widely discussed example of the use of regional epidemio-
logical information for resource allocation purposes is the formula 
for the allocation of finance to regional, district and area health 
authorities in England as developed by the Resource Allocation Working 
Party (RAWP)[22]. This so-called RAWP-formula is a serious attempt to 
base the geographical distribution of financial resources available 
for the National Health Service on the distribution of need in the 
population, instead of on historical patterns of supply. "Equal 
access" is the distribution principle. Apart from a number of demo-
graphic characteristics (size of the population, composition by age, 
sex and marital status), the formula employs Standardized Mortality 
Ratios (SMRs) by cause of death as measures ("proxies••) of 
differences in 11morbidity11 between regional populations. Mortality 
data by cause of death are generally considered to be the most pro-
mising source of information available [22-24], as will be illustrated 
in more detail for the Dutch situation in section 11.4.2. 
The need equivalent assigned to these measures of need is 
the "usual11 amount of the ••usual 11 resources. For instance, if the 
regional SMR for a given disease category is 1.10, presumably indica-
ting a 10% higher incidence or prevalence in this region as compared 
to the national population, the region receives 10% more funds from 
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the national budget currently spent on this disease category. 
The RAWP-formula has served as a source of inspiration for 
several other countries, both inside and outside the United Kingdom. 
Scotland [25], Wales [26], Northern Ireland [27], New Zealand [28] and 
New South Wales (Australia) [29] developed analogous formulas, though 
all substituting condition-specific mortality by Total mortality. 
Norway's formulas for the allocation of revenues from the social 
insurance system (covering health care expenditure) to regions and 
municipalities also employ standardized mortality (all causes) as a 
measure of need [30, 31]. 
Although the principle for assigning need equivalents in 
these countries is essentially the same as in England, table III.2 
shows some cracks in the reasoning. The table mentions the approximate 
"weights" assigned to standardized mortality data in the different 
formulas. A weight of 100% corresponds to the English position ex-
plained above. In Scotland the weights are smaller, though still 
considerable, due to the fact that the use of SMRs is limited to 
mortality and health care expenditure in the age groups 0-64 years. In 
Norway the weights are smaller still, due to a completely different 
structure of the formula. In New South Wales the weight assigned to 
the SMRs for the allocation of resources for in-patient hospital 
services is bigger than in England, because the budget includes the 
psychiatric hospitals. 
Table III.2 
England 
Scotland 
Wales 
"Weights" 
formulas 
regions. 
Northern Ireland 
New Zealand 
New South Wales 
Norway 
assigned to standardized mortality data 
for the allocation of financial resources 
In-patient 
hospital 
services [a] 
100 
ca 65 
100 
100 
100 
> 100 [b) 
ca 7 
Out- and 
day-patient 
hospital 
services [a) 
100 
ca 82 
100 
100 
100 
> 100 [b) 
n.a. 
Community 
health 
services 
100 
ca 78 
100 
100 
100 
100 
ca 5 
in 
to 
----------------------------------------------------------------------
[a) Excluding obstetrics and hospitals for mentally ill and mentally handicapped. 
[b) Including obstetrics and hospitals for mentally ill. 
Data from refs. [22) and [25-31). 
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The publication and adoption of the RAWP-formula, both in 
1976, have given rise to a lot of criticism, especially concerning its 
use of mortality data. Earlier in this paper, mortality data were 
introduced as possible outcome measures for a specific function of 
health care, but in RAWP- and related formulas mortality data are used 
as general measures of need. This conceptual leap is valid only if 
regional mortality differences reflect differences in incidence or 
prevalence over a wide range of conditions (i.e. if case fatality 
differences are small in comparison with incidence and prevalence 
differences) and of their consequences in terms of e.g disabilities/ 
handicaps. Many critics of the RAWP-formula have expressed doubts 
about the identification of mortality with morbidity [32-38]. A 
general conclusion from the debate, which has been reviewed elsewhere 
[39], would be that the use of mortality data in this formula is based 
on insufficiently validated assumptions. 
III.3.2 Using epidemiological information for regional health 
care policy 
Although RAWP meant its formula to be used for the allocation of the 
regional budget to (the since abolished areas and) districts too, this 
has been criticized on both statistical [40, 41] and philosophical 
grounds [42, 43]. As one critic wrote: "At lower levels of population 
aggregation real resource considerations operate too powerfully for 
abstract formulae to exert much influence. ( ... )National uniformity 
as a desirable aim in itself must be abandoned and the development of 
different methods of health care by different health authorities be 
encouraged" [43]. A fresh consideration of measures of need and out-
come at this level, in the light of regional circumstances, seems 
necessary. Again, mortality data have been tried first. In the United 
Kingdom, a number of causes of death has been selected as potential 
outcome indicators for use at the regional level [44]. The possibili-
ties and limitations of this study of "avoidable mortality" are now 
being investigated. This includes the development of a framework for 
studying the causes of regional differences in avoidable mortality 
[45]. 
A Swedish group studied the availability of regional epi-
demiological information [24], and decided to start with a "regional 
mortality display", indicating areas for further action or study. The 
same group has recently published a number of guidelines for regional 
mortality analyses [46]. The results of these studies are intended to 
be used for developing regional health policy, not merely regional 
health care policy. 
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III.4 A DutCh case-study 
III.4.1 The Dutch "provincie" and the health care system 
The Dutch "provincie" is an administrative layer between the municipal 
and national authorities, covering populations ranging from 350.000 to 
3.100.000 people. A predecessor of the Health Care Services Act, the 
Hospital Services Act, already charged the provincial authorities with 
certain responsibilities for the health care system, viz. the task of 
drawing up 4-year-plans for the hospital services (acute general 
hospitals, specialized hospitals, nursing homes, psychiatric 
hospitals, institutions for the mentally handicapped). The Health Care 
Services Act now extends this plan-making activity to all levels of 
administration and the whole health care sector. The following distri-
bution of responsibilities is envisaged: the.national authorities will 
draw up a plan for a limited number of services with national 
importance, the provincial authorities for the hospital services, and 
the municipal authorities for first echelon services (family practi-
tioners, midwives, district nurses etc.) and public health services. 
The distribution of the nationall~ available resources 
across provinces will be regulated by a number of central guidelines. 
These guidelines regarding the use of financial, material and manpower 
resources will act as constraints on the planning activities by pro-
vinces. The Ministry of Welfare, Public Health and Culture has 
expressed the wish that these guidelines will reflect the need for 
health care services. (The distribution of resources within provinces 
will be dealt with in the provincial plans, which will form the basis 
for granting licences (necessary to build or run a service) and certi-
fications (necessary to receive funds from public services)). 
The intention to use measures of need can at least in part 
be realized by using demographic information (size and composition of 
the population served) and relating this to the volume of services (as 
in the commonly used bed/population ratios), but this was felt as 
being insufficient. 
III.4.2 What use could be made of 
epidemiological information? 
routinely collected 
In The Netherlands, there are four general sources from which data can 
be made available at the regional (i.e. provincial) level: mortality 
statistics; hospital admission statistics; disability benefit 
statistics, based on a registration of new cases eligible for (long-
term) disability benefits; the Health Interview Survey, conducted in a 
yearly sample (n=ca.lO.OOO) of the non-institutionalized population. 
Unfortunately, there is no national cancer registry in The Nether-
lands, whereas one other potentially important form of information, 
short-term sickness benefits, cannot be made available on the pro-
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vincial level because place of residence is unrecorded. Apart from 
these general sources, there is a small number of sources more limited 
in scope (e.g. notifications of infectious diseases, traffic 
accidents) which this paper does not consider. 
Table III.1 summarizes the availability of information from 
the aforementioned four general sources. Apart from the lack of in-
formation for specific population subgroups there are other important 
problems. As indicated in table III.1, the small number of respondents 
in the Health Interview Survey renders an analysis by health problem 
difficult, even at the provincial level. Disability benefit statistics 
suffer from the problem that the size and composition of the popula-
tion-at-risk (those insured) are not exactly known, and that labour 
market conditions exert a powerful influence on disability benefit 
rates. Hospital statistics strongly reflect existing health care 
supply. Our conclusion, in line with the British and Scandinavian 
experience, was, that mortality data by cause of death are a relative-
ly promising source of regional epidemiological information for health 
care policy purposes. 
In view of the doubts surrounding their interpretation (see 
section III.3) we decided to limit the use of mortality data to 
disease groups displaying a certain degree of correspondence between 
mortality on the one hand, and hospital admissions and incidence of 
cases eligible for disability benefits on the other hand. A 
correspondence in the pattern of provincial differences between 
mortality and one or both of the other measures will be interpreted as 
evidence for the conclusion that mortality differences do reflect 
incidence or prevalence differences, a prerequisite for the use of 
mortality data as measures of need. 
III.4.3 Provincial differences in disease-specific 
hospital admissions and disability benefits 
mortality, 
The disability benefit data were restricted to males, because the 
female population at risk for this type of work disability is only a 
small part of the total female population. For males and females 
separately we selected diagnoses for which, on the national level, at 
least 250 deaths, hospital admissions or new disability cases 
respectively had been registered in the two years 1977 and 1978. 
Standardized Mortality Ratios were calculated with national age-
specific rates as the standard. For the sake of convenience, we will 
use the terms Standardized Mortality Ratios (SMRs), Standardized 
Hospitalization Ratios (SHRs) and Standardized Disability Incidence 
Ratios (SDIRs). We calculated Spearman rankorder correlations between 
SMRs and SHRs (males and females separately) and between SMRs and 
SDIRs (males only). 
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Provincial SMRs, SHRs and SDIRs for all causes combined are 
presented in table III.3. The southwestern province of Zeeland appears 
to occupy a favorable position in all the data, for males as well as 
for females. The southern provinces of Noord-Brabant and Limburg 
occupy unfavorable positions. For the other provinces the pattern is 
not very consistent, especially for the northern province of 
Groningen, which has low total SHRs, low to average SMRs, and very 
high SDIRs. 
Table III.3 Standardized Mortality Ratios (SMRs), Standardized Hospi-
talization Ratios (SHRs) and Standardized Disability 
Incidence Ratios (SDIRs), all causes, by "provincie" and 
sex (1977/1978 combined). 
Groningen 
Friesland 
Drenthe 
Overijssel 
Gelder land 
Utrecht 
Noord-Holland 
Zuid-Holland 
Zeeland 
Noord-Brabant 
Limburg 
Chi-square 
SMR 
(males) 
0.98 
0.95* 
0.94* 
0.99 
1.00 
1.00 
1.00 
0.99 
0.88* 
1.04* 
1.11* 
205.31 
SMR 
(females) 
0.98 
0.99 
0.98 
1.02 
1.02* 
0.99 
0.97* 
0.97* 
0.92* 
1.08* 
1.09* 
172.45 
SHR 
(males) 
0.83* 
0.90* 
0.83* 
0.93* 
1.00 
1.05* 
1.04* 
0.96* 
0.95* 
1.10* 
1.11* 
8119.05 
SHR 
(females) 
0.85* 
0.95* 
0.88* 
0.95* 
1.00 
1.05* 
1.05* 
0.96* 
0.94* 
1.04* 
1.11* 
6245.52 
SDIR 
(males) 
1.36* 
1.04* 
1.22* 
1.06* 
1.03* 
1.02* 
1.03* 
o. 74* 
0.73* 
1.04* 
1.44* 
6816.85 
----------------------------------------------------------------------
* p <.OS 
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rahle III.4 Diagnosis-specific rank order correlations between Standardized 
Mortality Ratios (SMRs) and Standardized Hospitalization Ratios (SHRs), 
and between SMRs and Standardized Disability Incidence Ratios (SDIRs). 
ICD-
chap-
ter 
Diagnosis 
II 1. Stomach cancer 
2. Intestinal cancer 
3. Rectum cancer 
4. Cancer respiratory organs 
5. Breast cancer 
6. Cervix uteri cancer 
7. Prostate cancer 
8. Bladder cancer 
9. Leukemia 
III 10. Diabetes mellitus 
IV 11. Paralysis agitans 
VII 12. Hypertension 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
Ischemic heart disease 
Symptomatic heart disease 
Cerebrovascular disease 
Arteriosclerosis 
Arterial embolism/thrombosis 
Pulmon. embolism/infarction 
Phlebitis/thromb./embo1ism 
VIII 20. Pneumonia and influenza 
21. Chronic obstr. pulm. dis. 
IX 22. Ulcer of stomach/duodenum 
23. Liver cirrhosis 
24. Cholelithiasis/-cystitis 
X 25. Nephritis/nephrosis 
26. Infection of kidney/bladder 
27. Hyperplasia of prostate 
XVII 28. Fracture of verebral 
column and trunk 
29. Fracture of neck of femur 
30. Intracranial injury 
All causes 
ICD-8 
151 
152-153 
154 
160-163 
174 
180 
185 
188 
204-207 
250 
342 
400-404 
410-414 
427 
430-438 
440 
444 
450 
451-453 
470-474, 
480-486 
490-493 
531-533 
571 
574-575 
580-584 
590-595 
600 
N805-809 
N820 
N850-854 
all 
SMRs vs 
SHRs 
males 
0.82* 
0.581< 
(0.10) 
0.42 
n.a. 
(0.23) 
0.51 
0.35 
(0.53) 
(0.60)~' 
(-0.05) 
0.13 
0.79* 
0. 71~· 
0. 75~' 
(0.67)'~ 
0.32 
(0.14) 
0.681< 
0.79>'< 
(0.05) 
(0.40) 
0.30 
(-0.06) 
(-0.05) 
(-0.03) 
0.51 
(0.85)* 
0.20 
0.86>'< 
SMRs vs 
SHRs 
females 
0. 78~' 
(0.52) 
(0.52) 
0.84~' 
0.41 
0.60~' 
n.a. 
(0.07) 
(0.12) 
0.44 
0.24 
0.26 
-0.12 
0.81''' 
0.49 
0.58''' 
0.66''' 
0.42 
(0.66)1< 
0.59>'< 
0.13 
(0.60)>'< 
(0.61)"' 
(-0.16) 
(0.10) 
(-0.41) 
n.a. 
(0.21) 
0. 73'~ 
-0.23 
0.45 
SMRs vs 
SDIRs 
males 
0.13 
-0.44 
n.a. 
(-0.10) 
(0.32) 
(-0.07) 
0.84>'< 
0.23 
0.05 
0.62* 
(0.51) 
0.08 
(0.30) 
(0. 70)'~ 
(-0.17) 
0.14 
(0.43) 
0.42 
0.18 
Rank order correlation coefficient significantly different from 0 (p <.05) 
Number of deaths, hospital admissions or new cases of disability benefits 
< 250 (1977+1978) 
( ) No statistically significant provincial differences {Chi-square test, p > 0.05) 
for one or both of the data 
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Rankorder correlations between SMRs and SHRs and between 
SMRs and SDIRs, for the selected conditions, are presented in table 
III.4. As could be expected on the basis of the patterns for total 
SMRs, SHRs and SDIRs, correspondence between SMRs and SHRs is 
generally better than that between SMRs and SDIRs. The correspondence 
between SMRs and SHRs is, however, not simply a matter of one under-
lying pattern. The positive correlations between mortality and hospi-
tal admissions for Stomach cancer (no. 1 in table III.4), for 
instance, are the result of a pattern completely different from the 
one seen in Total mortality and hospital admissions. Here, Groningen, 
Friesland and Zeeland have the highest rates (cf. table III.3). 
Although there is some correspondence between SMRs and SHRs, 
there are also important exceptions. For both males and females there 
is a conspicuous lack of agreement between mortality and hospital 
admissions for Ischemic heart disease (no. 13 in table III.4). In-
spection of the individual SMRs and SHRs (not shown in the tables) 
suggests that the main reason is that the high SMRs for Ischemic 
heart disease observed in Groningen for both males and females are not 
matched by high SHRs. 
III.5 Discussion 
Correspondence between mortality by cause of death and two other 
routinely available, equally doubtful indicators of morbidity is not a 
very powerful test of the validity of mortality as an indicator for 
regional morbidity differences. Nevertheless, a general identification 
of regional mortality with morbidity or need for a range of health 
problems, as assumed in RAWP- and related formulas, does require some 
support, and that certainly is not what this study provides. For 
example the lack of correspondence between mortality and hospital 
admissions for Ischemic heart disease could be due to a number of 
factors. The hospital data could be biased by differences in certifi-
cation of diagnostic information but so could the mortality data (for 
a bibliography on the validity of cause of death information see ref. 
47). There could be differences in admission policy, leading to a 
larger number of patients being treated outside hospital in Groningen, 
but also case fatality for this condition could be greater in 
Groningen. 
In view of these findings, and the uncertainties expressed 
in the literature, we conclude that in the context of the formal 
allocation of resources to administrative units, confidence in morta-
lity data by cause of death as indicators of morbidity is not enough 
to assign weights comparable to those used in RAWP- and related 
formulas [4, 5]. If one does want to allow for higher or lower total 
mortality in certain regions, in addition to differences in size and 
composition of the population, a more judicious procedure would be to 
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analyse case by case to check whether a higher or lower mortality for 
the two or three largest cause-of-death groups can be found back in 
health care consumption patterns, and to take the proportions of these 
groups of conditions in different health care sectors as weights in an 
allocation formula. On the other hand, in the context of developing 
and evaluating regional health care policy, where a more flexible 
approach is possible, mortality data by cause of death can be very 
useful by providing a focus on population health status and a starting 
point for further studies. Expressed more formally, mortality data 
will be useful in a stage of hypothesis formation, implying that other 
more powerful studies will follow to test and refine the hypotheses 
[48]. This will almost automatically broaden the scope from health 
care policy to health policy. 
III.6 Epilogue 
Throughout this paper, we have tried to specify information require-
ments from the health care policy viewpoint. Available information on 
the health status of regional populations offers only modest per-
spectives for a need- and outcome-based health care policy. It is, 
however, equally important to specify policy requirements from an 
epidemiological viewpoint. Two requirements are obvious when one 
wishes to focus health care policy on population health status: 
- the interpretation of regional epidemiological information requires 
intensive study (cf. the frameworks for regional mortality analysis 
developed in the United Kingdom [45] and Sweden [46]). This can only 
be realized if epidemiological expertise is at the disposition of the 
relevant authorities; 
- if the results of these studies are to be useful, the scope of 
possible actions open to the authority in question should not be very 
limited. As shown in section III.2.2, a careful consideration of 
measures of need and outcome always involves more than one link in the 
chain of health care utilization. The restriction of the responsi-
bilities of the provincial authorities in The Netherlands to hospital 
services is thus an important structural limitation to the development 
of an epidemiological approach towards regional health care policy. 
III.7 S1lllllllary 
In a number of countries, regional levels of administration have 
assumed responsibilities for the health care sector. This paper pre-
sents a specification of epidemiological information that could be 
relevant for health care policy towards and within regions, as well as 
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a review of a number of British and Scandinavian attempts at using 
routinely ·available mortality data for these purposes. A Dutch case-
study is then presented. To determine whether regional mortality data 
by cause of death can be used as indicators of need for health care, 
and consequently be used as criteria for the allocation of financial 
resources, the correspondence between provincial disease-specific 
mortality, hospital admissions and new cases of disability benefits 
was analyzed. The findings were not convincing: for a number of 
diseases a reasonable correspondence between mortality and hospital 
admissions could be shown; for other conditions however, especially 
Ischemic heart disease, none at all. It is concluded that: 
- in the context of the formal allocation of health care resources to 
administrative units, a strong confidence in mortality data by cause 
of death is unwarranted; 
- in a (broader) context of developing and evaluating regional health 
care policy mortality data by cause of death can be useful for pro-
viding a focus on population health status and a starting point for 
further studies. 
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Stained glass window in St. James's Church (Sussex Gardens, London). 
A commemorative text tells us that "This window, replacing one 
destroyed by home-blast in October 1940, holds in memory the many who 
gave their lives during the battle of Britain". In the lower right 
hand corner Alexander Fleming is shown at work in his laboratory, 
which was located in the vicinity of this church. 
The photograph was kindly made available by the Reverend Mr. D. Perkin. 
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IV.l 
Secular trends of infectious 
disease mortality in The 
Netherlands, 1911-1978 
quantitative estimates of changes coinciding with the 
introduction of antibiotics 
Introduction 
A large part of the decline of infectious disease mortality occurred 
before the introduction of efficacious drugs: the sulphonamides, just 
before World War II, and penicillin and a number of other 
antimicrobial drugs, just after World War II [1,2]. Nevertheless, 
visual inspection of mortality curves does suggest a certain impact of 
the first antibiotics (we will omit the bothersome "and 
chemotherapeutics") on mortality from Puerperal fever, Pneumonia, 
Syphilis and Tuberculosis in England and Wales [1]. 
A linear regression analysis on crude mortality rates in 
Sweden led the authors to conclude that, after the introduction of the 
first antibiotics, mortality rates declined faster for Septicemia, 
Syphilis and Non-meningococcal Meningitis, but not for 10 other 
infectious diseases, including Puerperal fever, Pneumonia and 
Tuberculosis [3]. The method of analysis employed in this study was, 
however, rather crude. Mortality rates were not standardized for age 
and sex, and used in the regression analysis without a logarithmic 
transformation. 
The study reported here is an analysis of secular trends of 
infectious disease mortality in The Netherlands, meant to provide 
quantitative estimates for changes coinciding with the introduction of 
antibiotics. Our "design" can be described as a "simple interrupted 
time series design" [4], in which a number of observations on 
mortality from infectious diseases before the introduction of 
antibiotics, serve as a baseline against which "signs of interruption" 
are to be detected. The main limitation of this design is, of course, 
the absence of a control group. No otherwise comparable populations 
without the benefit of antibiotics are available. 
Table IV.1 shows the causes of death for which an effect of 
the introduction of antibiotics could be expected. 
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Table IV.l Causes of death included in the analysis. 
Cause of death 
Puerperal fever 
Scarlet fever 
Rheumatic fever 
Erysipelas 
Septicemia 
Meningoccoccal meningitis 
Non-meningococcal meningitis 
Acute bronchitis 
Pneumonia 
Otitis media 
Upper respiratory infections 
Influenza 
Measles 
Pyelonephritis 
Cystitis 
Skin infections 
Osteomyelitis 
Syphilis 
Tuberculosis 
Bacillary dysentery 
Typhoid fever 
All other diseases 
Total mortality 
Deaths 
1911-1978 
5538 
4001 
5946 
6791 
17349 
3839 
21742 
22067 
331032 
6312 
10938 
97746 
21145 
16802 
4590 
10165 
3614 
21999 
279181 
2791 
6832 
5064713 
5965133 
Idem, as % of 
total mortality 
0.1 
0.1 
0.1 
0.1 
0.3 
0.1 
0.4 
0.4 
5.5 
0.1 
0.2 
1.6 
0.4 
0.3 
0.1 
0.2 
0.1 
0.4 
4.7 
0.0 
0.1 
84.9 
100 
Table IV.2 The first antibiotics: amounts delivered to hospitals in The Hague, 
The Netherlands, 1946-1958 
1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 
Peni~illin 1 9 14 39 46 52 68 86 90 100 109 106 114 
(10 i.U.) 
Streptomycin 2 10 13 18 26 26 33 50 47 45 49 56 
(kg) 
PAS 6 400 540 570 490 460 480 430 483 417 472 
(kg) 
Chloramphenicol 1 2 11 18 14 21 25 34 50 58 
(kg) 
Tetracyclin 0 3 3 5 11 13 12 14 17 16 
(kg) 
-----------------------------------------------------------------------------------
Data from annual reports Apotheek Haagse Ziekenhuizen, The Hague, The Netherlands. 
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Influenza and Measles are included in the analysis because 
death mainly occurs from bacterial superinfections; this may also 
apply to some other respiratory infections. "All other diseases" are 
included for comparison: changes resembling effects of antibiotics are 
expected not to be present for this category. 
Sulphanilamide was first used in The Netherlands in 1936, 
penicillin in 1944 (but supplies were very limited until 1947 [5, 6]), 
streptomycin in 1947 and chloramphenicol in 1949. A central 
registration of drug sales did not exist in The Netherlands in these 
years, but information is available on amounts of antibiotics 
delivered to hospitals in The Hague (table IV.2). 
Apart from PAS (used in the treatment of Tuberculosis) all 
drugs show gradual increases in the amounts delivered, suggesting slow 
diffusion. As the data apply to one of the more highly developed parts 
of the country, another number of years has to be added to allow for 
diffusion into more backward regions. 
Two types of effect on infectious disease mortality will 
therefore be considered: 
- a sharp reduction of mortality, approximately coincident with the 
moment of introduction of antibiotics, showing as a change in level or 
intercept in a regression analysis; 
- a longer lasting (acceleration of) mortality decline, in the period 
between introduction and large scale application of antibiotics, 
showing as a change in trend or slope in a regression analysis. 
Further improvements of the efficacy of antibiotics and 
indirect effects on incidence (due to treatment of otherwise infective 
cases, as in Syphilis and Tuberculosis, activating a "positive feed-
back loop" [7,8]) will tend to reinforce the second type of effect. 
IV.2 Sources of data 
Numbers of deaths by underlying cause, calendar year (1911-1978), age-
group and sex were extracted from the yearly publications of the Dutch 
Central Bureau of Statistics (CBS) [9]. Cause-of-death codes were 
carefully selected so as to minimize the effect of changes in the 
International Classification of Diseases (ICD) [see Annex 1 for code-
numbers]. Inspection of the numbers of deaths for the so-formed causes 
did not reveal important breaks between ICD-revisions. Changes in 
classification by age made it necessary to use ten-year age-groups 
(<1, 1-4, 5-9, 10-19, 20-29, 30-39, 40-49, 50-59, 60-69, 70-79, 80+). 
Population numbers, by age-group and sex, were available from other 
CBS-publications [10]. Approximate person-years at risk for a given 
calendar-year were calculated by averaging the population numbers of 
the 31st of December of the current and the previous year. 
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IV.3 Methods 
For a first impression, the mortality data were standardized for 
changes in age- and sex-structure of the population by calculating 
Standardized Mortality Ratios (SMRs) [11]. Average mortality rates by 
age and sex for the entire period 1911-1978 were used as 
standardrates. 
Inspection of SMR time trends was followed by loglinear 
regression analysis [12], in which the observed number of deaths (Y) 
was related to the explanatory variables person-years at risk, age-
group and sex, and calendar year as follows: 
E(y.) 
1 
where E(y) 
N 
e 
a, ~ = 
X 
i 
N (a. + ~X) .e 1 
1 
expected number 
person-years at 
base of natural 
of deaths 
risk 
logarithm 
parameters to be estimated 
calendar-year 
subscript denoting age-group and sex 
~ is the slope of the regression line of the natural 
logarithm of mortality density vs. calendar year, and thus represents 
the trend of mortality with time. a is the intercept of this 
regression line. The effect of assigning different values of a to 
different age- and sex-groups i is that ~ is not sensitive to changes 
in the age- and sex-structure of the population; ~ is assumed to have 
the same value for all age- and sex-groups. 
On the basis of this basic model we constructed a number of 
"segmented regression models" [13] in which a first segment covered 
the years before the introduction of antibiotics, and a second segment 
a period of approximately the same length thereafter. The first and 
second segments connected in 1947. The years before 1921 were excluded 
because of the effect of World War I. We ignored the observed values 
for 1940-1946 because of the effect of World War II, and assumed that 
in the absence of World War II mortality would have continued the 
trend of 1921-1939 (figure IV.1). 
The computations were performed with the GLIM computer 
package, specifying a Poisson regression model [14]. A sequence of 4 
models was fitted: 
1) no change between segments 1 and 2 (a2 = 0, ~2 = 0); 2) a change in intercept in 1947, but no cfiange in slope (~2 = 0); 3) a change in slope in 1947, but no change in intercept (a2 = 0); 4) a change in intercept and a change in slope in 1947. 
Because differences in scaled deviance between models showed that the 
addition of a 2 and that of ~2 were highly statistically significant (p 
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Figure IV.l Schematic representation of the segmented regression model. 
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where 
Segment 1 
1939 
intercept for segment 1 
slope for segment 1 
Segment 2 
0 
Cl1 
Cl2 
change in intercept between segments 1 and 2 
difference in slopes between segments 1 and 2 
calendar-year - 1947 
1968 
dummy variable (1 if calendar-year > 1946, 0 if 
calendar-year < 1947) 
For E(y), Nandi see text. 
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< 0.001) in almost all cases, we will uniformly report parameter 
estimates obtained with model 4. 
This regression analysis assumes a linear relationship 
between log mortality density and calendar-year within the two time-
periods. A formal test for linearity, based upon the Wald-Wolfowitz 
"runs test" [15], showed that some systematic deviations did occur. 
Deviations from linearity were highly statistically significant (p < 
.001) in Pyelonephritis, which was therefore excluded from the analy-
sis. Deviations for some other diseases, although statistically signi-
ficant (p < .OS), were relatively minor on visual inspection, and 
these were therefore retained in the analysis. 
IV.4 Results 
Mortality time trends for 21 infectious diseases, age- and sex-
standardized and semi-logarithmically plotted, are presented in figure 
IV.2. For most infectious diseases there is a general downward trend 
in mortality since 1911, temporarily interrupted by the effects of 
World War I and, even more so, of World War II. 
For some diseases a sharp reduction in mortality, to a level 
lower than that immediately before World War II, may have taken place 
in the late 1940 1 s: Erysipelas, Pneumonia, Otitis media, Upper 
respiratory infections, Skin infections, Osteomyelitis are examples. 
For a number of other diseases, however, mortality levels in the 
second half of the 1940s are higher than those in the years before 
World War II, e.g. for Meningococcal and Non-meningococcal meningitis 
and for Tuberculosis. 
If mortality trends before and after World War II are 
compared, an accelerated or fresh mortality decline seems to be 
present in the second period for e.g. Puerperal fever (possibly even 
starting before 1940, with the introduction of the sulphonamides?), 
Scarlet fever, Rheumatic fever, Erysipelas, Otitis media, Upper 
respiratory infections, Influenza, Tuberculosis, Syphilis, and 
Bacillary dysentery. 
The results of the regression analysis are presented in table 
IV.3. The downward trend of mortality before the introduction of 
antibiotics is reflected in the generally negative values for ~1 . The 
estimates for changes in level in 1947 are mostly negative, implying 
the expected sharp reductions of mortality after World War II. In "All 
other diseases" there is also a drop in mortality, but this is much 
smaller. As was already observed in the SMR plots (figure IV.2), the 
change in level is sometimes positive (Meningococcal and Non-
meningococcal meningitis; Acute bronchitis; Tuberculosis; Bacillary 
dysentery; Typhoid fever). Inspection of figure IV.2 suggests that, 
with the exception of Acute bronchitis, late effects of World War II 
may be involved. 
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table IV.3 Estimates and standard errors of changes in mortality level and changes 
in mortality trend in 1947 
Puerperal fever 
Scarlet fever 
Rheumatic fever 
Erysipelas 
Septicemia 
Meningococcal meningitis 
Non-meningococcal meningitis 
Acute bronchitis 
Pneumonia 
Otitis media 
Upper respiratory infections 
Influenza 
Measles 
Cystitis 
Skin infections 
Osteomyelitis 
Syphilis 
Tuberculosis 
Bacillary dysentery 
Typhoid fever 
All other diseases 
Total mortality 
Trend 1921-1939 Change in level Change in trend 
- .01 
- .03 
- .00 
- .02 
- .06 
- .01 
- .08 
- .07 
- .04 
.OS 
.03 
- .01 
- .08 
- .04 
- .03 
- .01 
- .01 
- .06 
.OS 
- .11 
- .01 
- .02 
s.e. 
.003 
.005 
.004 
.003 
.002 
.005 
.002 
.003 
.001 
.004 
.003 
.001 
.002 
.003 
.003 
.005 
.002 
.001 
.014 
.005 
.000 
.000 
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-1.37 
-1.33 
- .03 
- .98 
- .10 
.27 
.53 
.68 
- .41 
-1.26 
-1.22 
- .60 
- .37 
- .so 
- • 75 
-1.00 
- .40 
.24 
.40 
.62 
- .04 
- .OS 
s.e. 
.104 
.171 
.081 
.091 
.056 
.108 
.056 
.060 
.013 
.076 
.064 
.021 
.067 
.081 
.073 
.117 
.042 
.015 
.247 
.123 
.003 
.003 
- .11 
- .11 
- .18 
- .10 
.02 
- .OS 
.04 
- .02 
- .01 
- .13 
- .08 
- .04 
- .01 
- .02 
- .04 
- .04 
- .08 
- .12 
- .26 
.09 
.01 
.01 
s.e. 
.011 
.019 
.008 
.008 
.004 
.007 
.004 
.004 
.001 
.006 
.005 
.001. 
.006 
.006 
.006 
.009 
.003 
.002 
.021 
.008 
.000 
.000 
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The estimates for changes in trend are also mostly negative 
(and statistically significantly so in 16 infectious diseases), 
implying faster mortality decline after 1947. It is important to note 
that the pre-war decline in mortality from "All other diseases" did 
not accelerate, but instead slowed down after 1947. 
The estimated values for a2 and ~2 are not small. For 
example, a value for a 2 of -.41, as in the case of Pneumonia, implies 
a reduction of mortality to a level of exp(-.41) = .66 times the level 
expected on tee basis of the mortality experience of 1921-1939. Values 
for ~2 (if not too large, say> -.10 and< .10), multiplied by 100, 
are approximately equal to the difference in per cent per annum 
mortality decline before and after 1947. Thus, in the case of 
Syphilis, where mortality decreased 1 % per annum in 1921-1939 (100 x 
~1 ), the rate of decline accelerated with 8 % (100 x ~2 ) to 9 % per 
annum after 1947. 
IV.S Discussion 
Whether or not the introduction of the first antibiotics has had a 
notable impact on infectious disease mortality is one of the classical 
questions of epidemiology. Most analyses of this question have been of 
an informal nature. In the formal analysis presented here two types of 
change in secular trends of mortality, roughly coinciding with the 
introduction of antibiotics, were measured. The results show that 
these changes were present in a wider range of infectious diseases 
than was known so far. Differences between infectious diseases may be 
due to a number of factors, including differences in effectiveness of 
antibiotics. 
In order to obtain quantitative estimates for these changes 
it was necessary to make a number of assumptions. One of these 
(linearity of log mortality density vs. time within the two sub-
periods) was already shortly discussed in the Methods section. Some 
diseases included in table IV.3 had statistically significant devia-
tions from linearity, for example Tuberculosis and Syphilis. Within 
the second subperiod, the curve of log SMR vs. time is concave for 
Tuberculosis, and convex for Syphilis (figure IV.2). Although a 
different model might have produced slightly different estimates, a 
comparison between table IV.3 and figure IV.2 suggests that these and 
other deviations from linearity are not likely to invalidate the 
global picture. 
A second assumption, necessary because observed values for 
1940-1946 were ignored, was that without World War II mortality would 
have continued the trend of 1921-1939. Actually, World War II 
deflected mortality trends to such an extent that, for some diseases, 
mortality in 1947 was higher than in 1939 (figure IV.2). Possible 
explanations are that living conditions (food and housing) were still 
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precarious, and that sanitation efforts were not yet at pre-war 
levels. Observed changes in level of mortality in 1947 thus combine 
the late effects of World War II and the sharp mortality reductions 
that may have accompanied the introduction of antibiotics. Although 
observed changes in trend are less sensitive to violations of this 
assumption, underestimating a change in level may cause overestimation 
of a change in trend, and vice versa. For most infectious diseases 
both changes in level and changes in trend are however negative, so 
that it is difficult to escape the conclusion that some real changes 
in mortality occurred. 
A third assumption was absence of interactions between ~ , 
a2 , and ~2 , on the one hand, and age and sex, on the other hanA. Calculations with a model in which ~ 1 , a 2 , and ~2 were made age- and 
sex-specific, just as a 1 , show that differences between age- and sex-groups are frequently statistically significant and of a relevant 
magnitude. The estimates presented in table IV.3 must thus be 
thought of as crude weighted averages of the different mortality 
experiences of separate age- and sex-groups. Inspection of age- and 
sex-specific estimates suggested that the most important pattern is 
that of increasing (less negative) values for the three parameters 
with age, sometimes excepting the very young (< 10 years). For presen-
tation purposes, we collapsed this model into a version in which ~ 1 , 
a 2 and ~2 were estimated for three broad age-groups: 0-9, 10-59 and 60+ years. Results are presented for the two largest infectious 
diseases, Pneumonia and Tuberculosis, in table IV.4. 
Iable IV.4 Age-specific estimates of ~ , a and ~ for Pneumonia, Tuberculosis, All 
other diseases, and Total mJrtafity. 2 
~1 (s.e.) a 2 (s.e.) ~2 (s.e.) 
0-9 10-59 60+ 0-9 10-59 60+ 0-9 10-59 60+ 
Pneumonia -.06 -.04 -.03 -.29 -.87 -.41 -.01 -.04 -.02 
(.001)(.001)(.001) (.025)(.035)(.017) (.002)(.003)(.001) 
Tuberculosis -.08 -.06 -.04 .23 .21 -.52 -.25 -.16 -.08 
(.002)(.001)(.002) (.050)(.018)(.034) (.010)(.002)(.003) 
All other diseases -.03 -.01 -.00 .13 -.08 -.09 -.00 .01 .00 
(.000)(.000)(.000) (.010)(.007)(.004) (.001)(.000)(.000) 
Total mortality -.04 -.02 -.01 .08 -.10 -.11 .00 .01 .oo 
(.000)(.000)(.000) (.008)(.006)(.004) (.001)(.000)(.000) 
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Although the observed changes in mortality are roughly 
coincident with the introduction of antibiotics, a causal relationship 
is not necessarily implied. At least two other explanations should be 
considered: changes in the rate of improvement of a number of material 
circumstances, and changes in the intensity and effectiveness of 
public health programmes. The decline of infectious disease mortality 
since the 18th and 19th centuries has generally been ascribed to 
changes in material circumstances. McKeown, for example, has argued 
that increases in food supplies led to a decrease in incidence and 
case fatality of infectious diseases [16]. A favourable change in the 
rates of improvement of any of these material circumstances could act 
as a confounder of the relationship between antibiotics and infectious 
disease mortality trends. A favourable change in the rate of economic 
development certainly took place in The Netherlands. This is evident 
from the development of mean income levels, which increased slowly in 
The Netherlands from Hfl. 2805 in 1921 to Hfl. 2875 in 1939 (expressed 
in 1975 values). During the period 1948-1969 mean income levels 
increased rapidly from Hfl. 4300 to Hfl. 8907 [17]. On the other hand, 
longterm developments in availability of food (milk, meat) and 
fertility and crowding do not show accelerations after World War II 
[17]. 
Another alternative explanation for the changes in mortality 
trend could be a change in intensity or effectiveness of public health 
programmes (not involving the use of antibiotics). Immunization does 
not have to be considered, as no diseases are included in the analysis 
against which immunization was instituted in The Netherlands on a 
large scale before 1968. The only disease for which a significant 
change in public health programmes (not only involving the use of 
antiobiotics) took place is Tuberculosis. Pasteurization of milk was 
introduced in 1940, reducing the incidence of Non-respiratory 
tuberculosis [7,18]. Mass radiography was introduced in 1949, and the 
combined effects of early detection and effective treatment may have 
caused a considerable acceleration of the decline in Tuberculosis 
incidence [19]. Nevertheless, in the late 1940 1 s and the early 1950 1 s 
mortality from Tuberculosis declined much faster than incidence, in 
The Netherlands as well as in many other countries [20]. 
The fact that mortality from 11All other diseases 11 does not 
show an important reduction in level of mortality in 1947, and its 
trend, if anything, changes in the opposite direction, strongly 
suggests that the changes described in this paper have a cause that is 
specific to the infectious diseases. Although the exact contribution 
of antibiotics to these changes cannot be assessed, it may well have 
been substantial. Antibiotics have come late in the history of 
infectious diseases, but could well have been the miracle-drugs which 
contemporary reports claimed them to be. 
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IV.6 SUDIU.ry 
Secular trends of mortality from 21 infectious diseases in The 
Netherlands were studied by inspection of a~e/sex-standardized 
mortality curves and by loglinear regression analysis. An attempt was 
made to obtain quantitative estimates for changes coinciding with the 
introduction of antibiotics. Two possible types of effect were 
considered: a sharp reduction of mortality at the moment of the 
introduction of antibiotics, and a longer lasting (acceleration of) 
mortality decline after the introduction. 
Changes resembling the first type of effect were possibly 
present for many infectious diseases, but were difficult to measure 
exactly, due to late effects on mortality of World War II. Changes 
resembling the second type of effect were present in 16 infectious 
diseases and were sometimes quite large. For example, estimated 
differences in per cent per annum mortality change were 10% or larger 
for Puerperal fever, Scarlet fever, Rheumatic fever, Erysipelas, 
Otitis media, Tuberculosis, and Bacillary dysentery. No acceleration 
of mortality decline after the introduction of antibiotics was present 
in mortality from "All other diseases". 
Although the exact contribution of antibiotics to the 
observed changes cannot be inferred from this time trend analysis, the 
quantitative estimates of the changes show that even a partial 
contribution would represent a substantial effect of antibiotics on 
mortality from infectious diseases in The Netherlands. 
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V Improvements in cancer survival 
rates since the 1950's 
V.l Introduction 
Whether progress in the treatment of cancer patients has led to an 
improvement in the chance of survival has often been the subject of 
heated discussion [1-5]. On the one hand, there have been great 
developments in the treatment of cancer patients since World Wa~ II. 
The systematic use of radiotherapy since the 1950's and the 
introduction and use of combination chemotherapy, especially since the 
1960's, are regarded as important breakthroughs. It is clear from the 
results of clinical trials that improvements in survival rates have 
been achieved for Hodgkin's disease since the 1960's [6] and for 
Cancer of the testis since the 1970's [7] and also for a number of 
cancers that are especially found in children [8]. Significant 
progress was made with Wilm's tumour (a cancer of the kidney in 
children) as early as the 1950's [9] while progress with Acute 
lymphocytic leukemia followed in the 1970's [8]. 
On the other hand, from the large number of clinical trials 
it is extremely difficult to form a clear picture of the extent to 
which the survival rates at population level of these and other cancer 
patients have in fact improved. Two types of factor are of importance 
here. In the first place the reports of different trials often cannot 
be properly compared with each other [10]. Differences in the se-
lection of patients, in previous treatment, in therapy used, in defi-
nitions and measurements of the stage of disease and response to 
treatment, in completeness of follow-up and in methods of reporting, 
make it difficult to construct a systematic review of trial results 
from which it would be possible to ascertain, for example, trends in 
survival rates. 
In the second place, it is not justifiable to simply use 
trial results to make generalisations about the effect in the total 
population. These research projects are only concerned with treated 
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patients (patients who for one reason or another do not get treated 
are thus overlooked) and in many cases the research is carried out in 
leading clinics (which are not necessarily representative of the 
current treatment situation). 
It is thus important to have information about survival 
rates that apply to all cancer patients in the population and that can 
be monitored over a long period. The most suitable source of such 
information is a cancer registry in which not only the occurrence but 
also the length of survival of cancer patients is recorded. Here a 
review will be given of the improvements in survival rates that have 
been observed in cancer registries in the United States, Norway and 
Finland. The questions are: 
- are there notable improvements in survival rates? 
- are there notable international differences in the observed 
improvements in survival and the resulting survival rates? 
- how should the observed improvements in survival be interpreted? 
V.2 Data 
In a number of cancer registries not only is the date of diagnosis or 
first treatment of cancer patients recorded, but also the date of 
death, which makes it possible to get an impression of chance and 
length of survival. Although the date of death is now recorded by a 
large number of registries in many countries [11], only a few 
registries have been in existence long enough to enable an analysis of 
survival trends since the 1950's. The best-known registry is in the 
United States but those in Norway and Finland are also important. (The 
cancer registry in Denmark also has recorded date of death since the 
1940's but the most recent published survival data concern patients 
who were diagnosed in the period 1959-1962 [12]. In Great Britain 
published survival statistics are limited in scope and only cover a 
short period [13].) 
In the United States there are several regionally-operating 
cancer registries. The survival data from a number of these registries 
have been collected, analysed and published by the so-called 11End 
Results Section11 of the National Cancer Institute. This led to a 
series of 5 reports, the most recent having been published in 1976 
[14]. Data about patients diagnosed in the period 1950-1954 will be 
used as reference values. The most recent patient group that has been 
incorporated in this programme was diagnosed in the years 1970-1973. 
Information concerning these patients has recently been published 
[15]. 
In the meantime, the End Results programme has been incorpo-
rated into a wider Surveillance, Epidemiology and End Results (SEER) 
programme, of which the data are however not completely comparable 
with those in the End Results programme, due to a different selection 
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of cancer registries. Survival data have also been published from the 
SEER programme [16]; they refer to patients diagnosed in the period 
1973-1982. Only data concerning white patients will be used here. 
Norway has had a national cancer registry since 1952. The 
earliest published survival data concern patients diagnosed in the 
period 1953-1957 [17], the most recent are for patients diagnosed in 
the years 1972-1975 [18]. 
There has been a national cancer registry in Finland since 
1953. The earliest survival data concern patients from 1953-1959; the 
most recent are for patients from 1967-1974. These data have mostly 
only been published in graphical form [19], but were kindly supplied 
in tabular form by the author (Hakulinen, personal communication, 
1985). 
Although there was information for more categories of 
cancer, data available for all three countries concerned 30 types of 
cancer in males and 32 types in females. In some cases it was necessa-
ry to combine smaller categories, in which case weighted averages were 
calculated. 
It is not possible to deal with the registration procedures 
in detail here. However, in comparing changes in survival between the 
three countries it is important to know that: 
- in all three countries only invasive cancer is registered, thus 
carcinoma in situ is excluded; 
- in the analysis of survival data patients in whom cancer is only 
identified at autopsy or first recorded on a death certificate are 
excluded; 
- the cancer registries which provided data for analysis in the Ameri-
can End Results programme are partly population-based and partly 
hospital-based, while the Norwegian and Finnish registries are both 
population-based and cover the whole country; 
- in Norway and Finland the methods for registration and follow-up are 
practically identical: the definitions and criteria for classifica-
tion are regularly discussed in joint meetings [20] and both 
countries use linkage between cancer registry and death registra-
tion through personal identification numbers since the 1960's. 
V.3 The Relative Survival Rate 
Survival of cancer patients is usually expressed in terms of a Rela-
tive Survival Rate (RSR). The RSR is the quotient of: 
the proportion of patients that are still alive after a given 
period; 
- the proportion that would still have been alive after that period if 
in that calendar-period the death rate for the group had been the 
same as for the total population in the same age and sex groups. 
Both numerator and denominator are calculated using actuarial methods; 
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the quotient is usually multiplied by 100 so that the RSR is expressed 
as a percentage. If the RSR equals 100%, the probability of survival 
of patients is equal to that for the total population. If the RSR is 
less than 100%, the mortality of cancer patients is higher. A RSR of, 
for example, 60% can be interpreted as: there is a 60% chance that 
after the chosen period of time the patients have not died from the 
cancer. Conversely, the value of (100 - RSR), in the example 40%, can 
be interpreted as the chance of dying from the cancer within the 
chosen period of time. 
The chosen period of time is usually 5 years. Here too, 5-
year survival rates will be used. Only sometimes can the RSR after 5 
years be taken as a measure of the probability of complete recovery. 
Even after the fifth year mortality rates for cancer patients are 
generally higher than those for the total population. This is apparent 
from published survival rates after 10 and 15 years. The mortality 
rates for Cancer of the breast and prostate remain higher for an even 
longer period. Nevertheless, an improvement in 5-year survival rates 
will in general be accompanied by an increase in the percentage of 
patients that escape death from that cancer altogether. 
Although the denominator of the Relative Survival Rate makes 
allowance for the age of cancer patients in calculating "expected" 
survival, a comparison of Relative Survival Rates from different time-
periods or different countries requires further correction for 
possible differences in age distribution. The reason for this is that 
older patients have lower Relative Survival Rates than younger 
patients. Unfortunately, it is not possible to carry out this 
correction with published data. The effect of this omission on sur-
vival trends will generally be that, due to aging of the population 
and an associated increase in the average age of cancer patients, 
improvements in survival will be underestimated. 
We are concerned here with changes in the survival rates of 
cancer patients. There are various ways of expressing these changes 
which do not necessarily lead to the same interpretation. Calculating 
the difference between RSR's for two calendar-periods (RSR2 - RSR1 ) is 
one obvious method. This depicts the improvement in an "absolute" 
sense; a difference of 20% means that 20% more patients out of the 
group have not died from their cancer during the first 5 years. In 
addition, improvements in a "relative" sense can be shown, either as 
a percentage of the original survival rates ([RSR2 - RSR1 ] I RSR1 ), or 
as a percentage of the original case fatality raEes ([RSR2 - RSR1 ] I [ 100 - RSR1 ]). This last figure makes allowance for the fact that the 
higher the survival rates already are, the more difficult it may be to 
achieve further improvement. For those types of cancer for which the 
survival rates were already relatively high at the beginning of the 
period studied (for example, in the United States the RSR for Cancer 
of the uterus had then already reached 72%), it may therefore be of 
interest to express the improvement as a percentage of the 5-year case 
fatality rate in the first period. In the United States the RSR for 
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Cancer of the uterus increased to 81%, an "absolute" improvement of 
9%. but a "relative" change of 9/(100-72) = 32%. As the two methods of 
calculation do not give the same rank order for the degree of improve-
ment. the results from both methods will be presented. 
V.4 Results 
If the data for all types of cancer for which comparison was possible 
(30 for males and 32 for females) are taken together, it is apparent 
that in the United States, in Norway and in Finland 5-year survival 
rates have on average improved both for men and for women (table V.l). 
The high positive correlations between the survival rates for separate 
types of cancer show that there was a reasonable correspondence 
between the three countries at both the beginning and the end of the 
period studied (table V.2). 
There are, however, also important differences. The survival 
rate of registered cancer patients at the beginning of the 1950's was 
clearly higher in the United States than in Norway and Finland (table 
V.l). It seems that as a result of great improvements Norway has 
reduced that difference; it is difficult to express a judgement about 
Finland as the last period for which figures are available (1967-1974) 
is on average earlier than the corresponding period for the United 
States or Norway. Furthermore, there is not a particularly close 
correspondence between the trends in survival rates for different 
forms of cancer (table V.2). 
Figures V.l and V.2 show the degree of improvement for the 9 
types of cancer (approximately a quarter of the total number of 35 
cancers studied) for which, on average, the greatest improvements were 
found in these three countries. When the improvement is expressed as 
the difference between the two Relative Survival Rates (thus as the 
"absolute" difference) the rank order is (figure V.l): Hodgkin's 
disease, Cancer of the prostate, Malignant melanoma, Cancer of the 
thyroid, bone, testis, kidney, cervix and colon. For Cancer of the 
testis, for example, the proportion not dying in the first 5 years is 
between 10 and 20% higher in the most recent period than in the 
1950's. 
When the improvement is expressed as a percentage of the 
original case fatality rate (figure V.2) the rank order changes con-
siderably: now Cancer of the thyroid is first and Cancer of the uterus 
suddenly appears near the top of the list. For some forms of cancer 
the improvements are certainly striking. Note that there is sometimes 
a considerable difference between the three countries; for Hodgkin's 
disease, for example, there is a considerably larger improvement in 
the United States, and for Cancer of the thyroid there is a considera-
bly larger improvement in Norway. 
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Table V.l Averages and standard deviations for 5-year survival rates 
and for changes in 5-year survival rates (30 types for 
males and 32 for females) in the United States, Norway and 
Finland. 
RSR1 RSR2 RSR2 - RSR1 (RSR2 - RSR})/ (100 - RSR1 
(*) (**) (***) ( ~<,'d<) 
------------ ------------ ------------ -------------
av. (s.d.) av. (s.d.) av. (s.d.) av. (s.d.) 
----------------------------------------------------------------------
USA m 35 (24) 42 (25) 7 ( 9) 11 (19) 
f 39 (24) 45 (24) 7 ( 8) 11 (16) 
Norway m 31 (23) 40 (25) 10 (10) 16 (25) 
f 32 (23) 43 (26) 11 (10) 20 (29) 
Finland m 31 (22) 38 (23) 7 (7) 12 (14) 
f 34 (22) 42 (23) 8 ( 6) 12 (11) 
~< Relative Survival Rates (in %) for patients diagnosed in 1950-1954 ··(USA), 
1953-1957 (Norway) and 1953-1959 (Finland). 
·Me Relative Survival Rates (in%) for patients diagnosed in 1970-1973 (USA), 
1972-1975 (Norway) and 1967-1974 (Finland). 
*** See text for an explanation of these measures of changes in survival. 
Table V.2 Product moment correlation coefficients of 5-year survival 
rates and changes in 5-year survival rates for cancer (30 
types for males and 32 for females) in the United States, 
Norway and Finland. 
USA vs. Norway m 
f 
USA vs. Finland m 
f 
Finland vs. Norway m 
f 
*, ide, *** See footnotes to table V.l. 
RSR1 
(*) 
.92 
.90 
.90 
.94 
.92 
.92 
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(**) 
.93 
.92 
.90 
.92 
.92 
.94 
RSR2 - RSR1 
(~•**) 
.34 
.15 
.62 
.40 
.14 
-.11 
Figure V.l 
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Changes in 5-year survival rates for 9 types of cancer 
showing the greatest improvement, United States, Norway 
and Finland (RSR2 - RSR1, in %, see footnotes to table v.l). 
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Changes in 5-year survival rates, expressed as a per-
centage of the original case fatality rate, for 9 types 
of cancer showing the greatest improvement, United 
States, Norway and Finland ([RSR2 - RSR1]/[100 - RSR1], in%, see footnotes to table V.lJ. 
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From figure V.3 it is apparent that the relatively favour-
able developments with Hodgkin's disease in the U.S.A. have led to a 
higher survival rate among patients diagnosed at the beginning of the 
1970's. The relatively favourable development for Cancer of the thy-
roid in Norway would appear to be a catching up with developments 
elsewhere. 
With American and Finnish data it is possible to make a 
separate study of improvements in the survival rates of child and 
adolescent cancer patients (table V.3). In addition to significant 
improvements in Hodgkin's disease we also find considerable improve-
ments in Cancer of the kidney (i.e. Wilm's tumour) and, at least in 
the United States, Leukemia (i.e. Acute lymphocytic leukemia). The 
fact that this most recent improvement was not yet evident in Finland 
could indicate that there was a delay in introducing breakthroughs in 
therapy in that country. 
For the most recent period, i.e. cancer patients diagnosed 
after 1973 (U.S.A.), 1974 (Finland) and 1975 (Norway), only American 
data are available [16]. As these data (from the SEER programme) are 
not exactly comparable'with those from earlier periods, analysis of 
trends should as far as possible be carried out within that new pro-
gramme. For this purpose the data have been divided into two periods, 
1973-1976 and 1977-1982. It must be added that, at the time of publi-
cation, the follow-up for the most recent period was inevitably incom-
plete. No hopeful 'new' improvements in survival can be seen for 
adults. For children there is a continuation of the favourable trends 
in Hodgkin's disease, Wilm's tumour and especially Acute lymphocytic 
leukemia, and also a hopeful new development in Acute granulocytic 
leukemia and Non-Hodgkin's lymphomas. It will be another few years 
before it is possible to draw firm conclusions on these recent trends. 
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Figure V.3 Recent 5-year survival rates for types of cancer in which 
great improvements have been observed since the 1950's, 
United States, Norway and Finland (RSR2 , in %, see footnotes to table V.l). 
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Table V.3 Changes in 5-year survival rates for young cancer patients in the United 
States and Finland. 
USA 
(m + f) 
Finland 
(m + f) 
Testis Kidney 
9 23 
0 30 
Eye Brain 
-1 10 
32 15 
Bone Con- Non- Hodg- Leuke-
nective Hodgkin's kin's mia 
tissue lymphoma disease 
0 -19 0 34 26 
-8 -3 15 33 1 
* RSR in this case is for patients (under 15 or under 25 years old) diagnosed in 
195b-1959 (USA) and 1953-1959 (Finland). RSR
2 
is for patients diagnosed in 1967-
1973 (USA) and 1967-1974 (Finland). 
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V.S Discussion 
Improvements in the survival of cancer patients seem to be a fairly 
general phenomenon. It is striking that the types of cancer for which 
very considerable improvements were shown in clinical trials of new 
forms of treatment (Hodgkin's disease, Cancer of the testis, Wilm 1 s 
tumour and Acute lymphocytic leukemia), do not stand out con-
spicuously from types of cancer for which improvements were much less 
evident, such as Cancer of the thyroid and Cancer of the prostate. 
This in itself makes it clear that the observed improvements in 
survival must qe interpreted with great caution. 
In the introduction (section V.l) it has already been men-
tioned that these improvements are the subject of much discussion. The 
questions that have arisen can be summarised as follows: 
- are the observed improvements real or only apparent? 
- in as far as the improvements are real, are they due to improvements 
in therapy or to other factors? 
As far as the first question is concerned, various situa-
tions are imaginable in which one might observe an improvement in 
survival rates for cancer patients, without there being any real 
favourable development in the course of the illness (i.e. only an 
"apparent" improvement). The most important situations in which this 
can happen are [4, 5, 21]: 
1) Earlier diagnosis, so that the length of time between 
diagnosis and death (= the observed length of survival) increases, 
without there being any real change in the length of time between the 
start of the illness and death (=the real length of survival). This 
is known as "lead time bias". 
2) Extension of the registered categories by the addition 
of relatively benign forms of the same cancer: 
a. due to the detection of previously undiscovered cases that take a 
relatively favourable course. 
b. due to changes in the criteria for diagnosis and registration, 
whereby types that were not previously regarded as malignant (i.e. 
invasive), are later classified as such. 
It is extremely likely that many types of cancer are now 
diagnosed earlier on average than during past decades; the general 
increase in diagnostic possibilities and efforts must have led to 
earlier diagnosis. Moreover, for a few types of cancer (cervix, 
breast) there have been special campaigns aimed at earlier diagnosis. 
It is difficult to quantify the effect that this has had on the 
observed improvements in survival. This would only be possible if the 
method of staging had remained the same, and this is probably not the 
case [15]. Furthermore, the efforts made to find metastases and the 
ability to do so have also increased in the course of years; it has 
recently been demonstrated that this can flatter recent, stage-speci-
fic survival rates [22]. 
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Table V.4 Changes in the percentage of patients for 
whom stage of disease at registration 
was recorded as "localised", United 
States. 
Colon 
Cervix uteri 
Corpus uteri 
Vulva 
Prostate 
Testis 
Kidney 
Malignant melanoma 
Thyroid 
Bone 
Hodgkin's disease 
n.a. = not applicable 
Percentage "localised" 1970-1973 
minus 
percentage "localis~d" 1950-1954 
males 
+ 2 
+13 
9 
0 
+ 16 
+ 6 
+ 1 
n.a. 
females 
+ 1 
8 
+ 9 
0 
+ 1 
+ 18 
3 
- 19 
n.a. 
The best source of information about changes in stage-
distribution at registration are the American data. The published 
Norwegian data are not sufficiently detailed for this purpose, while 
in Finland the percentage of patients for whom the stage of illness 
was recorded as ''unknown•• at registration greatly increased between 
1953-1959 and 1967-1974, which renders further analysis rather dif-
ficult. Table V.4 shows the changes in the percentage of patients for 
whom the stage of illness was recorded as "localised'' at registration 
in the United States, for those types of cancer presented in figures 
V.1 and V.2. The average percentage (for all types of cancer for which 
data were available) has remained more or less the same. However, for 
some types of cancer it has greatly increased, despite the greater 
efforts and improved methods for tracing metastases. This strongly 
suggests earlier diagnosis, which may thus have been a relevant factor 
in the observed improvements in the 5-year surival rates, in 
particular for Cancer of the thyroid, Cancer of the prostate, 
Malignant melanoma and Cancer of the uterus. 
If we accept at least some of the improvements as "real'', 
the second question is whether these improvements can be ascribed to 
changes in therapy. It is conceivable that (real) improvements in the 
survival of cancer patients occur without an improvement in treatment, 
due to an increase in the "resistance" of the "host" or due to a 
135 
Survival of cancer patients 
decline in the malignancy of the disease. There are conjectures about 
the latter for a few types of cancer for which incidence has changed 
considerably: 
- The incidence of Malignant melanoma of the skin has great-
ly increased in white populations, partly due to an increase in the 
exposure to sunlight. This increase in incidence has possibly been 
accompanied by a reduction in the degree of malignancy [23]. 
- The incidence of Cancer of the uterus has increased in 
many countries, to some extent in association with the increase in the 
use of oestrogens for treating postmenopausal complaints. These "new" 
cases may be less malignant [24]. 
- The incidence of Cancer of the thyroid has also greatly 
increased, partly due to therapeutic radiation treatment of the neck 
area (including the thymus). This increase has been greatest for the 
histological type papillary carcinoma, for which the survival rates 
are relatively favourable [25]. 
In the final analysis, it is impossible to determine the 
reason for observed improvements in survival rates by using informa-
tion from the registries alone. We can only say that for a few types 
of cancer where clinical trials have shown that a clear advance has 
been made, improvements are also found in survival rates estimated on 
the basis of data from cancer registries. For some other forms of 
cancer it is true that significant improvements in survival rates 
have been observed, but the extent to which these are due to progress 
in therapy is uncertain. 
The problems associated with interpretation of the data, 
however, do not affect the importance of maintaining a cancer registry 
in which the survival of cancer patients is recorded. Such registries 
make it possible to examine to what extent and how quickly a break-
through in treatment for a given type of cancer actually benefits 
patients in the general population. Some of the differences that are 
observed between the three countries (especially for Hodgkin's disease 
and Leukemia in children), for example, indicate that there has pro-
bably been a delay of at least several years between the U.S.A. on the 
one hand and Norway and Finland on the other. 
Table V.S shows, by way of illustration, how the above-
mentioned breakthroughs are reflected in Dutch cause-specific mortali-
ty statistics. Changes in mortality are, however, the result of 
changes in survival and incidence and are thus a poor substitute for 
survival statistics. For a short time in the 1950's the survival of 
cancer patients in The Netherlands was registered, under the auspices 
of the Central Cancer Registry [26]. Survival data have so far not 
been recorded in the SOOZ cancer registry in the Eindhoven region. It 
is important that in The Netherlands information concerning the survi-
val of cancer patients is collected. A (preferably but not necessa-
rily nationwide) cancer registry which records information about 
factors affecting prognosis (histology, stage, treatment) and the 
date of death, could meet this need. 
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Table V.5 Percentage change in mortality [a] from certain types of 
cancer in The Netherlands since the 1950's (males). 
All ages Below 30 years 
'59/'63 '69/'73 '79/'83 '59/'63 '69/'73 '79/'83 
vs. vs. vs. vs. vs. vs. 
'S0/'53 '59/'63 '69/'73 'S0/53 '59/'63 '69/'73 
Testis + 5 - 14 - 48 + 5 1 - 54 
Kidney + 57 + 20 + 29 - 15 - 40 - 39 
Hodgkin's + 7 - 24 - 37 8 - 43 - 57 
disease 
Leukemia + 35 + 1 + 6 + 21 - 30 - 25 
All cancers + 13 + 15 + 8 + 7 - 11 - 25 
[a] Indirectly standardized for changes in the age structure of the population. 
V.6 Summary 
The extent to which five-year cancer survival rates have improved 
since the 1950's is studied using information from cancer registries 
in the United States, Norway and Finland. In these three countries 
there has, on the whole, been a modest improvement in five-year survi-
val rates. For some types of cancer, including Hodgkin's disease, 
Cancer of the prostate, Malignant melanoma, Cancer of the thyroid, 
bone and testis, there has been a more pronounced improvement. If the 
improvements are expressed as a percentage of the original case fata-
lity rate clear improvements are also seen in Cancer of uterus and 
cervix. Further great improvements are seen for Cancer of the kidney 
(Wilm's tumour) and Leukemia (Acute lymphocytic leukemia) in children. 
Some of these improvements can probably be explained by 
improvements in treatment (Hodgkin's disease, Cancer of the testis, 
Wilm's tumour and Acute lymphocytic leukemia). In other cases it is 
possible that other factors also play an important role. Trends in 
these three countries are certainly not identical. This is all the 
more reason for setting up a registry of cancer and cancer survival in 
The Netherlands. 
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VI.l 
Post-1950 mortality trends and 
medical care 
gains in life expectancy due to declines in mortality from 
conditions amenable to medical intervention 
Introduction 
Measured on a time-scale of centuries, medical care has probably had 
only a mo~est impact on the development of mortality in industrialized 
countries, as the work of the medical and demographic historian 
Thomas McKeown has clearly shown [1]. Unfortunately, a comprehensive 
analysis of mortality changes in the last 40 years, with the objective 
of assessing the impact of medical care innovations, is not available. 
It is evident from, for example, successive editions of textbooks of 
medicine [2], that there has been quite a :number of remarkable 
innovations since the 1920's. Not all of these have received due 
attention from McKeown, if only because his analysis ends in 1971. 
The publication by Rutstein et al. of lists of "unnecessary 
untimely mortality" [3] has provided a basis for an analysis of 
medical care impacts on recent trends in mortality. Rutstein's 
"Working Group on Preventable and Manageable Diseases" listed a number 
of conditions in which death can be avoided by adequate preventive or 
therapeutic intervention. Most of these conditions have only become 
preventable and/or manageable due to the remarkable innovations since 
the 1920's. 
Recently, two studies have shown mortality declines for a 
subset of this group of diseases in six countries since 1950 [4], and 
in Finland since 1969 [5]. The study reported in this paper is an 
attempt to assess the post-1950 mortality impact of medical care 
innovations in The Netherlands. We analysed mortality trends for a 
selection of conditions which was intended to cover all innovations, 
for which the evidence on favourable incidence or case fatality 
effects is relatively undisputed. This selection is presented in table 
VI.1. Medical care was defined as "the application of biomedical 
knowledge through a personal service system" [6] or that part of the 
health care system where preventive, curative and rehabilitative 
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Table VI.l Causes of death which have become amenable to medical care, by type of 
innovation. 
Innovation [a] 
Group I Specific medical therapies 
(1922, 1927, 1945) 
Group II Improvements in surgery/ 
anesthesia (ca. 1930?) 
Group III Improvements in antenatal 
and perinatal care (ca. 
1930?) 
Group IV Chemotherapeutics (1936) 
and antibiotics (1947) 
Group V Surgical repair of congen. 
anomalies (ca. 1950) 
Group VI Prophylaxis (ca. 1950) and 
heart valve surgery (ca. 
1965) 
Group VII Mass vacination (1953) 
Group VIII Hemodialysis (ca. 1960) 
Group IX Hypertension detection 
Group X 
Group XI 
and treatment (ca. 1960) 
Improvements in cancer 
treatment (a.o. combination 
chemotherapy (ca. 1970)) 
Mass screening (1976) 
Cause of death [b] 
Diseases of the thyroid; Diabetes mellitus (< 25 
years) ; Pernicious anemia; Other anemias 
Peptic ulcer; Appendicitis; Cholelithiasis/ 
-cystitis; Abdominal hernia; Ileus without 
hernia; Benign prostatic hyperplasia 
Maternal causes: £Q!!!P.h of pregnancy, deliverv, 
puerperium; Perinatal causes: diseases of mother, 
birth injury, hemolytic disease, other 
Tuberculosis; Pneumonia/influenza; Septicemia; 
Infections of the urinary system; Other infec-
tious diseases [c] 
Congenital digestive anomalies; Congenital car-
diovascular anomalies 
Rheumatic heart disease 
Diphtheria/whooping cough/tetanus/poliomyelitis 
Nephritis and nephrosis 
Hypertensive disease; Cerebrovascular disease 
Cancer of liP. and skin; Cancer of kidney ( < 15 
years); Morbus Hodgkin; Cancer of testis; 
Leukemia (< 15 years) 
Cancer of cervix uteri 
[a] With approximate year(s) of introduction for general use in The Netherlands. 
[b) For causes of death which have been underlined, there is evidence of "spontaneous" 
incidence trends during the study-period. These trends were all downward, except for 
Ileus without hernia, Infections of the urinary system, Cancer of lip and skin, and 
Cancer of testis (see text). 
[c] This category includes: a number of specific bacterial infections; viral diseases 
commonly occurring in children; Syphilis; Infections of the central nervous system 
other than Poliomyelitis; Bacterial endocarditis; Infections of the respiratory 
system other than Pneumonia/influenza; Infections of the skin; Infections of the 
locomotor system. 
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services are delivered in a personal encounter between a health care 
professional and a client [section I.3.3]; mass vaccination and mass 
screening were included. 
Although based on Rutstein et al. 1 s lists of "unnecessary 
untimely mortality", our selection of conditions is not completely the 
same. We omitted conditions for which effective intervention mainly 
takes place outside the medical care system (many forms of primary 
prevention) and conditions for which very small numbers of deaths were 
recorded even in 1950. We further omitted some conditions which have 
high survival rates and thus may have seemed "manageable" to Rutstein 
et al., but for which we were not able to find convincing evidence of 
significantly increasing effectiveness of medical care (as in the case 
of Cancer of the thyroid). We added a small number of conditions not 
mentioned by Rutstein et al., but for which evidence on increased 
effectiveness of medical care is available: Congenital digestive 
anomalies [7], Nephritis and nephrosis [8-11], and Cancer of the 
testis [12, 13]. [An annotated bibliography covering all diseases 
mentioned in table VI.l is added as Annex 2 to this thesis.] 
In most cases there was no clear evidence that incidence or 
case fatality effects were limited to certain age groups. Exceptions 
are Diabetes mellitus [14] (improved survival in the young only, where 
death was mainly due to diabetic coma), Cancer of the kidney [15] 
(more effective treatment of Wilm 1 s tumour only, which occurs mainly 
in children) and Leukemia [16, 17] (more effective treatment of Acute 
lymphocytic leukemia, which also occurs primarily in the young). 
Although some innovations were introduced before 1950 (such 
as insulin (1922), sulphonamides (1936) and penicillin (1947)), com-
plete diffusion throughout the relevant patient population probably 
required some time, and was only possible after improvements in acces-
sibility of medical care in the 1940's and 1950's [18]. Another reason 
for including conditions for which the increase in effectiveness of 
medical care started before 1950 is, that the treatment of many condi-
tions benefitted from gradual and multiple improvements over a pro-
tracted time period. A clear example of this is provided by improve-
ments in surgery and anesthesia, which, although starting with the 
introduction of intravenous fluid therapy around 1930, form a con-
tinuum till the present day [19-21]. Another example would be Diabetes 
mellitus: data from the Joslin clinic for diabetic patients show that 
survival of younger patients was still improving in the 1950's [14], 
although insulin then had already been available for 30 years. 
The effect of some innovations would be expected earlier in 
the study-period than the effect of others. In groups I, IV, and VII, 
one would roughly expect the largest effect in the first half of the 
period. In groups VIII, IX, X and XI, on the other hand, one would 
expect the largest effect in the second half of the period. For this 
reason, we divided the period 1950-1984 into two parts, and compared 
mortality trends of the first subperiod with those of the second. 
As indicated in table VI.l there is evidence of "sponta-
neous" (i.e. not related to increased effectiveness of medical care) 
143 
Post-1950 mortality trends 
incidence trends during the study period for many of the selected 
conditions. These trends were mostly downward, although incidence 
increases have probably occurred for Ileus without mention of hernia 
[22). Infections of the urinary system [23), Cancer of lip and skin 
[24]. and Cancer of testis [25]. Important examples of conditions with 
incidence declines are Tuberculosis and some other diseases of in-
fectious or~g~n (where improved living conditions have reduced in-
cidence [26, 27]). Maternal and Perinatal mortality (where the de-
clining birth-rate has reduced the proportion of high-risk pregnancies 
[28, 29]). and Cerebrovascular disease (where mortality and probably 
incidence has declined for unknown reasons since the 1940's [30, 31]). 
Mortality changes for the selected conditions can therefore not simply 
be interpreted as an estimate of the effect of medical care; for an 
unbiased estimate. the effect of spontaneous incidence declines would 
have to be subtracted. 
VI.2 Data and methods 
Numbers of deaths by calendar year (1950-1984), age (0, 1-4, 5-
14, ...... 85-94, 95+). sex. and cause of death (categories mentioned 
in table 1, translated into the appropriate code numbers of rev~s~ons 
6, 7, 8 and 9 of the International Classification of Diseases (ICD)) 
were extracted from a computerized file supplied by the Dutch Central 
Bureau of Statistics. 
Population numbers for the 31st of December of each calen-
dar-year, by . age and sex, were extracted from published and un-
published sources based on the Dutch population register. Approximate 
person-years at risk for the deaths occurring in a given calendar-year 
were calculated by averaging the population numbers for the 31st of 
December of the current and the previous year. 
Perinatal mortality is represented in our data by deaths due 
to "diseases of the newborn period" (chapter XV of the ICD). re-
gardless of age· at death and excluding still-births. This is not the 
usual measure of Perinatal mortality (still-births + all first-week 
deaths), but it assures consistency within our data set, and facili-
tates an analysis of constituent parts of Total mortality (from which 
still-births are usually excluded). 
In a loglinear regression analysis observed numbers of 
deaths (Y) were related to the explanatory variables person-years at 
risk, age and calendar-year. Parameters were estimated for males and 
females separately. We specified the following regression equation: 
E(y.) 
~ 
N (a.+f3X) .e ~ 
~ 
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e 
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a, ~ 
i 
expected number of deaths 
person-years at risk 
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base of the natural logarithm 
calendar-year 
= parameters to be estimated 
subscript denoting age-group 
~ is the parameter of interest. Technically speaking, it is the slope 
of the regression line of the natural logarithm of mortality density 
vs. time. If ~ is small (say, -.10 < ~ <.10), 100 times the value of ~ 
is approximately equal to the percent change in mortality density per 
annum. An estimated value for ~ of, for example, -.02 thus indicates 
2% mortality decline per annum. a is the intercept of the regression 
line, and takes on different values in different age-groups i. The 
effect of including a. is that the trend parameter (~) is not 
influenced by changes in1 age-composition of the population. 
~ was estimated separately for the subperiods 1950-1968 and 
1969-1984; the regression lines of the two subperiods are not necessa-
rily connected, as the model permitted a change in level between 1968 
and 1969. The division between the two parts of the period was chosen 
as 1968/1969 in order to coincide with the change between ICD-revi-
sions 7 and 8. 
The computations were performed with the GLIM computer pa-
ckage, specifying a Poisson regression model [32]. In a Poisson re-
gression model, the differences between the observed (Y) and the 
predicted (y) values of the dependent variable are evaluated in terms 
of the probability under a Poisson distribution of a value of Y being 
equal to y. The GLIM package calculates maximum likelihood estimates 
for the regression parameters by using an iteratively reweighted least 
squares procedure. 
VI.3 Results 
The predominant impression from table VI.2, in which the results from 
the loglinear regression analysis are presented, is that mortality 
declined for almost all selected conditions, both in the first and in 
the second subperiod and both for males and females. 
VI.3.1 First subperiod 
Very large mortality declines (~ < -.10) were found for Pernicious 
anemia; Maternal mortality due to complications of delivery; Tuber-
culosis; and Diphtheria/whooping cough/tetanus/poliomyelitis. 
Pernicious anemia is the only condition from group I (speci-
fic medical therapies introduced before 1950) with convincing mortali-
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table VI.2 Changes in mortality: results of loglinear regression analysis [a]. 
Cause of death 
Group l Diseases of the thyroid 
Diabetes mellitus (< 25 years) 
Pernicious anemia 
Other anemias 
Group II Peptic ulcer 
Appendicitis 
Cholelithiasis/-cystitis 
Abdominal hernia 
Ileus without hernia 
Benign prostatic hyperplasia 
Group III Maternal: compl. pregnancy [b] 
Maternal: compl. delivery [b] 
Maternal: compl. puerperium [b] 
Perinatal: diseases of mother 
Perinatal: birth injury 
Perinatal: hemolytic disease 
Perinatal: other 
Group IV Tuberculosis 
Pneumonia/influenza 
Septicemia 
Infections urinary system 
Other infectious diseases 
Group Y Congenital digestive anomalies 
Congenital cardiovasc. anomalies 
Group VI Rheumatic heart disease 
Group VII Diphth. /whoop. cough/tet. /polio 
Group VIII Nephritis and nephrosis 
Group IX Hypertensive disease 
Cerebrovascular disease 
Group X Cancer of lip and skin 
Cancer of kidney (< 15 years) 
Morbus Hodgkin 
Cancer of testis 
Leukemia ( < 15 years) 
Group XI Cancer of cervix uteri 
All other~ 
Total mortality 
Trend parameter estimate ( ~) 
1950-1968 1969-1984 
males 
-.00 
-.02 
- .091< 
.00 
-.031< 
- .05'~ 
-.00 
females 
-.01* 
-.041< 
-.121< 
-.021< 
- .01'~ 
-.061< 
-.04'~ 
-.01''' -.01 
-.02''' -.01'~ 
-.04* n.a. 
n.a. -.08*(-.081<) 
n.a. -.111<(-.10*) 
n.a. -.06*(-.06*) 
-.00 
- .05>~ 
-.061< 
- .021< 
-.15'~ 
-.061< 
-.041< 
.04>~ 
-.06>'< 
- .03'~ 
.00 
-.02''' 
-.23'~ 
-.031< 
- .03'~ 
- .011< 
-.05>'< 
-.01 
.00 
-.00 
.01''' 
n.a • 
• 011< 
.00 
-.00 
-.05'~ 
- .031< 
-.021< 
-.191< 
-.071< 
-.041< 
.031< 
-.07'~ 
-.02''' 
-.00 
-.03''' 
-. 251< 
- .061< 
-.03* 
-.021< 
-.06''' 
-.00 
-.011< 
n.a. 
.00 
- .011< 
-.011< 
-.02* 
males females 
-.08''' -.07>'< 
-.071< -.08'~ 
- .131< -.111< 
-.01 -.01 
-.05>'< 
-.02* 
-.10''' -.101< 
- .031< -.06>~ 
-.OS* -.06>'< 
-.01 .00 
-.091< n.a. 
n.a. -.lC*(-.06*) 
n.a. -.13>'<(-.08'~) 
n.a. -.07*(-.03 ) 
- .14''' - .121< 
- .09* -. 081< 
-.20* 
-.05''' 
-.02''' 
-.041< 
.061< 
-.07''' 
-.05* 
-.09''' 
-.04''' 
-.041< 
-.07>'< 
.01''< 
-.06'~ 
-.02>'< 
-.01* 
-.071< 
-.04''' 
-.06* 
-.04* 
n.a. 
-.00* 
- .011< 
- .211< 
-.05>'< 
- .031< 
-.041< 
.05'~ 
-.071< 
-.04>'< 
-.06>'< 
-.06* 
-.02>'< 
.02 
.01* 
-.081< 
- .031< 
-.03>'< 
-.08>'< 
- .051< 
n.a. 
-.061< 
-.04* 
-.02>'< 
-.02* 
* ~ statistically significantly different from 0 (two-sided test; p< .05). 
[a] For definitions of groups, see table VI.l. 
[b] Values between parentheses have been obtained with a model in which the number of 
births was substituted for person-years at risk (N). 
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ty declines during the first subperiod. Mortality due to Diseases of 
the thyroid and Diabetes mellitus declined more during the second 
period, which is not what one would expect if the morta~ity declines 
were related to the medical care innovations mentioned .in table VI.1. 
It is interesting to note that during the first subperiod the steep 
declines of Maternal mortality due to complications of delivery are 
parallelled by relatively favourable trends in Perinatal mortality due 
to birth ~nJury. This suggests that great progress was being made in 
obstetric care. Not only Tuberculosis, but also most other infectious 
diseases show their most pronounced mortality declines during the 
first subperiod. This is what one would expect given the time of 
introduction of antibiotics. The extremely steep mortality declines in 
group VII suggest that mass vaccination had a tremendous effect on 
Diphtheria/whooping cough/tetanus/poliomyelitis in a very short period 
of time. 
VI.3.2 Second subperiod 
For many of the selected conditions mortality declines accelerate 
after 1968. This applies not only to most of the conditions in group 
IX (hypertension detection and treatment), group X (combination chemo-
therapy), and group XI (mass screening for cervical cancer), but also 
to those in group II (improvements in surgery and anesthesia), group 
III (improvements in antenatal and perinatal care - but the accelera-
tion in maternal mortality decline appears to be due to fertility 
trends), and group V (surgical repair of congenital anomalies). 
A very impressive acceleration is visible in the decline of 
Perinatal mortality due to hemolytic disease (anti-D-immunoglobulin 
was introduced around 1970). Some of the other accelerations also 
coincide with known "accelerations" in the effectiveness of medical 
care, as in the case of Congenital cardiovascular anomalies, ~yperten­
sive and Cerebrovascular disease and a number of cancers. Cancer of 
lip and skin is the only condition in group X for which mortality 
declined considerably before 1969. This is consistent with the fact 
that effective treatment methods were available relatively early. 
Mortality from Cancer of the cervix declined faster in the second 
period, but apart from screening efforts this may also reflect a 
greater frequency of hysterectomy. 
The absence of an acceleration of mortality decline in 
Nephritis and nephrosis (mortality even increased in the second subpe-
riod) suggests that hemodialysis did not have an appreciable mortality 
impact in The Netherlands. Since hemodialysis was not available on a 
large scale before 1970, the mortality decline for this condition 
during the first subperiod must be due to other factors (a changing 
relationship between the human race and the streptococcus [27]?). 
Mortality from the digestive and urogenital conditions of 
group II also declined more after 1968. There are important differen-
ces between males and females for Peptic ulcer (female mortality 
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declined less) and Cholelithiasis and -cystitis (male mortality de-
clined less). These differences, which can hardly be explained by 
differences in effectiveness of medical care, could be due to 
differential incidence developments [33, ·34]. Ileus without mention 
of hernia did not show significant mortality declines; this could be 
due to an increase in incidence, following from a greater prevalence 
of operation-induced intraperitoneal adhesions [22]. 
VI.3.3 Effects on life expectancy 
Although the analysis by cause of death presented in table VI.2 gives 
a comprehensive and detailed view of mortality trends in the Nether-
lands since 1950, it does not provide us with a summary measure of the 
overall impact of mortality changes. The contributions of these condi-
tions to the over-all mortality level in the early 1950's differed 
widely. By far the largest cause of death in our selection is Cerebro-
vascular disease (accounting for more than 10% of Total mortality). 
Pernicious anemia, as an example of one of the smaller causes, ac-
counted for less than .1%. 
A summary measure of the impact of changes in mortality from 
the conditions in our selection is the effect on life expectancy at 
birth (table VI.3). Life expectancy at birth for Dutch males was 70.85 
years in 1950-54, and increased by almost 2 years to 72.76 years in 
1980-84. If mortality for the conditions analysed in this paper had 
remained at 1950-54 levels, life expectancy at birth for males in 
1980-84 would have been 69.80 years. (There has been an increase in 
mortality from some other causes, e.g. Lung cancer, Ischemic heart 
disease, Motor vehicle accidents.) The difference between the latter 
figure and the actual life expectancy at birth in 1980-84, 2.96 years, 
is a measure of the impact of reductions in mortality from the selec-
ted conditions on life expectancy of Dutch males. As table VI.3 shows, 
conditions in group IV (infectious diseases) made the largest contri-
bution. 
Life expectancy at birth of Dutch females was 73.32 years in 
1950-54, and increased by almost 6 years to 79.18 years in 1980-84. 
Without the reductions in mortality from conditions which have become 
amenable to medical intervention life expectancy in 1980-84 would have 
been 75.23 years. The contribution of these reductions to life expec-
tancy of Dutch females can thus be calculated as 79.18 - 75.23 = 3.95 
years. The difference with the corresponding figure for males can 
almost entirely be explained by the greater contribution of Hyperten-
sive disease and Cerebrovascular disease (Group IX), which are more 
important causes of death and declined faster in females (cf. table 
VI.2). 
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Iable VI.l The effects of mortality reductions for the selected conditions on 
life expectancy at birth (1950/54- 1980/84)[a]. 
males 
females 
Life expectancy gains (in years) [b] 
Group II Group III Group IV Group IX 
0.36 
0.25 
0.72 
0.63 
0.94 
1.13 
0.43 
1.32 
[a] For definitions of groups, see table VI.l. 
Other 
groups 
0.58 
0.80 
All selected 
conditions 
2.96 [c] 
3.95 [c] 
[b] Gains have been measured as the difference between life expectancy at birth 
calculated with 1980/84 mortality rates and life expectancy at birth calculated 
with 1950/54 mortality rates for the selected group(s) of conditions and 1980/84 
mortality rates for all other conditions. 
[c] The life expectancy gain due to reductions in mortality from all selected condi-
tions is not equal to the sum of the effects of mortality reductions for separate 
groups of conditions. 
VI.4 Discussion 
Post-1950 reductions in mortality from conditions which have to some 
extent become preventable and/or manageable with adequate medical 
care, have contributed appreciably to the life expectancy increases 
observed in the same period. 
As stated in the introduction, mortality decline from these 
conditions cannot be attributed solely to medical care innovations. 
There is evidence of "spontaneous" incidence declines in more than 
half of these conditions (cf. table VI.l). As a matter of fact, some 
of the results provide some indirect support for the view that sponta-
neous trends also played an important role: - differences between 
males and females, as in the case of Peptic ulcer, Cholelithiasis and 
-cystitis, and Cerebrovascular disease; - the occurrence of mortality 
declines before an effect of medical care innovations could reasonably 
be expected, as in the case of Hypertensive disease, Cerebrovascular 
disease, Nephritis and nephrosis, and Cancer of the cervix; - and the 
occurrence of mortality declines later than was expected on the basis 
of a priori knowledge of medical care innovations, as in the case of 
Diseases of the thyroid and Diabetes mellitus. 
Unfortunately there are no registrations of morbidity in The 
Netherlands which cover so wide a range of conditions, and which date 
back as far as 1950. The only source of information which can be used 
for comparison with our mortality data is the national registration of 
hospital admissions. Although this registration started in the early 
1960's, its coverage of Dutch hospital patients is considered to be 
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sufficient only since about 1971. Table VI.4 compares trends in 
mortality since 1971 with trends in hospital admissions. Because of 
important changes in obstetric care and a corresponding increase in 
the proportion of hospital deliveries, group III (Maternal and Peri-
natal causes) was omitted from this comparison; because of very small 
numbers Diphteria/whooping cough/tetanus/poliomyelitis was also ex-
cluded. 
The frequency of hospital admissions declined for a sub-
stantial number of the selected conditions, suggesting that incidence 
declines did play an important role in the mortality changes observed 
in the second subperiod. (Also, some anomalous mortality observations 
could well be related to incidence increases (Other anemias) or to 
differences in incidence decrease between males and females (Peptic 
ulcer, Cholelithiasis and -cystitis).) 
In some cases (Tuberculosis, Rheumatic heart disease, Hyper-
tensive disease, Cancer of cervix uteri) incidence declines could have 
been induced by medical care interventions, but in other cases they 
should probably be interpreted as "spontaneous". 
On the other hand, mortality rates declined faster than 
hospital admission rates, even if one takes into account a general 
increase in the rate of hospitalization, showing as an augmentation of 
over-all age-standardized hospital admission rates of 12% (males) and 
8% (females). This is generally true for groups I (!), II, V, IX and 
X. Hospital admission rates for some of these conditions even in-
creased, while mortality decreased, e.g. for Cerebrovascular disease. 
This suggests that case fatality changes did also play an important 
role in the second subperiod. 
The occurrence of "spontaneous" incidence declines implies 
that the calculated gains in life expectancy overestimate the impact 
of medical care to an essentially unknown extent. This may however be 
compensated to a certain degree by the fact that we included only 
those conditions for which the evidence on medical care effects is 
relatively undisputed. Like Rutstein et al. we excluded, for example, 
important causes of death such as Ischemic heart disease and Breast 
cancer, where evidence on medical care effects [35, 36] is more con-
troversial. 
As McKeown has shown, the contribution of medical care to 
the impressive decline in mortality since the 18th and 19th centuries 
has probably been small in comparison with that of other influences. 
Since 1950 increases in life expectancy have become less impressive, 
especially for males; nevertheless~ gains in life expectancy were 2 
and 6 years for Dutch males and females respectively. Reductions in 
mortality from conditions which have become amenable to medical inter-
vention have contributed appreciably to these gains in life ex-
pectancy. Although it is difficult to disentangle the various in-
fluences on mortality from these conditions, this observation shows 
that the post-1950 mortality impact of medical care could well have 
been substantial. 
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Table VI.~ Mortality and hospital admission rates 1981/83, expressed as a proportion 
of the rates in 1971/73 [a) 
Condition 
Group !. Diseases of the thyroid 
Diabetes mellitus (< 25 years) 
Pernicious anemia 
Other anemias 
Group II Peptic ulcer 
Appendicitis 
Cholelithiasis and -cystitis 
Abdominal hernia 
Ileus without hernia 
Benign prostatic hyperplasia 
Group IV Tuberculosis 
Pneumonia/influenza 
Septicemia 
Infections of the urinary system 
Group y Congenital digestive anomalies 
Congenital cardiovascular anomalies 
Rheumatic heart disease 
Group VIII Nephritis and nephrosis 
Group IX Hypertensive disease 
Cerebrovascular disease 
Cancer of lip and skin 
Cancer of kidney (< 14 years)) 
Morbus Hodgkin 
Cancer of testis 
Leukemia ( < 14 years) 
Group XI Cancer of cervix uteri 
Over-all mortality/hospital admis-
sions 
Mortality 
males females 
0.49>'< 
0.43 
0.39>'< 
0.90 
0.59>'< 
0.33>'< 
0.73* 
0.66''' 
0.90 
0.39"' 
0.74>'< 
0.66* 
1.61''< 
0.51* 
0.42"' 
0.71>'< 
0.72>'< 
1.14>'< 
0.55>'< 
o. 78>'< 
0.86 
0.58 
0.62>'< 
0.47>'< 
0.64>'< 
n.a. 
0.91>'< 
0.54>'< 
0.43 
0.28* 
0.84 
0.80* 
0.38* 
0.51* 
0.56>'< 
0.99 
n.a. 
0.68>'< 
0.62* 
1.57>'< 
0.44>'< 
0.48* 
0.56* 
0.78* 
1.22>'< 
0.41''< 
o. 71>'< 
0.68 
0.29''' 
0.62>'< 
n.a. 
0.49>'< 
0.64>'< 
0.80>'< 
* Value significantly different from 1 (two-sided test; p < .05). 
Hospital admissions 
males females 
0.77>'< 
1.14>'< 
0.70>'< 
1.60* 
0.47>'< 
0.74>'< 
0.89>'< 
0.88* 
1.41''< 
1.23>'< 
0.55>'< 
0.97''' 
1.11 
0.67* 
1.09>'< 
0.90>'< 
0.47>'< 
1.02 
0. 73>'< 
1.49>'< 
1.40>'< 
1.17 
0.88* 
2.02>'< 
0.93 
n.a. 
1.12''' 
0.78* 
0.92''' 
0.70>'< 
1.26>'< 
o. 75>'< 
0. 70>'< 
0.68* 
0.86>'< 
1.42''' 
n.a. 
0.65>'< 
0.93>'< 
1.05 
0.69* 
1.10>'< 
0.93>'< 
0.71>'< 
1.02 
o. 71''< 
1.33>'< 
1.42>'< 
0.82 
0.94 
n.a. 
1.14>'< 
0.53''' 
1.08* 
[a] Indirectly standardized for changes in age-composition of the population. 
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VI.S Suumary 
In order to assess the impact of medical care innovations on post-1950 
mortality in The Netherlands, we analysed trends in mortality from a 
selection of conditions suggested by Rutstein et al.'s lists of "un-
necessary untimely mortality". This selection covers 11 types of 
innovation, and includes 35 conditions which have become amenable to 
medical care. 
Loglinear regression analysis shows that for most of these 
conditions mortality declined during each of two subperiods (1950-
1968; 1969-1984). Mortality decline accelerated in the second sub-
period for many conditions. Reductions in mortality from these condi-
tions between 1950/54 and 1980/84 added 2.96 years and 3.95 years to 
life expectancy at birth of Dutch males and Dutch females respective-
ly. 
Both a priori evidence and a comparison with changes in 
hospital admission rates between 1971/73 and 1981/83 indicate that 
these mortality reductions are due in some extent to "spontaneous" 
incidence declines. Although the exact contribution of medical care 
innovations to these changes in mortality cannot be determined, the 
impact of medical care on post-1950 mortality in The Netherlands could 
well have been substantial. 
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VII 
VII.l 
Medical care and regional 
mortality differences within the 
countries of the European 
Community 
Introduction 
Regional mortality differences within countries are a universal and 
intriguing phenomenon. Many questions can be asked about their expla-
nation, of which the question to what extent these differences reflect 
differences in medical care has a special relevance. If it were to be 
shown that differences in supply, accessibility or effectiveness of 
medical care give rise to differences in mortality, there would be a 
clear case for action on the part of health care providers and policy 
makers. The literature on this subject does not, however, provide us 
with a clear answer to this question. 
In a large number of studies regional differences in total 
(all-cause) mortality have been related to differences in the total 
(all-conditions) supply of medical care. These studies generally found 
weak and inconsistent relationships. For example, Valkonen and Notkola 
examined the contribution of physician density to the explanation of 
regional all-cause mortality differences within Finland, Sweden and 
Norway, controlling for the percentage of urban population and housing 
density [1]. This contribution, measured as an increment in the 
variance explained, was small. Negative regression coefficients were 
expected, as a higher level of medical care supply should be asso-
ciated with a lower level of mortality, but the study found positive 
as well as negative signs for the regression coeffients. Auster et al. 
studied the relationship between medical care expenditures and varia-
tions in total mortality across states in the USA, controlling for a 
large number of confounding variables [2). Their findings were in 
agreement with the expectation of a negative relationship, but the 
contribution of the medical care variables was small as compared to 
that of other variables. 
Whereas these studies considered mortality from all causes 
of death it is for certain causes of death only that medical interven-
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tion can effectively reduce mortality risks. More convincing results 
can perhaps be expected from the analysis of regional patterns of 
mortality from such causes. For example, in his study on the relation-
ship between medical care use and mortality from cardiovascular 
diseases, cancer and "external" causes for county groups in the USA, 
Hadley found a negative relationship for the cardiovascular diseases 
only [3]. This was considered to lend support to the conclusion that 
the relationship between medical care supply and all-cause mortality 
was causal, as cardiovascular diseases are probably more amenable to 
medical intervention than cancer and external causes. 
Other examples are two studies from England and Wales on the 
relationship between Perinatal mortality and medical care variables at 
the area and local authority level [4, 5]. Both studies controlled for 
a large number of confounding variables, including birth-weight. Knox 
et al. considered condition-specific medical care supply variables as 
the number of hospital beds for pediatrics and for obstretrics, spe-
cial baby-care units, and hospital and home nurses [5). Nonetheless, 
both studies found a very low proportion of variance explained and 
inconsistent signs of regression coefficients. On the other hand, from 
a rigorous analysis of mortality in the states of the USA during the 
1960's, it was concluded that neonatal mortality and medical care were 
indeed negatively related [6). 
The present study represents a new attempt to establish a 
relationship between the level of medical care supply and regional 
differences in cause-specific mortality. It derives its focus from a 
new approach in which a series of causes of death amenable to medical 
intervention are selected for further analysis. 
VII.2 A new line of research: causes of death amenable 
to medical intervention 
A systematic approach to the study of the relationship between medical 
care and cause-specific mortality would require a comprehensive list 
of causes of death amenable to medical intervention. The lists of 
diseases that have been published by Rutstein et al., for which morta-
lity is considered to be largely avoidable given appropriate medical 
intervention, could serve as a basis for such an exercise [7]. 
A first attempt along these lines, using a selection from 
Rutstein's lists, showed large differences between Area Health Autho-
rities in England and Wales for such diseases as Tuberculosis, 
Hodgkin's disease and Appendicitis, all in principle amenable to 
medical intervention [8]. These differences could only in part be 
explained by a number of social indicators or available measures of 
morbidity, suggesting that at least part of the variation might be 
related to differences in medical care [9]. 
Following these publications from England and Wales, a 
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European Working Group was formed which, in the framework of a 
European Community (EC)-sponsored "Concerted Action Project", 
collected and analysed data on regional differences in mortality from 
a comparable set of conditions within the participating countries. 
These countries are: Belgium, Luxembourg, The Federal Republic of 
Germany, Denmark, France, Greece, Italy. Ireland, The Netherlands, 
Northern Ireland, England and Wales, and Scotland; the countries of 
Spain and Portugal, which were not yet EC member countries when the 
working group was formed, have not been included. Results will shortly 
be published in the "EC Atlas on Avoidable Mortality, 1974-1978" [10]. 
For some countries, descriptive studies on the same material have 
already been published [11, 12. 13]. 
Table VII.1 presents the selection of causes of death for 
which mortality data have been analysed in the Atlas. Tuberculosis is 
a manageable disease since the introduction of tuberculostatic drugs; 
preventive efforts, both within the health care system (mass scree-
ning. chemoprophylaxis in contacts) and outside this system (pasteuri-
zation of milk). have also played a role in the reduction of Tuber-
culosis mortality since World War II. Mortality from Cervical cancer 
can to some extent be prevented by mass screening. Hodgkin 1 s Disease 
is one of the few cancers for which an effective treatment has been 
developed in recent years. Chronic rheumatic heart disease can be 
prevented by penicillin treatment of Streptococcus infections, and can 
be treated by heart valve surgery or heart valve replacement. Respira-
tory diseases among children are mostly infectious in origin, and can 
be treated with antibiotics. Asthma, if treated carefully with the 
drugs which have become available, need not, in most cases, lead to 
premature death. Appendicitis, Abdominal hernia, and Cholelithiasis 
and cholecystitis are conditions which can be treated effectively by 
surgery. the safety of which has itself increased. Deaths due to 
Hypertensive and cerebrovascular disease can to some extent be pre-
vented nowadays by early detection and treatment of hypertension. The 
risk of Maternal and Perinatal mortality has been reduced by improve-
ments in antenatal and perinatal care. Medical interventions were 
considered to be most effective in selected age groups, mentioned in 
table VII. 1 . 
As the Atlas does not only contain data on mortality from 
the above-mentioned conditions, but also contains information on the 
supply of medical care and on socio-economic conditions, it presents 
an interesting opportunity to explore the relationship between morta-
lity and medical care a little further. In this paper we will address 
the following questions: 
Do these different causes of death have a common pattern 
of regional variation within each country of the European Community? 
If these selected causes of death have high, positive intercorrela-
tions, a common relationship with medical care would be suggested. 
For example, a common regional pattern for Appendicitis, Abdominal 
hernia, and Cholelithiasis and -cystitis would strongly suggest that 
similar aspects of basic surgical care underlie the regional mortality 
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Table VII.l Causes of death selected for analysis, with age-groups, !CD code numbers 
and crude death.rates for the EC as a whole (per 100,000 person-years, 
1974-1978). 
Cause of death Age-group !CD code numbers Crude death 
(8th revision) rate 
--------------------------------------------------------------------------------------
TUB Tuberculosis 5-64 010-019 1.63 
CERV Cancer of cervix uteri [a] 15-64 180 2.01 
HODG Hodgkin's disease 5-64 201 1.00 
CRHD Chronic rheumatic heart disease 5-44 393-398 0.61 
RESP All respiratory diseases 1-14 460-519 0.65 
ASTH Astluna 5-44 493 0.29 
APPX Appendicitis 5-64 540-543 0.28 
HERN Abdominal hernia 5-64 550-553 0.28 
CHOL Cholelithiasis and -cystitis 5-64 574-575 0.66 
HYP Hypertensive and 35-64 400-404, 18.21 
cerebrovascular disease 430-438 
MAT Maternal mortality all 630-678 0.21 [b] 
PERI Perinatal mortality < 1 week all 18.82 [b) 
ALL Total mortality, all causes all all 1076.25 
[a] For regional mortality analyses within France, Greece and Italy this category has 
been replaced by a category including both Cancer of the cervix and Cancer of the 
body of the uterus (ICD code 182), because mortality from Cancer of the uterus in 
these countries contains a considerable proportion of deaths from Cancer of the 
cervix [ 14] • 
[b] Number of deaths per 1000 live- and still-births; data were not available for 
Greece. 
distributions. Similarly, common medical care relationships would be 
possible if high positive correlations between Asthma and Respiratory 
diseases among children, and between Maternal and Perinatal mortality 
were to be found. 
To what extent can regional differences in condition-
specific mortality be explained by differences in the level of medical 
care supply ? We would expect that medical care variables succeed to 
explain more of the variation in mortality from the selected causes 
than in all-cause mortality. We further expect to find negative re-
lationships. As it may be anticipated that for many conditions some of 
the regional variation in mortality can be explained by socio-
economic indicators [15], these will be used as control variables. 
The available information allows us to examine whether simi-
lar answers are obtained for different countries. We expect to find 
more substantial relationships between mortality and medical care 
supply in countries with a low general level of supply and/or large 
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Table VII.2 Number and mean population size of 
administrative areas used in the analysis, 
by country. 
Belgium 
Luxembourg 
West-Germany 
Denmark [a] 
France 
Greece 
Italy 
Ireland 
The Netherlands 
Northern Ireland 
England and Wales 
Scotland 
Total 
Number 
of areas 
9 
1 
11 
15 
95 
10 
89 
8 
11 
1 
98 
12 
360 
Mean Population Size, 
1974-1978 (thousands) 
1090 
359 
5603 
338 
554 
922 
631 
404 
1250 
1538 
505 
434 
745 
(a] Bornholms County in Denmark was excluded from our 
analysis because of its very small population size. 
regional differences in the amount of medical care supply. 
Our primary interest is in within-country mortality diffe-
rences, and not in between-country differences. We will nevertheless 
without much comment also present the results of a cross-national 
analysis because between-country differences have been the subject of 
some earlier studies [16]. Such analyses are, however, severely handi-
capped by data problems (see next section). 
VII.3 Data 
Table VII.2 shows that there is a considerable variation in the number 
of areas distinguished within each country. No data are given on 
within-country differences for Luxembourg and Northern Ireland, while 
data are available for a large number of areas in the case of France, 
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Italy, and England and Wales. The fourth large country, West Germany, 
could only provide data for a few, disproportionally large areas (the 
federal states). 
For each area the Atlas gives information on the level of 
mortality from twelve selected causes of death and on the Total (all-
cause) mortality level. Only deaths in the selected age-ranges are 
considered; Total mortality applies to all ages. The mortality data 
are for 1974-1978, except for France (1973-1977). For the relevant 
age-ranges, Standardized Mortality Ratios (SMR's) have been calculated 
by using two different sets of standardrates: one set for the whole EC 
and another for each individual country. The between-country analysis 
is based on SMR's calculated from the first set of standardrates, 
while the within-country analyses use the SMR's from the second set. 
The within-country SMR's were tested to see (a) whether for the 
country as a whole the degree of heterogeneity between different areas 
is greater than could be expected to occur by chance alone [17], and 
(b) for each area, whether the mortality level is significantly higher 
than the national level (one-sided test)[18]. 
Maternal mortality is expressed as the number of deaths per 
1000 live- and still-births, and Perinatal mortality is expressed as 
the number of still-births and first-week deaths per 1000 live- and 
still-births. The same significance tests were carried out for these 
two causes of death. 
The outcomes of the significance tests are given in table 
VII.3 for each cause of death. For a number of causes there are few 
countries with significant heterogeneity among regions; also, few of 
these regions have mortality levels significantly above the national 
level. Most of these causes have low mortality rates (see table 
VII.1). Significant heterogeneity in almost all countries is only 
found for Tuberculosis, Cervical cancer, Chronic rheumatic heart 
disease, Hypertensive and cerebrovascular disease, and Perinatal mor-
tality. 
Information on the three available measures of medical care 
supply is given in table VII.4. A substantial variation in the amount 
of medical care supply is found within France and Greece. The situa-
tion in Greece is particularly interesting for our analysis because 
the uneven distribution of medical care supply is combined here with a 
low over-all level of supply. 
Data on the following three indicators of socio-economic 
conditions were available: the percentage of households with a fixed 
shower or bath, the average number of persons per room, and the number 
of private cars per 100 population. For England and Wales these have 
been substituted by the following socio-economic measures: the per-
centage of households with basis amenities, the percentage of house-
holds renting accomodation, and the percentage of households with 
cars. No socio-economic indicators were available on a regional level 
for Ireland. 
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Table VII.3 Number of EC countries.with significant regional hetero-
geneity of mortality, and number of regions with mortali-
ty rates significantly above the national level, by cause 
of death, 1974-1978 [a,b]. 
Cause of death 
Tuberculosis 
Cancer of cervix uteri 
Hodgkin's disease 
Chronic rheumatic heart 
disease 
All respiratory diseases 
among children 
Asthma 
Appendicitis 
Abdominal hernia 
Cholelithiasis and -cystitis 
Number of countries 
signif. heterogen. 
(n = 10) 
10 
8 
4 
7 
5 
5 
3 
5 
4 
Hypertensive and cerebrovascular 10 
disease 
Maternal mortality 4 
Perinatal mortality 10 
Total mortality, all causes 10 
[a) Significance level is 95%. 
[b) Countries excluded are: Luxembourg and Northern Ireland. 
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Number of regions 
signif. higher 
(n = 358) 
65 
68 
35 
57 
45 
33 
33 
39 
39 
113 
38 
97 
145 
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Table VII.4 Mean and coefficient of regional variation (c.v., in%) 
of medical care variables [a], by country, 
appr. 1974-1978. 
GPS BED CONS 
mean c.v. mean c.v. mean c.v. 
Belgium 102 23 4.9 22 86 43 
w. Germany 45 14 8.6 24 44 23 
Denmark 49 6 6.0 36 28 37 
France 86 33 6.0 26 47 57 
Greece [b) 3.7 46 [b) 
Italy 87 28 [c) 7.8 20 [c) 17 22 [c) 
Ireland 47 11 5.1 27 22 39 
Netherlands 37 8 5.2 16 51 32 
England/Wales 44 11 [c) 3.8 38 20 13 
Scotland 60 16 4.3 25 27 55 
EC [d) 60 43 5.8 21 42 60 
----------------------------------------------------------------------
[a) Definitions of the variables: 
GPS - number of general practitioners per 100,000 population 
BED - number of acute hospital beds per 1000 population 
CONS - number of consultants per 100,000 population 
[b) The number of general practitioners and consultants in small areas in Greece was 
only available for both together; mean= 60, c.v. = 85. 
[c) Data were only available for larger areas, and we had to assume that the values 
applied to all regions within such a larger area. 
[d) Means and coefficients of variation were calculated from national data. Greece 
(for GPS and CONS), Luxembourg (for CONS), and Northern Ireland (all variables) 
~1ere excluded because of incompatible or missing data. 
It is quite likely that there are considerable differences 
in registration criteria and procedures between countries. For exam-
ple, the differences in medical care supply between countries, as 
suggested by table VII.4, could in part be due to international diffe-
rences in the definition of a general practitioner, an acute hospital 
bed, or a consultant. Similarly, it has been shown that EC countries 
differ in certification and coding of causes of death [19]. Such 
differences are an important obstacle to between-country analyses of 
the relationship between medical care supply and mortality. 
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VII.4 Methods 
We will look for a common pattern of regional variation of mortality 
from the selected causes of death in two ways. Firstly, factor ana-
lysis (principal components analysis, without rotation) will be 
carried out in order to examine whether there is a first factor 
which indeed represents a common regional pattern for most causes of 
death. Secondly, Spearman rank order correlations will be calculated 
for specific combinations of causes of death that were expected to 
show particularly strong covariations (see section VII.2). 
The question on the relationship between mortality and 
medical care supply will be examined by a forward stepping, multiple 
regression procedure, during which the three socio-economic variables 
are forced to enter before the three medical care variables. 
All analyses were carried out for each country separately. 
In addition, the results of a transnational analysis, using national 
data, will be presented too. The calculations were performed with the 
BMDP compu_ter package. SMR 1 s were used as input without any trans-
formations. 
Because of lack of data, 
regional mortality differences within 
The regression analysis has not been 
no socio-economic data were available. 
no analyses could be made of 
Luxembourg and Northern Ireland. 
carried out for Ireland because 
VII.S Regional covariation among the selected causes of death 
Table VII.5 presents the results of the factor (principal components) 
analysis of regional variation in mortality from the selected causes. 
For each country, it gives the loading of each separate cause of death 
on the first factor. The variance explained by this factor ranges from 
19 per cent in France to 44 per cent in Greece. For most countries, 
the loadings are clearly positive for most of the selected conditions 
(a higher score on the first factor goes together with higher cause-
specific mortality). This means that this first factor represents a 
common regional pattern underlying most of the selected causes of 
death. 
It is important, however, also to note the exceptions. 
Hodgkin's disease rather frequently has negative loadings on the first 
factor. Also, the 11 composi tion'' of the first factor varies among 
countries. In most countries, for example, including the larger 
countries France and England and Wales~ Tuberculosis is an important 
component of the first factor. In some countries, however, not at all, 
e.g. in Italy. 
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Table VII.5 Loading of each cause of death [a] on the first unrotated 
factor, by country, 1974-1978. 
TUB CERV HODG CRHD RESP ASTH APPX HERN CHOL HYP MAT PERI 
---------------------------------------------------------------------------
Belgium 1.0 .5 .2 .5 -.5 .8 .7 .8 .8 .6 .7 .2 
w. Germany .6 .1 .7 .8 -.7 .2 -.0 .8 .8 .8 .5 .5 
Denmark .8 .3 -.1 .6 -.4 .0 .1 .3 .1 .9 .5 -.1 
France .7 .5 -.0 .2 .0 .5 .3 .3 .2 .8 .1 . 5 
Greece .9 -.6 -.6 .6 .9 .2 -.5 .2 .7 .9 n.a. 
Italy -.o .5 -.4 .9 .8 .0 .5 .6 .5 .5 .6 .8 
Ireland -.0 .5 -1.0 .1 .7 .7 -.2 .4 .5 .8 -.7 .1 
Netherlands -.2 -.6 -.7 .7 .6 -.4 .7 -.3 .4 .9 -.6 .8 
England/Wales .6 .7 .2 .8 .3 .2 .5 .2 .3 .9 .1 .8 
Scotland .7 -.3 .7 .7 -.1 -.1 .6 .8 -.2 .7 .8 .9 
EC [b] .7 -.7 .8 .8 .8 .4 .1 .7 .3 .6 -.1 .9 
---------------------------------------------------------------------------
[a] For abbreviations, see table VII.l. 
[b] Results of factor analysis on national data. Greece was excluded 
because of missing data. 
The correlation between the first and second factor and 
Total mortality, all causes, is presented in figure VII.l. In most 
countries, the exceptions being West-Germany and Italy, the correla-
tion is high for the first factor. In these cases, the common pattern 
of "avoidable" mortality appears to be determined by factors which are 
associated geographically with the factors that underlie the regional 
variation in Total mortality. These factors may even be the same. 
(Part of the correlation between the first factor and Total mortality 
might, of course, be due to the fact that the selected causes of death 
are included in Total mortality, but the proportion of all deaths that 
can be attributed to the selected causes in the selected age-groups, 
excluding perinatal deaths, is low: 2.4% for the EC as a whole.) 
The situation in West-Germany and Italy, where the first 
factor is not strongly associated with the all-cause mortality level 
but where the second factor is, can be described as follows. The 
findings for Italy are explained. by the fact that the well-known 
north-south contrast is different for mortality from the selected 
causes than it is for Total mortality. The regions south of Naples 
have high scores on the first factor (i.e. high mortality from the 
selected causes) but have low Total mortality rates, while areas in 
the northern part of Italy have low scores on the first factor but 
high Total mortality rates. 
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Figure VII.l Product moment correlations between the first and second 
factors and Total mortality, all causes, by country, 
1974-78 
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Note: For each country, the figure shows the line which connects the two points 
representing the correlation of the first and the second factor with 
Total mortality. 
The situation in West-Germany is less clear and seems to be 
determined by the mortality pattern of two urban federal states. The 
first, Hamburg, scores low on the first factor (i.e. Hamburg in gene-
ral has low "avoidable" mortality) while its Total mortality is not 
very different from the national level. The second, Berlin, has both a 
high Total mortality level and a very high score on the second factor. 
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Table VII.6 Rank order correlation coefficients between specific combinations of 
causes of death, and mean values of all correlations between these causes 
and other selected causes, by country, 1974-1978 [b]. 
APPX APPX HERN A,H,C RESP R,A PERI P,M 
vs. vs. vs. vs. vs. vs. vs. vs. 
HERN CHOL CHOL other ASTH other MAT other 
France .OS .14 .09 .08 .OS .10 .17 .07 
Italy .29 .11 .19 .16 .14 .12 .44 .20 
England/Wales .14 .13 .21 .16 .23 .13 .07 .1S 
EC [b] .27 .34 .39 .20 .4S .19 .07 .34 
--------------------------------------------------------------------------------------
[a] For abbreviations, see table VII.1; A,H,C = APPX, CHOL, HERN; R,A = RESP, ASTH; 
P,M = PERI, MAT. 
[b] Correlations calculated from national data. Greece was excluded because of 
missing data. 
The results of the analysis of intercorrelations among 
specific causes of death will be presented for three large countries 
only: France, Italy, and England and Wales (table VII.6). For the 
smaller countries, the same results are obtained. Rank order corre-
lations "within" combinations of specific causes of death are compared 
with the arithmetic mean of their correlations with the other 
"avoidable" causes of death. Relatively high correlations within each 
combination would suggest specific medical care effects that are 
common to the causes making up the combination. Such situations are, 
however, not found, with the exception perhaps of Perinatal and 
Maternal mortality in Italy. 
VII.6 Relationship with medical care supply variables 
Table VII.7 gives a short summary of the results of the regression 
analysis. For some of the selected causes of death (all causes for 
which there was significant regional heterogeneity in most countries, 
cf. table VII.3) and for Total mortality, table VII.7 presents the 
signs of the regression coefficients for each medical care variable, 
estimated with a model containing all socio-economic and medical care 
variables. Negative coefficients were expected, implying lower 
mortality in regions with a larger supply of medical care. 
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Table VII.7 Signs [a] of the regression coefficients of medical care variables [b], 
controlling for socio-economic variables, by country and cause of death 
[c], 1974-78. 
TUB CERV CRHD HYP PERI ALL 
G B C G B C G B C G B C G B C G B C 
Belgium + - + + + - + - + + -
W.Germany - + + - + - + - + + - + - - + + 
Denmark - + + + - + - + + - + - + -
France - + + - + + + - + -
-
+ + 
Greece + 
-
+ + + + - n.a. + 
Italy -
-
+ + + -
Netherlands + - + + + - + + - + + - + -
England/Wales - + + 
-
+ 
-
+ -
Scotland + - + + + - + + 
-
+ + - + -
EC [d] + - + + + - + + + -
[a] A sign of the regression coefficient is denoted by 1 - 1 if the one-sided test 
that it is less than zero is significant (p < 0.05). When no sign is given the 
variable pas not been entered into the regression because the tolerance level was 
exceeded. 
[b] The variables are represented by the following characters: 
G - number of general practitioners per 100,000 population 
B - number of acute hospital beds per 1000 population 
C - number of consultants per 100,000 population 
In the case of Greece 1 G1 stands for the number of general practitioners and con-
sultants together. 
[c] For abbreviations, see table VII.l. 
[d] Calculated on the basis of national data. Luxembourg, Greece, Ireland, Northern 
Ireland, and England and Wales were excluded because of incompatible or missing 
data. 
The general pattern suggests that the coefficients assume 
positive and negative values in a random way. Not surprisingly, the 
coefficients only very rarely attain statistical significance in the 
countries with a small number of regions. In Italy and England and 
Wales, but not in France, the coefficients are slightly more often 
negative than positive. Unexpectedly, a negative association 
(statistically significant) with general practitioner density is also 
found for Total mortality in France, Italy, and England and Wales. 
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Table VII.8 Percentage of variance in SMR's explained by medical care variables only 
(MC), by socio-economic variables only (SE), and by both medical care 
and socio-economic variables (MC + SE), by cause of death [a] and 
country, 1974-1978. 
TUB CERV CRHD HYP PERI ALL 
MC SE MC+SE MC SE MC+SE MC SE MC+SE MC SE MC+SE MC SE MC+SE MC SE MC+SE 
France 6 49 50 5 10 12 16 8 23 17 41 46 11 30 35 12 61 64 
Italy 21 6 26 19 19 27 47 76 77 26 9 26 55 70 76 29 10 35 
England/W. 29 57 60 28 32 50 11 36 39 16 58 67 16 35 49 26 77 83 
--------------------------------------------------------------------------------------
[a] For abbreviations, see table VII.1. 
Table VII.8 gives the percentage of variance explained by 
medical care variables only (MC), by socio-economic variables only 
(SE), and by both medical care and socio-economic variables (MC+SE). 
The difference between SE and MC+SE gives the additional percentage of 
variance explained by medical care variables after entering socio-
economic variables. We only present the results for France, Italy and 
England and Wales. The number of regions is small in other countries, 
so that when six independent variables are entered into the 
regression, the percentage of variance explained will be artificially 
high. 
It appears that the contribution of medical care variables 
to the. explanation of regional mortality differences is quite modest, 
both without control for confounding variables and when measured as 
the additional percentage of variance explained after entering socio-
economic variables. Without control for confounding variables, the 
percentage of variance explained by medical care variables is 
relatively high for Chronic Rheumatic Heart Disease and Perinatal 
mortality in Italy. After entering socio-economic variables, however, 
the extra contribution of medical care variables is small. There is no 
systematic difference in the contribution of medical care variables 
between the selected causes of death and Total mortality. 
The contribution of socio-economic variables to the explana-
tion of regional mortality differences is sometimes considerable. 
Generally, better socio-economic conditions are associated, as expec-
ted, with a lower level of mortality, both from the selected causes 
and from all causes together. It is interesting to see that socio-
economic variables can account for a large part of the variance in 
Total mortality in France and England and Wales, but not in Italy. 
This points again at the peculiar regional pattern of Total mortality 
in Italy that was already mentioned in section VII.S. 
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VII.7 Discussion 
With this paper we aim at contributing to the debate on the relation-
ship between medical care and regional differences in mortality. We 
are aware of the fact that mortality covers only one objective of 
medical care, but it is an important and relatively 11hard11 criterion. 
Our analyses of the relationship between medical care and mortality 
differ from previous studies in two respects: 
- we analysed mortality from a number of carefully chosen conditions, 
known to be amenable to medical intervention; 
- we made parallel analyses of the situation in a number of countries 
which are known to have different levels and degrees of variation in 
medical care supply. 
The results show that, although a common pattern of regional 
mortality for the selected conditions can to a certain extent be 
distinguished, this pattern generally resembles the pattern of 
regional variation in Total mortality. More specific intercorrela-
tions, e.g. between causes of death which refer to broadly the same 
type of medical care, were not found. This suggests that the pattern 
of regional variation for these causes is not determined by a common 
medical care factor. 
The results further show that levels of medical care supply 
generally add little to the explanation of regional differences in 
mortality from the selected conditions. This also applies to countries 
like France and Greece, where regional variation in medical care 
supply is substantial. The relationships found are seldom statistical-
ly significant, and are not very consistent. No important differences 
with Total mortality have been observed. 
Before coming to any conclusions, one preliminary question 
should be whether these results could be explained by deficiencies in 
the data or in the analysis. Our mortality data certainly have a 
number of weaknesses: 
- Small numbers of deaths: mortality from conditions 
amenable to medical intervention is generally low, which leads to a 
rather important role of chance fluctuations, for example evident from 
the less consistent loading of smaller causes of death in the factor 
analysis. This is inherent to the approach, but it is theoretically 
possible that important relationships between mortality from one of 
the smaller conditions and levels of medical care supply exist, which 
are obscured by the 11noise11 present in the data. 
- Misclassification of deaths: cause-specific mortality data 
potentially suffer from misclassification, as both certification of 
the cause of death (by doctors) and coding of death certificates (by 
coding officers) are subject to error. Even if one assumes these 
misclassifications to be nondifferential (cf. ref. 20), there will be 
a bias toward the nuli, i.e. measures of medical care supply effects 
will be underestimated [21]. 
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- Aggregate level: the area level chosen for the presenta-
tion of mortality data in the Atlas conceals a certain amount of 
medical care supply variation present at lower levels of aggregation, 
which might have a stronger relationship with mortality levels. The 
information for West-Germany is particularly handicapped by its level 
of aggregation, but in principle the same problem applies to all 
countries. 
A feature of our analysis which might also have obscured 
some of the relationship, if any, between medical care supply and 
mortality is that we considered socio-economic variables to be con-
founding variables, and consequently controlled for socio-economic 
variations in the regression analysis. Socio-economic conditions and 
the level of medical care supply are often correlated [22]. For most 
countries of the EC we found high correlations (smaller than -0.7 or 
larger than +0.7) between socio-economic variables and medical care 
variables, most of them indicating an inverse relationship (better 
socio-economic conditions, more medical care). Such multicollinearity 
renders estimates of regression coefficients unstable. 
Although the results from the regression analysis may in 
part be explained by features of the data or the analysis, we tend to 
believe that in most EC countries regional differences in mortality 
from selected conditions do not to any serious extent reflect in-
equalities in the level of medical care supply. Levels of medical care 
supply within EC countries are probably above a minimum level 
necessary for effective modification of case fatality, and any real 
shortages in medical care supply are probably readily compensated for 
by cross-regional patient flows. Mortality differences are then much 
more the result of variations in other factors. 
This is not to say, however, that any relationship between 
regional mortality and medical care factors is necessarily non-exis-
tant. The way in which the available level of supply is organised, 
made to conform to quality standards, and made accessible to the 
population is probably more important in the prevention of "avoidable" 
deaths than the level of supply itself. The low correlation which was 
found between mortality from Cholelithiasis and -cystitis, Appendici-
tis, and Abdominal hernia may perhaps be interpreted as an indication 
that the relevant medical care factors are much more subtle than 
originally expected. 
An important next step might therefore be to examine whether 
more subtle, condition-specific indicators of the quality and accessi-
bility of medical care at the regional level can be developed and used 
in aggregate level analyses. As it is highly improbable that these 
indicators will be comparable across countries further studies should 
be done within individual countries. At this moment, such studies are 
in progress in England and Wales, Belgium, The Netherlands, and 
France. 
Another, at least as promising line of research would be to 
leave the realm of aggregate data studies and to investigate indivi-
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dual deaths in an attempt to identify deficiencies in the availabili-
ty, uptake, and effectiveness of medical services. There is an im-
portant tradition for this type of study in the field of Maternal and 
Perinatal mortality, where confidential enquiries have been used to 
obtain detailed information on the care received by the deceased [23, 
24]. This approach is probably also feasible for other causes of 
death. Local "avoidable factors" in medical services may be found to 
have a substantial impact on the incidence of deaths from these cau-
ses. One of the main uses of the data of the Atlas of Avoidable 
Mortality would then be the identification of "hot spots" of avoidable 
mortality, where further investigation promises high rewards [25]. 
VII.8 Summary 
This paper addresses the question whether regional mortality 
differences within developed countries reflect differences in supply 
of medical care. It adds two new elements to previous studies on this 
subject: its focus is on mortality from selected conditions, con-
sidered to be amenable to medical intervention, and it makes parallel 
analyses for ten EC countries. The results show that levels of medical 
care supply contribute little to the explanation of regional 
differences in mortality from the selected conditions. It is concluded 
that if regional differences in mortality from these conditions are 
related to medical care, other factors than the level of supply are 
probably involved. 
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VIII Regional differences in mortality 
from conditions amenable to 
medical intervention in The 
Nether lands 
- a comparison of 4 time-periods 
VIII.l Introduction 
Monitoring the effectiveness of medical care services at population 
level is not the easiest task of health care policy makers. This 
activity requires the availability of outcome indicators that are 
precise and valid, and that are easy to collect. Unfortunately, there 
is no abundance of such indicators [1]. 
An English research group, building upon the work of 
Rutstein et al [2], has proposed to use data on mortality from condi-
tions which are considered to be largely amenable to medical interven-
tion [3]. Important geographical variation in mortality from such 
conditions has been demonstrated, both in England and Wales [3] and in 
other countries of the European Community [4]. The important question 
now is, whether these mortality differences indeed reflect differences 
in medical care outcome, and, if so, to which aspects of medical care 
delivery these outcome differences can be traced. 
Two approaches to obtain an answer to this question have 
been distinguished: studies of the association between mortality, 
medical care characteristics, and potential confounding factors at an 
aggregate level, and in-depth studies of medical care and other fac-
tors in individual deaths from such causes [5]. The latter approach, 
while probably being the most informative, presents many practical and 
methodological difficulties, and has not yet yielded any published 
results. 
The former approach however, being more feasible, has 
already produced some empirical findings. In England and Wales, it was 
found that regional variation in morbidity, estimated from hospital 
admissions, notifications of infectious diseases, and cancer registry 
data, could only partly explain regional variation in mortality from 
conditions amenable to medical intervention [6]. In another study, 
negative associations were found between mortality from such "avoida-
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ble" causes and some indicators of the level of resource provision 
(i.e. a higher level of provision was associated with a lower level of 
mortality, as expected). It was noted that a correction for socio-
economic differences would probably reduce the associations, as medi-
cal care supply and socio-economic conditions are strongly correlated 
in England and Wales [7]. In Belgium, positive associations were found 
between mortality from the selected conditions and the level of medi-
cal care supply, after controlling for socio-economic conditions [8]. 
From France, weak negative associations, after controlling for socio-
economic factors, have been reported [9]. In a comprehensive analysis 
of the relationship between medical care supply and mortality from 
these conditions in all countries of the European Community, we found 
associations to be generally weak and inconsistent [Chapter VII]. 
Mortality from conditions which have become amenable to 
medical intervention has generally decreased in the past decades [10, 
11; Chapter VI]. For each of these conditions, mortality decline in 
part reflects the introduction and diffusion of (a number of) innova-
tions in the medical care system. This suggests that associations 
between mortality levels and medical care supply characteristics at 
regional level could well be time-dependent in the following way: 
- before a given cause of death becomes amenable to medical interven-
tion, regional mortality levels are not associated with medical care 
supply characteristics; 
- during introduction and diffusion of the innovation(s) an associa-
tion may emerge between regional mortality levels and one or more 
medical care supply characteristics if the latter determine the degree 
of application of the intervention at that particular moment in time; 
- after general diffusion, the association disappears again, due to 
the "law of diminishing returns" (a similar difference in degree of 
application produces a smaller difference in the level of mortality), 
and due to the fact that the prevailing degree of regional variation 
in medical care supply is not likely to bring about large enough 
differences in effort. 
The analysis reported in this paper is an attempt to intro-
duce this time dimension into the study of regional differences in 
mortality from "amenable" causes in The Netherlands. A presentation of 
the association with medical care supply characteristics in the early 
1980's will be followed by an analysis of its evolution over time 
since the early 1950's. 
VIII.2 Data 
For four time-periods (1950-54, 1960-64, 1970-74, 1980-84) .numbers of 
deaths, by age (0, 1-4, 5-14, ..... 85-94, 95+), sex, region, and cause 
of death were extracted from a large computerfile supplied by the 
Dutch Central Bureau of Statistics. Population numbers, by age, sex, 
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Table VIII.l Causes of death selected for analysis, grouped according to time of 
introduction of effective medical interventions within the study period 
(1950-1984). 
Group Cause of death Age-limits Total number of deaths 
1950-54 1980-84 
I Influenza and pneumonia 0-74 8973 2233 
"Early" Tuberculosis 0-74 5867 429 
Other infectious diseases [a] 0-74 4967 1162 
II Peptic ulcer 0-74 2197 901 
"Early/ Three "surgical" conditions [b] 0-74 3646 1055 
late" Prostate hyperplasia 0-74 1365 194 
Perinatal mortality [c] < 1 week 37898 9089 
Rheumatic heart disease 0-74 3905 2563 
III Congenital heart disease 0-74 2584 1453 
"Late" Cerebrovascular disease 0-74 21959 18492 
Hypertensive disease 0-74 4528 1618 
Cancer of cervix uteri 0-74 1443 1190 
Cancer at younger ages 0-34 3758 3069 
IV Total mortality, all causes 0-74 240504 277536 
--------------------------------------------------------------------------------------
[a] Specific bacterial infections; viral diseases commonly occurring in children; 
Syphilis; Infections of central nervous system; Bacterial endocarditis; Infec-
tions of respiratory system other than Influenza and pneumonia; Infections of 
skin; Infections of locomotor system. 
[b] Appendicitis; Cholelithiasis/-cystitis; Abdominal hernia. 
[c] Still-births plus first-week deaths. 
and region, were available from several sources based on the Dutch 
population register. 
Although the mortality-file permits a larger number of re-
gions to be distinguished, we amalgamated small contiguous regions so 
as to obtain a minimum population size of approximately 200.000 
throughout the period 1950-84. The resulting number of regions was 28, 
with a minimum population size of 184.000 in 1950 and 225.000 in 1980, 
and with a median population size of 293.000 in 1950 and 477.000 in 
1980. 
The causes of death included in the analysis reported in 
this paper are presented in table VIII.l. International Classification 
of Disease (ICD)-codes [12] for the four revisions in force during the 
period 1950-1984 were selected to achieve maximum correspondence be-
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tween revisions. National trends in mortality from each of the so-
formed causes did not show important breaks between rev1s1ons, which 
suggests that the nosological content of these causes has not changed 
to a degree invalidating comparison over time. Age-limits were applied 
because avoidability of death and quality of cause-of-death certifica-
tion become increasingly questionable with age. 
The causes of death presented in table VIII.1 form a selec-
tion from a larger number of conditions which can be considered amena-
ble to medical intervention (cf. ref. [2]). The analysis was restric-
ted to those causes for which the number of deaths was reasonably 
large during most of the study-period, and for which mortality has 
declined in The Netherlands during (parts of) the period 1950-1984 
[Chapter VI, in which selected references are given too]. In order to 
reach sufficient numbers of deaths, some smaller causes were grouped 
together (a number of "Other infectious diseases", 3 "Surgical" condi-
tions, and all Cancers in children and young adults, a large pro-
portion of which has become manageable with the advances against 
Morbus Hodgkin, Leukemia, Cancer of the testis, &cetera [13]). 
The resulting selection of diseases has been ordered in 
table VIII.1 according to the moment of introduction of medical care 
innovations. Chemotherapeutics and antibiotics, important in the re-
duction of infectious disease mortality, were introduced before 1950. 
Although some effective interventions were available before 1950 for 
group II, important improvements and further significant innovations 
took place during the study-period. Effective medical interventions 
for Congenital heart disease, Cerebrovascular and Hypertensive 
disease, Cancer of cervix uteri and Cancer at younger ages only became 
available late in the study-period. 
The number of variables available for "explanation" of re-
gional mortality patterns (table VIII.2) is rather restricted, due to 
the fact that statistical information on a regional level has become 
more extensive only in recent years. Four medical care supply charac-
teristics (two on the general level of supply, and two indicators of 
the level of technology in hospital care) were available for the whole 
study-period. Three sociodemographic characteristics could be used to 
control for possible confounding: average income (as an indicator of 
socio-economic conditions), net immigration (which may indicate an-
other aspect of socio-economic development, and perhaps also selection 
processes) and urbanisation (as an indicator of ways of living). The 
fertility rate (number of births per 1000 females 15-49 years), not 
mentioned in table VIII.2, will be used as an additional control 
variable in the analysis of Perinatal mortality. 
It is clear from table VIII.2 that general practitioner 
density has decreased since 1950-54, and that hospital bed density has 
increased, whereas there has been a sharp reduction in the percentage 
of regional hospital beds located in small hospitals. The coefficient 
of variation of general practitioner density has decreased substan-
tially, which indicates increasing geographic homogeneity. Average 
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Table VIII.2 The medical c~re supply characteristics and sociodemographic variables 
used in the analysis. 
Variable 
GP Number of general practitio-
ners (per 10.000 population) 
BED Number of hospital beds (per 
1000 population) 
UNIV Percentage of regional 
hospital beds located 
in university hospitals 
SMALL Percentage of regional 
hospital beds located 
in small hospitals (i.e. 
with less than 200 beds) 
INC Mean income per capita 
(in 1000 guilders) 
MIGRA Crude immigration rate 
(per 1000 population) 
URB Degree of urbanisation [b) 
Mean 
4,48 
3.94 
7.14 
46.34 
1.16 
-2.66 
25.20 
1950-54 
Coeff. of 
variation 
26 
28 
255 
69 
16 
0.45 [a] 
108 
[a] Standard deviation instead of coefficient of variation. 
Mean 
3.81 
4.57 
7.33 
12.07 
12.27 
0.17 
28.15 
1980-84 
Coeff. of 
variation 
7 
25 
2D 
105 
11 
0.33 [a] 
78 
[b] Calculated as (0.5 * A) + B, where A and B are the percentage of population 
living in cities with 50,000 - 100,000 and more than 100,000 inhabitants 
respectively. 
income has of course increased (not corrected for inflation), but 
geographical heterogeneity has decreased. 
Intercorrelations between medical care and other independent 
variables were generally of a modest magnitude. In 1950-54 the only 
product-moment correlation > .50 or < -.50 was between the percentage 
of beds in small hospitals (SMALL) and degree of urbanization (URB) 
(-.57). In 1980-84 the only larger correlation was between hospital 
bed density (BED) and average income (INC) (.50). 
VIII.3 Methods 
For each cause of death (except Perinatal mortality) and for each of 
the 4 periods, regional Standardized Mortality Ratios (SMR 1 s) were 
calculated using national age- and sex-specific mortality rates of the 
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same period as the standard. Regional Perinatal mortality rates 
(still-births and first-week deaths, per 1000 births) were expressed 
as a percentage of the national rate for the same period. For each 
cause of death and each period an over-all chi-square-test on hetero-
geneity between regions was carried out [14]. 
In the regression analyses, the (natural) logarithm of the 
SMR (ln SMR) was used as the dependent variable, so that, for example, 
an SMR of .50 is treated as having the same distance to 1.00 as an SMR 
of 2.00. In order to minimize the influence of chance fluctuations, 
regions were weighted according to the reciprocal of the variance of 
their SMR's, under the assumption that for these, mostly small, causes 
of death the variance of the error term in the regression is dominated 
by sampling variation [15]. The variance of ln SMR is equal to the 
reciprocal of the observed number of deaths [16]. The calculations 
were carried out with the BMDP-package. 
Spatial patterns, either of disease or of explanatory varia-
bles, often exhibit a simple gradient structure; e.g. in The Nether-
lands there is a north-south gradient of mortality which can be fol-
lowed through Belgium into Northern France [17]. Such mortality gra-
dients probably reflect (otherwise unobservable) environmental, social 
or cultural factors, i.e. not medical care. The a priori probability 
of two geographic grad'ients being non-orthogonal is high, so that a 
significant association between e.g. medical care supply and mortality 
might exist solely because of similar gradients [15]. 
Variables describing geographic mortality gradients can thus 
be treated as potential confounders. Two series of multiple regression 
analyses were therefore carried out. In a first series only the inde-
pendent variables mentioned in table VIII.2 were entered. In a second 
series we added a set of variables which permit the measurement of 
geographic gradients in mortality: longitude, latitude, the squared 
values of longitude and latitude, and the cross-product. The parameter 
estimates obtained with the regression model of the first series were 
quite robust against the addition of variables describing geographic 
gradients, so that we will only report the results of the more 
parsimonious model. 
VIII.4 Results 
Regional variation in mortality from the selected causes is mostly 
much larger than could be expected to occur by chance alone (table 
VIII.3). Cancer in children/young adults, where geographic heteroge-
neity never reached conventional levels of statistical significance, 
is the exception. This is not a small number problem (cf. table 
VIII.1), but appears to be due to a lack of variation. As was to be 
expected, the coefficient of variation in general is larger with 
smaller numbers of deaths (compare tables VIII.1 and VIII.4). On the 
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Table VIII.3 Regional variation in mortality from the selected causes: coefficient 
of variation of SMRs and significance level according to chi-square-test 
for heterogeneity between regions. 
Coefficient of variation/ significance level 
1950-54 1960-64 1970-74 1980-84 
--------------------------------------------------------------------------------------
I Influenza and pneumonia 21 'Jd::J:. 19 I 1dd< 20 1<1<* 16 **''' 
Tuberculosis 23 *1'* 40 I •kJC'J'•: 25 37 ':t'o'dc 
Other infectious diseases 10 ** 12 I i< 16 '"* 16 "J':* 
II Peptic ulcer 22 -J:.-:.'c:J: 23 I 'fo'c'lc 14 28 *'~ 
Three "surgical" conditions 18 ':J'dc.* 20 I 'Jo'cl: 18 ·Jc:Jcolc 26 I **''' 
Prostate hyperplasia 23 1dd< 24 I 1<* 31 "~'* 44 I 
Perinatal mortality 9 1<1:1: 8 I ·Jcolc':t': 8 '1<1<1: 8 I ·Jc:Jc'J: 
Rheumatic heart disease 20 1<1<>~ 15 I 1dd: 17 '~~ 18 I ':Jdc":.': 
III Congenital heart disesae 19 I •kl: 13 >'<'i< 15 I ':t': 19 I ';,'( 
Cerebrovascular disease 9 I *1'* 12 ":.':·ld: 10 I 'io~'i< 10 I >'dd< 
Hypertensive disease 17 I 'Jddc 25 ":t'd::Jc. 20 I 'idd< 15 I ,., 
Cancer of cervix uteri 23 I ':t'C':t':.* 21 ·k'kJc 15 I 'i< 20 I -Jddc 
Cancer at younger ages 12 I 13 11 I 15 I 
IV Total mortality, all causes 6 ':t'dc'l: 6 'J:•lo':. 5 ·k:Jcolc 5 -:,'c"kl: 
--------------------------------------------------------------------------------------
Significance levels: blank p ~ .05; -:;': p < .05; 1d< p < .01; 'lc:Jc)': p < .001 
other hand, Other infectious diseases, "Surgical" conditions, and 
Cancer of cervix uteri, being about equal in size in 1980-84, have 
differing degrees of regional variation, with "Surgical" conditions 
clearly in top. 
In the course of time, most of the causes of death have 
decreased in size. The accompanying increase in the relative 
importance of chance fluctuations will tend to inflate the coefficient 
of variation. It is remarkable, therefore, that in some of these 
causes the coefficient of variation has decreased or remained stable 
instead, as in Influenza and pneumonia, Perinatal mortality, and 
Hypertensive disease. This suggests increasing geographic homogeneity 
of mortality from these causes. 
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Table VIII.4 Correlation of mortality with medical care supply characteristics, 
1980-1984. 
Product moment correlations [a] 
I 
II 
III 
IV 
Influenza and pneumonia 
Tuberculosis 
Other infectious diseases 
Peptic ulcer 
Three "surgical" conditions 
Perinatal mortality 
Rheumatic heart disease 
Congenital heart disease 
Cerebrovascular disease 
Hypertensive disease 
Cancer of cervix uteri 
Total mortality, all causes 
GP 
.13 
.oo 
-.07 
.13 
-.20 
.20 
-.45~' 
.16 
-.21 
.06 
.18 
.09 
BED 
.10 
.30 
.22 
-.02 
-.26 
.OS 
-.04 
-.06 
-.14 
.25 
.11 
.01 
UNIV 
-.00 
-.11 
-.03 
.09 
-.53~' 
-.28 
.06 
-.32+ 
-.26 
-.25 
.04 
.07 
Significance levels (two-sided test): + p < .10; ~' p < .OS. 
[a] Unweighted correlations (n = 28). 
SMALL 
-.07 
-.13 
-.22 
.17 
.35+ 
-.16 
-.OS 
.09 
-.31 
.34+ 
.28 
-.26 
Table VIII.4 gives a first impression of the association 
between mortality and medical care supply characteristics in 1980-84, 
excluding causes for which no statistically significant geographic 
heterogeneity was found. The number of significant correlations is 
very small. The overall pattern is not very consistent, although all 
correlations attaining some degree of statistical significance are in 
the expected direction: negative for general practitioner density (GP) 
and percentage of regional hospital beds located in university hospi-
tals (UNIV), positive for percentage of regional hospital beds located 
in small hospitals (SMALL). 
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Table VIII.S Regression of mortality on medical care supply characteristics, 
controlling for sociodemographic variables, 1980-1984 [a]. 
Regression coefficient 
GP BED UNIV SMALL 
I Influenza and pneumonia .177 .011 -.0027 -.0011 
Tuberculosis -.103 .253* -.0076 -.0076 
Other infectious diseases -.092 .023 -.0020 -.0023 
II Peptic ulcer .224 -.004 .0028 
Three "surgical" conditions -.151 .012 -.0087>'< .0048 
Perinatal mortality .045 -.017 -.0014 .0003 
Rheumatic heart disease -.337+ .063 .0008 .0019 
III Congenital heart disease -.036 -.003 -.0047 -.0018 
Cerebrovascular disease -.037 .017 -.0040* -.0042* 
Hypertensive disease -.080 .025 -.0027 .0043 
Cancer of cervix uteri .132 -.029 .0001 .0049 
IV Total mortality, all causes .oos .006 -.0005 -.0010 
Significance levels (two-sided test): + p < .10; ~' p < • OS. 
[a] Multiple regression model containing four medical care variables and three socio-
demographic variables. Dependent variable is ln SMR, weighted with the observed 
number of deaths. When no value is mentioned in the table, the variable has not 
been entered into the regression model because the tolerance level was exceeded. 
Multiple regression analysis produces a slightly different 
picture of the associations between mortality and medical care supply 
characteristics in 1980-84 (Table VIII.S). The number of statistically 
significant associations is again very small. Some of these are in the 
expected direction, but others are not, e.g. beLween mortality from 
Tuberculosis and hospital bed density (positive), and between Cerebro-
vascular disease mortality and% beds in small hospitals (negative). 
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Figure VIII.l Additional percentage of variance explained by medical 
care supply characteristics, after controlling for 
sociodemographic variables. 
Group 
50 
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In order to investigate whether the associations between 
mortality from the selected causes and medical care supply charac-
teristics are time-dependent, the results of regression analyses for 
each of the 4 time-periods were compared. For each cause of death 
figure VIII.1 shows the (additional) percentage of variance explained 
by the four medical care supply variables, after controlling for 
sociodemographic variables. We expect relatively important contri-
butions of medical care variables in 1950-54 and 1960-64 for group I, 
and in 1970-74 and 1980-84 for group III. For group II, it is more 
difficult to specify such a hypothesis. 
The findings show that the associations are indeed.·· time-
dependent, but that the timing of changes only partly conforms to our 
expectations. In group I, medical care variables contribute little in 
1950-54, and a bit more in 1960-64. The largest contribution is for 
Tuberculosis in 1980-84. 
In group III, the contribution of medical care supply 
characteristics to the explanation of regional mortality patterns is 
relatively small in 1950-54 and 1960-64 for all diseases, except for 
Cerebrovascular disease. An important association emerges in 1970-74 
for Congenital heart disease. For Cerebrovascular disease .the contri-
bution of medical care variables increases towards the end of the 
study-period. 
In group II, changes in the association with medical care 
variables can be seen for several diseases. For "Surgical" conditions 
the additional percentage of variance explained is larger in 1970-74 
and 1980-84. For Prostate hyperplasia the contribution is relatively 
large in 1950-54, then decreases, and finally increases again. For 
Perinatal mortality, a larger contribution of medical care supply 
characteristics emerges temporarily in 1970-74. 
For Total mortality the additional percentage of variance 
explained by medical care variables after controlling for 
sociodemographic factors is uniformly small. 
Table VIII.6 presents parameter estimates for those combina-
tions of time-periods and causes of death that were characterized by 
relatively high additional percentages of variance explained (~ 207.) 
by medical care variables. General practitioner density has many 
statistically significant associations with mortality, but many of 
these are not in the expected direction. The negative associations 
between the percentage of regional hospital beds located in university 
hospitals are in line with our expectations. 
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table VIII.6 Regression of mortality on medical care supply characteristics, 
controlling for sociodemographic variables, for a few selected causes of 
death and time-periods [a). 
Regression coefficient 
I 
II 
III 
Tuberculosis (1980-84) 
Other infectious diseases (1960-64) 
Other infectious diseases (1970-74) 
Peptic Ulcer (1950-54) 
Peptic Ulcer (1970-74) 
"Surgical" conditions (1970-74) 
"Surgical" conditions (1980-84) 
Prostate hyperplasia (1950-54) 
Prostate hyperplasia (1970-74) 
Prostate hyperplasia (1980-84) 
Perinatal mortality (1970-74) 
Rheumatic heart disease (1950-54) 
Rheumatic heart disease (1970-74) 
Congenital heart disease (1970-74) 
Cerebrovascular disease (1950-54) 
Cerebrovascular disease (1970-74) 
Cerebrovascular disease (1980-84) 
GP 
-.103 
.039+ 
.250* 
.034 
-.045 
.038 
-.151 
BED 
.253* 
.020 
.007 
.064 
.048 
.069 
.012 
.046 .151~' 
.464* .006 
-.700* -.037 
.134* -.004 
-.100* -.039 
- • 288~' • 064 
.022* 
.097 
-.087 
-.037 
.010 
.016 
.027 
.017 
Significance levels (two-sided test): + p < .10; * p < .OS. 
[a) See note a, table VIII.5. 
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UNIV SMALL 
-.0076 -.0076 
-.0005 -.0008 
-.0019 -.0007 
• 0015 • 0037~' 
-.0037+ -.0008 
-.0034 
- .0087~• 
-.0008 
-.0061 
.0039+ 
.0048 
.0024 
.0029 
.0058 
- .0026~' -.0004 
.0031 -.0024 
-.0010 .0002 
-.0018 -.0006 
.0005 -.0012 
-.0020+ -.0006 
-.0040* -.0042* 
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VIII.S Discussion 
In The Netherlands, as in many other countries, important geographical 
variation in mortality from conditions amenable to medical interven-
tion exists. For a recent time-period (1980-84) associations with a 
number of simple medical care supply characteristics were shown to be 
weak and inconsistent - a finding analogous to that of other studies. 
Meaningful associations were, however, not totally absent. 
The presence of a university hospital appears to be associated with 
lower mortality levels for "Surgical" conditions and Cerebrov'ascular 
disease. Further study is necessary to reveal whether or not this is a 
spurious association, occurring by chance (multiple significance 
testing as in tables VIII.4 and VIII.5 is likely to produce a small 
number of statistically significant coefficients, even in the absence 
of any real associations), or due to insufficient control of con-
founding variables. 
A comparison of regression results over time shows, that the 
percentage of variance in regional mortality levels which can be 
"explained" by medical care supply variables is rather time-dependent. 
Associations emerge and disappear, and although the timing of these 
changes is not very different from what one would expect on an a 
priori basis, the exact nature of the associations is sometimes 
puzzling. A larger number of general practitioners per 10.000 popula-
tion (which is equivalent to smaller average list-size of general 
practitioners) repeatedly was associated with higher mortality from 
conditions amenable to medical intervention. Again this could be a 
spurious association, but it could also indicate that improvements in 
medical care reach the average patient with these conditions later in 
regions where a larger proportion of patient care is being delivered 
by general practitioners. 
In the regression analyses the sociodemographic variables 
were treated as possible confounders, suggesting that associations 
between these variables and mortality are not to be viewed as effects 
of variations in medical care delivery. This is not necessarily true. 
Part of the effects of average income and degree of urbanisation on 
mortality might arise from differences in other aspects of medical 
care delivery than were reflected in the four measures of medical care 
supply used in this study. Unfortunately, it is very difficult to 
separate the contribution of different mechanisms without more de-
tailed information. 
The question, whether geographic variation in mortality from 
conditions amenable to medical intervention reflects differences in 
medical care outcome, and, if so, to which aspects of medical care 
delivery these outcome differences can be traced, is only partly 
answered by this study. 
The absence of a clear pattern of associations between 
medical care supply characteristics and mortality from these 
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conditions does not invalidate the latter as indicators of medical 
care outcome. Mortality could be determined by more specific aspects 
of medical care delivery, that are not strongly associated with the 4 
crude variables available in this study. 
On the other hand, our findings on the relationship between 
mortality and the supply of medical care suggest that, within the 
prevailing range of variation, differences in supply do not have 
serious effects on at least one outcome indicator, mortality. Whether 
this is a comforting or a disturbing thought is difficult to say. 
VIII.6 SUJIJIIIary 
In The Netherlands, as in many other countries, important geographical 
variation in mortality from conditions amenable to medical interven-
tion exists. Associations with a number of simple medical care supply 
characteristics (general practitioner density, hospital bed density, 
and percentage of regional hospital beds located in university and 
small hospitals, respectively). are generally weak and inconsistent, 
both before and after controlling for possible confounders. 
One of the possible reasons for this lack of consistency, 
viz. time-dependen~y of the relationship between medical care supply 
and mortality from these causes, was explored. A comparison of asso-
ciations in 4 time-periods (1950-54, 1960-64, 1970-74 and 1980-84) 
shows that the percentage of variance in regional mortality levels 
which can be "explained" by the medical care supply variables, has 
changed over time. 
Although patterns of change are not very different from what 
one would expect on the basis of the time of introduction of medical 
care innovations, the exact nature of the associations is puzzling. 
Apart from some expected negative associations between mortality and 
the presence of university hospitals, a few unexpected positive 
associations are found with general practitioner density. 
Possible explanations for these findings are discussed, and 
it is concluded that further study is necessary to reveal the causes 
of a higher or lower mortality level for conditions considered to be 
amenable to medical intervention. 
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IX 
IX.l 
Regional differences in decline of 
mortality from selected 
conditions, The Nether lands, 
1969-1984 
Introduction 
After a period of rather stable all-cause mortality rates, a decline 
set in at the end of the 1960's or the beginning of the 1970's in many 
industrialized countries. A reversal from an increasing to a 
decreasing mortality trend for Ischemic heart disease was among the 
main contributors to this event [1]. Other conditions have contributed 
as well, either through acceleration of an already apparent decline, 
such as in Cerebrovascular disease [2] and Perinatal mortality [3], or 
through the onset of new declines, as seen in certain smaller cancers 
[ 4]. 
Although very few would disagree that improvements in 
medical care did have some effect, there is no consensus on their 
exact contribution, and other factors certainly also played an im-
portant role. The trend reversal for Ischemic heart disease, the most 
widely discussed of the favourable cause-specific mortality changes, 
is generally ascribed to a combination of changes in life-style and 
medical care [5]. The contribution of medical care to mortality de-
cline may have been relatively large for causes of death which are now 
considered to be amenable to medical intervention, like Cerebro-
vascular disease, Perinatal and Maternal mortality, some "surgical" 
conditions (such as Appendicitis), Hodgkin's disease, Cancer of the 
cervix etc. [6, 7]. 
The study reported here analysed regional variation in de-
cline of mortality from a number of conditions for The Netherlands. A 
description of regional differences in mortality improvement was 
thought to provide useful information for health policy makers, be-
cause it identifies regions where progress is unsatisfactory. The ana-
lyses addressed the following questions: 
- Did regions within The Netherlands differ in their rate of mortality 
decline for a number of important conditions during the period 1969-
191 
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1984? 
- What patterns are formed by these differences, and how do regional 
differences in mortality decline relate to differences in mortality 
level? 
- With which of a number of available socio-demographic or health care 
characteristics are these differences in mortality decline associated? 
IX.2 Data and methods 
Numbers of deaths, by age(< 1 week, 1-52 weeks, 1-4, 5-14, ...... 85-
94, 95+ years), sex, calendar-year (1969-1984), region, and cause of 
death were available from a large computerfile supplied by the Dutch 
Central Bureau of Statistics. Numbers of still-births (necessary for 
the calculation of Perinatal mortality) were also obtained from the 
Central Bureau of Statistics. Mid-year population numbers, by age, 
sex, calendar-year and region were available from various sources 
based upon the Dutch population register. 
39 regions were distinguished, with a median population size 
of 235.000 in 1969 and_303.000 in 1984. These so-called COROP-regions 
have been created for statistical purposes only, and represent geo-
graphical areas serviced by one or more larger cities. Region no. 40 
(Zuidelijke IJsselmeer Polders), land which was recently claimed from 
the waters of the former Zuiderzee, was omitted because its population 
was increasing rapidly during the study-period (from 14.000 in 1969 to 
116.000 in 1984). 
Loglinear regression analysis was used to obtain estimates 
for regional mortality levels and trends, controlling for differences 
in (changes of) the size and age/sex-composition of the population. 
For computational reasons we first estimated national mortality 
levels, by age-group and sex, and national mortality trends. Then 
regional departures from national mortality levels and trends were 
estimated. For each region a regression equation was fitted to the 
observed number of deaths which had the following formal structure: 
in which: E(y) 
N 
e 
X 
a 
a' 
N .. eai+a'+(~+~')X 
1J 
absolute number of deaths in a region as 
expected under the model 
person-years at risk in a region 
base of the natural logarithm 
calendar-year 
national mortality level, fixed 
regional departure from national mortality 
level, to be estimated 
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national mortality trend, fixed 
regional departure from national 
trend, to be estimated 
subscript denoting age/sex-group 
= subscript denoting calendar-year 
mortality 
In the case of Perinatal mortality, person-years at risk 
were replaced by the number of births. The model assumes that national 
mortality trends and regional departures from national levels and 
trends are the same, on a logarithmic scale, for all age/sex-groups 
(i.e. that there is no interaction between age/sex and calendar-year 
or region). The calculatio~ts were performed with the GLIM-package, 
specifying a Poisson regression model [8]. The GLIM-package produces 
maximum likelihood estimates using an iteratively reweighted least 
squares procedure. 
Differences in scaled deviance (SD) between this model and a 
model not containing~· (but including a 1 ) were used to assess the 
statistical significance of ~·. by comparison with a chi-square-
distribution with one degree of freedom [8]. Fitting these models to 
the observed values for each region r produces a s~ries of differences 
in scaled deviance (dSD ), the summation of which (L dSD ) gives a 
test-statistic for the rstatistical significance of rovef-all geo-
graphical heterogeneity of mortality trends (chi-square-distribution, 
38 degrees of freedom). 
The causes of death selected for analysis are presented in 
table IX.1. Apart from Total mortality (all causes) we selected a 
number of important contributors to mortality decline in The Nether-
lands in the period 1969-1984. Perinatal mortality, Cerebrovascular 
disease and a global category of conditions which are frequently 
considered to be amenable to medical intervention are included, 
because an earlier analysis had shown that mortality decline for these 
conditions has contributed app~eciably to trends in Total mortality in 
The Netherlands [Chapter VI] as it has in other countries [6, 7]. 
Stomach cancer is included because it is the only larger cancer for 
which mortality declined in the study-period [9]. Aft~r earlier sharp 
increases, mortality from Ischemic heart disease has been declining in 
The Netherlands since 1972 [10]. Mortality from Traffic accidents has 
shown a trend reversal comparable to that of Ischemic heart disease in 
The Netherlands [11], coinciding with the introduction of a number of 
preventive measures. International Classification of Disease (ICD)-
code numbers for each of these conditions were carefully chosen so as 
to m1n1m1ze the effects of the introduction of the 9th Revision in 
1979. Inspection of mortality trends did not reveal important breaks 
between 1978 and 1979. 
We exclude deaths at ages 75 and over, in order to reduce 
possible age/sex-interactions (mortality generally declined less in 
the very old) and because the validity of cause-of-death certifica-
tion becomes increasingly questionable at higher ages. Mortality from 
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Table IX.l Causes of death selected for analysis. 
Cause of death Age-range 
Perinatal mortality [bl < 1 week 
Cerebrovascular disease 0-74 
"Amenable" selection [c) 0-74 
Cancer of the stomach 0-74 
Ischemic heart disease 0-74 
Traffic accidents 0-74 
Total mortality 0-74 
[a] Calculated as 100(J3). 
[b] Still-births plus first-week deaths. 
Regional mortality trend differences 
National 
deaths 
1969-84 
43877 
67666 
185743 
24188 
210175 
36721 
922220 
National trend 
(%per armum 
mortality change) 
1969-84 [a] 
- 4.9 
- 3.2 
- 4.5 
- 3.6 
- 1.4 
- 5.8 
- 1.6 
[c] A selection of causes of death considered to be amenable to medical intervention 
[6, 7, 13]: Tuberculosis; Influenza and pneumonia; a number of other infectious 
diseases; Perinatal and Maternal mortality; Rheumatic heart disease; Appendicitis; 
Cholelithiasis and -cystitis; Abdominal hernia; Cerebrovascular disease; 
Hypertensive disease; Hodgkin's disease; Cancer of the cervix uteri. 
the selected causes declined considerably in the age-group below 75 
years during the study-period, as indicated by the last column of 
table XI.l. Total mortality also declined, although less than most of 
the selected conditions (except Ischemic heart disease). 
IX.J Results 
Table IX.2 shows that the rate of mortality decline differed between 
regions in The Netherlands for most of the selected conditions. Over-
all regional heterogeneity of mortality trends is statistically signi-
ficant for Perinatal mortality, Cerebrovascular disease, the "Amena-
ble" selection, and Ischemic heart disease, as well as for Total 
mortality. For Cancer of the stomach and Traffic accidents, however, 
the regional variation in mortality decline is what could be expected 
to occur by chance alone. 
A truncated range of variation is given by the last two 
columns of table IX.2, which present the lOth and 90th percentile 
values for the regional rates. of mortality decline (in per cent per 
annum, calculated as 100(~ + ~')). For e.g. Perinatal mortality, four-
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Table IX.2 Geographic heterogeneity of cause-specific mortality trends, 39 Dutch 
regions, 1969-1984. 
Cause of death 
Perinatal mortality 
Cerebrovascular disease 
"Amenable" selection 
Cancer of the stomach 
Ischemic heart disease 
Traffic accidents 
Total mortality 
[a) Calculated as 100(~ + ~'). 
Significance tests 
Over-all 
test [b) 
71.9** 
60.1~' 
76.3*'~'* 
39.7 
114.0*'~'* 
52.4 
124. 7'~** 
No. regions 
different 
(p < .05) 
3 
4 
6 
1 
12 
4 
11 
Truncated range of 
variation of regional 
trends (% per annum 
mortality change)[a) 
lOth 
per-
centile 
- 3.7 
- 2.4 
- 3.8 
- 2.7 
- 0.6 
- 4.4 
- 1.3 
90th 
per-
centile 
- 6.1 
- 4.2 
- 5.5 
- 5.0 
- 1.9 
- 7.0 
- 2.0 
[b) I: dSD , comparing the full model with an otherwise identical model not 
c~ntalning ~·; significance levels (chi-square distribution, 38 degrees of 
freedom): 1< p < .05; *'~< p < .01; 1•** p < .001. 
fifths of all regions thus have mortality declines between 3.7 and 6.1 
% per annum. On the whole, the range of variation appears to be 
considerable. 
On the other hand, for each of the selected conditions no 
region had a steady level of mortality (0 % decline), or a mortality 
increase; Total mortality also declined in all regions. 
For Perinatal mortality, Cerebrovascular disease, Ischemic 
heart disease and Total mortality, patterns of regional variation are 
illustrated graphically in figure IX.1. To facilitate comparisons, 
figure IX.1 shows both the (long-term) regional departures from the 
national mortality level (a 1 ) and the regional departures from the 
national mortality trend (~ 1 ). Dark shading implies higher mortality 
levels (a• positive) and less rapid mortality decline c~· positive). 
Average levels of Perinatal mortality over the entire period 
1969-1984 were elevated in certain areas in the north, east and south 
of the country. It is only for a small number of regions that the 
trend of Perinatal mortality differed statistically significantly (p < 
.05) from the national trend, but areas of faster and slower decline 
tend to cluster together, suggesting a systematic pattern of varia-
tion. Mortality declined faster in some areas in the north, east and 
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Regional mortality trend differences 
south. Note that the region of Greater Amsterdam, which is the only 
region shaded black in the trend map (mortality decline slower than 
the national average, p < .05), did also have an unfavourable over-all 
level of Perinatal mortality. 
Low levels of Cerebrovascular disease mortality can be found 
in a belt stretching from the north-east to the south-west of The 
Netherlands, and high levels in a large contiguous area in the south-
east. Trends in mortality form a rather different pattern. 
Although average mortality levels for Ischemic heart disease 
were also high in the south-east, there are some important differences 
with the pattern for Cerebrovascular disease: Ischemic heart disease 
mortality 
Mortality 
parts of 
north-east 
was also high in a large contiguous area in the north-east. 
decline has been fastest in the highly urbanized western 
the country, as well as in some areas in the south. The 
and south-east have had the least favourable trends. 
One of the important features of the pattern of decline for 
Total mortality is that the decline was slower in the western regions 
containing the three largest cities, Amsterdam, Rotterdam and The 
Hague. In contrast to this, declines for Ischemic heart disease were 
faster in these regions. 
A comparison between average levels and trends is important 
from a monitoring perspective: regions with both a higher average 
level and a more unfavourable trend clearly warrant attention. This 
comparison may, however, not give an accurate impression of tendencies 
of convergence or divergence. The average mortality level over the 
entire period 1969-1984 is partly determined by the trend of mortality 
over the same period: faster decline results in a lower average level 
of mortality. We therefore calculated correlations between the morta-
lity trend and the mortality level in 1969 (as estimated with the 
parameter values obtained in the regression analysis)(table IX.3). 
For Perinatal mortality, the correlation between the 1969-84 
mortality trend and the 1969 mortality level is negative. Mortality 
declined faster in regions with a higher starting level, suggesting a 
certain convergence. For the other conditions, the correlation is 
positive, especially for Ischemic heart disease. For Ischemic heart 
disease mortality declined faster in those regions where the starting 
level was already lower, indicating a divergence of mortality levels. 
200 
Regional mortality trend differences 
Table IX.3 Correlations between regional departures from national 
mortality trends c~·) and mortality levels in 1969. 
Cause of death 
Perinatal mortality 
Cerebrovascular disease 
"Amenable" selection 
Ischemic heart disease 
Total mortality 
Product-moment correlations [a] 
with mortality level 1969 [b) 
-.28 
.20 
.26 
.45 
.12 
Note: Positive values for correlation coefficients imply less mortality decline in 
regions with a higher level of mortality in 1969. 
[a] Weighted product-moment correlations (each pair of observations was 
weighted by !/variance (~'); the variance is given as a result of the 
regression analysis). 
[b] Value calculated for X = 0 using the estimated regression parameters. 
In an exploratory search for covariates of regional trends 
in mortality we calculated correlation coefficients between the 
regional departures from the national mortality trend (~ 1 ) and a 
number of variables, measured at the beginning of the study-period 
(table IX.4). We chose the following variables, which were hypo-
thesized to be determinants of the uptake of innovations of whatever 
kind: the percentage of hospital beds located in university hospitals 
(UNIV), the percentage of population living in larger cities (URB), 
the distance in kilometers from the nearest city in the 1 Randstad 1 
(the cultural and economic centre of the country, located in an 
urbanized belt stretching between ~sterdam, The Hague, Rotterdam and 
Utrecht) (PERIF), and average income per inhabitant (INC). 
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Table IX.4 Correlations between regional departures from national 
mortality trends (~')and selected regional characteris-
tics, ca.1970 
Product-moment correlations [a] with [c] 
Cause of death UNIV URB PER IF INC 
Perinatal mortality .18 .28 -.51 .44 
Cerebrovascular disease -.11 .16 .15 .00 
"Amenable" selection -.07 .40 -.15 .20 
Ischemic heart disease -.06 -.55 .63 -.48 
Total mortality .50 .53 -.05 .42 
Note: Positive values for correlation coefficients imply less mortality decline in 
regions with a higher level of the other variable. 
[a] See note a, table IX.3. 
[b] UNIV: % of regional hospital beds located in university hospitals 
URB: % of regional population living in larger cities 
PERIF: distance in kilometers to the nearest city in the 'Randstad' 
INC: average income per inhabitant. 
These variables are of course intercorrelated, but some 
differences in the association with regional mortality decline do 
emerge (table IX.4). For Perinatal mortality, the "Amenable" selec-
tion, and for Total mortality, mortality in general declined less, 
contrary to what one might expect, in regions with a high degree of 
urbanization, a central location, and/or a high average income in ca. 
1970. Note that Perinatal mortality, Cerebrovascular disease, and the 
"Amenable" selection did not decline faster in regions with a univer-
sity hospital. These findings suggest that faster mortality decline 
for these conditions is not due to faster diffusion of new medical 
technologies. 
Mortality from Ischemic heart disease declined faster in 
urbanized, centrally located, high income areas. There is, again, no 
association with the presence of a university hospital. This suggests 
that faster mortality decline is related to faster diffusion of new 
life-styles. 
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Table IX.5 Correlations between regional departures 
mortality trends (~') and changes in 
possible mortality determinants. 
from 
the 
national 
level of 
Product-moment correlations [a] with average 
yearly change (ca. 1970- ca. 1980) in [b]: 
BED GP INC EDUC UNEMP 
Perinatal mortality .00 -.02 -.12 -.31 .30 
Cerebrovascular disease -.20 .19 -.26 -.28 -.18 
"Amenable" selection -.08 .22 -.33 -.40 -.06 
Ischemic heart disease -.25 -.06 .17 .45 -.19 
Total mortality .OS -.05 -.65 -.21 .07 
-----------------------------------------------------------------------
Note: Positive values for correlation coefficients imply less mortality decline in 
regions with a larger increase in the other variable. 
[a] See note a, table IX.3. 
[b] BED: number of hospital beds per 1000 population 
GP: number of general practitioners per 1000 population 
INC: average income per inhabitant 
EDUC: % of population having attained more than first-level education 
UNEMP: % of working population temporarily without work. 
An alternative way of looking for covariates of differences 
in mortality trend is to investigate the association between changes 
in mortality and changes in possible determinants of mortality. Table 
IX.S, which provides correlations between changes in mortality and 
the supply of medical care, as well as between changes in mortality 
and socio-economic characteristics, may give some clues. Changes in 
hospital bed density (BED) and general practitioner density (GP) do 
not seem to be associated with rates of mortality decline. On the 
other hand, Perinatal mortality, Cerebrovascular disease, the "Amena-
ble" selection and Total mortality declined faster where average 
income (INC) and/or education level (EDUC) increased more, mirrorring 
the well-known negative association between mortality levels and so-
cio-economic conditions in cross-sectional analyses. Again, declines 
in Ischemic heart disease mortality show the reverse. 
We included the association between changes in mortality and 
changes in unemployment levels (UNEMP) in table IX.S, because the rise 
in unemployment has been one of the most significant socio-economic 
developments in The Netherlands during this period. The correlations 
are however low, and not very consistent. 
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IX.4 Discussion 
In the analysis reported above we explored an alternative approach to 
the study of geographical variation in mortality. Whereas most studies 
focus on differences in level of mortality, we tried to measure diffe-
rences in trend. Cause-specific mortality trends are frequently quite 
dynamic, so that "snap-shots" of regional mortality levels at one 
moment in time can only give an incomplete picture of the regional 
mortality experience. We found regional differences in decline of 
mortality from selected conditions in The Netherlands to be of a 
relevant magnitude, although the range of variation did not include 0 
% mortality decline. 
Mere description of regional rates of mortality decline may 
already prove a useful addition to more conventional methods of 
surveillance. This applies both to the surveillance of mortality from 
conditions considered to be amenable to medical intervention [12] and 
to that of mortality from many other conditions, including those 
amenable to forms of primary prevention, such as Traffic accidents. 
For the area of infant mortality Kleinman has recently 
suggested to look for the combination of a higher mortality level and 
a slower mortality decline, in order to focus further investigation on 
those regions where concern is certainly warranted [13]. Such regions 
can indeed be identified. For The Netherlands, examples of a combina-
tion of a higher level and a slower decline were pointed out above in 
the case of Perinatal mortality. The relevance of further study is 
enhanced here by the fact that national mortality declines for Perina-
tal mortality have recently been less favourable than in e.g. the 
Scandinavian countries, Switzerland and West-Germany [14]. For Ische-
mic heart disease, many areas in the north-east and south-east of The 
Netherlands are characterized by high mortality levels and unfavoura-
ble mortality trends. 
Regional differences in decline of cause-specific mortality 
may be due to: - different trends in cause-of-death certification; 
different trends in incidence; - and different trends in case fatali-
ty. Different trends in incidence and case fatality could be due to 
differences in effectiveness of certain interventions (primary and 
secondary prevention, treatment), but could also be "spontaneous". 
In our very simple, exploratory analysis we found no eviden-
ce for an effect of differences in medical care on regional patterns 
of mortality decline. For Ischemic heart disease, the associations 
with other regional characteristics suggest that faster decline re-
flects a faster diffusion of new life-styles. If this were to be 
confirmed in further study, a clear case for primary prevention ef-
forts in areas with slower decline would be present. 
In addition some interesting associations with socio-econo-
mic characteristics were found. Mortality from Ischemic heart disease 
declined faster in high income areas, which already had favourable 
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mortality levels at the beginning of the study-period. This suggests a 
widening of mortality differentials, analogous to that reported on the 
basis of occupational mortality data from England and Wales [15]. 
Total mortality declined faster in areas where average income levels 
increased more. This may increase confidence in the existence of a 
causal relationship between socio-economic circumstances and mortality 
[16, 17]. The absence of an association at the regional level between 
trends in Total mortality and changes in unemployment levels is in 
line with the findings of a similar study from England and Wales [18]. 
The analysis of regional variation in mortality decline had 
a number of limitations. Although over-all geographical heterogeneity 
was statistically significant in all but two cases, the small number 
of regions for which the departure from the national mortality trend 
was significant at conventional levels, even for large causes of 
death, suggests that there are power problems which warrant further 
investigation. 
One assumption on which the analysis is based was already 
mentioned in the Data and methods section (no interaction between 
age/sex and calendar-year or region). Another assumption is linearity, 
on a logarithmic scale, of the relationship between mortality density 
and calendar-year (for each region !). Visual inspection of regional 
mortality trends suggested that in the case of Ischemic heart disease 
this assumption was to some extent violated. Regions which apparently 
had faster mortality declines, actually were sometimes characterized 
by an early onset of mortality decline (i.e. before 1972, or even 
1969). Regions for which the estimated value of ~· was positive, 
sometimes had a relatively late onset of mortality decline. Geographic 
variation in the onset of mortality decline for Ischemic heart disease 
may more adequately be described with a quadratic regression model 
[19). 
A general conclusion could be that the area of regional 
variation in mortality trends offers interesting prospects for further 
study. 
IX.5 SUDDDary 
In The Netherlands, as in many other industrialized countries, recent 
mortality developments have been characterized by rapid declines for a 
number of important causes of death. The results of an analysis of 
regional variation in mortality decline within The Netherlands are 
reported, covering the period 1969-1984. The causes of death included 
in this analysis are Perinatal mortality, Cerebrovascular disease, a 
more global "Amenable" selection (formed by aggregating a number of 
causes of death considered to be amenable to medical intervention), 
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Cancer of the stomach, Ischemic heart disease and Traffic accidents. 
For Perinatal mortality, Cerebrovascular disease, the 
"Amenable" selection, and Ischemic heart disease, as well as for Total 
mortality, declines have not been geographically homogeneous. Peri-
natal mortality had a tendency to decline faster in regions where 
starting levels were higher, suggesting a certain convergence. For 
Cerebrovascular disease and the "Amenable" selection, but especially 
for Ischemic heart disease, the reverse was true. 
A simple correlation analysis shows that for Perinatal 
mortality, as well as for the "Amenable" selection, mortality declined 
faster in less urbanized, more peripherally located, lower income 
areas. There is no association with the presence of a university 
hospital. This pattern suggests that faster mortality decline for 
these conditions is due to other factors than faster diffusion of new 
medical technologies. 
For Ischemic heart disease, mortality declined faster in 
more urbanized, more centrally located, higher income areas. Although 
this pattern is what one would expect as a result of regional 
differences in the diffusion of new medical technologies, it may also 
be due to differences in the diffusion of new life-styles. The absence 
of an association with the presence of university hospitals supports. 
the latter view. 
It is concluded that the monitoring of changes in mortality 
at the regional level is an important addition to the more usual 
analyses of mortality variation at one moment in time. 
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X General discussion 
X.l Summary of the main findings and conclusions 
Not so very long ago, the mortality rate in The Netherlands was much 
higher than it is to-day. In the mid-nineteenth century, the mortality 
rate fluctuated between 25 and 30 per 1000 person-years, and the 
average life expectancy at birth was less than 40 years. In the 
1980's, the mortality rate is only 8 per 1000 person-years, and at 
current mortality rates life expectancy is well above 70 years. Al-
though appr. 120.000 people die each year in The Netherlands death has 
become a rare event. 
Nevertheless, even in recent time-periods important 
differences in mortality rates, by cause of death, can be observed 
between different 11 times, places and persons11 • The studies in the 
preceding chapters show that the words of one of the pioneers of 
mortality analysis in the nineteenth century, William Farr, still 
apply to-day: 11Deaths and causes of death are scientific facts which 
admit of numerical analysis; and science has nothing to offer more 
inviting in speculation than the laws of vitality, the variations of 
those laws in the two sexes at different ages, and the influence of 
civilization, occupations, locality, seasons, and other physical 
agencies, either in generating disease and inducing death, or in 
improving the public health11 (First Annual Report of the Registrar 
General, 1839, quoted in ref. 1). 
X.l.l Validity of cause-of-death statistics 
This is of course dependent on the validity of cause-of-death 
information. Possible causes of bias in international comparisons of 
mortality were investigated in chapter II for two (groups of) causes 
of death, Chronic Obstructive Pulmonary Disease and a number of can-
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cers. Differences in certification and coding of causes of death 
between countries of the European Community were studied by sending 
sets of case histories to samples of certifying physicians. 
Detection fractions (the proportion of deaths with a true 
underlying cause X which actually receives the code number for X) 
ranged from 60 to 92% in the study of Chronic Obstructive Pulmonary 
Disease, and from 80 to 94% in the study of cancer. The contribution 
of errors in certification and errors in coding differed from country 
to country. The findings clearly suggest that differences in certifi-
cation and coding of causes of death can bias international mortality 
comparisons. Case history studies as reported in chapter II are a 
convenient way of obtaining estimates of detection fractions (for a 
further discussion, see sections X.2.4 and X.4.4). 
The study also showed that Dutch certification and coding 
practices compare favourably with those in other countries of the 
European Community. Detection fractions for Chronic Obstructive Pulmo-
nary Disease and cancer were estimated to be 91% and 94% respectively 
in The Netherlands. Although these may be overestimates of real life 
detection fractions (a part of the diagnostic process was not included 
in the test situation, and the study may have stimulated participating 
doctors to behave less suboptimally than in every-day life), the 
results do justify some confidence in the validity of Dutch cause-of-
death statistics. 
A detailed analysis of the certificates completed by the 
Dutch participants in the study revealed a substantial frequency of 
errors in certification (which were in part corrected in the coding 
process). The nature of these errors points to possibilities for 
improvement of the validity of cause-of-death information, both by 
changes in the lay-out and phrasing of the death certificate and by 
education of doctors (see section X.4.1). 
X.1.2 Use of mortality data to address health care policy 
questions 
The use of mortality data by cause of death in health policy has a 
long history. The use of mortality data to address health care policy 
questions is of more recent origin, probably because health care 
policy has only grown in importance with the recent expansion of the 
health care system. Chapter III contains a discussion of one of the 
most widely cited examples of the use of mortality data in a health 
care policy context. In England and several other countries, mortality 
data are used in formulas for the allocation of financial resources to 
regions, on the assumption that mortality differences reflect 
differences in morbidity and thus "need" for health care services. 
Although it is probably true that regional mortality 
differences generally reflect differences in incidence (and not case 
fatality) of potentially fatal conditions, there are at least two 
objections to this use of mortality data. The first of these is that 
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the translation into money equivalents requires an accurate picture of 
the excess incidence in regions with higher mortality. The crucial 
question is: how much, and of which conditions (conditions differ in 
resource requirements). The results of the study of provincial diffe-
rences ih mortality, hospital admissions and new cases of disability 
benefits, reported in chapter III, show that for a number of condi-
tions a reasonable degree of correspondence between these three sour-
ces of information existed, but for other conditions none at all. 
Given doubts regarding the validity of cause-of-death information, and 
given the possibility of differences in case fatality, it is not 
likely that regional mortality data by cause of death give a suffi-
ciently accurate picture of morbidity differences. This was inter-
preted as giving insufficient support for a general identification of 
regional mortality with morbidity for a wide range of health problems, 
as assumed in the allocation formulas mentioned above. 
A second objection is that mortality data may also be 
"outcome" indicators. Mortality rates reflect, at least in part, the 
outcome of preventive and curative efforts, either within or outside 
the health care system. It would seem to be unwise to take away 
incentives for mortality reduction by "rewarding" high mortality re-
gions with more health care resources (most of which will not be spent 
on mortality reduction), especially now that health care policy is 
imbedded in a broader framework of health policy. 
Both objections combine into the same general conclusion. If 
regional mortality data by cause of death are used as a criterion for 
the allocation of health care resources,· it should be in a less 
"mechanical" way. A more informal procedure would create room for a 
careful interpretation of mortality differences, as well as for a 
linkage with efforts at mortality reduction (see section X.4.2 for 
further elaboration). 
X.l.3 Mortality time trends and medical care 
The decline of mortality since the eighteenth and nineteenth centuries 
is largely due to other factors than the introduction of efficacious 
medical interventions. But that is not to say that there has been no 
effect of improvements in medical care on time trends of cause-speci-
fic mortality at all. 
Our analysis of the "tail" of the declining mortality curves 
for 21 infectious diseases (chapter IV) has shown that the intro-
duction of antibiotics was accompanied by important changes in morta-
lity. Late effects of World War II made it difficult to assess whether 
sharp reductions in mortality at the moment when antibiotics were 
introduced, were present. However, a longer lasting (acceleration of) 
mortality decline after the introduction was present in many infec-
tious diseases. No acceleration of mortality decline could be shown in 
mortality from "All other diseases". 
Other factors than antibiotics, such as the acceleration of 
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economic development after World War II and preventive programs 
against Tuberculosis, may have contributed also to these changes. On 
the whole, however, the results of the analysis are consistent with 
the hypothesis of substantial effects of antibiotics on infectious 
disease mortality in The Netherlands. 
Contrary to popular belief, changes in mortality since 1950 
have not been much smaller than those in the period 1850-1950. Changes 
in average life expectancy at birth were generally more impressive 
before 1950, but this does not apply to changes in age-specific morta-
lity rates. With the exception of a temporary increase in mortality in 
certain age-groups in males, between the early 1950's and the late 
1960's, the proportional declines in age-specific mortality rates were 
as large after 1950 as they had been before (section I.4.2). 
Many conditions have contributed to favourable mortality 
developments after 1950, or after 1970 for males. The most important 
exception is cancer: mortality rates for many forms of cancer have 
remained stable or have even increased (section I.4.2). One of the 
reasons (apart from unfavourable incidence developments) is that medi-
cal care has only made modest advances in the treatment of cancer. The 
analysis of cancer survival data from the United States, Norway and 
Finland in chapter V shows that survival has on the average increased 
only slightly since the 1950's. 
It is only for a small number of cancers, and mostly not the 
quantitatively important ones, that increases in survival were more 
considerable. These changes in survival are partly due to earlier 
diagnosis ("lead time bias"), changes in registration, and perhaps 
also changes in the degree of malignancy of the disease. For Hodgkin's 
disease, Cancer of the testis, Wilm's tumour, and Acute lymphocytic 
leukemia, on the other hand, increases in survival are probably due to 
dramatic improvements in medical care. These changes have also become 
visible in mortality trends for these conditions in The Netherlands. 
Conditions which have become amenable to medical interven-
tion have contributed appreciably to favourable mortality changes 
since 1950 (chapter VI). Trends in mortality from a selection of 
conditions suggested by Rutstein et al.'s lists of "unnecessary 
untimely mortality" were analysed. This selection covered 11 types of 
medical care innovation and included 35 conditions which have to some 
extent become amenable to medical intervention. Apart from a number of 
infectious diseases and treatable cancers, the selection included some 
endocrine and hemopoietic disorders, a number of "surgical" condi-
tions, Maternal and Perinatal mortality, some congenital anomalies, 
Rheumatic heart disease, Diphtheria/whooping cough/tetanus/poliomyeli-
tis, Nephritis and nephrosis, Hypertensive and Cerebrovascular 
disease, and Cancer of the cervix uteri. 
For most of these conditions, mortality declined during each 
of two subperiods (1950-1968; 1969-1984). Mortality decline accele-
rated in the second subperiod for many conditions. Reductions in 
mortality from these conditions between 1950-54 and 1980-84 added 
appr. 3 years and appr. 4 years to the average life expectancy at 
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birth of Dutch males and Dutch females respectively. Part, but not 
all, of the mortality decline may be due to "spontaneous" incidence 
declines, as indicated by declines in hospital admission rates in the 
second subperiod. The evidence that these mortality declines are (at 
least partly) due to improvements in medical care will be reviewed 
more extensively in section X.2. 
These analyses of recent changes in mortality were intended 
to supplement McKeown's analysis of changes in mortality since the 
eighteenth century. The findings show that improvements in medical 
care have probably led to substantial mortality reductions during the 
second half of this century. 
X.1.4 Regional mortality differences and medical care 
There is important regional variation in cause-specific mortality 
within The Netherlands, but there is no evidence for a substantial 
relationship with the level of supply of medical care. An effect of 
regional differences in the level of medical care supply on mortality 
is most likely to be found for conditions which have become amenable 
to medical intervention. Mortality from these conditions varies con-
siderably between regions, but generally is not associated with a 
number of simple measures of medical care supply, like hospital bed 
and general practitioner density. 
This is a finding common to many countries, as is shown in 
our analysis of variations in mortality within countries of the 
European Community (chapter VII). The parallel analysis for 10 EC 
countries of mortality from conditions which have become amenable to 
medical intervention, shows that the percentage of variance explained 
by medical care variables, after controlling for socio-economic 
variables, is generally small, especially in countries with a large 
number of regions. Moreover, the nature of the (weak) associations 
with medical care supply is puzzling, as negative and positive asso-
ciations are found in approximately equal frequencies. 
One hypothesis which we have tested is that these findings 
are to be explained by time-dependence of the association between 
mortality from the selected conditions and the level of supply of 
medical care. Mortality from conditions which have become amenable to 
medical intervention has decreased in the past decades, and an effect 
of medical care supply would perhaps be expected in a certain phase of 
mortality decline only, for example during early diffusion of the 
relevant innovation. The results of our analysis of regional variation 
in mortality from the selected conditions in The Netherlands, in which 
4 time-periods were compared (1950-54, 1960-64, 1970-74, 1980-84), do 
however not provide clear support for this hypothesis (chapter VIII). 
Associations between mortality and a number of simple 
measures of the supply of medical care (hospital bed density, general 
practitioner density, percentage of hospital beds located in universi-
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ty hospitals, idem in small hospitals) were generally weak and incon-
sistent in 1980-84. A comparison with earlier time-periods shows that 
although the percentage of variance explained by medical care 
variables did change over time, and although the pattern of change was 
more or less consistent with the hypothesis for some causes of death, 
the nature of the associations was puzzling. 
The number of statistically significant associations between 
mortality and medical care supply variables, both before and after 
controlling for possible confounding variables, was very small, and 
apart from some expected negative associations with the percentage of 
hospital beds located in university hospitals, also some positive 
associations between mortality and general practitioner density were 
found. A more thorough discussion of these weak and inconsistent 
associations between mortality and medical care supply at the regional 
level will be presented in section X.3.2. 
Whereas the studies reported in chapters VII and VIII 
focussed on regional variation in the level of mortality, chapter IX 
was concerned with an exploratory analysis of regional variation in 
the rate of decline of mortality from a number of conditions in the 
period 1969-84. Apart from the two largest among the conditions which 
have become amenable to medical intervention (Perinatal mortality and 
Cerebrovascular disease), also some other conditions with important 
mortality declines (Cancer of the stomach, Ischemic heart disease, 
Traffic accidents) were included in the analysis. 
For Perinatal mortality, Cerebrovascular disease, and Ische-
mic heart disease, as well as for Total mortality, the rate of morta-
lity decline differed between regions in The Netherlands. The analysis 
permits the identification of regions where progress has been less 
satisfactory. In combination with a higher average level of mortality, 
a slower rate of mortality decline should be an important warning 
signal to health policy makers, including health care policy makers in 
the case of conditions which have become amenable to medical interven-
tion. Possible approaches to the investigation of the causes of a 
higher mortality level and/or a slower rate of mortality decline will 
be discussed in section X.4.4. 
A simple analysis of correlations between regional rates of 
mortality decline and other regional characteristics shows that 
changes in hospital bed or general practitioner density between 1970 
and 1980 were not associated with changes in mortality, confirming the 
findings on the relationship between medical care supply and mortality 
from the cross-sectional studies in chapter VII and VIII. Changes in 
some indicators of socio-economic status, on the other hand, were 
associated with changes in mortality: mortality declined faster where 
average income and/or education level rose faster. The relationship 
between mortality and indicators of socio-economic status will be 
taken up again in section X.3.3. 
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medical care 
X.2.1 A note on the evidence 
Chapter VI presented a comprehensive analysis of recent mortality 
changes for conditions which have to some extent become amenable to 
medical intervention. Reductions in mortality at population level are 
a measure of the "effectiveness" of medical care, defined here as "the 
ability to reduce incidence or case fatality of a condition in the 
population". A distinction has to be made between effectiveness and 
"efficacy". The latter is defined as "the ability to reduce incidence 
or case fatality in selected patient groups under optimal circum-
stances". 
Effectiveness is of course dependent on efficacy, but re-
quires something more. Effectiveness can be thought of as the end-
product of: - the efficacy of the intervention; - the proportion of 
the patient population that comes into contact with medical care; 
- the sensitivity of the diagnostic procedures used to identify 
patients who are eligible for the intervention; - the degree of 
provider compliance with professional standards; - and the degree of 
patient compliance. 
Selection of causes of death 
Although we only included conditions for which the evidence on 
efficacy or effectiveness of medical interventions is relatively un-
disputed, the evidence is in fact not entirely uncontroversial. Table 
VI.l linked 11 innovations to 35 conditions which, due to these inno-
vations, became amenable to medical intervention. Table X.l lists most 
of these conditions again, and includes the crude mortality rates in 
1950-54 and 1980-84. The 11 groups have been chosen to reflect the 
chronology of different innovations and to produce nosologically more 
or less homogeneous groups of causes of death (see table VI.I for the 
titles of the groups). Although separate causes are sometimes q~te 
small, all causes together were responsible for an important part of 
Total mortality in the early 1950's: 33% for males, and 37% for fe-
males. Mortality declines, and increases in mortality from other 
causes of death, reduced this contribution to Total mortality to 16% 
for males and 24 i. for females in 1980-84. 
Our selection of conditions is based upon that of Rutstein 
et al. [2] and akin to selections used in other studies of mortality 
trends and medical care [3, 4], but there are also differences, some 
of which have been mentioned in section VI.l. For each condition, 
Annex 2 renders a detailed account of the reasons for inclusion in 
our selection, and also gives a short discussion of the main 
weaknesses in the evidence. The fact that these selections of 
conditions, although basically similar, are not identical, illustrates 
the lack of consensus inside and ouside the medical profession on the 
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Table X.l Mortality rates of the selected conditions (per 10 person-years). 
I Diseases of the thyroid 
Pernicious anemia 
Other anemias 
II Peptic ulcer 
Appendicitis 
Cholelithiasis/-cystitis 
Abdominal hernia 
Ileus without hernia 
Benign prostatic hyperplasia 
III Maternal causes 
Perinatal causes 
IV Tuberculosis 
Pneumonia/influenza 
Septicemia 
Infections urinary system 
Other infectious diseases 
V Congenital digestive anomalies 
Congenital digestive anomalies 
VI Rheumatic heart disease 
VII Diphtheria/whooping cough/tetanus/polio 
VIII Nephritis and nephrosis 
IX Hypertensive disease 
Cerebrovascular disease 
X Cancer of lip and skin 
Morbus Hodgkin 
Cancer of testis 
XI Cancer of cervix uteri 
Subtotal 
Total mortality, all ~ 
1950-54 
males 
0.35 
0.75 
0.87 
8.38 
2.36 
3.23 
2.42 
2.10 
15.66 
30.79 
14.14 
34.22 
1.33 
1.42 
13.20 
2.17 
6.14 
8.57 
3.10 
11.38 
12.13 
79.68 
1.50 
2.32 
1.31 
260 
781 
females 
1.85 
0.99 
0.92 
2.20 
1.47 
8.85 
1. 75 
1.86 
3.67 
19.83 
11.35 
35.29 
1.13 
2.37 
9.85 
1.30 
4.93 
10.52 
2.80 
12.96 
17.98 
101.31 
1.03 
1.55 
6.37 
264 
717 
1980-84 
males 
0.18 
0.09 
0.98 
3.61 
0.37 
2. 76 
1.34 
1.98 
3.54 
4.50 
1.49 
19.96 
1.60 
1.37 
2.47 
0.24 
2.46 
5.47 
0.05 
8.57 
4.01 
73.50 
0.82 
1.26 
0.64 
143 
903 
females 
0.84 
0.18 
1.21 
3.11 
0.30 
4.03 
1.29 
3.51 
0.19 
3.09 
0.88 
23.48 
1.71 
2.77 
2.48 
0.23 
1.69 
8.02 
0.05 
10.12 
5.76 
94.76 
0.46 
0.78 
4.38 
175 
734 
This selection of diseases is identical to that of tables VI.l and VI.2, except that 
Diabetes mellitus (< 25 y.), Cancer of the kidney (< 15 y.) and Leukemia (< 15 y.) 
have been omitted. 
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efficacy and effectiveness of medical care. 
This is due in the first place to the lack of 
methodologically sound studies evaluating the efficacy of medical 
interventions, and to difficulties in the synthesis of findings from 
different studies (see section V.l). The Randomized Controlled Trial 
was introduced into this area of research in the late 1940's, with the 
Medical Research Council Study of the effects of streptomycin in the 
treatment of Tuberculosis [5]. Innovations introduced earlier have not 
had the chance to be tested in such a rigorous way. For example, the 
most important study accompanying the introduction of penicillin for 
the treatment of acute infections involved its application to a large 
number of patients, after which the results were compared informally 
with those of previous treatment methods [6]. But even after the 
introduction of the Randomized Controlled Trial many interventions 
have only been evaluated with methodologically inferior designs [7]. 
Mortality decline as a measure of effectiveness 
Given these uncertainties on the efficacy of medical interventions, 
and given the possibility of other causes of mortality change, the 
observed reductions in mortality cannot simply be interpreted as 
measures of the increased effectiveness of medical care. The separa-
tion of the effects of medical care from those of other influences is 
unfortunately a rather difficult enterprise. Over time, improvements 
in medical care are frequently closely correlated with changes in 
other significant factors. 
It is not by chance, for example, that the introduction of 
penicillin and other antibiotics coincided with the beginning of an 
era of rapid economic development. Both the development of efficacious 
treatment methods for infectious diseases and the start of a new 
economic growth phase were related in one way or other to World War 
II. 
A careful interpretation of changes in mortality over time, 
and a comparison with other causes of death, are about as far as one 
can go in these (necessarily "observational") mortality analyses. The 
"simple interrupted time series design" [8], chosen in chapter IV for 
the assessment of changes in mortality coincident with the intro-
duction of antibiotics, is a good example of a formalized comparison 
of mortality before and after the introduction of an innovation. The 
comparison with non-infectious disease mortality was a further aid in 
interpretation, although it remained difficult to rule out the possi-
bility that the change in mortality is (partly) due to other changes, 
occurring at approximately the same moment as the change in medical 
care. 
tion 
become 
lines: 
by a 
groups 
In the following sections the discussion on the interpreta-
of post-1950 trends in mortality from conditions which have 
amenable to medical intervention, will be extended along two 
by a comparison with other causes of death (section X.2.2), and 
consideration of differences in mortality trends between age-
(section X.2.3). 
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Figure X.l Post-1950 time trends of mortality from Appendicitis, 
Cholelithiasis/-cystitis, Abdominal hernia, and Benign 
prostatic hyperplasia (Standardized Mortality Ratios). 
SMR 
.5 
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males and females 
.25~-r-------r------,-------~-. 
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.5 
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rate 1950-811: 1.0 x to·S 
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Note: The rates shown at the bottom of each graph are the average crude death rates 
(per person-year) for the entire period 1950-84. 
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Post-1950 time trends of mortality from four causes of 
Perinatal mortality (Standardized Mortality Ratios). 
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Figure X.3 Post-1950 time trends of mortality from Congenital diges-
tive anomalies and Congenital cardiovascular anomalies 
(Standardized Mortality Ratios). 
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Post-1950 time trends of mortality from Morbus Hodgkin 
and Cancer of the testis (Standardized Mortality Ratios). 
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X.2.2 A comparison with other causes of death 
One of the remarkable findings of the analysis of post-1950 trends in 
mortality from conditions amenable to medical intervention was, that 
mortality decline accelerated for many of the selected conditions in 
the second part.of this period (1969-1984) (cf. table VI.2). Although 
the uniform periodization hides some differences in timing between 
causes, figures X.1, X.2, X.3 and X.4 show that the late 1960's and 
early 1970's are indeed characterized by accelerating mortality 
declines. The same applies to many other of the selected causes, not 
shown in these figures. 
Trends in mortality from other, i.e. the largest causes of 
death have been presented graphically in section 1.4.2 (figure 1.9). 
Some of these causes also show favourable changes in trend in the late 
1960's or early 1970's, just as many of the causes which have become 
amenable to medical intervention: Ischemic heart disease, Diabetes 
mellitus, Chronic Obstructive Pulmonary Disease (in males), Traffic 
accidents, Non-traffic accidents. 
The similarity could of course be coincidence, but might 
also point at a common cause of the changes in mortality from the 
selected and some other conditions. Two possibilities will have to be 
considered: either these other conditions have also been affected by 
increasing effectiveness of medical care, or a factor reducing inci-
dence or case fatality for many conditions, but not related to medical 
care, has begun to operate around 1970. 
Medical care and other causes of death 
It is possible to argue that improvements in medical care have also 
had an effect on mortality from at least some causes which were not in 
our selection of conditions amenable to medical intervention. 
There is no consensus on the role of medical care in the 
decline in Ischemic heart disease mortality [9]. Changes in risk 
factor prevalence, reducing incidence, have probably been important. 
Studies of trends in incidence have produced conflicting findings [10-
14], but on the whole it seems probable that changes in lifestyle, 
specifically reductions in serum cholesterol level and cigarette smo-
king, have contributed to declining mortality through incidence re-
ductions [15]. (The favourable change in mortality trend for Chronic 
Obstructive Pulmonary Disease is perhaps also related to changes in 
smoking habits.) 
On the other hand, it is also increasingly becoming clear 
that there have been case fatality reductions in Ischemic heart 
disease, showing as declines in rates of sudden death among people 
with a prior history of myocardial infarction and as improved short 
term survival among hospitalized patients [10-14]. Coronary care 
units, and medical treatment of clinical Ischemic heart disease and 
hypertension have been identified as possibly important contributors 
[15]. 
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Another condition which was not included in our selection 
but which may to some extent have become amenable to medical interven-
tion, is Fracture of the neck of the femur. Trends in mortality from 
Non-traffic accidents (figure I.9) are mainly based on trends in 
mortality from this type of injury, common in elderly people. It has 
been argued that the decline is due to better treatment, specifically 
a higher frequency of surgery. Surgery rates have indeed gone up, and 
in-hospital case fatality rates have gone down [16]. Others have 
suggested a favourable effect of early mobilization after hip opera-
tion [17]. 
Favourable changes in other common determinants 
Medical care is not the only possible candidate for a factor common to 
many causes of death which caused (an acceleration of) mortality 
decline after ca. 1970. A general improvement in health could also 
show as a simultaneous mortality decline for a number of conditions. 
The reversal of the mortality trend for Ischemic heart disease 
suggests an improvement in the condition of the cardiovascular system. 
Failure of the cardiovascular system is an important "immediate" or 
"contributory" cause of death, even if non-cardiovascular disease is 
the "underlying cause". It is thus possible that an improvement in the 
condition of the cardiovascular system has contributed to declines in 
mortality from other diseases. This remains however entirely 
speculative. 
The reversal of the mortality trend is at least partly due 
to changes in life-styles (vide supra), and these changes could have 
reduced the risks of dying from other diseases too. An obvious example 
is Cerebrovascular disease, but for many of the other selected condi-
tions this is not very likely. 
(The rapid post-1970 decline in Perinatal mortality can only 
for a small part be explained by changes in the birth-weight distri-
bution of babies ("general health") or changes in the birth rate and 
the age and parity of mothers ("life-style")[18-20].) 
The reversal of the time trend for mortality from Traffic 
accidents has at least two major causes. The first is a deceleration 
of the increase in car driving, prompted by the economic recession 
which started in the early 1970's, and the second a number of preven-
tive measures taken in the same time-period (safety belts, anti-
alcohol law, speed-limits, compulsory helmet wearing for moped dri-
vers) [21]. 
Specific preventive efforts, not involving medical care, 
were taken for none of the selected causes around 1970, but the possi-
ble effects of the economic recession deserve a little more considera-
tion. It is conceivable that the economic recession has removed a 
number of health risks for other conditions too, for example through 
the modification of income-related hazardous life-styles. This is, 
again, entirely speculative, and not very likely in view of the fact 
that the recession did not have major effects on average income levels 
until the end of the 1970's [22]. Also, the analysis of regional 
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mortality declines in chapter IX showed that mortality from conditions 
amenable to medical intervention declined faster where income in-
creased more. 
A cautious conclusion is that the similarity between the 
trends in mortality from conditions amenable to medical intervention 
and those of some other conditions, is probably partly due to an 
effect of medical care on a few of these other conditions, partly due 
to an effect of life-style changes on some of the conditions amenable 
to medical intervention, and partly "due to" coincidence. 
X.2.3 Differences in mortality decline between age-groups 
Differences in mortality decline between age-groups may give 
additional information on the contribution of improvements in medical 
care. In general, mortality reductions due to improvements in medical 
care are expected to be smaller in older age-groups because of the 
effects of multi-morbidity. 
Differences between age-groups have been ignored in chapter 
VI, and the mortality trends (~) have been calculated assuming that 
mortality trends are the same (on a logarithmic scale) for all age-
groups (cf. section VI.2). Just as in the case of infectious disease 
mortality time trends (see section IV.5 for a discussion), this as-
sumption does not hold for the post-1950 trends in mortality. The 
loglinear regression model used for the analysis of mortality trends 
can be expanded to include the interaction between calendar-year and 
age-group. The result is a series of different estimates of the trend 
parameter~ for different age-groups i (~.). 
The results of such an analysis are presented in summary 
form in table X.2. Formal testing for statistical significance 
revealed that this interaction is highly statistically significant for 
almost all diseases studied. For a selection of causes of death, table 
X.2 shows the "sign" of the estimates for ~. in those cases where ~. 
is significantly different (two-sided test; ~p < .05) from. 0. Negativ~ 
values imply mortality decline. 
The results do indicate that for many of the selected condi-
tions the higher age-groups did not experience statistically signifi-
cant mortality declines, or even experienced mortality increases. On 
the other hand, it is surprising that mortality declines are still 
quite general among those 65-74 years old. Most studies of regional 
differences in mortality from conditions amenable to medical interven-
tions have applied strict age-limits to mortality, by excluding deaths 
over 65 years of age (e.g. refs. 23, 24). Mortality among elderly 
people was supposed to be less "avoidable" - an argument which seems 
to be contradicted, at least for those between 65 and 74, by these 
mortality declines. (For this reason we applied other age-limits in 
the studies reported in chapters VIII and IX.) 
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Table x.a Age-specific mortality trends for selected "amenable" conditions, 
1950-68 and 1969-1984. 
1950-1968 
0 1 5 15 25 35 45 55 65 75 85 95 
+ 
4 14 24 34 44 54 64 74 84 94 
-------------------------------------------------------------------------------
I Diabetes mellitus 
II Peptic ulcer 
Cholelithiasis/-cystitis 
Ileus w.o. hernia 
IV Influenza and pneumonia 
Septicemia 
VI Rheumatic heart disekse 
VIII Nephritis and nephrosis 
IX Cerebrovascular disease 
X Cancer of kidney 
Leukemia 
Total mortality 
Declining mortality (p < .OS). 
+ Increasing mortality (p < .OS). 
M + 
F - -
M - -
F 
M - - -
F 
M -
F - + 
M 
F 
M 
F 
M 
F 
M 
F 
M 
F + + 
M 
F 
M + 
F -
M - - - -
F 
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+ + + + 
- - - - + 
- - - + + 
- - - + + 
+ 
+ 
- - - - - + 
+ + + + + 
+ + + + 
+ + + + 
+ + + 
+ + + 
Discussion: comments on time trend studies 
Table X.2 (continued) Age-specific mortality trends for selected "amenable" 
conditions, 1950-68 and 1969-1984. 
I Diabetes mellitus 
II Peptic ulcer 
Cholelithiasis/-cystitis 
Ileus w.o. hernia 
IV Influenza and pneumonia 
Septicemia 
VI Rheumatic heart disease 
VIII Nephritis and nephrosis 
IX Cerebrovascular disease 
X Cancer of kidney 
Leukemia 
Total mortality 
Declining mortality (p < .05) 
+ Increasing mortality (p < .05). 
M 
F 
M 
F 
M 
F 
M 
F 
M 
F 
M 
F 
M 
F 
M 
F 
M 
F 
M 
F 
M 
F 
M 
F 
1969-1984 
0 1 5 15 25 35 45 55 65 75 85 95 
+ 
4 14 24 34 44 54 64 74 84 94 
-
+ 
+ + 
- - - -
- - - -
+ + + + + 
+ + + + 
+ + 
+ 
+ + + 
+ + + 
- - - -
- - -
+ + + 
+ + + 
+ 
+ 
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For some conditions the absence of mortality decline for all 
ages combined can be explained by extreme heterogeneity of mortality 
decline with respect to age. For the second subperiod this applies to 
Ileus without mention of hernia and Nephritis and nephrosis. For both 
conditions statistically significant mortality declines are seen for 
ages below 75, and mortality increases for higher ages (which have a 
larger share in mortality for all ages combined). 
The increase in mortality from Ileus without mention of 
hernia at higher ages has been ascribed to increasing frequencies of 
intra-abdominal surgery, the adverse effects of which will only become 
manifest at higher ages [25]. 
For Nephritis and nephrosis, the conclusion reached in 
chapter VI on the apparent absence of an effect of hemodialysis on 
mortality has to be modified in the light of these findings. 
The unfavourable trend for Septicemia in the second sub-
period, however, is seen in all age-groups. A possible explanation is 
that it is an effect of increasing non-specificity in cause-of-death 
certification (cf. section I.2.2). Mortality trends for Septicemia 
could easily be affected by such a development, if it also causes 
increased reporting of only an "immediate" cause of death: Septicemia 
is a frequent immediate cause of death (cf. section I.2.1). 
X.2.4 Differences in recent mortality levels between The Nether-
lands and other countries of the European Community 
Declines in mortality from conditions which have to some extent become 
amenable to medical intervention, have been observed in many countries 
[3, 4]. It is interesting to see that mortality levels for these 
conditions are generally lower in The Netherlands than in most other 
countries of the European Community. Large differences between 
countries of the European Community are apparent from table X.3, which 
presents 1974-78 Standardized Mortality Ratios (using average mortali-
ty rates by age and sex for the whole EC as standardrates) for a 
number of conditions amenable to medical intervention. 
The SMR 1 s for Total mortality again show the low Total 
mortality levels in Greece and The Netherlands (cf. section I.5.1). In 
The Netherlands mortality rates are lower than the EC average for 
almost all amenable causes, lower also than Total mortality levels 
alone can explain. 
The only exception is Cancer of the cervix uteri, but this 
is, ironically enough, probably due to differences in cause-of-death 
certification and coding between EC countries (see chapter II and ref. 
26). In the study reported in chapter II one of the case histories 
described a patient with Cancer of the cervix uteri. The results for 
this case history are presented in table X.4. Greece was not yet an EC 
member when this study was carried out, and Scotland was not included 
as a separate country, so the comparison between tables X.3 and X.4 
must be limited to 8 countries. 
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Tabl&X.l Mortality differences between countries of the European Community for a 
number of conditions amenable to medical intervention, Standardized 
Mortality Ratios for both sexes, 1974-78. 
Tuberculosis 
Appendicitis 
Abdominal hernia 
Cholelithiasis/-cystitis 
Chronic Rheum. Heart Dis. 
Maternal mortality [a] 
Perinatal mortality [b] 
Hypertensive and 
cerebrovascular disease 
Hodgkin's disease 
Cancer of the cervix uteri 
Total mortality 
B D 
91 106 
53 159 
69 115 
60 136 
30 79 
12 
19 
34 
17 
DK F GR I IRL NL E/W Sc 
40 131 140 125 165 
59 98 37 98 111 
38 105 47 110 83 
45 84 44 173 36 
40 65 115 187 126 
23 
66 
78 
65 
56 
6 
12 
20 n.a. 23 
17 n.a. 23 
14 11 
20 14 
54 86 
69 70 
94 99 
37 37 
87 134 
12 
18 
60 
19 
94 90 66 92 93 116 134 65 107 151 
103 94 75 83 118 135 95 84 91 88 
75 142 246 67 29 28 81 115 151 153 
108 104 95 96 88 96 117 91 104 115 
B = Belgium; D = West-Germany; DK = Denmark; F = France; GR = Greece; I = Italy; 
IRL = Ireland; NL = Netherlands; E/W = England and Wales; Sc = Scotland; 
n.a. = not available 
[a] Maternal deaths per 100.000 births. 
[b] Still-births and first-week deaths per 1000 births. 
Data from ref. 24. 
Table X.4 International differences in certification and coding of Cancer of 
the cervix: results of a case history study. 
Detection 
fraction (%) 
Den- W-Ger- Engl./ Ire- Neth.- Bel- France Italy All 
mark many Wales land lands gium 
90 82 100 94 98 86 72 82 88 
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There is a positive correlation between the observed SMR's 
of table X.3 and the detection fractions of table X.4 (.38, n.s.), 
suggesting that countries with higher mortality from Cervical cancer, 
including The Netherlands, simply have more complete reporting. In 
countries with lower detection fractions, a transfer has taken place 
from Cancer of the cervix uteri to "Cancer of the uterus, site 
unspecified". 
Differences in certification and coding of causes of death, 
and in incidence of conditions may be behind some of the mortality 
differences (see ref. 27 for a detailed analysis of the differences 
between The Netherlands and Belgium). The over-all picture does 
however suggest a greater-than-average effectiveness of medical care 
in The Netherlands. 
The case of Perinatal mortality 
In 1974-78, The Netherlands had lower Perinatal mortality than all 
other countries of the EC, with the exception of Denmark (table X.3). 
Since then, the Dutch Perinatal mortality rate has decreased to 10 per 
1000 births. This compares unfavourably with mortality declines in a 
number of other European countries, for example England and Wales and 
West-Germany, which had higher mortality levels in 1974-78, but morta-
lity levels equal to or just below those of The Netherlands in the 
early 1980's. Perinatal mortality in Sweden, Norway, Finland, Denmark 
and Switzerland are presently all considerably below that of The 
Netherlands [28]. 
The explanation of this relatively unfavourable development 
is as yet unknown. At first sight, registration artefacts do not seem 
to be a plausible explanation: it is unlikely that the degree of 
underregistration in The Netherlands (cf. section I.6.1) has 
diminished in recent years, relative to that in all the countries 
mentioned above. Further study is clearly necessary. 
These trends for Perinatal mortality again demonstrate the 
importance of a continuous surveillance of mortality time trends. 
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medical care 
X.3.1 A remark on the "avoidable mortality" approach 
The studies reported in chapters VII, VIII and IX have focussed on 
regional differences in mortality from selected conditions. The term 
"avoidable mortality" has become the current abbreviation of "mortali-
ty from conditions (which have to some extent become) amenable to 
medical intervention", and is almost sure to attract the attention of 
health care policy makers. Contrary to what this term suggests, how-
ever, it is not true that every single death from the selected causes 
can be avoided by adequate medical care. 
Important constraints are operating which may render the 
prevention of every single death from these causes practically im-
possible. There is a resource constraint: the prevention of the last 
deaths will probably require efforts for which the cost-effectiveness 
ratio is very high. The problem of cost-effectiveness can be taken 
even further, however, to include the adverse effects of medical 
intervention itself. 
Case fatality in patients with Appendicitis is the sum of 
the mortality risks of the disease itself (mainly through perforation) 
and the mortality risks of operation. Frequently, there is uncertainty 
on the diagnosis of patients presenting with complaints resembling 
those of Appendicitis. In these situations a trade-off is necessary 
between the two mortality risks: operation reduces the risk of death 
due to perforation, but introduces a risk of death due to the proce-
dure itself. 
Figure X.S illustrates another important trade-off. (The 
figure is based upon the assumption that the mortality risks of opera-
tion are minimal, but there is substantial controversy about this 
[30].) The objective of medical care is not only to prevent death, but 
also to prevent other adverse outcomes of disease. One measure of such 
adverse outcomes, convalescent days necessary to recover from disease 
(and operation!), will actually increase if the decision to operate is 
taken too frequently. The curves of mortality and convalescent days 
have their optimum at a different frequency of operation. 
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Figure X.S Deaths and convalescent days associated with various 
degrees of surgical interventionism in_Appendicitis. 
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Note: This figure shows the expected deaths and convalescent days for every 
one of the possible ranks which could be used as a cutoff point between opera-
tive and nonoperative treatment assuming that 100% of Appendicitis patients not 
operated upon would perforate. 
The death curve is flat near its minimum which occurs when patients with mild 
symptoms are operated. There is a conflict between the optimum strategies for 
reducing deaths and for reducing convalescence. 
Reprinted from ref. 29. 
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The interpretation of a "weak and inconsistent" relationship 
between mortality and the supply of medical care 
The "weak and inconsistent" relationships between the level of supply 
of medical care and mortality from conditions which have become amen-
able to medical intervention, as found in the studies reported in 
chapters VII, VIII and IX, do not have an immediately clear interpre-
tation. That this is an artefact of the analysis can practically be 
excluded, given the fact that essentially the same results were found 
in studies in which different statistical techniques were employed 
(not only the studies reported in chapters VII, VIII and IX, but also 
those in refs. 31 and 32). Are we to conclude that in general regional 
differences in medical care supply have no consequences for the 
effectiveness of medical care (as far as mortality reduction is con-
cerned)? Or is it also possible that differences in effectiveness of 
medical care have gone undetected in regional mortality data? 
Possibility no. 1: 
Differences in medical care supply do not cause differences 
in effectiveness, as far as mortality reduction is concerned 
What circumstances could account for the absence of a relationship 
between regional differences in the effectiveness of medical care and 
differences in supply, as measured in the studies reported in chapters 
VII, VIII and IX? 
A possible explanation is that the decisive factor in 
achieving effectiveness of medical care is the correct application of 
specific medical procedures to as many eligible patients in the com-
munity as possible, and that this varies more or less independently 
from the level of supply (cf. figure I.18). At the levels observed in 
most industrialized countries, an increase in supply of hospital beds 
and physicians will mainly lead to an increase in "discretionary" 
admissions and procedures, and much less to an increase in admissions 
and procedures for more serious conditions, which are treated anyhow 
[33]. (This increasing efficiency at low levels of supply may be an 
example of a "structural" effect, which modifies the original 
relationship between supply and mortality (see section I.6.4).) 
Effects of cross-regional patient flows may further reduce any 
effects of different supply of medical care (an effect of mobility, 
section I. 6. 5) . 
Possibility no. 2: 
Differences in supply cause differences in effectiveness, 
but these are not reflected in mortality statistics 
At first sight, it is also possible to argue that differences in 
effectiveness of medical care (with regard to mortality reduction) 
caused by differences in supply, may have gone unnoticed because of 
e.g.: - misclassification of causes of death; -overwhelming influence 
of chance fluctuations on mortality rates; - lag-times and migration; 
- and/or overwhelming influence of "spontaneous" differences in inci-
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dence. 
A certain degree of misclassification of causes of death 
does exist (cf. chapter II), and even when it is the same in all 
regions will tend to bias all associations between cause-specific 
mortality and other characteristics, including the level of medical 
care supply, towards the null [34]. On the whole, however, it is 
unlikely that important differences in effectiveness, associated with 
the level of supply of medical care, would not have found expression 
in mortality from the selected conditions. Given the fact that cause-
specific mortality patterns have been shown to reflect geographic 
patterns of smoking, diet, exposure to sun-light, religion, ethnicity, 
socio-economic status, etc. [35], it is unclear why they would be 
unable to reflect differences in effectiveness of medical care. 
As table VIII.l has shown~ the national number of deaths, in 
the selected age-groups and pooled over a 5-year period, is typically 
in the range between 1000 and 2500 in 1980-84 in The Netherlands. Only 
Perinatal mortality and Cerebrovascular disease are larger (9000 and 
18000, respectively). This introduces important problems of statisti-
cal power in an analysis of regional variation: only large differences 
in mortality have a reasonably large chance of being detected. 
(The population size of the median COROP-region is approxi-
mately 2 % of the national population, so that the expected number of 
deaths under a null hypothesis (no difference with the national morta-
lity level) is between 20 and 50 for many of the selected causes of 
death. At conventional significance levels (a = 0.05), a true 
difference of 25% above the national level has a chance of going 
undetected (type II-error) of between 77% (20 deaths) and 58% (50 
deaths). For a difference of +50% these chances are between 42% and 
10%, and for a difference of +75% between 15% and <1% [36].) 
The "noise" of chance fluctuations may also to some extent 
have drowned the associations with other variables, although this does 
not really apply to the findings from some of the larger EC countries 
(chapter VII) and those for larger causes of death, like Perinatal 
mortality and Cerebrovascular disease. 
For most of the conditions analysed in chapters VII, VIII 
and IX, the effects of medical intervention on mortality would not 
seem to have very long (say, more than 5 years) lag-times. Rheumatic 
heart disease may be an exception, as far as prevention by treatment 
of streptococcal infections is concerned. 
Mortality patterns for the selected causes of death may also 
be dominated by "spontaneous" differences in incidence. An important 
part of chapter III was devoted to the question whether regional 
mortality differences by cause of death reflect differences in "morbi-
dity". Generally speaking, they probably do. Some of the conditions 
considered to be amenable to medical intervention were included in 
this analysis. For Cancer of the cervix uteri, Cerebrovascular disease 
and Influenza and pneumonia correlations between mortality and hospi-
tal admissions were clearly positive, just as for many conditions not 
amenable to medical intervention. This suggests underlying differences 
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in incidence of these conditions (table III.4). However, for Cancer of 
the cervix and Cerebrovascular disease incidence differences are not 
necessarily spontaneous, because incidence can be modified by medical 
intervention. Furthermore, we tried to control for spontaneous 
differences in incidence by the inclusion of a number of potential 
confounding variables in the multiple regression analyses. 
It is difficult to make a definite choice between these two 
possibilities. Both may be true to some extent, but the first appears 
to be the most plausible of the two. Although we cannot exclude the 
possibility that some subtle differences in mortality, associated with 
regional differences in medical care supply, were missed, the findings 
suggest that on the whole these differences have no important con-
sequences for mortality. Which is not to say, of course, that there 
are no effects on other outcome measures, nor that there are no 
effects of other aspects of medical care on mortality. 
X.3.3 Mortality and socio-economic status: a contribution of 
medical care? 
Patterns of regional variation in mortality from amenable conditions 
have something important in common with the patterns of variation for 
other causes of death and Total mortality. Where socio-economic condi-
tions are unfavourable, mortality is higher for many causes of death, 
whether amenable or not. This is one of the reasons why mortality from 
conditions amenable to medical intervention is generally higher in 
regions which also have higher Total mortality, as was demonstrated in 
chapter VII for most European countries. 
That mortality from conditions amenable to medical interven-
tion is higher in unfavourable socio-economic circumstances has also 
been found in data collected on individuals, instead of regions (table 
X.S). The "Occupational mortality" data from England and Wales show 
that for most of these causes of death, mortality is higher in the 
lower socio-economic strata [37]. Respiratory tuberculosis and Pneumo-
nia have extremely steep gradients. 
Socio-economic mortality differentials in The Netherlands 
Although Dutch data on mortality by socio-economic status are very 
scarce, there is enough evidence that these differences are also 
present in The Netherlands. Most of this evidence derives from aggre-
gate data studies, e.g. the analysis of differences between neigh-
bourhoods of the city of Amsterdam [38]. It is interesting to see that 
mortality differences by socio-economic status also seem to shine 
through at the regional level (table X.6). 
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TahleX.S Mortality from conditions amenable to medical intervention, by 
socio-economic status, Standardized Mortality Ratios, England and 
Wales, 1970-72. 
Socio-economic status [a) 
I II IIIN IIIM IV V All 
Respiratory tuberculosis [b) 26 
Pneumonia [b) 41 
Perinatal mortality [c) 72 
Maternal mortality [d) 79 
Appendicitis [b) 60 
Abdominal hernia [b) 60 
Cholelithiasis and -cystitis [b) 114 
Chronic rheum. heart dis. [b) 77 
Hypertensive disease [b) 71 
Cerebrovascular disease [b) 80 
Total mortality [b) 77 
Data from ref. 37. 
41 
53 
82 
63 
95 
56 
102 
80 
85 
86 
81 
84 89 
78 92 
90 99 
86 99 
125 99 
65 88 
99 88 
117 103 
104 104 
98 106 
99 106 
124 254 
115 195 
106 143 
147 144 
89 117 
130 143 
127 80 
116 124 
112 141 
111 136 
114 137 
[a) I: professionals; II: intermediate; IIIN: skilled non-manual; 
IIIM: skilled manual; IV: partly skilled; V: unskilled. 
[b) Males 15-64 years. 
[c) Still-births and first-week deaths, males and females. 
[d) Females 15-64 years. 
100 
100 
100 
100 
100 
100 
100 
100 
100 
100 
100 
In 1980-84, Total mortality tended to be higher in regions 
with a lower average income per inhabitant. Such negative associations 
are also present for many separate causes of death, and more strongly 
so for Ischemic heart disease, Cancer of the stomach, and Traffic 
accidents. A small number of causes of death is more frequent in 
regions with a higher average income, notably Cancer of the lung and 
Cancer of the prostate. 
Between 1950-54 and 1980-84 the relationship between morta-
lity and average income seems to have changed for a number of condi-
tions, e.g. for Ischemic heart disease, where the association has made 
a dramatic reversal, and Cancer of the colon. 
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Table X.6 Correlations [a] between age-standardized mortality for the 
largest causes of death and average income, The Netherlands, 
1980-84 and 1950-54. 
1980-84 
Ischemic heart disease -.66* 
Other heart disease [b) -.13 
Cerebrovascular disease -.24 
Hypertensive disease -.14 
Diseases of arteries .29 
Cancer of stomach -.50>~ 
Cancer of colon -.23 
Cancer of lung .48* 
Cancer of breast .20 
Cancer of prostate .32* 
Diabetes mellitus -.37* 
Influenza/pneumonia .13 
Chronic Obstructive Pulmonary Dis. -.07 
Perinatal mortality [c] -.27 
Traffic accidents -.73* 
Non-traffic accidents -.21 
Total mortality -.31* 
Significance level (two-sided test): * p < .05. 
[a] Product-moment correlations, unweighted (n=39). 
[b] Non-ischemic, non-rheumatic heart disease. 
[c] Still-births plus first-week deaths. 
1950-54 
.51* 
-.28 
.17 
.11 
-. 3 7~~ 
-. 41 ~~ 
.51* 
.65* 
.50* 
.46* 
.02 
-.23 
-.37* 
-.56* 
-.51* 
-.22 
-.23 
Reversals from positive to negative associations have been 
documented repeatedly in other studies. The "epidemic" of Ischemic 
heart disease probably started in the upper socio-economic strata but 
is now a disease with higher mortality in the lower strata [39, 40]. 
Another example is Diabetes mellitus. In England and Wales, mortality 
was highest in the higher social classes in the 1920's and 1930's, but 
after World War II the association has gradually changed to a negative 
one in 1970-72 (cf. table X.6) [37]. Just as Total mortality, morta-
lity from specific conditions seems to go through an "epidemiologic 
transition". A certain analogy between socio-economic differences 
within countries and international differences (section I.4.1) is 
apparent: populations or population groups which lag behind in socio-
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economic development, also lag behind a number of years in the 
development of their mortality pattern. 
Specific factors which may account for the relationship 
between socio-economic status and mortality are material life 
circumstances, work environment, health related habits, psychosocial 
factors, and also use.of health care services, including medical care 
[42]. The association between socio-economic status and mortality from 
conditions amenable to medical intervention may provide a good 
starting-point for further study of the contribution of medical care 
factors. 
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X.4.1 Further improvement of cause-of-death statistics 
The studies reported in chapters III-IX have demonstrated that morta-
lity data by cause of death are a rich source of information, which 
permits detailed analyses of time trends and geographical variation in 
mortality from a wide range of conditions. The interpretation of these 
trends and differences is frequently dependent on the assumption of a 
reasonable validity of cause-of-death information. 
Fortunately, the case history studies of chapter II have 
indicated that the Dutch certification and coding process has a satis-
factory performance, and compares favourably to that of other European 
Community countries, at least as far as detection fractions for 
Chronic Obstructive Pulmonary Disease and a number of cancers are 
concerned. The results from these case history studies however also 
suggest that some further improvement is possible. This will largely 
depend on the dedication of certifying physicians, but some minor 
changes of the death certificate might also be helpful. 
Careful completion of death certificates is an important 
contribution of medical care to the furtherance of public health. This 
is not always appreciated by the medical profession, which tends to 
regard cause-of-death certification as a mere bureacratic obligation. 
Physicians will perhaps be stimulated to improve their cause-of-death 
certification practices, if the usefulness of cause-of-death statis-
tics is demonstrated regularly to them. Medical education, including 
post-graduate education, and general medical journals have an impor-
tant role to play here. 
As was already mentioned in section I.2.1, the Dutch death 
certificate has some subtle differences with the internationally 
agreed upon death certificate. The lay-out of the Dutch certificate 
slightly emphasizes the immediate cause of death (cf. Figure I.l), by 
printing the Dutch word for "immediate" in italics. This may be a 
partial explanation for our finding of a high frequency of "Correct 
diagnosis in part I, but in the wrong sequence" (chapter II). The 
phrasing of part II of the certificate is also not very clear (cf. 
section I. 2.1), which may partly explain our finding of a "Correct 
diagnosis in part II". The fact that the instructions for filling in 
the certificate are placed on the back-side, will not be very helpful 
either. A recent proposal intended to take away some of these pro-
blems, while retaining correspondence with the international certifi-
cate of cause of death, therefore deserves serious consideration [43]. 
Whereas the proposals mentioned above would be investments 
in the quality of cause-of-death information at the national level, 
one might in addition consider the possibility of conducting some 
small-scale experiments to provide more extensive and/or more 
thoroughly validated information on causes of death [44]. A sample of 
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doctors sending in death certificates could be asked to provide more 
information on the deceased, in order to assess the validity of stated 
causes of death. The same approach could be used to elicit more in-
formation on 11 secondary11 causes of death, which could then be coded 
systematically in order to give a more complete picture of conditions 
present at and contributing to death [45]. 
Such experiments could be linked to in-depth studies of 
11avoidable11 factors in deaths from selected causes (see section 
X.4.4). 
X.4.2 Using mortality data to address health care policy questions 
The health care policy question addressed in chapter III was, whether 
regional mortality data by cause of death can be used as indicators of 
the need for health care in a formula for the allocation of financial 
resources. The conclusion was that, although in general regional 
mortality differences appeared to reflect morbidity differences, a 
more judicious approach is preferable. It is uncertain whether regio-
nal mortality profiles by cause of death give a sufficiently accurate 
picture of these morbidity differences, and mortality at least in part 
also reflects the 11 outcome11 of preventive and curative efforts. 
A more judicious approach to the use of mortality data could 
be based on a Swedish model, in which regional mortality data are 
being used in a more informal planning process. Data which contribute 
to "community diagnosis" are combined in a "planning base" with 
"state-of-the-art reports". in which knowledge on the possibilities 
for prevention and treatment is compiled from various sources. This 
planning base is analysed and discussed regionally with policy makers 
and health care professionals, in an attempt to create conditions for 
change, where necessary. Such a change could be the organization of a 
prevention programme. An example of this is the cardiovascular disease 
prevention programme undertaken in the county of Vasterbotten, after 
an extensive phase of community diagnosis in which the possible causes 
of the high cardiovascular disease mortality rates were investi-
gated. Decisions on budget allocations can be taken in the same pro-
cess, in which negotiations to a large extent replace mathematical 
formulas [ 46] . 
The conclusion on the use of regional mortality data in the 
context of resource allocation decisions is generalizable to most or 
all uses of mortality data to address health care policy questions (or 
health policy questions, for that matter). Mortality analyses contri-
bute fragments of a community diagnosis, but in most cases our know-
ledge of the ailment and its causes will not immediately be sufficient 
to decide upon a treatment plan, and additional information will have 
to be collected. 
Recent developments in health care policy in The Netherlands 
When the study reported in chapter III was carried out, the prevailing 
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trend was towards more state intervention in the health care sector. 
Adoption and implementation of the Health Care Services Act, which 
formed the direct background to the study, has been very slow. After 
many years of preparation it was adopted by Parliament in 1982, and it 
has not yet been implemented, except for a small number of regions 
where introduction experiments are carried out. In the mean time, the 
climate has changed considerably, and the utility of extensive state 
intervention is increasingly being questioned. 
A recent product of this trend reversal is the report of the 
Dekker commission, called after its chairman, former president of the 
Philips company Dr. W. Dekker [47]. Among other measures, the commis-
sion has recommended the abolishment of the Health Care Services Act, 
in order to reintroduce an element of free enterprise and competition 
in the health care "market". One of the remaining roles of the state, 
however, will be to provide rules and mechanisms for quality assurance 
in the health care sector. It is interesting to note that one of the 
possible uses of mortality data is in monitoring the effectiveness of 
health care services. It is thus to be expected that, although the 
political climate and bureaucratic context may change a bit, the 
results of studies of the relationship between mortality and medical 
care will continue to be relevant to health care policy. 
X.4.3 Monitoring the effectiveness of medical care 
The decline of infectious disease mortality since the eighteenth and 
nineteenth centuries is largely due to other factors than improvements 
in medical care. Nevertheless, a closer look at mortality time trends 
for infectious diseases reveals that the introduction of antibiotics 
was accompanied by important changes (chapter IV). 
Since 1950 improvements in life expectancy have been modest, 
but proportional declines in age-specific mortality rates have on the 
whole not been less impressive than in the period 1850-1950. An 
analysis of cause-specific changes in mortality since 1950 showed that 
large declines in mortality have occurred for conditions which have 
become amenable to medical intervention. These mortality declines have 
made an important contribution to improvements in life expectancy 
since 1950. More than in earlier time-periods, the effects of improve-
ments in medical care may thus have been important, relative to chan-
ges induced by other factors (chapter VI). 
These findings show that, contrary to what is frequently 
believed, recent mortality time trends do not provide reasons for 
skepticism on the effectiveness of medical care. It 
disappointing that important progress in the treatment 
been limited to a small number of relatively infrequent 
ter V). 
is, however, 
of cancer has 
cancers (chap-
It is important to continue monitoring mortality trends by 
cause of death in The Netherlands. Some of the conditions which have 
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become amenable to medical intervention continue to cause substantial 
numbers of deaths, and further analysis of mortality may help to 
reveal barriers to progress that can be removed. 
Perinatal mortality trends are not as favourable in recent 
years as in a number of comparable countries (section X.2.4). A 
further analysis of mortality changes, including an analysis of the 
possible causes of regional differences in trends of Perinatal morta-
lity (cf. chapter IX), might be helpful in finding barriers to pro-
gress. 
The importance of other data than mortality 
Monitoring the effectiveness of medical care cannot exclusively rely 
on analyses of mortality time trends. The availability of information 
on trends in incidence and survival of specific conditions would 
greatly help the interpretation of mortality time trends. A registry 
of (incidence and) survival of cancer, still not available in The 
Netherlands, except for Leukemia in children [48], is an obvious 
example (chapter V). 
Information on trends in morbidity is also necessary to 
answer questions about the effects of medical care on other outcome 
measures than mortality. One unanswered question, for example, is 
whether mortality declines have led to changes in prevalence of 
disease in the population. Changes in the prevalence of disease, for 
example due to increasing survival, may have consequences for the need 
for health care services. Some have claimed that the "rectangulariza-
tion" of the survival curve (section 1.4.1), i.e. the "compression" of 
mortality in higher age-groups, has been accompanied by a compression 
of morbidity, leading to a lower prevalence of disease [49]. 
Increasing or decreasing prevalence of disease? 
In a short intermezzo, intended to suggest an important area for 
additional data collection and further study, we will discuss this 
question on the basis of figure X.6. Data on the prevalence of 
disease, by age, are not routinely available in The Netherlands, but 
the results of a large survey held in 1971/1972 may provide some 
illustrative material [30]. (The survey did not intend to measure the 
prevalence of disease, but to measure the prevalence of physical 
handicap, and its causes. Most physical handicaps are caused by 
chronic disease. Diseases which do not lead to physical handicaps 
until perhaps late in their course, such as Diabetes mellitus, are 
underrepresented in these data.) 
The information on prevalence of handicap permits the cal-
culation of "survival without handicap" for males and females, in 
selected age-groups, under the rates prevailing at that particular 
moment in time. With advancing age, the vertical distance between the 
curves for survival and survival-without-handicap increases, indica-
ting that physical handicap due to disease is more prevalent at higher 
ages. At the same time, the horizontal distance between the two curves 
decreases with age, reflecting the fact that the average length of 
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Survival and survival without physical handicap in The 
Netherlands, by sex, ca. 1971/1972. 
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survival after a physical handicap has arisen, is less at higher ages. 
The surface between both curves, expressed as a fraction of the 
surface below the curve for survival, is an estimate for the (crude) 
prevalence of physical handicap in the Dutch population, under the 
rates prevailing in 1971/1972. 
If a shift in survival curves to the right is not accompa-
nied by a shift to the right of the curves for survival. without 
physical handicap, the prevalence rate of physical handicap in the 
population increases. So the crucial question is: what happened to 
age-specific incidence and survival of (causes of) physical handicap? 
The effect of mortality reductions on the prevalence of 
diseases which are themselves seldomly fatal, such as Rheumatoid 
arthritis and disorders of sight and hearing, is relatively simple. 
Assuming that age-specific incidence remains unchanged, prevalence 
will increase. 
The effect of mortality reductions on the prevalence of 
frequently fatal conditions is more complicated. We have seen that 
mortality reductions for e.g. Ischemic heart disease have probably 
been caused by both a decrease in incidence and a decrease in case 
fatality (section X.2.2). In general it can be said that both inciden-
ce and case fatality reductions have contributed to mortality de-
clines. Reductions in incidence shift the curve for survival without 
disease to the right, and will generally increase the average age at 
incidence. Due to the fact that length of survival with disease is 
frequently shorter at higher ages, the surface between the curve for 
survival and survival without disease will shrink. Reductions in case 
fatality, however, increase the horizontal distance between the two 
curves, and thus lead to an increase in prevalence. 
The question is complicated even further by the fact that 
improvements in medical care may not only have affected incidence and 
case fatality, but also chances of complete recovery. 
Without information on trends in the prevalence of specific 
conditions it is impossible to infer the net effect of these changes, 
which also implies that recent speculations on the 11 compression of 
morbidity11 in higher age-groups [49] are premature. 
X.4.4 Further study of regional mortality differences 
Substantial regional differences in mortality by cause of death within 
The Netherlands have been documented in the preceding chapters (sec-
tion I.5.2, chapter VIII). We also found regional differences in trend 
of mortality from a number of conditions (chapter IX). Regional morta-
lity differences do not appear to be related to differences in the 
level of supply of medical care, and, except for a short discussion of 
the contribution of socio-economic factors (chapter IX and section 
X.3.3), have largely remained unexplained. 
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Finding out the reasons for regional differences in mortali-
ty may lead to opportunities for effective intervention, and is thus 
important from a health policy perspective. Reducing the long-standing 
higher mortality rate in parts of the south-east of The Netherlands 
(section I.5.2). for example, should be recognized as a challenge of 
the first importance. Because the causes of death for which the 
differences were found are to some extent amenable to medical inter-
vention, further study may also be relevant for health care policy 
makers. 
A number of approaches has been developed for such further 
study [51-53]. A compilation of these various approaches is presented 
in table X.7. Two purposes of further study are distinguished: verifi-
cation, and assessment of possible causal factors. As a matter of 
fact, some of the studies reported in the previous chapters fit into 
this schematic representation. The case history approach used in 
chapter II could also be used for the analysis of possible differences 
in cause-of-death certification between regions. The studies discussed 
in chapters VII, VIII and IX may be viewed as examples of studies of 
"aggregate associations" with determinants of health status. 
The possibilities for further aggregate data studies are 
certainly not yet exhausted; it would be interesting to see whether 
more specific medical care data, for example on the application of 
specific interventions, would be able to explain more of regional 
differences in mortality from conditions amenable to medical inter-
vention, preferably controlling for "spontaneous" differences in in-
cidence. Regional mortality trends can be related to trends in other 
aspects of health status and trends in determinants. 
A promising new line of enquiry, currently in development, 
is that of studies of "avoidable factors" in individual deaths. This 
approach builds upon the experience in the surveillance of Maternal 
[54, 55] and Perinatal mortality [56-58], and can be regarded as the 
equivalent of the clinical audit at population level. The identifica-
tion of shortcomings in the delivery or uptake of medical care in the 
history of patients who died from specific causes, may contribute 
appreciably to a further improvement of medical care. The finding of a 
higher proportion of such "avoidable" deaths in regions with higher 
mortality would strongly support the hypothesis that mortality diffe-
rences are related to the delivery and uptake of medical care. 
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Table X.7 Approaches to the analysis of possible causes of a regional deviation 
from national mortality levels or trends by cause of death 
Purpose 
Verification 
Assessment of 
possible 
causal factors 
Approach 
Consistency 
- in time, in space, 
across population groups 
- with other data 
Validation of 
recorded causes of death 
- by simulation of death 
certification 
- by retrospective 
evaluation 
Aggregate associations 
- with other aspects of 
health status 
- with determinants of 
health status 
Individual associations 
- with other aspects of 
health status 
- with determinants of 
health status 
Additional sources 
of information required 
None 
Other data on health status of 
population 
Case history study 
Death certificates, patient records, 
autopsy records 
Other data on health status of 
population 
Data on health care, sociodemographic 
factors, and other determinants 
Death certificates, patient records, 
interviews with family and health care 
providers, etc. 
Patient records, interviews with 
family and health care providers 
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X.S Epilogue 
The preceding pages were .devoted to death ("mortality") as a reflec-
tion of changes and differences in the health status of populations. 
In this epilogue we will write a few, probably insufficient, words on 
the rather obvious fact that death is more than this. Needless to say, 
the "vital event" of demographers and epidemiologists is in the first 
place the event that terminates precious lives, and that inspires most 
of us, including those who study death professionally, with a certain 
awe. 
One of the consequences of the recession of death into old 
age has been that death has at the same time lost and gained in 
terror. When life was expected to be short, death was accepted with a 
certain equanimity. The studies of Philippe Aries have shown that 
Western attitudes towards death have gradually changed, and that in 
modern times death has become something unfamiliar, laden with 
feelings of repulsion [59]. 
On the other hand, changing attitudes towards matters of 
life and death may themselves have contributed to the successful 
elimination of premature death by environmental change and medical 
care. In the eighteenth century, the idea that modification of morta-
lity risks was possible, and that death was not entirely unavoidable, 
gradually found acceptance. Health became a serious preoccupation, and 
physicians acquired more importance than ever before [60]. Confidence 
in the powers of medical care anteceded the era of effective inter-
vention by two centuries, and, although unfounded at that moment in 
time, may have created a favourable climate for scientific develop-
ment. 
There is of course no guarantee that war, famine and epi-
demics, the main causes of the high mortality rates before the demo-
graphic transition, have left us forever. The final passage of Camus' 
novel "La peste" [61] expresses this eloquently, and also illustrates 
the powerful metaphors that lethal diseases, due to their awe-
inspiring character, give rise to [62]. 
The Plague epidemic which occurred in Oran (Algeria) in the 
1940 1 s has left the city, and Rieux, the physician through whose eyes 
the events have been described, realizes that it may not be forever. 
"Car il savait ce que cette foule en joie ignorait, et qu'on peut lire 
dans les livres, que le bacille de la peste ne .meurt ni ne disparait 
jamais, qu'il peut rester pendant des dizaines d'annees endormi dans 
les meubles et le linge, qu 1 il attend patiemment dans les chambres, 
les caves, les malles, les mouchoirs et les paperasses, et que, peut-
etre, le jour viendrait ou, pour le malheur et l 1 enseignement des 
hommes, la peste reveillerait ses rats et les enverrait mourir dans 
une cite heureuse." 
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Dit proefschrift gaat over sterfte en doodsoorzaken, over het gebruik 
dat van sterftegegevens in het gezondheidszorgbeleid gemaakt zou 
kunnen worden, en meer in het bijzonder over het gebruik van sterfte-
cijfers als indicator van de effectiviteit van medische zorg. Het 
bevat, grotendeels in de vorm van al dan niet reeds gepubliceerde 
artikelen, de resultaten van een aantal analyses van de sterfte in 
Nederland in heden en verleden, op verschillende plaatsen aangevuld 
met gegevens uit andere landen. 
In een uitvoerige inleiding (hoofdstuk I) wordt eerst ge-
schetst hoe sterftecijfers naar doodsoorzaak totstandkomen, en wat er 
bekend is over de kwaliteit van deze gegevens. Daarna wordt, mede aan 
de hand van een aantal historische voorbeelden, ~esproken welke 
functie sterfte-analyses voor het beleid ten aanzien van de volksge-
zondheid kunnen hebben. Tenslotte volgt een overzicht van wat er in 
de literatuur bekend is over de effecten van verbeteringen van me-
dische zorg op de sterfte-ontwikkeling in historisch perspectief, en 
over de effecten van verschillen in medische zorg op regionale 
sterfteverschillen. 
De resultaten van de verschillende analyses zijn gegroepeerd 
in 4 thema's. Het eerste thema is dat van de validiteit (geldigheid) 
van de doodsoorzaakgegevens zoals deze in de sterftestatistiek 
beschikbaar zijn. Bij de aangifte van overlijden moet door de behande-
lend arts een doodsoorzaakverklaring worden ingevuld, waarvan de gege-
vens op het Centraal Bureau voor de Statistiek worden verwerkt. Aan de 
kwaliteit van deze gegevens wordt nogal eens getwijfeld. De studie 
waarvan in hoofdstuk II verslag wordt gedaan was een poging om van die 
kwaliteit een indruk te krijgen. Het betrof een onderzoek naar de 
onderlinge vergelijkbaarheid van de sterftecijfers voor CARA (chro-
nische aspecifieke respiratoire aandoeningen) en kanker van een aantal 
Europese landen. Door aan steekproeven van artsen in die landen een 
aantal 11 papieren11 ziektegeschiedenissen van patienten die aan deze 
ziekten waren overleden, toe te zenden, en hun te vragen van die 
249 
Samenvatting 
patienten een doodsoorzaakformulier in te vullen, kon het proces van 
aangifte en codering van doodsoorzaken worden nagebootst. Er bleken 
aanzienlijke verschillen tussen de deelnemende landen te bestaan in de 
kans dat een patient die aan CARA of kanker was overleden, ook werke-
lijk onder die ziekte in de statistiek terechtkomt. Opmerkelijk was 
dat die kans in Nederland hoog is: 91% voor CARA en 94% voor kanker. 
Dit geeft enig vertrouwen in de Nederlandse doodsoorzaakstatistiek. 
Het tweede thema is dat van het gebruik van sterftecijfers 
voor het beantwoorden van vragen uit het gezondheidszorgbeleid. 
Sterftecijfers geven informatie over de gezondheidstoestand van de 
bevolking. In het gezondheidszorgbeleid is aan dat type informatie 
uiteraard nogal eens behoefte, bijvoorbeeld wanneer het gaat om de 
vraag hoe de (financiele) middelen verdeeld moeten worden. Het ligt 
voor de hand die verdeling op de gezondheidstoestand van de bevolking 
af te stemmen. In het onderzoek waarvan hoofdstuk III verslag doet, is 
nagegaan of regionale sterftecijfers een voldoende nauwkeurige indruk 
geven van verschillen in het v66rkomen van aandoeningen in de bevel-
king om ze als verdelingscriterium te kunnen gebruiken. Uit een verge-
lijking tussen sterftecijfers naar doodsoorzaak enerzijds en zieken-
huisopname- en arbeidsongeschiktheidscijfers anderzijds moest worden 
geconcludeerd dat dit vermoedelijk niet het geval is. Hoewel sterfte-
cijfers waardevolle informatie geven over de gezondheidstoestand van 
de bevolking, is de interpretatie van regionale verschillen onvoldoen-
de eenduidig om belangrijke beslissingen als die van de verdeling van 
middelen klakkeloos op sterfteverschillen te baseren. 
Het derde en vierde thema borduren op deze conclusie voort. 
Een van de redenen waarom regionale sterfteverschillen niet zonder 
meer een nauwkeurige afspiegeling van het v66rkomen van aandoeningen 
in de bevolking vormen, is dat de kans om aan die aandoeningen te 
overlijden ook op de hoogte van het sterftecijfer van invloed is. 
Anders gezegd: sterftecijfers weerspiegelen mede het effect van medi-
sche zorg. 
De vraag of verbeteringen in medische zorg een belangrijk 
effect hebben gehad op de ontwikkeling van de sterfte in het recente 
verleden vormt het derde thema van dit proefsehrift. Sinds het werk 
van de Engelse onderzoeker McKeown is, terecht, twijfel ontstaan aan 
de bijdrage van de medische zorg aan de grote sterftedaling zoals die 
sinds de achttiende en negentiende eeuw in vele Europese landen is 
opgetreden. Deze sterftedaling, die voornamelijk op een reductie van 
de infectieziekten-sterfte berustte, had zich eenvoudigweg al groten-
deels voltrokken toen de eerste echt effectieve medische behandelingen 
beschikbaar kwamen. De verklaring van de sterftedaling moet 
hoofdzakelijk bij andere factoren gezocht worden, zoals een betere 
voeding en verschillende hygienische maatregelen. 
Dat neemt niet weg dat een zorgvuldige bestudering van de 
ontwikkeling van de sterfte aan infectieziekten laat zien, dat de 
introductie van antibiotica vermoedelijk wel degelijk nog een be-
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langrijk effect gesorteerd beeft (boofdstuk IV). In Nederland is voor 
een groot aantal infectieziekten een versnelling van de sterftedaling 
zicbtbaar nadat de eerste antibiotica aan bet eind van de jaren dertig 
en in de jaren veertig bescbikbaar waren gekomen. Hoewel_ bet niet 
uitgesloten is dat andere factoren aan die versnelling ook een bij-
drage geleverd bebben, wijst alles er tocb op dat deze geneesmiddelen 
een belangrijk effect op de sterfte-ontwikkeling bebben gebad. 
Vormen infectieziekten een voorbeeld van een groep ziekten 
waartegen de geneeskunde niet langer macbteloos staat, bij veel vormen 
van kanker is dat belaas anders. Tocb zijn in de overlevingskansen bij 
kanker wel degelijk verbeteringen waarneembaar (boofdstuk V). Gegevens 
uit een aantal buitenlandse kankerregistraties laten zien, dat voor 
veel vormen van kanker een licbte verbetering van de overlevingskansen 
is opgetreden sinds de jaren vijftig. Voor een aantal vormen van 
kanker is die verbetering meer uitgesproken, maar ten dele berust dit 
op veranderingen in bet tijdstip van diagnose, registratieprocedures 
e.d. Niettemin kan de aanzienlijke verlenging van de overlevingsduur 
bij de ziekte van Hodgkin, Kanker van de testis, Acute lymfatiscbe 
leukemie, en Wilm 1 s tumor (een vorm van nierkanker die bij kinderen 
voorkomt) vermoedelijk wel aan verbetering van de bebandeling worden 
toegescbreven. 
Op grond van een systematisch overzicbt van alle aandoenin-
gen waartegen in de laatste decennia effectieve mediscbe zorg bescbik-
baar is gekomen, is tenslotte een globale analyse gemaakt van mogelij-
ke effecten van mediscbe zorg op ontwikkelingen in de sterfte sinds 
1950 (boofdstuk VI). Het gaat bierbij in totaal om 35 aandoeningen, 
sommige kwantitatief belangrijk, andere niet, waarvoor in de meeste 
gevallen in Nederland aanzienlijke sterftedalingen zijn opgetreden. In 
tegenstelling tot wat wel wordt gedacbt, zijn ook na 1950 nog 
belangrijke sterftereducties gerealiseerd, en aandoeningen die door 
medische zorg voork66mbaar of behandelbaar zijn geworden, bebben 
bieraan een grote bijdrage geleverd. Sterftedalingen voor deze aan-
doeningen sinds 1950 bebben ca. 3 jaar aan de gemiddelde levensver-
wacbting van Nederlandse mannen, en ca. 4 jaar aan die van Nederlandse 
vrouwen toegevoegd. (Door ongunstige ontwikkelingen bij andere 
doodsoorzaken is de levensverwacbting bij de geboorte van mannen netto 
slecbts ca. 2 jaar toegenomen. Voor vrouwen waren de ontwikkelingen 
bij andere doodsoorzaken gunstiger, en is de levensverwacbting in 
totaal met ca. 6 jaar toegenomen.) Ook bier geldt weer dat verbeterin-
gen in mediscbe zorg waarscbijnlijk niet de enige verklaring voor deze 
sterftedalingen zijn, maar dat een effect van enige betekenis tocb wel 
aannemelijk is. 
Het vierde tbema is dat van de regionale sterfteverscbillen, 
en van bet mogelijke verband tussen deze sterfteverscbillen en ver-
scbillen in bet aanbod van mediscbe zorg. Binnen Nederland, evenals 
binnen andere landen, bestaan beboorlijke geografiscbe sterftever-
schillen. Deze zijn een intrigerend verscbijnsel, en suggereren dat 
met de juiste maatregel de sterfte aan bepaalde doodsoorzaken in een 
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aantal gebieden nog behoorlijk gereduceerd zou kunnen worden. Dit 
geldt eens te meer voor de sterfte aan aandoeningen waartegen effec-
tief medisch ingrijpen mogelijk is. Ook voor de sterfte aan deze 
aandoeningen worden belangrijke regionale sterfteverschillen gezien. 
In de hoofdstukken VII en VIII is nagegaan of deze sterfte-
verschillen wellicht samenhangen met verschillen in het aantal zieken-
huisbedden, het aantal arten e.d. In hoofdstuk VII gebeurt dit in een 
parallelle analyse voor een aantal Europese landen; dit heeft als 
voordeel dat het verband tussen zorgaanbod en sterfte in een groat 
aantal verschillende contexten betudeerd kan worden. In hoofdstuk VIII 
gebeurt dit voor Nederland, maar op 4 verschillende tijdstippen: 1950-
54, 1960-64, 1970-74 en 1980-84; het voordeel hiervan is dat ook 
verbanden die s1echts in een bepaalde fase van de ontwikkeling van 
medische zorg bestaan, zo naar voren moeten komen. Ret resultaat van 
beide analyses is min of meer hetzelfde: er zijn geen duidelijke 
verbanden tussen de "omvang" van de medische zorg op regionaal niveau, 
en de hoogte van de sterfte aan aandoeningen die tech geselecteerd 
waren op een zekere afhankelijkheid van goede medische zorg. 
Voor de verklaring van deze sterfteverschillen moet dus een 
beroep worden gedaan op andere factoren. Hiervoor is meer gedetail-
leerd onderzoek noodzakelijk. Een van de elementen van zulk verder 
onderzoek kan ook een studie van regionale verschillen in ontwikkeling 
(i.t.t. niveau op een of meer momenten) van de sterfte zijn. Omdat de 
sterfte voor een aantal aandoeningen nogal sterk gedaald is, kan het 
van belang zijn na te gaan of bepaalde regie's zijn achtergebleven. 
Een verkennende analyse van regionale verschillen in sterftetrend in 
Nederland in de periode 1969-1984 liet zien dat de sterfte aan een 
aantal aandoeningen inderdaad niet in alle regie's even snel gedaald 
is (hoofdstuk IX). Evenals dit met verschillen in sterfteniveau het 
geval is, blijken ook verschillen in sterftetrend samen te hangen met 
sociaal-demografische kenmerken van de bevolking, o.a. met indicatoren 
voor de sociaal-economische status. 
In hoofdstuk X wordt tenslotte, na enkele aanvullende com-
mentaren op de resultaten van de analyses, een aantal conclusies en 
aanbevelingen geformuleerd. Deze hebben betrekking op verdere verbete-
ring van de sterftestatistiek, op het belang van sterftecijfers voor 
gezondheidszorgbeleid, met name voor de evaluatie van verbeteringen in 
medische zorg, en op de verdere analyse van regionale sterfteverschil-
len. 
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Annex 1 
ICD-codes for the causes of death analysed in Chapters I, IV, VI, 
VIII, IX and X 
Introduction 
The mortality data used in many of the analyses reported in this 
thesis have been extracted from a large computer-file, supplied by the 
Central Bureau of Statistics, which contained detailed information on 
all deaths registered in The Netherlands since 1950. Besides age, sex, 
year of death and region (i.e. the COROP-region where the deceased was 
last registered as having his/her domicily), this information included 
a numerical code for the underlying cause of death. This numerical 
code was the four-digit code according to the International Classifi-
cation of Diseases (ICD) [1], of which four different Revisions were 
in force during the period 1950-1984. The 6th Revision was used for 
classification in The Netherlands from 1950-1957; the 7th Revision 
from 1958-1968; the 8th Revision from 1969-1978; and the 9th Revision 
from 1979 onwards. 
Simply stated, each Revision of the International Classifi-
cation of Diseases consists of a list of code-numbers, for each code-
number a longer or shorter list of the nosological entities designated 
by it, and a set of coding rules which help coders to select the right 
nosological entity from the information present on the death certifi-
cate. Revisions differ in all three respects, although these differen-
ces are sometimes minor. The 6th and 7th Revisions are practically 
identical as far as the code-numbers and the corresponding nosological 
entities are concerned, but rules for coding did change a little. The 
other Revisions each brought about major changes in the structure of 
the list of code-numbers and in the assignment of nosological entities 
to code-numbers; also, some coding rules changed. 
Every analysis of mortality by cause of death covering a 
time-period during which more than one ICD-revision was in force, 
requires a careful consideration of possible changes in classifica-
tion. Before the analyses reported in Chapters I, VI, VIII, IX and X 
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were carried out, a list of causes of death was created, of which the 
nosological content had remained more or less the same during the 
period 1950-84. A number of studies in which a detailed comparison was 
made between two ICD-revisions, mainly carried out in the United 
States, was very helpful in constructing this list [2, 3, 4], although 
changes between Revisions were sometimes different in The Netherlands, 
probably due to other interpretations of coding rules. For each of 
these causes of death, numbers of death were tabled against calendar-
year to check for sudden changes coinciding with the introduction of a 
new ICD-revision. Several modifications were necessary in this stage, 
but the resulting causes of death were reasonably robust against 
changes introduced by new ICD-revisions. Table 1 gives the exact 
specifications. 
Not all the analyses reported in this thesis have been 
performed with the same mortality data-file. Mortality data presented 
in Chapters II, III, IV, V, and VII were drawn from different (inter-
mediate) sources, and sometimes slightly different groupings of code-
numbers have been used. The data of Chapter IV, on secular trends of 
infectious disease mortality, form a special case, because a longer 
time-period had to be covered (1911-1978). Table 2 gives the specifi-
cations for the selection of causes of death used in this analysis. 
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Table 1 ICD-codes used for mortality analysis by cause of death, 1950-1984. 
Cause of death 
Tuberculosis 
Specific bacterial 
infections 
Diphtheria/whooping cough/ 
tetanus/poliomyelitis 
Septicemia 
Viral infections of 
children 
Syphilis 
Cancer of lip and skin 
Cancer of the stomach 
Cancer of the colon 
Cancer of the lung 
Cancer of the breast 
Cancer of the cervix uteri 
Cancer of the prostate 
Cancer of the testis 
Cancer of the kidney 
Morbus Hodgkin 
Leukemia 
Diseases of the thyroid 
Diabetes mellitus 
Pernicious anemia 
Other anemias 
Infections of central 
nervous system 
Rheumatic heart disease 
Hypertensive disease 
Ischemic heart disease 
(Sub)acute endocarditis 
Other heart disease 
Cerebrovascular disease 
Arterial disease 
ICD-6/7 
001-019 
030-039,050-052, 
057 
055,056,061,080, 
081 
053,054,767,768 
085-087,089 
020-029 
140,191 
151 
153 
162,163 
170 
171 
177 
178 
180 
201 
204 
250-254 
260 
290 
291-293 
082,083, 
340-344 
400-416,421 
440-447 
420,422.1 
430 
r422,431-434, 
782.4 
330-334 
450-456 
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ICD-8 
010-019 
098,099,034-036 
032,033,037,040-
044 
038 
052,055,056,057, 
072 
090-097 
140,173 
151 
153 
162,163.0,163.9 
174 
180 
185 
186 
189 
201 
204-207 
240-246 
250 
281 
280,282-285 
ICD-9 
010-018,137 
092,099,034-036 
032,033,037,045, 
138 
038,790.7 '771.8 
052,055,056,057, 
072 
090-097 
140,173 
151 
153 
162,163,165 
174,175 
180 
185 
186 
189 
201 
204-208 
240-246 
250 
281 
280,282-285 
045,046,064-066, 046-049,139.0, 
320-324 320-326 
390-398,424 390-398,424 
400-404 401-405 
410-414 410-414,429.2 
421 421 
420,r(422-426), 416,420,422,423, 
427-429,782.4 425-428,r429 
430-438 430-438 
440-448, 440-448,785.4 
excl. 444.2 
rahle 1 (continued) 
Cause of death 
Infections of respiratory 
system 
Influenza and pneumonia 
Chronic obstructive 
pulmonary disease 
Peptic ulcer 
Appendicitis 
Abdominal hernia 
Ileus w.o. mention of hernia 
Cholelithiasis/-cystitis 
Nephritis/nephrosis 
Infections of the 
urinary system 
Benign prostatic hyperplasia 
Maternal causes: 
Complications of pregnancy 
Complications of delivery 
Complications of puerperium 
Infections of the skin 
Infections of the 
locomotor system 
Congenital cardiovascular 
anomalies 
Congenital digestive 
anomalies 
Perinatal causes: 
Diseases of mother 
Birth injury 
Hemolytic disease of 
newborn 
Other perinatal causes 
ICD-6/7 
390-394, 
470-475,500 
480-483, 
490-493,763 
501,502,526, 
527.1,241 
540-542 
550-553 
560,561 
570,excl.570.2 
584-586 
590-594,603,792 
600,605 
610 
640-649,680 
650-652,660-678 
681-689 
690-698 
720,730 
754 
756 
769 
760,761 
770 
r(760-776) 
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380-384, 
460-466 
470-474, 
480-486 
490-493,518 
531-534 
540-543 
550-553 
560 
574-576 
580-584,593,792 
590,595 
600 
630-639 
640-645,650-662 
670-678 
680-686 
710,720 
746,747 
750,751 
760-763 
764-768,770-772 
774,775 
r(760-779) 
ICD-codes 
ICD-9 
380-385, 
460-466 
487, 
480-486 
490-496 
531-534 
540-543 
550-553 
560 
574-576 
580-589,593 
590,595 
600 
630-633,640-648 
634-639,650-669 
670-676 
680-686 
711,730 
745-747 
750,751 
760 
762,763,767 
773,774 
r(760-779) 
I CD-codes 
Table 1 (continued) 
Cause of death ICD-6/7 ICD-8 ICD-9 
Senility without mention 794 794 797 
of psychosis 
Sudden death 795.2 795 798.0,798.1 
Other ill-defined causes r(780-796) r(780-799), r(780-799), 
286.5,286.6 267-269 > 260-263,578.0, 
excl.269.0 578.1 
Traffic accidents E800-866,960 E800-845,940,941 E800-848,929.0, 
929.1 
Other accidents E900-904,910-929 E880-887,890-909, E880-888,890-909, 
930-936,961,962, 910-929,943-946, 910-928,929.2-.9, 
870-895 980-989, . 980-989 > 
850-877,942 850-869 
r ; remainder of 
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Table 2 ICD-codes for causes of death analysed in Chapter IV. 
--------------------------------------------------------------------------------------
ICD-2 ICD-3* ICD-4 ICD-5 ICD-6 ICD-7 ICD-8 
1911-1920 1921-1930 1931-1940 1941-1949 1950-1957 1958-1968 1969-1978 
-----------------------------------------------------------------·---------------------
Puerperal 137 146 140,145a 140a,b, 651,681 6§1,681 670 
fever 147a,b 
Scarlet 7 8 8 8 050 050 034 
fever 
Rheumatic 47,72 51,81 56,87a 58,87a 400-402 400-402 390-392 
fever 
Erysipelas 18 21 15 11 052 052 035 
Septicemia 20 41 36a,b,c 24a,b,c, 053,063, 053,063, 038 
767 '768 767 '768 
Meningococcal 6lbis Z4 18 6 057 057 036 
meningitis 
Non-meningoc. 61 71 79 8la,b 340 340 320 
meningitis 
Acute 89 99a 106a 106a 500 500 466 
bronchitis 
Pneumonia 91,92 lOO,lOla, 107-109 107-109, 490-493, 480-493, 480-486 
lOlb 763 763 
Otitis media, 76 86 89a,b 89a,b 391-393 391-393 381-383 
mastoiditis 
Upper resp. 86,87, 97,98, 104,105, 104a,b, 470-475, 470-475, 460-465 
infections 99,100 108b,l09 115 105,115 510-516 510-516 500-506 
Influenza 10 11a,b 11a,b 33a,b 480-483 480-483 470-474 
Measles 6 7 7 35 085 085 055 
Pyelo- 122 131 133a 133a 600 600 590 
nephritis 
Cystitis 124 133 135a 135a 605 605 595 
Skin/subcut. 142-144 151-153 151,152 151,152 690-693 690-693 680-682 
infections 
Osteomyelitis 146 156 154 154a,b,c .730 730 720 
Syphilis 37,62,67 38,72,76 34,80, 30 020-029 020-029 090-097 
83,96 
--------------------------------------------------------------------------------------
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Iable 2 (continued) 
ICD-2 ICD-3* ICD-4 ICD-5 ICD-6 ICD-7 ICD-8 
1911-1920 1921-1930 1931-1940 1941-1949 1950-1957 1958-1968 1969-1978 
--------------------------------------------------------------------------------------
Tuberculosis 28-35 31-37 23-32 13-22 001-019 001-019 010-019 
Bacillary 14 16b,c 13b,c 27a,c 045,048 045,048 004 
dysentery 
Typhoid fever, 1 la,b,c 1,2a,b 1,2a,b,c 040,041 040,041 001,002 
paratyph. fever 
All other all all all all all all all 
diseases other other other other other other other 
* In the period 1922-1924 a slightly different classification was used in The Nether-
lands. 
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Annex 2 
Short bibliography on causes of death selected for analysis in 
Chapter VI 
Introduction 
This short annotated bibliography is presented as background material 1 
to table VI.l in chapter VI. This table contains a selection of causes 
of death which have become amenable to medical intervention, and which 
have been used in the time trend analysis. For each of these condi-
tions references will be given to literature which describes favour-
able incidence or case fatality effects of medical care innovations. 
The bibliography also includes references to literature providing 
evidence on "spontaneous" changes in incidence or case fatality. 
As others have noted before, available evidence on the 
efficacy and effectiveness of specific medical intervention can be 
characterized as scarce and therefore incomplete, and more often than 
not as methodologically questionable. Methodological problems include 
the following: 
- Most studies are observational, with at best a historical or contem-
porary reference gr?UP of dubious comparability with the study-
group. 
- Many studies use selected patient groups (e.g. hospital patients), 
rendering difficult the necessary extrapolation from "efficacy" to 
"effectiveness" at population level. 
- Many studies employ a fragmentary outcome measure, such as post-
operative or hospital mortality. 
As no other comprehensive bibliography on this subject 
exists (cf. the absent or cursory justification of comparable selec-
tions of conditions in references 1-6), this compilation of evidence 
is not much more than a first attempt. Further study is certainly 
necessary, for example employing formal synthesis methods. 
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Specific medical therapies (group I) 
In the period 1920-1945 a number of efficacious drugs was introduced, 
affecting case fatality of several endocrine and hemopoietic disorders 
[7]. In the first decennia after the introduction of insulin in 1922 
case fatality of Diabetes mellitus appeared to decline considerably, 
especially among younger patients; this decline continued during the 
1950's [8]. The introduction of liver therapy for Pernicious anemia in 
1927 was followed immediately by moderate reductions in mortality in 
many countries [9]. Antithyroid drugs and radioiodine treatment were 
introduced in the years immediately following World War II. Treatment 
of deficiency anemias may have improved by the systematic application 
of substitution therapies. 
Improvements in surgery and anesthesia (group II) 
There has been a wide range of improvements in surgery and anesthesia, 
facilitating progress in the treatment of a number of specific 
diseases. The introduction of antibiotics (group IV) may have contri-
buted also. The start of this series of major improvements has arbi-
trarily been fixed at 1930 in table VI.l, when intravenous fluid 
therapy was introduced. 
Reviews of studies on bleeding Peptic ulcer show reductions 
in case fatality since the 1940's [10, 11]. Continuing reductions in 
case fatality of Appendicitis, starting in the 1930's, have been 
reported from many centres [14-17]. The same applies to acute Chole-
cystitis, and non-malignant biliary tract disease in general [21-23]. 
Although elective hernioplasties will have become safer as part of the 
general trend, developments of case fatality of strangulated hernia 
are less clear [24]. Case fatality in intestinal obstruction (ileus) 
appears to have decreased since the 1940's, according to a review of 
the literature [25]-. This also applies to specific subgroups like 
Gallstone ileus [25] and Intussusception [26], a cause of ileus in 
infants. Case fatality in prostatectomy for Benign prostatic hyper-
plasia has fallen too [28]. Part of this could be due to a shift from 
suprapubic and other surgical approaches to transurethral resection, 
but case fatality has fallen for each of these procedures separately 
too [29, 30]. 
There have been reports from several countries on declining 
incidence of Peptic ulcer, especially Duodenal ulcer, mainly based on 
hospital admission data [12, 13]. The same applies to acute Appendici-
tis [18-20]. Probably the incidence of ileus due to peritoneal adhe-
sions has risen [25, 27]. 
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Improvements in antenatal and perinatal care (group III) 
Gradual improvements of antenatal and obstetric care probably started 
in the first decennia of this century, but it was not until the 1930's 
that Maternal mortality started to decline substantially [31]. Part of 
this advance has been ascribed to improvements in antenatal and obste-
tric care, resulting from the movement for a safe maternity [32], 
like systematic antenatal checkups and screening, improved standard of 
obstetric care, an increasing proportion of hospital deliveries, and 
the introduction of a number of specific technologies. Important among 
these were blood transfusions, antibiotics, and cesarian section [31, 
33, 34]. 
Substantial declines in Perinatal mortality started around 
1940 [31, 35]. This decline may in part be due to the same factors as 
the decline in maternal mortality. Reports from several countries 
indicate that mortality decline accelerated in the late 1960's 
(figures corrected for changes in age and parity distributions of 
mothers, and for birth weight) [36, 37]. This development approximate-
ly coincided with the introduction of neonatal intensive care. Reviews 
of the experience of centres where neonatal intensive care was intro-
duced suggest significant improvements of survival among low birth 
weight infants [38]. Control of Hemolytic disease of the newborn by 
improved treatment and prevention (anti-D immunoglobulin was intro-
duced around 1970), probably had a moderate separate effect on Perina-
tal mortality [40]. 
Other influences have also had a lowering effect upon both 
Maternal and Perinatal mortality during the study period. The most 
notable among these have been changes in age and parity distributions 
of mothers [33, 39]. 
Chemotherapeutics and antibiotics (group IV) 
In the Netherlands, sulphonamides were introduced in 1936, penicillin 
in 1944 (but availability was very limited before 1947), and strepto-
mycin in 1947. Effects were probably substantial in a wide range of 
infectious diseases. Both sulphonamides and penicillin appeared to 
reduce case fatality in Pneumonia [44, 45]. A randomized controlled 
trial proved the efficacy of streptomycin in reducing case fatality in 
Tuberculosis [41]. Chemoprophylaxis in contacts is effective in 
preventing Tuberculosis [42]. Case fatality of Septicemia went down 
during the 1940's in a hospital population [46]. 
Other improvements in medical care may have contributed also 
to a decline in Tuberculosis mortality, e.g. the introduction of mass 
screening by radiography in 1949. During the study period, incidence 
of Tuberculosis declined due to a number of factors, including pasteu-
rization of milk and other public health measures, and the ever 
smaller number of infectious hosts (itself resulting from reductions 
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in incidence, already apparent before World War II) [43]. 
There have been suggestions of increasing incidence of Py-
elonephritis, possibly due to increased intake of analgesics [47]. 
Surgical repair of certain congenital anomalies (group V) 
Case fatality of Oesophageal atresia, an important congenital anomaly 
of the digestive system, was reduced when direct anastomosis proved 
successful in the late 1940's [48]. 
Except for Patent ductus arteriosus, for which surgical 
therapy became available in the 1940's [49], relatively safe pallia-
tive and definitive surgical treatments for Congenital anomalies of 
heart and great vessels were gradually introduced in the 1950's and 
1960's. Reports on survival are mainly limited to early postoperative 
survival which has clearly improved for many procedures [50, 51]. 
Prophylaxis and surgical treatment of heart valve disease 
(group VI) 
Several trials have shown that treatment with antibiotics of strepto-
coccal infections prevents Acute rheumatic fever [52], and that pro-
phylactic administration of antibiotics after a first attack of rheu-
matic fever prevents recurrences [53]. Introduction of these proce-
dures was around 1950. 
valvotomy 
Stated in 
in 1961, 
mortality 
The first surgical treatment of heart valve disease was 
for mitral stenosis, which was introduced in the United 
1948 [54]. The first mitral valve prosthesis was implanted 
and the first aortic valve prosthesis in 1963 [55]. Early 
appears to have decreased considerably [55]. 
Rheumatic heart disease mortality started to decline in the 
1930's, which has been ascribed to a change in character of strepto-
cocci [56]. As there is an association between crowding and incidence 
of rheumatic fever, the decline in incidence has also been attributed 
to improved housing conditions. 
Mass vaccination (group VII) 
Mass vaccination against Diphtheria, Whooping cough, Tetanus and 
Smallpox was introduced in the Netherlands in 1953. Poliomyelitis was 
added to the regimen in 1957. Vaccination campaigns have reduced 
incidence and mortality from these diseases in many countries [56-58]. 
Mortality from Diphtheria and Whooping cough was already 
declining during the first half of this century, which has been 
ascribed to improvements in living conditions and, for Diphtheria, 
possibly the introduction of antitoxin [56]. 
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Hemodialysis (group VIII) 
After small-scale applications during the 1940 1 s and 1950's hemodialy-
sis became accepted therapy for end-stage renal disease in the 1960's. 
There has been an exponential rise in the dialysis population since 
then due to liberal financing and extension of treatment to patient 
groups like diabetics who formerly were excluded. Three-year survival 
is above 50% in many patient series [59-61]. These patients would 
otherwise have had a very poor prognosis [62]. 
Before hemodialysis the introduction of corticosteroids in 
the 1950 1 s may have prolonged survival in childhood nephrosis. Kidney 
transplantation has had a more limited use than hemodialysis; survival 
rates are comparable and probably improving. 
Mortality from Nephritis and nephrosis declines since the 
1930 1 s. As this condition is believed to frequently be a sequel to 
streptococcal and other infections, just as Rheumatic heart disease 
which shows the same decline, the decline in mortality has been attri-
buted to a change in character of the infectious agent(s) [56]. 
Hypertension detection and treatment (group IX) 
The first antihypertensive drugs were introduced in the 1950's, but by 
1960 a number of effective drugs was in use [63]. Systematic blood 
pressure control by casefinding and subsequent treatment started in 
the 1970's. Several trials have shown the effectiveness of hyperten-
sion control in reducing case fatality, especially that due to Cere-
brovascular accidents [64-67]. Incidence of stroke, especially due to 
hemorrhage, appears to have declined subsequently [68]. 
Mortality due to Hypertensive disease and Cerebrovascular 
disease has been declining since 1940 [63], so other factors than 
improved medical care must also have been involved. 
Improvements in cancer treatment (a.o. combination chemothe-
rapy )(group X) 
Cancer of the skin, other than melanoma, is a mild form of cancer, 
which can be treated effectively, if diagnosed in time, by surgery 
and/or radiotherapy [69]. Adequate treatment methods have been availa-
ble for a longer period, and survival has been improving since the 
1950's [70]. 
Successful treatment of Wilm 1 s tumour, a cancer of the 
kidney which occurs in children, was already possible before 1970 with 
surgery, radiotherapy and Actinomycin D [73]. 
Intensive radiotherapy and combination chemotherapy led to 
the sucessful treatment of Hodgkin's disease, starting around 1970 
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[75, 76). Combination chemotherapy was also an important breakthrough 
for Cancer of the testis [77, 78] and for Acute lymphocytic leukemia, 
an important cancer in children [80, 81). For all these forms of 
cancer, survival has improved dramatically [74). 
Incidence of Cancer of the skin appears to be increasing 
[71, 72], just as the incidence of Cancer of the testis [71, 79). 
Mass screening for cancer of cervix uteri (group XI) 
Mass screening with cervical smears in the Netherlands 
started in 1976. It has been shown to have reduced the incidence of 
invasive cancer and mortality from Cervical cancer in many countries 
[82, 83, 84). 
::·--~·{::.· 
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